Processing 00000000.tx.1: Receptor for Advanced Glycation End Products (RAGE) Signaling Induces CREB-dependent Chromogranin Expression during Neuronal Differentiation* Henri J. 

Phrase: "Receptor for Advanced Glycation End Products (RAGE)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   716   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]

Phrase: "Signaling"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0037083:Signaling [Cell Function]
  1000   C3537152:signaling [Biologic Function]
   966 E C1710082:Signal [Phenomenon or Process]

Phrase: "Induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "CREB-dependent Chromogranin Expression during Neuronal Differentiation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   751   C1171362:expression protein [Genetic Function]
   736   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "* Henri J."
Processing 00000000.tx.2: Huttunen, Juha Kuja-Panula, and Heikki Rauvala From the Programme of Molecular Neurobiology, Institute of Biotechnology and the Department of Biosciences, University of Helsinki, Helsinki FIN-00014, Finland Received for publication, March 15,2002, and in revised form, August 6,2002  ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES Receptor for advanced glycation end products (RAGE) mediates neurite outgrowth and cell migration upon stimulation with its ligand, amphoterin. 

Phrase: "Huttunen,"

Phrase: "Juha Kuja-Panula,"

Phrase: "and"

Phrase: "Heikki Rauvala From the Programme of Molecular Neurobiology,"

Phrase: "Institute of Biotechnology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0021622:institute [Organization]
   790   C1272753:Institute [Idea or Concept]

Phrase: "and"

Phrase: "the Department of Biosciences,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704729:Department [Organization]

Phrase: "University of Helsinki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Helsinki FIN-00014,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0230113:Fin [Body Part, Organ, or Organ Component]

Phrase: "Finland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016132:Finland [Geographic Area]

Phrase: "Received for publication,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034036:Publication [Intellectual Product,Manufactured Object]
   790   C0034037:Publication [Occupational Activity]
   790   C1514756:Received [Qualitative Concept]
   790   C1704324:Publication [Intellectual Product]

Phrase: "March 15,"

Phrase: "2002,"

Phrase: "and in revised form,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1515981:And [Idea or Concept]
   770   C1522492:Form [Functional Concept]
   770   C1527075:Revised [Therapeutic or Preventive Procedure]

Phrase: "August 6,"

Phrase: "2002  ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Receptor for advanced glycation end products"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   716   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]

Phrase: "(RAGE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   716   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]

Phrase: ")"

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "neurite outgrowth"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3158384:neurite outgrowth [Cell Function]
   861   C0085103:Neurite [Cell Component]

Phrase: "and"

Phrase: "cell migration upon stimulation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1622501:Migration, Cell [Cell Function]
   770   C0600210:Migration [Social Behavior]
   770   C1533574:Migration [Physiologic Function]
   770   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "with its ligand,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023688:Ligand [Chemical]

Phrase: "amphoterin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0019796:Amphoterin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1333908:AMPHOTERIN [Gene or Genome]
Processing 00000000.tx.3: We show here that RAGE-dependent changes in cell morphology are associated with proliferation arrest and changes in gene expression in neuroblastoma cells. 

Phrase: "We"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "here"

Phrase: "that RAGE-dependent changes in cell morphology"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   751   C1514760:Receptor Cell [Cell]
   736   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "are"

Phrase: "associated with proliferation arrest"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0237477:Arrest [Temporal Concept]
   770   C0334094:Proliferation [Pathologic Function]
   770   C0392351:arrest [Governmental or Regulatory Activity]
   770   C1514485:Proliferation [Functional Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "changes in gene expression"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0017262:Gene Expression [Genetic Function]
   770   C0017337:Gene [Gene or Genome]
   770   C0185117:Expression [Therapeutic or Preventive Procedure]
   770   C0392747:Change [Functional Concept]
   770   C0443172:change [Quantitative Concept]
   770   C1705241:Change [Quantitative Concept]

Phrase: "in neuroblastoma cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C0815000:neuroblastoma cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.4: Chromogranin B, a component of secretory vesicles in endocrine cells and neurons, was found to be up-regulated by RAGE signaling during differentiation of neuroblastoma cells along with the two other members of the chromogranin family, chromogranin A and secretogranin II. 

Phrase: "Chromogranin B,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0055635:chromogranin B [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332755:CHROMOGRANIN B [Gene or Genome]
   861   C0008586:Chromogranin [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "a component of secretory vesicles"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0036538:Secretory Component [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   760   C0449432:Component [Manufactured Object]
   760   C1705248:Component [Conceptual Entity]

Phrase: "in endocrine cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0229525:Endocrine Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0014136:Endocrine [Body System]
   861   C0521425:Endocrine [Functional Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "neurons,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "up-regulated by RAGE"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   882   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   818   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   762   C3242459:regulated products [Intellectual Product]
   745 E C1552022:regulated product [Idea or Concept]
   742   C0205179:Advanced [Qualitative Concept]
   742   C0444930:End [Spatial Concept]
   742   C0547043:Up [Spatial Concept]
   742   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   742   C0598528:glycation [Phenomenon or Process]
   742   C0851285:Regulated [Governmental or Regulatory Activity]
   742   C1282911:Up [Spatial Concept]
   742   C1514468:Products [Entity]
   742   C2746065:End [Temporal Concept]
   708 E C0725066:Advance [Medical Device]
   708 E C1704444:Product [Quantitative Concept]

Phrase: "signaling during differentiation of neuroblastoma cells"
Meta Candidates (Total=17; Excluded=4; Pruned=0; Remaining=13)
   783   C0007589:cells differentiation [Cell Function]
           Differentiation
   773   C0815000:neuroblastoma cell [Cell]
   767   C0037083:Cell Signaling [Cell Function]
           Signaling
   753   C0007634:Cells [Cell]
   753   C0027819:Neuroblastoma [Neoplastic Process]
   753   C0700095:neuroblastoma [Neoplastic Process]
   753   C1511938:Differentiation [Clinical Attribute]
   753   C2945687:Differentiation [Functional Concept]
   753   C3282337:Cells [Cell]
   753   C3537152:signaling [Biologic Function]
   753   C3540583:Neuroblastoma [Intellectual Product]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1710082:Signal [Phenomenon or Process]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "along with the two"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205448:Two [Quantitative Concept]

Phrase: "other members of the chromogranin family,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   783   C0086282:Family Members [Family Group]
   767 E C1611821:Family Member [Intellectual Product]
   753   C0680022:members [Population Group]
   719 E C2698041:Member [Professional or Occupational Group]

Phrase: "chromogranin A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0055633:Chromogranin A [Amino Acid, Peptide, or Protein,Hormone,Indicator, Reagent, or Diagnostic Aid]
  1000   C1332754:CHROMOGRANIN A [Gene or Genome]
   861   C0008586:Chromogranin [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "and"

Phrase: "secretogranin II."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0055637:Secretogranin II [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1335805:SECRETOGRANIN II [Gene or Genome]
Processing 00000000.tx.5: Ligation of RAGE by amphoterin lead to rapid phosphorylation and nuclear localization of cyclic AMP response element-binding protein (CREB), a major regulator of chromogranin expression. 

Phrase: "Ligation of RAGE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0023690:Ligation [Therapeutic or Preventive Procedure]
   743   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]

Phrase: "by amphoterin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0019796:Amphoterin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1333908:AMPHOTERIN [Gene or Genome]

Phrase: "lead to rapid phosphorylation"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C0031715:Phosphorylation [Molecular Function]
   770   C0439831:Rapid [Qualitative Concept]
   770   C1158886:Phosphorylation [Molecular Function]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1522538:Lead [Functional Concept]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "nuclear localization of cyclic AMP response element-binding protein (CREB),"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   762   C0597704:protein localisation [Cell Function]
   762   C1159772:Protein Localization [Cell Function]
   742   C0475264:Localisation [Functional Concept]
   742   C1744691:localisation [Biologic Function]
   716   C0056695:Cyclic AMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "a major regulator of chromogranin expression."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0182953:REGULATOR [Medical Device]
   753   C1704734:Regulator [Medical Device]
   753   C1704735:Regulator [Conceptual Entity]
Processing 00000000.tx.6: Furthermore, inhibition of ERK1/2-Rsk2-dependent CREB phosphorylation efficiently inhibited up-regulation of chromogranin gene expression upon RAGE activation. 

Phrase: "Furthermore,"

Phrase: "inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0021467:Inhibition [Mental Process]
  1000   C0021469:Inhibition [Molecular Function]
  1000   C1628982:% inhibition [Quantitative Concept]
  1000   C3463820:Inhibition [Activity]
   928 E C0311403:Inhibited [Qualitative Concept]

Phrase: "of ERK1/2-Rsk2-dependent CREB phosphorylation efficiently"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   820   C1157225:AMP phosphorylation [Molecular Function]
   793   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   785   C0031715:Phosphorylation [Molecular Function]
   709   C1333498:Extracellular Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "up-regulation of chromogranin gene expression"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   858   C0017263:Regulation of Gene Expression [Genetic Function]
           Gene Expression Regulation
           Gene Regulation
   790   C0041904:Up-Regulation [Cell Function,Molecular Function]
   790   C0162493:Up-Regulation [Genetic Function]
   753   C0547043:Up [Spatial Concept]
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1282911:Up [Spatial Concept]
   753   C1327622:Regulation [Biologic Function]

Phrase: "upon RAGE activation."
Meta Candidates (Total=16; Excluded=5; Pruned=0; Remaining=11)
   923   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   878   C1514758:Receptor Activation [Cell Function]
   861   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   793   C0205179:Advanced [Qualitative Concept]
   793   C0444930:End [Spatial Concept]
   793   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   793   C0598528:glycation [Phenomenon or Process]
   793   C1514468:Products [Entity]
   793   C1720176:Upon [Functional Concept]
   793   C1879547:Activation [Activity]
   793   C2746065:End [Temporal Concept]
   760 E C0725066:Advance [Medical Device]
   760 E C1704444:Product [Quantitative Concept]
   737 E C0205088:Terminal [Temporal Concept]
   737 E C1705314:Terminal [Manufactured Object]
   737 E C1705315:Terminal [Spatial Concept]
Processing 00000000.tx.7: To further study the effects of RAGE and amphoterin on cellular differentiation, we stimulated embryonic stem cells expressing RAGE or a signaling-deficient mutant of RAGE with amphoterin. 

Phrase: "To further"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1517331:Further [Spatial Concept]
   861   C1883351:To [Qualitative Concept]
   827 E C0205108:far [Spatial Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "the effects of RAGE"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   882   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   818   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   742   C0205179:Advanced [Qualitative Concept]
   742   C0444930:End [Spatial Concept]
   742   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   742   C0598528:glycation [Phenomenon or Process]
   742   C1280500:effects [Qualitative Concept]
   742   C1514468:Products [Entity]
   742   C2746065:End [Temporal Concept]
   708 E C0725066:Advance [Medical Device]
   708 E C1704444:Product [Quantitative Concept]
   708 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "amphoterin on cellular differentiation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0019796:Amphoterin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1333908:AMPHOTERIN [Gene or Genome]

Phrase: "we"

Phrase: "stimulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "embryonic stem cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
  1000   C0596508:Embryonic Stem Cells [Cell]
   901   C0038250:Stem cells [Cell]
   896   C1947950:Embryonic Cell [Embryonic Structure]
   827   C0007634:Cells [Cell]
   827   C0013935:Embryonic [Embryonic Structure]
   827   C0242767:Stem [Plant]
   827   C1186763:Stem [Body Part, Organ, or Organ Component]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "RAGE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   716   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]

Phrase: "or"

Phrase: "a signaling-deficient mutant of RAGE"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   846   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   797   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   754   C1514762:Receptor Signaling [Molecular Function]
   738   C0011155:Deficient [Functional Concept]
   738   C0037083:Signaling [Cell Function]
   738   C0205179:Advanced [Qualitative Concept]
   738   C0444930:End [Spatial Concept]
   738   C0596988:Mutant [Cell or Molecular Dysfunction]
   738   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   738   C0598528:glycation [Phenomenon or Process]
   738   C1514468:Products [Entity]
   738   C1636779:% deficient [Quantitative Concept]
   738   C2746065:End [Temporal Concept]
   738   C3537152:signaling [Biologic Function]
   704 E C0725066:Advance [Medical Device]
   704 E C1704444:Product [Quantitative Concept]

Phrase: "with amphoterin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0019796:Amphoterin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1333908:AMPHOTERIN [Gene or Genome]
Processing 00000000.tx.8: Amphoterin was found to promote RAGE-dependent neuronal differentiation of embryonic stem cells characterized by up-regulation of neuronal markers light neurofilament protein and -III-tubulin, activation of CREB, and increased expression of chromogranins A and B.

Phrase: "Amphoterin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0019796:Amphoterin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1333908:AMPHOTERIN [Gene or Genome]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "RAGE-dependent neuronal differentiation of embryonic stem cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   822   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   749   C2325760:Neuronal receptor [Cell Component]
   735   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   732   C1514760:Receptor Cell [Cell]

Phrase: "characterized by up-regulation of neuronal markers light neurofilament protein"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   782   C0068590:light neurofilament protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0085418:Neurofilament protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C0670902:LIGHT Protein [Amino Acid, Peptide, or Protein,Immunologic Factor]
   739   C0023693:Light [Natural Phenomenon or Process]
   739   C0027834:Neurofilament [Cell Component]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0521390:Neuronal [Immunologic Factor]
   739   C0851285:Regulation [Governmental or Regulatory Activity]
   739   C1306462:Light [Functional Concept]
   739   C1327622:Regulation [Biologic Function]
   739   C1880022:Characterized [Activity]
   739   C1881376:Light [Qualitative Concept]
   706   C0005516:Marker [Clinical Attribute]

Phrase: "and -"

Phrase: "III-tubulin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2937342:tubulin [Cell Component]

Phrase: "activation of CREB,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   815   C2245434:activation of protein binding [Molecular Function]
   793   C2259194:activation of binding [Molecular Function]
   767   C0599177:protein activation [Genetic Function]
   744   C1879547:Activation [Activity]
   743   C0056695:Cyclic AMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   703   C3158668:cyclic-AMP response element binding [Genetic Function]

Phrase: "and"

Phrase: "increased expression of chromogranins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "A"

Phrase: "and"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.9: These data suggest that RAGE signaling is capable of driving neuronal differentiation involving CREB activation and induction of chromogranin expression.  

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that RAGE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   946   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "signaling"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0037083:Signaling [Cell Function]
  1000   C3537152:signaling [Biologic Function]
   966 E C1710082:Signal [Phenomenon or Process]

Phrase: "is"

Phrase: "capable of driving neuronal differentiation"

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "CREB activation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   818   C0599177:protein activation [Genetic Function]
   795   C1879547:Activation [Activity]
   787   C0056695:Cyclic AMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   747   C3158668:cyclic-AMP response element binding [Genetic Function]
   710   C1511573:Cyclic AMP Response Element [Gene or Genome]
   701   C1148918:cyclic AMP binding [Molecular Function]

Phrase: "and"

Phrase: "induction of chromogranin expression."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205263:Induction [Functional Concept]
   770   C0857127:induction [Therapeutic or Preventive Procedure]
Processing 00000000.tx.10: INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES Receptor for advanced glycation end products (RAGE),1 a member of the immunoglobulin superfamily of cell surface proteins (1), interacts with a range of ligands leading to diverse cellular responses varying from cytokine secretion and increased cellular oxidant stress to neurite outgrowth and cell migration (for recent reviews, see Refs. 2-4). 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Receptor for advanced glycation end products"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   716   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]

Phrase: "(RAGE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   716   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]

Phrase: ")"

Phrase: ","

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "a member of the immunoglobulin superfamily of cell surface proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0680022:member [Population Group]
   739   C2698041:Member [Professional or Occupational Group]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "interacts with a range of ligands"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0023688:Ligands [Chemical]
   753   C1514721:Range [Quantitative Concept]
   753   C2348147:Range [Quantitative Concept]
   753   C3542016:Range [Intellectual Product]

Phrase: "leading to diverse cellular responses"
Meta Candidates (Total=13; Excluded=7; Pruned=0; Remaining=6)
   760   C0007634:Cellular [Cell]
   760   C0178539:Cellular [Functional Concept]
   760   C0332152:Leading [Temporal Concept]
   760   C0871261:responses [Organism Attribute]
   760   C1522538:Leading [Functional Concept]
   760   C1880371:Diverse [Qualitative Concept]
   726 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   726 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   726 E C1704632:Response [Finding]
   726 E C1706817:Response [Intellectual Product]
   726 E C2348269:Lead [Element, Ion, or Isotope]
   726 E C2911692:Response [Mental Process]
   726 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "varying from cytokine secretion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1327414:cytokine secretion [Cell Function]
   770   C0036536:secretion [Biologic Function]
   770   C0036537:Secretion [Body Substance]
   770   C0079189:cytokine [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "increased cellular oxidant stress to neurite outgrowth"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0231298:Increased stress [Functional Concept]
   774   C1516373:Cellular Stress [Cell or Molecular Dysfunction]
   748   C0038435:Stress [Finding]

Phrase: "and"

Phrase: "cell migration"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1622501:Migration, Cell [Cell Function]
   861   C0600210:Migration [Social Behavior]
   861   C1533574:Migration [Physiologic Function]
   861   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "("

Phrase: "for recent reviews,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0282443:reviews [Intellectual Product]
   827 E C1552617:Review [Idea or Concept]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Refs. 2-4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1425988:REF [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.11: Many of these responses are dependent of RAGE-mediated signal transduction and altered gene expression. 

Phrase: "Many of these responses"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0439064:Many [Quantitative Concept]
   770   C0747726:many [Conceptual Entity]
   770   C0871261:responses [Organism Attribute]
   737 E C1704632:Response [Finding]
   737 E C1706817:Response [Intellectual Product]
   737 E C2911692:Response [Mental Process]

Phrase: "are"

Phrase: "dependent of RAGE-mediated signal transduction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   738   C0851827:Dependent [Qualitative Concept]
   738   C1701901:Dependent [Qualitative Concept]
   738   C3244310:dependent [Functional Concept]

Phrase: "and"

Phrase: "altered gene expression."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0017262:Gene Expression [Genetic Function]
   827   C0017337:Gene [Gene or Genome]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.12: Ligation of RAGE has been shown to activate multiple signaling pathways, including Ras-extracellular signal-regulated kinase 1/2 (ERK1/2) (5), Cdc42/Rac (6), stress-activated protein kinase/c-Jun-NH2-terminal kinase (SAPK/JNK) and p38 MAP kinase pathways (7) culminating in increased DNA-binding activity of the transcription factors NF-B (8) and Sp1 (9). 

Phrase: "Ligation of RAGE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0023690:Ligation [Therapeutic or Preventive Procedure]
   743   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "multiple signaling pathways,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   884   C0037080:Signal Pathways [Molecular Function]
   884   C0037083:signaling pathway [Cell Function]
   884   C0086982:Signaling Pathway [Molecular Function]
   827   C1704259:Pathways [Molecular Function]
   827   C1705987:Pathways [Conceptual Entity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "Ras-extracellular signal-regulated kinase 1/2 (ERK1/2)"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   913   C0082529:Extracellular Signal-Regulated Kinase 1 [Amino Acid, Peptide, or Protein,Enzyme]
   913   C1366765:EXTRACELLULAR SIGNAL-REGULATED KINASE 1 [Gene or Genome]
   911   C0170168:Extracellular Signal-Regulated Kinase 2 [Amino Acid, Peptide, or Protein,Enzyme]
   911   C1366882:EXTRACELLULAR SIGNAL-REGULATED KINASE 2 [Gene or Genome]
   856   C0600388:Extracellular Signal Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   856   C0752312:Extracellular Signal-Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0034678:RAS [Gene or Genome]
   795   C0521119:Extracellular [Cell Component]
   795   C0851285:Regulated [Governmental or Regulatory Activity]
   795   C1710082:Signal [Phenomenon or Process]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "Cdc42/Rac (6"

Phrase: ")"

Phrase: ","

Phrase: "stress-activated protein kinase/c-Jun-NH2-terminal kinase (SAPK/JNK)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   877   C1259877:protein kinase C kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "p38 MAP kinase pathways"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C3179232:p38 Kinase Pathways [Cell Function,Molecular Function]
   812   C1704259:Pathways [Molecular Function]
   812   C1705987:Pathways [Conceptual Entity]
   756   C0257535:p38 map kinase [Amino Acid, Peptide, or Protein,Enzyme]
   756   C1120843:p38 MAP Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(7"

Phrase: ")"

Phrase: "culminating in increased DNA-binding activity"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   790   C1148673:DNA Binding [Genetic Function]
   790   C2266866:Binding Activity [Molecular Function]
   783   C0474395:increased activity [Finding]
   753   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0205177:Activity [Functional Concept]
   753   C0205217:Increased [Quantitative Concept]
   753   C0205260:Culminating [Qualitative Concept]
   753   C0243122:binding [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C0442805:Increased [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "of the transcription factors NF-B (8"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   894   C1420645:TRANSCRIPTION FACTOR 8 [Gene or Genome]
   894   C3537279:Transcription Factor 8 [Amino Acid, Peptide, or Protein]
   840   C0040648:Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   836   C0033453:Factor B [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   836   C1824728:FACTOR B [Gene or Genome]
   804   C0040649:Transcription [Genetic Function]
   771   C1521761:Factor [Functional Concept]
   771   C2827422:Factor [Conceptual Entity]

Phrase: ")"

Phrase: "and"

Phrase: "Sp1"

Phrase: "(9"

Phrase: ")."
Processing 00000000.tx.13: Several gene targets up-regulated upon activation of RAGE signaling pathways have been identified. 

Phrase: "Several gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "targets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1521840:Target [Functional Concept]
  1000   C2986546:TARGET [Diagnostic Procedure]

Phrase: "up-regulated upon activation of RAGE"
Meta Candidates (Total=18; Excluded=3; Pruned=0; Remaining=15)
   846   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   797   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   754   C1514758:Receptor Activation [Cell Function]
   754   C3242459:regulated products [Intellectual Product]
   738   C0205179:Advanced [Qualitative Concept]
   738   C0444930:End [Spatial Concept]
   738   C0547043:Up [Spatial Concept]
   738   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   738   C0598528:glycation [Phenomenon or Process]
   738   C0851285:Regulated [Governmental or Regulatory Activity]
   738   C1282911:Up [Spatial Concept]
   738   C1514468:Products [Entity]
   738   C1879547:Activation [Activity]
   738   C2746065:End [Temporal Concept]
   737   C0596035:activation product [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   737 E C1552022:regulated product [Idea or Concept]
   704 E C0725066:Advance [Medical Device]
   704 E C1704444:Product [Quantitative Concept]

Phrase: "signaling"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0037083:Signaling [Cell Function]
  1000   C3537152:signaling [Biologic Function]
   966 E C1710082:Signal [Phenomenon or Process]

Phrase: "pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704259:Pathways [Molecular Function]
  1000   C1705987:Pathways [Conceptual Entity]

Phrase: "have"

Phrase: "been"

Phrase: "identified."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]
Processing 00000000.tx.14: These include interleukin-6 (10), vascular cell adhesion molecule-1 (11), macrophage-colony stimulating factor) (12), tissue factor (13), and Bcl-2 (14), many of which are related to the role of RAGE in inflammation and accelerated atherosclerosis in diabetes. 

Phrase: "These"

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "interleukin-6"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021760:Interleukin-6 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1527132:interleukin 6 [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(10"

Phrase: ")"

Phrase: ","

Phrase: "vascular cell adhesion molecule-1"
Meta Candidates (Total=26; Excluded=8; Pruned=0; Remaining=18)
  1000   C0078056:Vascular Cell Adhesion Molecule-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Vascular Cell Adhesion Molecule
  1000   C1421435:VASCULAR CELL ADHESION MOLECULE 1 [Gene or Genome]
   937   C1416373:cell adhesion molecule 1 [Gene or Genome]
   884   C0007578:Cell adhesion molecule [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Adhesion Molecule
   840   C0007577:Cell Adhesion [Cell Function]
   804   C0001511:Adhesion [Pathologic Function]
   804   C0005847:vascular [Body Part, Organ, or Organ Component]
   804   C0007634:Cell [Cell]
   804   C0175633:Adhesion [Natural Phenomenon or Process]
   804   C0567416:Molecule [Substance]
   804   C1269647:Cell [Cell]
   804   C1558950:VASCULAR [Finding]
   804   C1704653:Cell [Medical Device]
   804   C1801960:Vascular [Qualitative Concept]
   804   C1948049:Cell [Spatial Concept]
   798   C2328697:Hemal cell [Cell]
   790 E C0005773:Blood cell [Cell]
   748 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   748 E C1511228:VESSEL, BLOOD [Tissue]
   733 E C1521991:Molecular [Qualitative Concept]
   704 E C0005767:Blood [Tissue]
   704 E C0005768:blood [Body Substance]
   704 E C0229664:Blood [Body Substance]
   704 E C0392895:Bloods [Population Group]

Phrase: "(11"

Phrase: ")"

Phrase: ","

Phrase: "macrophage-colony stimulating factor"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0079784:Macrophage Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1524095:macrophage colony-stimulating factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   923   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0024432:macrophage [Cell]
   812   C0439158:colony [Quantitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C1947989:Colony [Cell]
   812   C1948023:Stimulating [Natural Phenomenon or Process]
   812   C2827422:Factor [Conceptual Entity]

Phrase: ")"

Phrase: "(12"

Phrase: ")"

Phrase: ","

Phrase: "tissue factor"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0040048:Tissue Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1333522:TISSUE FACTOR [Gene or Genome]
   861   C0040300:Tissue [Tissue]
   861   C1521761:Factor [Functional Concept]
   861   C1547928:Tissue [Intellectual Product]
   861   C2827422:Factor [Conceptual Entity]

Phrase: "(13"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "Bcl-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0376515:Bcl-2 [Gene or Genome]

Phrase: "(14"

Phrase: ")"

Phrase: ","

Phrase: "many of which"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0439064:Many [Quantitative Concept]
   790   C0747726:many [Conceptual Entity]

Phrase: "are"

Phrase: "related to the role of RAGE"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   846   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   797   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   738   C0035820:Role [Social Behavior]
   738   C0205179:Advanced [Qualitative Concept]
   738   C0439849:Related [Qualitative Concept]
   738   C0444930:End [Spatial Concept]
   738   C0445223:Related [Finding]
   738   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   738   C0598528:glycation [Phenomenon or Process]
   738   C1514468:Products [Entity]
   738   C1705810:Role [Conceptual Entity]
   738   C2746065:End [Temporal Concept]
   704 E C0163712:Relate [Organic Chemical]
   704 E C0725066:Advance [Medical Device]
   704 E C1704444:Product [Quantitative Concept]

Phrase: "in inflammation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021368:Inflammation [Pathologic Function]

Phrase: "and"

Phrase: "accelerated atherosclerosis in diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1849618:Accelerated atherosclerosis [Finding]
   770   C0004153:Atherosclerosis [Disease or Syndrome]
Processing 00000000.tx.15: However, possible alterations in gene expression induced by RAGE signaling during neuronal development remain elusive. 

Phrase: "However,"

Phrase: "possible alterations in gene expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0017263:Gene Expression Alteration [Genetic Function]
   781   C0596611:Gene Alteration [Genetic Function]
   726   C1515926:Alteration [Idea or Concept]

Phrase: "induced by RAGE"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   909   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   833   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   744   C0205179:Advanced [Qualitative Concept]
   744   C0205263:Induced [Functional Concept]
   744   C0444930:End [Spatial Concept]
   744   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   744   C0598528:glycation [Phenomenon or Process]
   744   C1514468:Products [Entity]
   744   C2746065:End [Temporal Concept]
   711 E C0725066:Advance [Medical Device]
   711 E C1704444:Product [Quantitative Concept]

Phrase: "signaling during neuronal development"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   797   C1657987:neuron development [Cell Function]
   770   C0037083:Signaling [Cell Function]
   770   C0243107:development [Physiologic Function]
   770   C0521390:Neuronal [Immunologic Factor]
   770   C0678723:Development [Organism Function]
   770   C1527148:Development [Functional Concept]
   770   C3537152:signaling [Biologic Function]
   737 E C1710082:Signal [Phenomenon or Process]

Phrase: "remain"

Phrase: "elusive."
Processing 00000000.tx.16: RAGE has been reported to be expressed in the developing nervous system where it serves as a receptor for amphoterin (15) and particular members of the S100 protein family (14, 16). 

Phrase: "RAGE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   716   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "expressed in the developing nervous system where"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   778   C0027763:Nervous System [Body System]
   778   C0422837:NERVOUS SYSTEM [Finding]
   778   C1269560:Nervous system [Body System]
   748   C0027769:Nervous [Sign or Symptom]
   748   C0449913:System [Functional Concept]
   748   C0599851:Nervous [Functional Concept]
   748   C1553451:System [Manufactured Object]
   748   C1704459:System [Medical Device]
   723 E C0205494:Neurologic [Qualitative Concept]

Phrase: "it"

Phrase: "serves as a receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "for amphoterin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0019796:Amphoterin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1333908:AMPHOTERIN [Gene or Genome]

Phrase: "(15"

Phrase: ")"

Phrase: "and"

Phrase: "particular members of the S100 protein family"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   774   C0086282:Family Members [Family Group]
   757 E C1611821:Family Member [Intellectual Product]
   748   C0680022:members [Population Group]
   714 E C2698041:Member [Professional or Occupational Group]

Phrase: "(14,"

Phrase: "16"

Phrase: ")."
Processing 00000000.tx.17: Amphoterin is a neurite outgrowth-promoting protein that is highly expressed in embryonic and transformed cells (17-19). 

Phrase: "Amphoterin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0019796:Amphoterin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1333908:AMPHOTERIN [Gene or Genome]

Phrase: "is"

Phrase: "a neurite outgrowth-promoting protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "is"

Phrase: "highly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:Highly [Qualitative Concept]

Phrase: "expressed in embryonic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0013935:Embryonic [Embryonic Structure]

Phrase: "and"

Phrase: "transformed cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(17-19"

Phrase: ")."
Processing 00000000.tx.18: Amphoterin and RAGE co-localize at the leading edge of advancing neurites in the developing nervous system, and antibodies against RAGE block neurite outgrowth of cortical neurons on amphoterin-coated substrates (6, 15). 

Phrase: "Amphoterin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0019796:Amphoterin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1333908:AMPHOTERIN [Gene or Genome]

Phrase: "and"

Phrase: "RAGE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   716   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]

Phrase: "co-localize at the leading edge of advancing neurites"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   742   C0085103:Neurites [Cell Component]
   742   C0205154:Edge [Spatial Concept]
   742   C0332152:Leading [Temporal Concept]
   742   C0392752:localize [Spatial Concept]
   742   C1522538:Leading [Functional Concept]
   742   C2697523:Edge [Conceptual Entity]
   708 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   708   C0725066:Advance [Medical Device]
   708 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   708 E C2348269:Lead [Element, Ion, or Isotope]
   708 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in the developing nervous system,"
Meta Candidates (Total=15; Excluded=7; Pruned=0; Remaining=8)
   901   C0027763:Nervous System [Body System]
   901   C0422837:NERVOUS SYSTEM [Finding]
   901   C1269560:Nervous system [Body System]
   845 E C0205494:Neurologic [Qualitative Concept]
   827   C0027769:Nervous [Sign or Symptom]
   827   C0449913:System [Functional Concept]
   827   C0599851:Nervous [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   808 E C0027855:Neurology [Biomedical Occupation or Discipline]
   790 E C2707261:Neurological [Clinical Attribute]
   755 E C0205373:Systemic [Functional Concept]
   711 E C0027740:Nerve [Tissue]
   711 E C0027757:NERVE [Tissue]
   711 E C1280541:Nerve [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "antibodies against RAGE"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   767   C0034805:antibodies receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   744   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   743   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   711 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "neurite outgrowth of cortical neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C3158384:neurite outgrowth [Cell Function]
   760   C0085103:Neurite [Cell Component]

Phrase: "on amphoterin-coated substrates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1710236:Substrate [Manufactured Object]

Phrase: "(6,"

Phrase: "15"

Phrase: ")."
Processing 00000000.tx.19: S100 proteins form a multigenic family of Ca2+ binding, EF-hand type proteins with both intracellular and extracellular functions (reviewed in Ref. 20). 

Phrase: "S100 proteins"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0027758:S100 Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1441165:S-100 [Immunologic Factor]
   861   C3273837:S100 [Gene or Genome]
   861   C3274824:S100 [Gene or Genome]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "a multigenic family of Ca2+ binding,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0015576:Family [Family Group]
   753   C1704727:Family [Conceptual Entity]

Phrase: "EF-hand type proteins with both intracellular"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "extracellular functions"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0542341:Functions [Functional Concept]
   827 E C0031843:function [Physiologic Function]
   827 E C0700205:FUNCTION [Classification]
   827 E C1705273:Function [Intellectual Product]
   777 E C0205245:Functional [Functional Concept]
   777 E C2700217:Functional [Conceptual Entity]

Phrase: "("

Phrase: "reviewed in Ref. 20"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0282443:reviewed [Intellectual Product]
   770   C1425988:REF [Gene or Genome]
   770   C1709940:Reviewed [Qualitative Concept]
   737 E C1552617:Review [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.20: Many S100 proteins are expressed in the nervous system of which S100B is perhaps the most studied example. 

Phrase: "Many S100 proteins"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0027758:S100 Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1441165:S-100 [Immunologic Factor]
   861   C3273837:S100 [Gene or Genome]
   861   C3274824:S100 [Gene or Genome]

Phrase: "are"

Phrase: "expressed in the nervous system of which S100B"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   770   C0027763:Nervous System [Body System]
   770   C0422837:NERVOUS SYSTEM [Finding]
   770   C1269560:Nervous system [Body System]
   744   C0027769:Nervous [Sign or Symptom]
   744   C0449913:System [Functional Concept]
   744   C0599851:Nervous [Functional Concept]
   744   C1419790:S100B [Gene or Genome]
   744   C1553451:System [Manufactured Object]
   744   C1704459:System [Medical Device]
   715 E C0205494:Neurologic [Qualitative Concept]

Phrase: "is"

Phrase: "perhaps"

Phrase: "the most studied example."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1707959:Example [Conceptual Entity]
Processing 00000000.tx.21: Recently we showed that amphoterin and some S100 proteins are able to coregulate neurite outgrowth and cell survival through their binding to RAGE (14). 

Phrase: "Recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "we"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that amphoterin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0019796:Amphoterin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1333908:AMPHOTERIN [Gene or Genome]

Phrase: "and"

Phrase: "some S100 proteins"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0027758:S100 Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1441165:S-100 [Immunologic Factor]
   861   C3273837:S100 [Gene or Genome]
   861   C3274824:S100 [Gene or Genome]

Phrase: "are"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "coregulate"

Phrase: "neurite outgrowth"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3158384:neurite outgrowth [Cell Function]
   861   C0085103:Neurite [Cell Component]

Phrase: "and"

Phrase: "cell survival through their binding"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0007620:Cell Survival [Cell Function]
   760   C0007634:Cell [Cell]
   760   C0038952:Survival [Activity]
   760   C0220921:survival [Functional Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]

Phrase: "to RAGE"
Meta Candidates (Total=14; Excluded=5; Pruned=0; Remaining=9)
   954   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   877   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   795   C0205179:Advanced [Qualitative Concept]
   795   C0444930:End [Spatial Concept]
   795   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   795   C0598528:glycation [Phenomenon or Process]
   795   C1514468:Products [Entity]
   795   C1883351:To [Qualitative Concept]
   795   C2746065:End [Temporal Concept]
   762 E C0725066:Advance [Medical Device]
   762 E C1704444:Product [Quantitative Concept]
   740 E C0205088:Terminal [Temporal Concept]
   740 E C1705314:Terminal [Manufactured Object]
   740 E C1705315:Terminal [Spatial Concept]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.22: However, it is not clear whether RAGE-mediated neurite outgrowth is just a simple motility-type morphological response or a sign of true neuronal differentiation. 

Phrase: "However,"

Phrase: "it"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "whether"

Phrase: "RAGE-mediated neurite outgrowth"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   882   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   742   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "is"

Phrase: "just"

Phrase: "a simple motility-type morphological response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0871261:Response [Organism Attribute]
   804   C1704632:Response [Finding]
   804   C1706817:Response [Intellectual Product]
   804   C2911692:Response [Mental Process]

Phrase: "or"

Phrase: "a sign of true neuronal differentiation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0311392:Sign [Finding]
   753   C1547188:Sign [Idea or Concept]
Processing 00000000.tx.23: In the present study, we have studied RAGE-induced changes in gene expression during neuronal differentiation using two models, a neuroblastoma cell line and an embryonic stem cell line. 

Phrase: "In the present study,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "have"

Phrase: "studied RAGE-induced changes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   882   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   742   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "in gene expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0017262:Gene Expression [Genetic Function]
   861   C0017337:Gene [Gene or Genome]
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "during neuronal differentiation"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C1518294:Neuronal Differentiation [Finding]
   964 E C1159970:neuron differentiation [Cell Function]
   861   C0007589:Differentiation [Cell Function]
   861   C1511938:Differentiation [Clinical Attribute]
   861   C2945687:Differentiation [Functional Concept]
   789 E C0205615:Differentiated [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "two models,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Models [Intellectual Product]

Phrase: "a neuroblastoma cell line"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   901   C0007600:Cell Line [Cell]
   901   C0815000:neuroblastoma cell [Cell]
   827   C0007634:Cell [Cell]
   827   C0027819:Neuroblastoma [Neoplastic Process]
   827   C0205132:Line [Spatial Concept]
   827   C0700095:neuroblastoma [Neoplastic Process]
   827   C1269647:Cell [Cell]
   827   C1550648:Line [Substance]
   827   C1552960:Line [Quantitative Concept]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   827   C3540583:Neuroblastoma [Intellectual Product]

Phrase: "and"

Phrase: "an embryonic stem cell line."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1512140:Embryonic Stem Cell Line [Cell]
   861   C0007600:Cell Line [Cell]
   812   C0205132:Line [Spatial Concept]
   812   C1550648:Line [Substance]
   812   C1552960:Line [Quantitative Concept]
   756   C0596508:Embryonic stem cell [Cell]
   708   C1947950:Embryonic Cell [Embryonic Structure]
Processing 00000000.tx.24: We found that activation of RAGE induces expression of chromogranins, a family of acidic proteins involved in maturation and function of dense core vesicles in various endocrine cells and some populations of neurons (reviewed in Refs. 21-23). 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that activation of RAGE"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   882   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   818   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   762   C1514758:Receptor Activation [Cell Function]
   745   C0596035:activation product [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0205179:Advanced [Qualitative Concept]
   742   C0444930:End [Spatial Concept]
   742   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   742   C0598528:glycation [Phenomenon or Process]
   742   C1514468:Products [Entity]
   742   C1879547:Activation [Activity]
   742   C2746065:End [Temporal Concept]
   708 E C0725066:Advance [Medical Device]
   708 E C1704444:Product [Quantitative Concept]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "expression of chromogranins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "a family of acidic proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C1335532:Protein Family [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0015576:Family [Family Group]
   760   C1704727:Family [Conceptual Entity]

Phrase: "involved in maturation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0678723:Maturation [Organism Function]
   790   C0870861:maturation [Phenomenon or Process]
   790   C1254042:Maturation [Physiologic Function]
   790   C1314939:Involved [Functional Concept]

Phrase: "and"

Phrase: "function of dense core vesicles"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0031843:function [Physiologic Function]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1705273:Function [Intellectual Product]

Phrase: "in various endocrine cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   901   C0229525:Endocrine Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C0014136:Endocrine [Body System]
   827   C0521425:Endocrine [Functional Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "some populations of neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0032659:Population [Quantitative Concept]
   770   C1257890:Population [Population Group]

Phrase: "("

Phrase: "reviewed in Refs. 21-23"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0282443:reviewed [Intellectual Product]
   760   C0450348:23 [Quantitative Concept]
   760   C1425988:REF [Gene or Genome]
   760   C1709940:Reviewed [Qualitative Concept]
   726 E C1552617:Review [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.25: Furthermore, we found that cyclic AMP (cAMP) response element-binding protein (CREB), an immediate early gene and a major regulator of chromogranin expression, was phosphorylated upon RAGE activation. 

Phrase: "Furthermore,"

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that cyclic AMP (cAMP) response element-binding protein"
Meta Candidates (Total=21; Excluded=1; Pruned=0; Remaining=20)
  1000   C0056695:Cyclic AMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   947   C3158668:cyclic-AMP response element binding [Genetic Function]
   901   C1511573:Cyclic AMP Response Element [Gene or Genome]
   885   C1148918:cyclic AMP binding [Molecular Function]
   858   C1148922:AMP binding [Molecular Function]
   827   C0001455:Cyclic AMP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   827   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0013879:Element [Element, Ion, or Isotope]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0243122:binding [Functional Concept]
   799   C0439596:Cyclic [Temporal Concept]
   799   C0871261:Response [Organism Attribute]
   799   C1145667:Binding [Activity]
   799   C1167622:Binding [Molecular Function]
   799   C1511572:Cyclic [Temporal Concept]
   799   C1704632:Response [Finding]
   799   C1705248:Element [Conceptual Entity]
   799   C1706817:Response [Intellectual Product]
   799   C2911692:Response [Mental Process]
   727 E C0031084:Cyclicities [Temporal Concept]

Phrase: "(CREB"
Meta Candidates (Total=21; Excluded=1; Pruned=0; Remaining=20)
  1000   C0056695:Cyclic AMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   947   C3158668:cyclic-AMP response element binding [Genetic Function]
   901   C1511573:Cyclic AMP Response Element [Gene or Genome]
   885   C1148918:cyclic AMP binding [Molecular Function]
   858   C1148922:AMP binding [Molecular Function]
   827   C0001455:Cyclic AMP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   827   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0013879:Element [Element, Ion, or Isotope]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0243122:binding [Functional Concept]
   799   C0439596:Cyclic [Temporal Concept]
   799   C0871261:Response [Organism Attribute]
   799   C1145667:Binding [Activity]
   799   C1167622:Binding [Molecular Function]
   799   C1511572:Cyclic [Temporal Concept]
   799   C1704632:Response [Finding]
   799   C1705248:Element [Conceptual Entity]
   799   C1706817:Response [Intellectual Product]
   799   C2911692:Response [Mental Process]
   727 E C0031084:Cyclicities [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "an immediate early gene"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0206256:Immediate-Early Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   827   C0205253:Immediate [Temporal Concept]
   827   C0205548:Immediate [Temporal Concept]
   827   C1279919:Early [Temporal Concept]

Phrase: "and"

Phrase: "a major regulator of chromogranin expression,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0182953:REGULATOR [Medical Device]
   753   C1704734:Regulator [Medical Device]
   753   C1704735:Regulator [Conceptual Entity]

Phrase: "was"

Phrase: "phosphorylated upon RAGE activation."
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   882   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   818   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   762   C1514758:Receptor Activation [Cell Function]
   745   C0596035:activation product [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0205179:Advanced [Qualitative Concept]
   742   C0444930:End [Spatial Concept]
   742   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   742   C0598528:glycation [Phenomenon or Process]
   742   C1514468:Products [Entity]
   742   C1879547:Activation [Activity]
   742   C2746065:End [Temporal Concept]
   708 E C0725066:Advance [Medical Device]
   708 E C1704444:Product [Quantitative Concept]
Processing 00000000.tx.26: RAGE-induced phosphorylation and nuclear localization of CREB was found to be dependent on upstream ERK1/2-Rsk2 activation as inhibition of these kinases abolished CREB phosphorylation and chromogranin expression. 

Phrase: "RAGE-induced phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   909   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   744   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "nuclear localization of CREB"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   762   C0597704:protein localisation [Cell Function]
   762   C1159772:Protein Localization [Cell Function]
   742   C0475264:Localisation [Functional Concept]
   742   C1744691:localisation [Biologic Function]
   716   C0056695:Cyclic AMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "dependent on upstream ERK1/2-Rsk2 activation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   738   C0851827:Dependent [Qualitative Concept]
   738   C1701901:Dependent [Qualitative Concept]
   738   C3244310:dependent [Functional Concept]

Phrase: "as inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0021467:Inhibition [Mental Process]
  1000   C0021469:Inhibition [Molecular Function]
  1000   C1628982:% inhibition [Quantitative Concept]
  1000   C3463820:Inhibition [Activity]
   928 E C0311403:Inhibited [Qualitative Concept]

Phrase: "of these kinases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "abolished"

Phrase: "CREB phosphorylation"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   877   C1157225:AMP phosphorylation [Molecular Function]
   818   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   795   C0031715:Phosphorylation [Molecular Function]
   787   C0056695:Cyclic AMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   747   C3158668:cyclic-AMP response element binding [Genetic Function]
   710   C1511573:Cyclic AMP Response Element [Gene or Genome]
   701   C1148918:cyclic AMP binding [Molecular Function]

Phrase: "and"

Phrase: "chromogranin expression."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.27: As RAGE activation was sufficient to cause withdrawal from cell cycle, neurite outgrowth, and differentiation toward a secretory phenotype in neuroblastoma cells, we tested if activation of RAGE signaling could have similar effects in a noncommitted, nave cellular background. 

Phrase: "As RAGE activation"
Meta Candidates (Total=15; Excluded=5; Pruned=0; Remaining=10)
   923   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   878   C1514758:Receptor Activation [Cell Function]
   861   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   793   C0205179:Advanced [Qualitative Concept]
   793   C0444930:End [Spatial Concept]
   793   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   793   C0598528:glycation [Phenomenon or Process]
   793   C1514468:Products [Entity]
   793   C1879547:Activation [Activity]
   793   C2746065:End [Temporal Concept]
   760 E C0725066:Advance [Medical Device]
   760 E C1704444:Product [Quantitative Concept]
   737 E C0205088:Terminal [Temporal Concept]
   737 E C1705314:Terminal [Manufactured Object]
   737 E C1705315:Terminal [Spatial Concept]

Phrase: "was"

Phrase: "sufficient to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205410:Sufficient [Qualitative Concept]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "withdrawal from cell cycle,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C2349954:Withdrawal [Activity]
   770   C2825032:Withdrawal [Mental or Behavioral Dysfunction]

Phrase: "neurite outgrowth,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3158384:neurite outgrowth [Cell Function]
   861   C0085103:Neurite [Cell Component]

Phrase: "and"

Phrase: "differentiation toward a secretory phenotype"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0007589:Differentiation [Cell Function]
   760   C1511938:Differentiation [Clinical Attribute]
   760   C2945687:Differentiation [Functional Concept]

Phrase: "in neuroblastoma cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C0815000:neuroblastoma cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "we"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "if"

Phrase: "activation of RAGE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C1514758:Receptor Activation [Cell Function]
   750   C0596035:activation product [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1879547:Activation [Activity]
   743   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]

Phrase: "signaling"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0037083:Signaling [Cell Function]
  1000   C3537152:signaling [Biologic Function]
   966 E C1710082:Signal [Phenomenon or Process]

Phrase: "could"

Phrase: "have"

Phrase: "similar effects in a noncommitted, nave cellular background."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C1280500:effects [Qualitative Concept]
   711 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.28: When embryonic stem (ES) cells transfected with RAGE were stimulated with amphoterin they began differentiation toward neuronal direction as manifested by neurite outgrowth and expression of neuronal markers neurofilament light chain protein and -III-tubulin. 

Phrase: "When"

Phrase: "embryonic stem (ES) cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
  1000   C0596508:Embryonic Stem Cells [Cell]
   901   C0038250:Stem cells [Cell]
   896   C1947950:Embryonic Cell [Embryonic Structure]
   827   C0007634:Cells [Cell]
   827   C0013935:Embryonic [Embryonic Structure]
   827   C0242767:Stem [Plant]
   827   C1186763:Stem [Body Part, Organ, or Organ Component]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with RAGE"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   909   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   833   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   744   C0205179:Advanced [Qualitative Concept]
   744   C0444930:End [Spatial Concept]
   744   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   744   C0598528:glycation [Phenomenon or Process]
   744   C1514468:Products [Entity]
   744   C2746065:End [Temporal Concept]
   711 E C0725066:Advance [Medical Device]
   711 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "stimulated with amphoterin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0019796:Amphoterin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1333908:AMPHOTERIN [Gene or Genome]
   790   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "they"

Phrase: "began"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0439659:Begin [Temporal Concept]

Phrase: "differentiation toward neuronal direction"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   819   C1518294:Neuronal Differentiation [Finding]
   783 E C1159970:neuron differentiation [Cell Function]
   770   C0007589:Differentiation [Cell Function]
   770   C1511938:Differentiation [Clinical Attribute]
   770   C2945687:Differentiation [Functional Concept]

Phrase: "as"

Phrase: "manifested by neurite outgrowth"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C1280444:Manifested by [Qualitative Concept]
           manifested
   833   C3158384:neurite outgrowth [Cell Function]
   770   C0085103:Neurite [Cell Component]
   770   C0205319:manifested [Functional Concept]

Phrase: "and"

Phrase: "expression of neuronal markers neurofilament light chain protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1171362:expression protein [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and -"

Phrase: "III-tubulin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2937342:tubulin [Cell Component]
Processing 00000000.tx.29: Interestingly, CREB phosphorylation and increased expression of chromogranins A and B were found to accompany neuronal differentiation of RAGE-transfected ES cells but not cells transfected with a signaling-incapable mutant of RAGE. 

Phrase: "Interestingly,"

Phrase: "CREB phosphorylation"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   877   C1157225:AMP phosphorylation [Molecular Function]
   818   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   795   C0031715:Phosphorylation [Molecular Function]
   787   C0056695:Cyclic AMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   747   C3158668:cyclic-AMP response element binding [Genetic Function]
   710   C1511573:Cyclic AMP Response Element [Gene or Genome]
   701   C1148918:cyclic AMP binding [Molecular Function]

Phrase: "and"

Phrase: "increased expression of chromogranins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "were"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "accompany"

Phrase: "neuronal differentiation of RAGE-transfected ES cells"
Meta Candidates (Total=34; Excluded=6; Pruned=0; Remaining=28)
   822   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   784   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   766   C0596508:Embryonic Stem Cells [Cell]
   750   C0038250:Stem cells [Cell]
   750   C1518294:Neuronal Differentiation [Finding]
   749   C0007589:cells differentiation [Cell Function]
           Differentiation
   749   C2325760:Neuronal receptor [Cell Component]
   747   C1514964:Stem Cell Differentiation [Cell Function]
   735   C0007634:Cells [Cell]
   735   C0013935:Embryonic [Embryonic Structure]
   735   C0205179:Advanced [Qualitative Concept]
   735   C0242767:Stem [Plant]
   735   C0444930:End [Spatial Concept]
   735   C0521390:Neuronal [Immunologic Factor]
   735   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   735   C0598528:glycation [Phenomenon or Process]
   735   C1186763:Stem [Body Part, Organ, or Organ Component]
   735   C1511938:Differentiation [Clinical Attribute]
   735   C1514468:Products [Entity]
   735   C2746065:End [Temporal Concept]
   735   C2945687:Differentiation [Functional Concept]
   735   C3282337:Cells [Cell]
   732   C1514760:Receptor Cell [Cell]
   732   C1656978:cell end [Cell Component]
   732   C1947950:Embryonic Cell [Embryonic Structure]
   730   C1706452:Stem cell product [Immunologic Factor]
   721   C2752630:terminal differentiation [Cell Function]
   714 E C1159970:neuron differentiation [Cell Function]
   702 E C0725066:Advance [Medical Device]
   702 E C1269647:Cell [Cell]
   702 E C1704444:Product [Quantitative Concept]
   702 E C1704653:Cell [Medical Device]
   702 E C1948049:Cell [Spatial Concept]

Phrase: "but"

Phrase: "not cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with a signaling-incapable mutant"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0037083:Signaling [Cell Function]
   753   C0596988:Mutant [Cell or Molecular Dysfunction]
   753   C1550518:incapable [Idea or Concept]
   753   C3537152:signaling [Biologic Function]

Phrase: "of RAGE."
Meta Candidates (Total=14; Excluded=5; Pruned=0; Remaining=9)
   954   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   877   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   795   C0205179:Advanced [Qualitative Concept]
   795   C0332285:Of [Spatial Concept]
   795   C0444930:End [Spatial Concept]
   795   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   795   C0598528:glycation [Phenomenon or Process]
   795   C1514468:Products [Entity]
   795   C2746065:End [Temporal Concept]
   762 E C0725066:Advance [Medical Device]
   762 E C1704444:Product [Quantitative Concept]
   740 E C0205088:Terminal [Temporal Concept]
   740 E C1705314:Terminal [Manufactured Object]
   740 E C1705315:Terminal [Spatial Concept]
Processing 00000000.tx.30: These results indicate that RAGE signaling can induce cellular differentiation and directly regulate genes required for functional secretory phenotype. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that RAGE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   946   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "signaling"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0037083:Signaling [Cell Function]
  1000   C3537152:signaling [Biologic Function]
   966 E C1710082:Signal [Phenomenon or Process]

Phrase: "can"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "cellular differentiation"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C1511938:Cellular Differentiation [Clinical Attribute]
           Differentiation
   861   C0007589:Differentiation [Cell Function]
   861   C2945687:Differentiation [Functional Concept]
   789 E C0205615:Differentiated [Qualitative Concept]

Phrase: "and"

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "regulate"

Phrase: "genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "required for functional secretory phenotype."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0031437:Phenotype [Organism Attribute]
   760   C0205245:Functional [Functional Concept]
   760   C0542341:Functional [Functional Concept]
   760   C1285572:Phenotype [Laboratory Procedure]
   760   C1327616:Secretory [Cell Function]
   760   C1514873:Required [Functional Concept]
   760   C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.31: In addition, our results identify the transcription factor CREB as a new target for RAGE signaling.  

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "identify"

Phrase: "the transcription factor CREB as a new target"
Meta Candidates (Total=26; Excluded=1; Pruned=0; Remaining=25)
   836   C0213709:Cyclic AMP Response Element-Binding Protein A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   822   C0056695:Cyclic AMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   802   C3158668:cyclic-AMP response element binding [Genetic Function]
   784   C1511573:Cyclic AMP Response Element [Gene or Genome]
   763   C1148918:cyclic AMP binding [Molecular Function]
   763   C1149367:transcription factor binding [Genetic Function]
   750   C0001455:Cyclic AMP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   750   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   750   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   749 E C0033618:Protein Binding [Molecular Function]
   749   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   749   C1148922:AMP binding [Molecular Function]
   749   C1159372:protein target [Molecular Function]
   749   C3272920:Target Response [Finding]
   735   C0013879:Element [Element, Ion, or Isotope]
   735   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   735   C0243122:binding [Functional Concept]
   735   C0439596:Cyclic [Temporal Concept]
   735   C0871261:Response [Organism Attribute]
   735   C1145667:Binding [Activity]
   735   C1167622:Binding [Molecular Function]
   735   C1511572:Cyclic [Temporal Concept]
   735   C1704632:Response [Finding]
   735   C1705248:Element [Conceptual Entity]
   735   C1706817:Response [Intellectual Product]
   735   C2911692:Response [Mental Process]

Phrase: "for RAGE"
Meta Candidates (Total=13; Excluded=5; Pruned=0; Remaining=8)
   877   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   795   C0205179:Advanced [Qualitative Concept]
   795   C0444930:End [Spatial Concept]
   795   C0521125:For [Qualitative Concept]
   795   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   795   C0598528:glycation [Phenomenon or Process]
   795   C1514468:Products [Entity]
   795   C2746065:End [Temporal Concept]
   762 E C0725066:Advance [Medical Device]
   762 E C1704444:Product [Quantitative Concept]
   740 E C0205088:Terminal [Temporal Concept]
   740 E C1705314:Terminal [Manufactured Object]
   740 E C1705315:Terminal [Spatial Concept]

Phrase: "signaling."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0037083:Signaling [Cell Function]
  1000   C3537152:signaling [Biologic Function]
   966 E C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.32: MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES Recombinant Proteins and Antibodies-- The production and purification of baculovirus-expressed rat amphoterin has been described previously (24). 

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Recombinant Proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0034861:Recombinant Proteins [Amino Acid, Peptide, or Protein]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1514798:recombinant [Organism]

Phrase: "and"

Phrase: "Antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "-"

Phrase: "-"

Phrase: "The production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033268:production [Occupational Activity]

Phrase: "and"

Phrase: "purification of baculovirus-expressed rat amphoterin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0243114:purification [Functional Concept]
   753   C1998793:Purification [Functional Concept]

Phrase: "has"

Phrase: "been"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.33: Recombinant S100B was a kind gift from Prof. 

Phrase: "Recombinant S100B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419790:S100B [Gene or Genome]

Phrase: "was"

Phrase: "a kind gift from Prof."
Processing 00000000.tx.34: Rosario Donato (University of Perugia, Perugia, Italy), and laminin was purchased from Sigma. 

Phrase: "Rosario Donato"

Phrase: "(University of Perugia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Perugia,"

Phrase: "Italy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022277:Italy [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "laminin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022984:Laminin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "purchased from Sigma."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0869011:purchased [Activity]
   790   C1719918:Sigma [Intellectual Product]
Processing 00000000.tx.35: Phospho-specific antibodies to ERK1/2 (Thr-202/Tyr-204) and CREB (Ser-133) were obtained from Cell Signaling Technology/New England Biolabs, Inc. 

Phrase: "Phospho-specific antibodies to ERK1/2"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   782   C1257988:Antibodies, Phospho-Specific [Amino Acid, Peptide, or Protein,Immunologic Factor]
   743   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   739   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   739   C0205369:Specific [Qualitative Concept]
   739   C1552740:specific [Intellectual Product]
   706 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Thr-202/Tyr-204"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0040005:Thr [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0041484:TYR [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0041485:TYR [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C1421250:TYR [Gene or Genome]

Phrase: ")"

Phrase: "and"

Phrase: "CREB"
Meta Candidates (Total=21; Excluded=1; Pruned=0; Remaining=20)
  1000   C0056695:Cyclic AMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   947   C3158668:cyclic-AMP response element binding [Genetic Function]
   901   C1511573:Cyclic AMP Response Element [Gene or Genome]
   885   C1148918:cyclic AMP binding [Molecular Function]
   858   C1148922:AMP binding [Molecular Function]
   827   C0001455:Cyclic AMP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   827   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0013879:Element [Element, Ion, or Isotope]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0243122:binding [Functional Concept]
   799   C0439596:Cyclic [Temporal Concept]
   799   C0871261:Response [Organism Attribute]
   799   C1145667:Binding [Activity]
   799   C1167622:Binding [Molecular Function]
   799   C1511572:Cyclic [Temporal Concept]
   799   C1704632:Response [Finding]
   799   C1705248:Element [Conceptual Entity]
   799   C1706817:Response [Intellectual Product]
   799   C2911692:Response [Mental Process]
   727 E C0031084:Cyclicities [Temporal Concept]

Phrase: "(Ser-133"

Phrase: ")"

Phrase: "were"

Phrase: "obtained from Cell Signaling Technology/New England Biolabs,"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   770   C0027965:New England [Geographic Area]
   770   C0037083:Cell Signaling [Cell Function]
           Signaling
   767   C0683887:new technology [Intellectual Product]
   762   C1371607:Increased Cell Signaling [Cell Function]
   744   C0007634:Cell [Cell]
   744   C0014282:England [Geographic Area]
   744   C0039421:Technology [Occupation or Discipline]
   744   C0205314:New [Temporal Concept]
   744   C1269647:Cell [Cell]
   744   C1301820:Obtained [Functional Concept]
   744   C1704653:Cell [Medical Device]
   744   C1948049:Cell [Spatial Concept]
   744   C3537152:signaling [Biologic Function]
   711 E C1706701:Obtain [Activity]
   711 E C1710082:Signal [Phenomenon or Process]

Phrase: "Inc."
Processing 00000000.tx.36: Antibodies to chromogranin A, chromogranin B, secretogranin II, and ERK1/2 were purchased from Santa Cruz Biotechnology, anti-synaptophysin from Roche Molecular Biochemicals, anti-glutamate receptor subunit 1(GluR1) from Upstate Biotechnology, anti-light neurofilament protein (NFL), anti--III-tubulin (Tuj1), anti-glial fibrillar acidic protein (GFAP), and anti-RAGE from Chemi-Con. 

Phrase: "Antibodies to chromogranin A,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0055633:Chromogranin A [Amino Acid, Peptide, or Protein,Hormone,Indicator, Reagent, or Diagnostic Aid]
   861   C1332754:CHROMOGRANIN A [Gene or Genome]
   812   C0008586:Chromogranin [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "chromogranin B,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0055635:chromogranin B [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332755:CHROMOGRANIN B [Gene or Genome]
   861   C0008586:Chromogranin [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "secretogranin II,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0055637:Secretogranin II [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1335805:SECRETOGRANIN II [Gene or Genome]

Phrase: "and"

Phrase: "ERK1/2"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   947   C0082529:Extracellular Signal-Regulated Kinase 1 [Amino Acid, Peptide, or Protein,Enzyme]
   947   C1366765:EXTRACELLULAR SIGNAL-REGULATED KINASE 1 [Gene or Genome]
   941   C0170168:Extracellular Signal-Regulated Kinase 2 [Amino Acid, Peptide, or Protein,Enzyme]
   941   C1366882:EXTRACELLULAR SIGNAL-REGULATED KINASE 2 [Gene or Genome]
   880   C0600388:Extracellular Signal Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   880   C0752312:Extracellular Signal-Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0521119:Extracellular [Cell Component]
   799   C0851285:Regulated [Governmental or Regulatory Activity]
   799   C1710082:Signal [Phenomenon or Process]

Phrase: "were"

Phrase: "purchased from Santa Cruz Biotechnology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0005574:Biotechnology [Biomedical Occupation or Discipline]
   760   C0869011:purchased [Activity]

Phrase: "anti-synaptophysin from Roche Molecular Biochemicals,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0633763:anti-synaptophysin [Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   753   C0085255:Synaptophysin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1420554:SYNAPTOPHYSIN [Gene or Genome]

Phrase: "anti-glutamate receptor subunit 1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   888   C1415287:GLUTAMATE RECEPTOR 1 [Gene or Genome]
   840   C0061465:Glutamate Receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   804   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C1711351:Subunit [Quantitative Concept]

Phrase: "(GluR1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415287:GLUR1 [Gene or Genome]

Phrase: ")"

Phrase: "from Upstate Biotechnology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005574:Biotechnology [Biomedical Occupation or Discipline]

Phrase: "anti-light neurofilament protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C0068590:light neurofilament protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   875   C0670902:LIGHT Protein [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0085418:Neurofilament protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(NFL"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1417668:NFL [Gene or Genome]
  1000   C1455438:NF-L [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1518285:NF-L [Cell Component]
  1000   C2981619:NF-L [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "anti"

Phrase: "--"

Phrase: "III-tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2937342:tubulin [Cell Component]

Phrase: "(Tuj1"

Phrase: ")"

Phrase: ","

Phrase: "anti-glial fibrillar acidic protein (GFAP),"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   937   C0017626:Glial fibrillar acidic protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "anti-RAGE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   946   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "from Chemi-Con."
Processing 00000000.tx.37: Peroxidase-conjugated secondary antibodies were from Amersham Biosciences, and TRITC/fluorescein isothiocyanate-conjugated secondary antibodies from Jackson ImmunoResearch Laboratories. 

Phrase: "Peroxidase-conjugated secondary antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were from Amersham Biosciences,"

Phrase: "and"

Phrase: "TRITC/fluorescein isothiocyanate-conjugated secondary antibodies from Jackson ImmunoResearch Laboratories."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   739   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   706 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.38: Cell Culture and Transfection-- Stably transfected clones of N18 mouse neuroblastoma cells were obtained as has been described previously (14). 

Phrase: "Cell Culture"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0007585:Cell Culture [Laboratory Procedure]
   861   C0007634:Cell [Cell]
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   861   C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "Transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "--"

Phrase: "Stably transfected clones of N18 mouse neuroblastoma cells"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   750   C0009013:Clone Cells [Cell]
           Clones
   711 E C1522642:Clone [Tissue]

Phrase: "were"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "as"

Phrase: "has"

Phrase: "been"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.39: Cells were cultured in DMEM supplemented with 0.1mg/ml streptomycin, 100units/ml penicillin G, 10% fetal calf serum, and 100g/ml G418 (Invitrogen) in 5% CO2 atmosphere. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "cultured in DMEM"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   756   C0010453:Culture [Idea or Concept]
   756   C0220814:culture [Functional Concept]
   756   C0430400:Culture [Laboratory Procedure]
   756   C2242979:Culture [Laboratory Procedure]

Phrase: "supplemented with 0.1mg/ml streptomycin,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0038425:Streptomycin [Antibiotic,Carbohydrate]
   753   C0439526:/mL [Quantitative Concept]
   719   C0242295:Supplement [Food]
   719   C1947943:Supplement [Intellectual Product]
   719   C2348609:Supplement [Functional Concept]

Phrase: "100units/ml penicillin G,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   875   C1637390:mL/g [Quantitative Concept]
   861   C0030827:Penicillin G [Antibiotic,Organic Chemical]
   812   C0030842:Penicillin [Antibiotic,Organic Chemical]
   812   C0220892:Penicillin [Antibiotic,Organic Chemical]
   812   C0439267:g% [Quantitative Concept]

Phrase: "10% fetal calf serum,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   812   C0015965:Fetal [Embryonic Structure]
   812   C0229671:Serum [Body Substance]
   812   C0230445:Calf [Body Location or Region]
   812   C0521457:Fetal [Functional Concept]
   812   C1305418:Calf [Body Part, Organ, or Organ Component]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]
   756 E C0626053:sural [Pharmacologic Substance]

Phrase: "and"

Phrase: "100g/ml G418"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0052009:G418 [Antibiotic,Organic Chemical]

Phrase: "(Invitrogen"

Phrase: ")"

Phrase: "in 5% CO2 atmosphere."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0004178:Atmosphere [Natural Phenomenon or Process]
   827   C0678214:atmosphere [Quantitative Concept]
Processing 00000000.tx.40: For differentiation studies the cells were detached from culture plates by incubation in PBS+0.5mM EDTA, washed with serum-free DMEM supplemented with 1% bovine serum albumin (BSA; Sigma) and plated without serum on 60-mm plates coated with 20g/ml recombinant amphoterin or 10g/ml laminin (for details, see Ref. 14). 

Phrase: "For differentiation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]

Phrase: "studies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557651:Study [Manufactured Object]
  1000   C0947630:studies [Laboratory Procedure]
  1000   C2603343:Study [Research Activity]

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "detached from culture plates"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   833   C0180454:culture plates [Medical Device]
   770   C0010453:Culture [Idea or Concept]
   770   C0220814:culture [Functional Concept]
   770   C0430400:Culture [Laboratory Procedure]
   770   C0687118:Detached [Functional Concept]
   770   C1139930:plates [Medical Device]
   770   C1561504:detached [Idea or Concept]
   770   C2242979:Culture [Laboratory Procedure]
   737 E C0005971:Plate [Medical Device]
   737 E C3537155:Plate [Manufactured Object]

Phrase: "by incubation"

Phrase: "in PBS+0.5mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "washed with serum-free DMEM"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   760   C0229671:Serum [Body Substance]
   760   C0332296:free [Functional Concept]
   760   C1546774:Serum [Intellectual Product]
   760   C1548982:Washed [Idea or Concept]
   760   C1550100:Serum [Body Substance]
   760   C1880497:Free [Qualitative Concept]
   760   C1996904:Free [Qualitative Concept]
   726 E C0441648:Wash [Activity]

Phrase: "supplemented with 1% bovine serum albumin"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   833   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   790   C0728877:serum albumin [Laboratory or Test Result]
   783 E C0523465:Albumin - serum [Laboratory Procedure]
   753   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0007452:Bovine [Mammal]
   753   C0229671:Serum [Body Substance]
   753   C1140701:bovine [Mammal]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   719   C0242295:Supplement [Food]
   719   C1947943:Supplement [Intellectual Product]
   719   C2348609:Supplement [Functional Concept]

Phrase: "(BSA"

Phrase: "; Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "plated without serum"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0229671:Serum [Body Substance]
   790   C1546774:Serum [Intellectual Product]
   790   C1550100:Serum [Body Substance]
   756   C0005971:Plate [Medical Device]
   756   C1139930:plate [Medical Device]
   756   C3537155:Plate [Manufactured Object]

Phrase: "on 60-mm plates"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1139930:plates [Medical Device]
   793 E C0005971:Plate [Medical Device]
   793 E C3537155:Plate [Manufactured Object]

Phrase: "coated with 20g/ml recombinant amphoterin"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   753   C0019796:Amphoterin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0439526:/mL [Quantitative Concept]
   753   C1333908:AMPHOTERIN [Gene or Genome]
   753   C1514798:recombinant [Organism]
   753   C1522408:Coated [Qualitative Concept]
   719 E C0453946:Coat [Manufactured Object]
   719 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "or"

Phrase: "10g/ml laminin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0022984:Laminin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "("

Phrase: "for details,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1522508:Details [Qualitative Concept]
   966 E C1561567:detail [Functional Concept]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Ref. 14"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1425988:REF [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.41: Control cells were grown on gelatin-coated (0.1%; Sigma) plates with or without all-trans-retinoic acid (1M; Sigma). 

Phrase: "Control cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   861   C0007634:Cells [Cell]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "grown on gelatin-coated"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0017237:Gelatin [Amino Acid, Peptide, or Protein,Biomedical or Dental Material,Pharmacologic Substance]
   770   C1145617:Gelatin [Food]
   770   C1522408:Coated [Qualitative Concept]
   737 E C0453946:Coat [Manufactured Object]
   737 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "(0.1%"

Phrase: "; Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "plates with"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0005971:Plate [Medical Device]
   833   C1139930:plate [Medical Device]
   833   C3537155:Plate [Manufactured Object]

Phrase: "or without all-trans-retinoic acid"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0040845:trans-Retinoic Acid [Organic Chemical,Pharmacologic Substance,Vitamin]
           Retinoic Acid
   753   C0001128:Acid [Chemical]
   753   C0202406:Acid [Laboratory Procedure]
   753   C2826298:TRANS [Idea or Concept]

Phrase: "(1M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0470296:1M [Quantitative Concept]

Phrase: "; Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.42: Morphological differentiation was followed by observing neurite outgrowth response of the cells for up to 7days. 

Phrase: "Morphological differentiation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0007589:Differentiation [Cell Function]
   861   C1511938:Differentiation [Clinical Attribute]
   861   C2945687:Differentiation [Functional Concept]
   789 E C0205615:Differentiated [Qualitative Concept]

Phrase: "was"

Phrase: "followed by observing neurite outgrowth response of the cells"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   764   C0332283:Followed by [Temporal Concept]
           followed
   764   C3158384:neurite outgrowth [Cell Function]
   742   C0007634:Cells [Cell]
   742   C0085103:Neurite [Cell Component]
   742   C0871261:Response [Organism Attribute]
   742   C1704632:Response [Finding]
   742   C1706817:Response [Intellectual Product]
   742   C2911692:Response [Mental Process]
   742   C3282337:Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1719822:Follow [Intellectual Product]
   708 E C1948049:Cell [Spatial Concept]

Phrase: "for"

Phrase: "up to 7days."
Processing 00000000.tx.43: The proportions of neurite-bearing cells (processes longer than one diameter of the cell soma) of all cells were counted in five random fields. 

Phrase: "The proportions of neurite-bearing cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1709707:Proportion [Quantitative Concept]

Phrase: "(processes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1184743:Process [Body Part, Organ, or Organ Component]
   966   C1522240:Process [Phenomenon or Process]

Phrase: "longer than one diameter of the cell soma"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   750   C0552406:Diameter.long [Quantitative Concept]
   711   C0205166:Long [Qualitative Concept]
   711   C1706317:Long [Qualitative Concept]

Phrase: ")"

Phrase: "of all cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "counted in five random fields."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   760   C0034656:RANDOM [Research Activity]
   760   C0205451:Five [Quantitative Concept]
   760   C0439605:Random [Qualitative Concept]
   726   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   726   C0750480:Count [Activity]
   726   C1521738:Field [Conceptual Entity]
   726   C1705566:Count [Quantitative Concept]
   726   C2346620:Field [Conceptual Entity]
   726   C2349184:Field [Conceptual Entity]
   726   C3539073:FIELD [Spatial Concept]
Processing 00000000.tx.44: Undifferentiated mouse embryonic stem cells (line R1) were cultured in knockout DMEM supplemented (Invitrogen) with 15% ES cell-tested fetal calf serum (Invitrogen), 500/50 g/ml penicillin-streptomycin, 2mM L-glutamine, 1mM sodium-pyruvate, 1mM -mercaptoethanol, 1 minimum Eagle's medium nonessential amino acids and 1000units/ml leukemia inhibitory factor (Invitrogen) on mouse embryonic fibroblast (NeoR) feeder cell layers. 

Phrase: "Undifferentiated mouse embryonic stem cells"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   884   C0596508:Embryonic Stem Cells [Cell]
   872   C1514965:Mouse Stem Cell [Cell]
   840   C0038250:Stem cells [Cell]
   836   C1947950:Embryonic Cell [Embryonic Structure]
   804   C0007634:Cells [Cell]
   804   C0013935:Embryonic [Embryonic Structure]
   804   C0242767:Stem [Plant]
   804   C1186763:Stem [Body Part, Organ, or Organ Component]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "(line R1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1335648:R1 [Gene or Genome]
   861   C1824685:R1 [Gene or Genome]
   861   C2697937:R1 [Quantitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "cultured in knockout DMEM"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0560617:knock out [Injury or Poisoning]
   770   C1522225:Knock-out [Experimental Model of Disease]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "supplemented"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0242295:Supplement [Food]
   966   C1947943:Supplement [Intellectual Product]
   966   C2348609:Supplement [Functional Concept]

Phrase: "(Invitrogen"

Phrase: ")"

Phrase: "with 15% ES cell-tested fetal calf serum"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   793   C0015965:Fetal [Embryonic Structure]
   793   C0229671:Serum [Body Substance]
   793   C0230445:Calf [Body Location or Region]
   793   C0521457:Fetal [Functional Concept]
   793   C1305418:Calf [Body Part, Organ, or Organ Component]
   793   C1546774:Serum [Intellectual Product]
   793   C1550100:Serum [Body Substance]
   737 E C0626053:sural [Pharmacologic Substance]

Phrase: "(Invitrogen"

Phrase: ")"

Phrase: ","

Phrase: "500/50 g/ml penicillin-streptomycin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0038425:Streptomycin [Antibiotic,Carbohydrate]

Phrase: "2mM L-glutamine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017797:Glutamine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "1mM sodium-pyruvate,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1576824:Sodium Pyruvate [Organic Chemical,Pharmacologic Substance]
   827   C0034354:pyruvate [Organic Chemical]
   827   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]

Phrase: "1mM -mercaptoethanol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025402:Mercaptoethanol [Organic Chemical]

Phrase: "1 minimum Eagle's medium nonessential amino acids"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   829   C0311461:Non-Essential Amino Acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   818   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   795   C0001128:Acids [Chemical]
   785 E C2917660:Amino Acid [Pharmacologic Substance]
   762 E C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "1000units/ml leukemia inhibitory factor"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   884   C0125606:leukemia inhibitory factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   884   C1366463:LEUKEMIA-INHIBITORY FACTOR [Gene or Genome]
   884   C1453955:Leukemia-Inhibitory Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   884   C1761537:leukemia inhibitory factor [Molecular Function]
   804   C0023418:Leukaemia [Neoplastic Process]
   804   C1521761:Factor [Functional Concept]
   804   C2827422:Factor [Conceptual Entity]
   804   C3463820:Inhibitory [Activity]

Phrase: "(Invitrogen"

Phrase: ")"

Phrase: "on mouse embryonic fibroblast"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1516828:Mouse Embryonic Fibroblast [Tissue]
   913   C1522260:Mouse Fibroblast [Cell]
   827   C0016030:Fibroblast [Cell]

Phrase: "(NeoR"

Phrase: ")"

Phrase: "feeder cell layers."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C3179112:Feeder Cell Layers [Biomedical or Dental Material]
           Feeder Layers
           Feeder Cell
   827   C0934502:layers [Body Part, Organ, or Organ Component]
   793 E C1522408:Layer [Qualitative Concept]
   793 E C1561599:Layer [Intellectual Product]
   734   C3179110:Cell, Feeder [Cell]
Processing 00000000.tx.45: 10million ES cells were transfected with 30g of linearized vector DNA by electroporation (960F/250 V) in knockout DMEM supplemented with 20mM Hepes. 

Phrase: "10million ES cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   923   C0596508:Embryonic Stem Cells [Cell]
   861   C0038250:Stem cells [Cell]
   858   C1947950:Embryonic Cell [Embryonic Structure]
   812   C0007634:Cells [Cell]
   812   C0013935:Embryonic [Embryonic Structure]
   812   C0242767:Stem [Plant]
   812   C1186763:Stem [Body Part, Organ, or Organ Component]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transfected with 30g of linearized vector DNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0442335:Vector [Spatial Concept]
   748   C1705099:Vector [Idea or Concept]

Phrase: "by electroporation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206691:Electroporation [Laboratory Procedure,Research Activity]

Phrase: "(960F/250 V) in knockout DMEM"

Phrase: "supplemented with 20mM Hepes."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   737   C0242295:Supplement [Food]
   737   C1947943:Supplement [Intellectual Product]
   737   C2348609:Supplement [Functional Concept]
Processing 00000000.tx.46: Stably transfected single cell clones were picked under a light microscope after a 14-day selection with 500g/ml G418 (Invitrogen). 

Phrase: "Stably"

Phrase: "transfected"

Phrase: "single cell clones"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   901   C0009013:cell clones [Cell]
           Clones
   793 E C1522642:Clone [Tissue]
   743 E C1704387:Clonal [Qualitative Concept]
   721 E C0796368:clonality [Diagnostic Procedure]

Phrase: "were"

Phrase: "picked under a light microscope"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0491970:Light Microscope [Medical Device]
   760   C0023693:Light [Natural Phenomenon or Process]
   760   C0181839:Microscope [Medical Device]
   760   C1306462:Light [Functional Concept]
   760   C1706379:Microscope [Medical Device]
   760   C1707391:Picked [Activity]
   760   C1881376:Light [Qualitative Concept]
   726 E C1826583:PICK [Gene or Genome]

Phrase: "after a 14-day selection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0036576:selection [Genetic Function]

Phrase: "with 500g/ml G418"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0052009:G418 [Antibiotic,Organic Chemical]

Phrase: "(Invitrogen"

Phrase: ")."
Processing 00000000.tx.47: After expansion of single cell cultures, high expression clones were selected based on Western blot expression data. 

Phrase: "After expansion"

Phrase: "of single cell cultures,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   901   C0007585:Cell Cultures [Laboratory Procedure]
   827   C0010453:Cultures [Idea or Concept]
   793 E C0220814:culture [Functional Concept]
   793 E C0430400:Culture [Laboratory Procedure]
   793 E C2242979:Culture [Laboratory Procedure]

Phrase: "high expression clones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0009013:Clones [Cell]
   793 E C1522642:Clone [Tissue]
   743 E C1704387:Clonal [Qualitative Concept]
   721 E C0796368:clonality [Diagnostic Procedure]

Phrase: "were"

Phrase: "selected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707391:Select [Activity]

Phrase: "based on Western blot expression data."
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   790   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   790   C0949466:Western Blot [Laboratory Procedure]
   767   C0242356:data base [Intellectual Product]
   767   C0993637:Data Base [Intellectual Product]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C1511726:Data [Idea or Concept]
   753   C1527178:Based [Functional Concept]
   753   C1705493:Western [Spatial Concept]
   753   C1705938:Based [Idea or Concept]
   753   C3245479:data [Medical Device]
   719 E C0002055:base [Inorganic Chemical]
   719 E C0178499:Base [Chemical Viewed Functionally]
   719 E C1880279:Base [Biomedical or Dental Material]
Processing 00000000.tx.48: To prevent differentiation, the ES cells were grown on feeder cells in the presence of 1000units/ml leukemia inhibitory factor during all the above steps. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "differentiation,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]

Phrase: "the ES cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
  1000   C0596508:Embryonic Stem Cells [Cell]
   901   C0038250:Stem cells [Cell]
   896   C1947950:Embryonic Cell [Embryonic Structure]
   827   C0007634:Cells [Cell]
   827   C0013935:Embryonic [Embryonic Structure]
   827   C0242767:Stem [Plant]
   827   C1186763:Stem [Body Part, Organ, or Organ Component]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "grown on feeder cells"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   833   C3179110:Feeder Cells [Cell]
   816 E C3179112:Feeder Cell [Biomedical or Dental Material]
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 1000units/ml leukemia inhibitory factor"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   884   C0125606:leukemia inhibitory factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   884   C1366463:LEUKEMIA-INHIBITORY FACTOR [Gene or Genome]
   884   C1453955:Leukemia-Inhibitory Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   884   C1761537:leukemia inhibitory factor [Molecular Function]
   804   C0023418:Leukaemia [Neoplastic Process]
   804   C1521761:Factor [Functional Concept]
   804   C2827422:Factor [Conceptual Entity]
   804   C3463820:Inhibitory [Activity]

Phrase: "during all"

Phrase: "the above steps."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C1261552:steps [Conceptual Entity]
   827 E C1704379:Step [Functional Concept]
   827 E C1705117:Step [Quantitative Concept]
   827 E C2825408:Step [Manufactured Object]
Processing 00000000.tx.49: In all of the subsequent steps, R1/RAGE and R1/RAGEcyto cells were grown in the presence of 50g/ml G418. 

Phrase: "In all"

Phrase: "of the subsequent steps,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C1261552:steps [Conceptual Entity]
   827 E C1704379:Step [Functional Concept]
   827 E C1705117:Step [Quantitative Concept]
   827 E C2825408:Step [Manufactured Object]

Phrase: "R1/RAGE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   946   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "R1/RAGEcyto cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "grown in the presence of 50g/ml G418."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0052009:G418 [Antibiotic,Organic Chemical]
   744   C0392148:Presence [Therapeutic or Preventive Procedure]
   744   C0439526:/mL [Quantitative Concept]
Processing 00000000.tx.50: Neuronal Differentiation of ES Cells-- Parental R1 cells or selected clones expressing either RAGE or RAGEcyto were grown as embryoid bodies (300,000cells/ml) on bacterial Petri dishes in full knockout DMEM medium in the presence of 1M retinoic acid, 20g/ml amphoterin, or a control containing no addition. 

Phrase: "Neuronal Differentiation of ES Cells"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   804   C1514964:Stem Cell Differentiation [Cell Function]
   790   C1518294:Neuronal Differentiation [Finding]
   783   C0007589:cells differentiation [Cell Function]
           Differentiation
   754 E C1159970:neuron differentiation [Cell Function]
   753   C1511938:Differentiation [Clinical Attribute]
   753   C2945687:Differentiation [Functional Concept]

Phrase: "--"

Phrase: "Parental R1 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "or"

Phrase: "selected clones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0009013:Clones [Cell]
   827 E C1522642:Clone [Tissue]
   777 E C1704387:Clonal [Qualitative Concept]
   755 E C0796368:clonality [Diagnostic Procedure]

Phrase: "expressing"

Phrase: "either RAGE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   946   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "or"

Phrase: "RAGEcyto"

Phrase: "were"

Phrase: "grown as embryoid bodies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   833   C2936498:Embryoid Bodies [Cell]
   770   C0242821:bodies [Human]
   770   C1995017:Bodies [Cell Component]
   737 E C0460148:Body [Anatomical Structure]
   737 E C1268086:Body [Anatomical Structure]

Phrase: "(300,"

Phrase: "000cells/ml) on bacterial Petri dishes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439526:/mL [Quantitative Concept]

Phrase: "in full knockout DMEM medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0009458:Medium [Intellectual Product]
   812   C0439536:Medium [Quantitative Concept]
   812   C1705217:Medium [Substance]
   812   C3244283:medium [Intellectual Product]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 1M retinoic acid,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0040845:Retinoic Acid [Organic Chemical,Pharmacologic Substance,Vitamin]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: "20g/ml amphoterin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0019796:Amphoterin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1333908:AMPHOTERIN [Gene or Genome]

Phrase: "or"

Phrase: "a control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "no addition."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]
Processing 00000000.tx.51: Importantly, no leukemia inhibitory factor was present in any steps of the differentiation protocol. 

Phrase: "Importantly,"

Phrase: "no leukemia inhibitory factor"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0125606:leukemia inhibitory factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1366463:LEUKEMIA-INHIBITORY FACTOR [Gene or Genome]
  1000   C1453955:Leukemia-Inhibitory Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1761537:leukemia inhibitory factor [Molecular Function]
   827   C0023418:Leukaemia [Neoplastic Process]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]
   827   C3463820:Inhibitory [Activity]

Phrase: "was"

Phrase: "present in any steps of the differentiation protocol."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0150312:Present [Quantitative Concept]
   744   C0449450:Present [Idea or Concept]
Processing 00000000.tx.52: After 4days, the embryoid bodies were trypsinized and the cells were plated on gelatin-coated plates (60-mm plates, 1.0106 cells) in the same medium containing either 1M retinoic acid, 20g/ml amphoterin, or no addition in the control. 

Phrase: "After 4days,"

Phrase: "the embryoid bodies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C2936498:Embryoid Bodies [Cell]
   861   C0242821:bodies [Human]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]

Phrase: "were"

Phrase: "trypsinized"

Phrase: "and"

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "plated on gelatin-coated plates"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   760   C0017237:Gelatin [Amino Acid, Peptide, or Protein,Biomedical or Dental Material,Pharmacologic Substance]
   760   C1139930:plates [Medical Device]
           plate
   760   C1145617:Gelatin [Food]
   760   C1522408:Coated [Qualitative Concept]
   726   C0005971:Plate [Medical Device]
   726 E C0453946:Coat [Manufactured Object]
   726 E C2987482:Coat [Body Part, Organ, or Organ Component]
   726   C3537155:Plate [Manufactured Object]

Phrase: "(60-mm plates,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1139930:plates [Medical Device]
   793 E C0005971:Plate [Medical Device]
   793 E C3537155:Plate [Manufactured Object]

Phrase: "1.0106 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: "in the same medium containing either 1M retinoic acid,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   818   C0040845:Retinoic Acid [Organic Chemical,Pharmacologic Substance,Vitamin]
   795   C0001128:Acid [Chemical]
   795   C0202406:Acid [Laboratory Procedure]

Phrase: "20g/ml amphoterin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0019796:Amphoterin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1333908:AMPHOTERIN [Gene or Genome]

Phrase: "or"

Phrase: "no addition in the control."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1883712:Addition [Functional Concept]
Processing 00000000.tx.53: After 2days of culture, the medium was changed to neurobasal medium containing the B27 supplement (Invitrogen), and either amphoterin, retinoic acid, or no addition. 

Phrase: "After 2days"

Phrase: "of culture,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0010453:Culture [Idea or Concept]
  1000   C0220814:culture [Functional Concept]
  1000   C0430400:Culture [Laboratory Procedure]
  1000   C2242979:Culture [Laboratory Procedure]

Phrase: "the medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009458:Medium [Intellectual Product]
  1000   C0439536:Medium [Quantitative Concept]
  1000   C1705217:Medium [Substance]
  1000   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "changed to neurobasal medium"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0009458:Medium [Intellectual Product]
   770   C0392747:Changed [Functional Concept]
   770   C0439536:Medium [Quantitative Concept]
   770   C0443172:Changed [Quantitative Concept]
   770   C1705217:Medium [Substance]
   770   C3244283:medium [Intellectual Product]
   737 E C1705241:Change [Quantitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the B27 supplement"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0242295:Supplement [Food]
   861   C1947943:Supplement [Intellectual Product]
   861   C2348609:Supplement [Functional Concept]

Phrase: "(Invitrogen"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "either amphoterin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0019796:Amphoterin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1333908:AMPHOTERIN [Gene or Genome]

Phrase: "retinoic acid,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0040845:Retinoic Acid [Organic Chemical,Pharmacologic Substance,Vitamin]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "or"

Phrase: "no addition."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]
Processing 00000000.tx.54: During the subculture, the medium was changed every 2days. 

Phrase: "During the subculture,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0200940:Subculture [Laboratory Procedure]
  1000   C0699799:subculture [Population Group]

Phrase: "the medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009458:Medium [Intellectual Product]
  1000   C0439536:Medium [Quantitative Concept]
  1000   C1705217:Medium [Substance]
  1000   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "changed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:Changed [Functional Concept]
  1000   C0443172:Changed [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "every 2days."
Processing 00000000.tx.55: For analysis, cells were plated on gelatin-coated (0.1%) or amphoterin-coated (20g/ml) plates/glasses and cultured in the above-mentioned differentiation conditions for 4days. 

Phrase: "For analysis,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002778:Analysis [Laboratory Procedure]
  1000   C0936012:Analysis [Research Activity]
  1000   C1524024:analysis [Functional Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "plated on gelatin-coated"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   770   C0017237:Gelatin [Amino Acid, Peptide, or Protein,Biomedical or Dental Material,Pharmacologic Substance]
   770   C1145617:Gelatin [Food]
   770   C1522408:Coated [Qualitative Concept]
   737   C0005971:Plate [Medical Device]
   737 E C0453946:Coat [Manufactured Object]
   737   C1139930:plate [Medical Device]
   737 E C2987482:Coat [Body Part, Organ, or Organ Component]
   737   C3537155:Plate [Manufactured Object]

Phrase: "(0.1%"

Phrase: ")"

Phrase: "or"

Phrase: "amphoterin-coated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1522408:Coated [Qualitative Concept]
   827 E C0453946:Coat [Manufactured Object]
   827 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "(20g/ml)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "plates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005971:Plate [Medical Device]
  1000   C1139930:plate [Medical Device]
  1000   C3537155:Plate [Manufactured Object]

Phrase: "/glasses"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0015421:Glasses [Medical Device]
   966 E C0017596:Glass [Manufactured Object]
   966 E C1947936:Glass [Medical Device]
   916 E C0074759:Glassy [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   916 E C0522500:Glassy [Qualitative Concept]

Phrase: "and"

Phrase: "cultured in the above-mentioned differentiation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0007589:Differentiation [Cell Function]
   753   C1511938:Differentiation [Clinical Attribute]
   753   C2945687:Differentiation [Functional Concept]
   719   C0010453:Culture [Idea or Concept]
   719   C0220814:culture [Functional Concept]
   719   C0430400:Culture [Laboratory Procedure]
   719   C2242979:Culture [Laboratory Procedure]

Phrase: "conditions for 4days."
Meta Candidates (Total=9; Excluded=6; Pruned=0; Remaining=3)
   790   C0012634:condition [Disease or Syndrome]
   790   C0348080:Condition [Qualitative Concept]
   790   C1705253:Condition [Conceptual Entity]
   734 E C0040607:Training [Educational Activity]
   734 E C0220931:Training [Educational Activity]
   734 E C0336809:Train [Manufactured Object]
   734 E C1552514:Train [Manufactured Object]
   734 E C2673163:training [Qualitative Concept]
   706 E C0009647:Conditioned [Mental Process]
Processing 00000000.tx.56: Morphological differentiation was followed by observing neurite outgrowth response of the cells for up to 4+16days (4days of differentiation as embryoid bodies followed by 16days of differentiation as separated cells in various conditions). 

Phrase: "Morphological differentiation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0007589:Differentiation [Cell Function]
   861   C1511938:Differentiation [Clinical Attribute]
   861   C2945687:Differentiation [Functional Concept]
   789 E C0205615:Differentiated [Qualitative Concept]

Phrase: "was"

Phrase: "followed by observing neurite outgrowth response of the cells"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   764   C0332283:Followed by [Temporal Concept]
           followed
   764   C3158384:neurite outgrowth [Cell Function]
   742   C0007634:Cells [Cell]
   742   C0085103:Neurite [Cell Component]
   742   C0871261:Response [Organism Attribute]
   742   C1704632:Response [Finding]
   742   C1706817:Response [Intellectual Product]
   742   C2911692:Response [Mental Process]
   742   C3282337:Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1719822:Follow [Intellectual Product]
   708 E C1948049:Cell [Spatial Concept]

Phrase: "for"

Phrase: "up to 4+16days"

Phrase: "(4days of differentiation"

Phrase: "as embryoid bodies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C2936498:Embryoid Bodies [Cell]
   861   C0242821:bodies [Human]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]

Phrase: "followed by 16days of differentiation"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   806   C0332283:Followed by [Temporal Concept]
           followed
   760   C0007589:Differentiation [Cell Function]
   760   C1511938:Differentiation [Clinical Attribute]
   760   C2945687:Differentiation [Functional Concept]
   726 E C1719822:Follow [Intellectual Product]

Phrase: "as separated cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "in various conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: ")."
Processing 00000000.tx.57: Phase contrast micrographs were taken with an Olympus IX-70 reversed microscope with Hoffman modulation phase contrast optics and an Olympus DP-10 digital camera. 

Phrase: "Phase contrast micrographs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   734   C0444701:Phase contrast [Laboratory Procedure]
   721   C0240341:Micrographia [Finding]
   721   C0596928:micrography [Laboratory Procedure]

Phrase: "were"

Phrase: "taken with an Olympus IX-70 reversed microscope"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   744   C0015491:IX [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0181839:Microscope [Medical Device]
   744   C1706379:Microscope [Medical Device]
   744   C1883727:Taken [Conceptual Entity]
   711 E C1515187:Take [Health Care Activity]
   711   C1555029:Reverse [Idea or Concept]

Phrase: "with Hoffman modulation phase contrast optics"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0029144:Optics [Occupation or Discipline]
   771 E C0015392:Optic [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "an Olympus DP-10 digital camera."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0179533:Camera [Medical Device]
   804   C1654607:Camera [Eukaryote]
   804   C1706254:CAMERA [Medical Device]
Processing 00000000.tx.58: Immunocytochemistry and Cell Proliferation Assay-- Cells were fixed with 4% paraformaldehyde buffered in PBS for 20min at room temperature followed by permeabilization with PBS+0.1% Triton X-100 for 10min and blocking with PBS+2% BSA for 30min. 

Phrase: "Immunocytochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242349:Immunocytochemistry [Laboratory Procedure]

Phrase: "and"

Phrase: "Cell Proliferation Assay"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   901   C0596290:Cell Proliferation [Cell Function]
   827   C0005507:Assay [Laboratory Procedure]
   827   C0007634:Cell [Cell]
   827   C0243073:assay [Qualitative Concept]
   827   C0334094:Proliferation [Pathologic Function]
   827   C1269647:Cell [Cell]
   827   C1510438:Assay [Laboratory Procedure]
   827   C1514485:Proliferation [Functional Concept]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "--"

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "fixed with 4% paraformaldehyde"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0070066:Paraformaldehyde [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   770   C0231441:Fixed [Finding]
   770   C0443218:Fixed [Qualitative Concept]
   770   C2827483:Fixed [Body Substance]

Phrase: "buffered in PBS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]

Phrase: "for 20min"

Phrase: "at room temperature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "followed by permeabilization"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   882   C0332283:Followed by [Temporal Concept]
           followed
   756 E C1719822:Follow [Intellectual Product]

Phrase: "with PBS+0.1% Triton X-100"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   827   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   799   C0242759:Triton [Geographic Area]

Phrase: "for 10min"

Phrase: "and"

Phrase: "blocking with PBS+2% BSA"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   760   C0233660:Blocking [Mental or Behavioral Dysfunction]
   760   C0332206:Blocking [Functional Concept]
   760   C1720830:PBS [Disease or Syndrome]
   760   C1823521:PBS [Gene or Genome]
   726 E C0028778:Block [Pathologic Function]
   726 E C1533157:Block [Substance]
   726 E C1706084:Block [Geographic Area]
   726 E C2828370:Block [Quantitative Concept]

Phrase: "for 30min."
Processing 00000000.tx.59: Cells were then incubated with primary antibodies for either 1h at room temperature or overnight at +4C followed by 1h of incubation with TRITC- or fluorescein isothiocyanate-conjugated secondary antibodies (Jackson ImmunoResearch Laboratories, Inc.) corresponding to the species where the primary antibodies were made. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "incubated with primary antibodies"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0205225:Primary [Qualitative Concept]
   770   C0439631:Primary [Therapeutic or Preventive Procedure]
   770   C1439852:Incubated [Laboratory Procedure]
   737 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "for either 1h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1442450:1H [Temporal Concept]

Phrase: "at room temperature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "or"

Phrase: "overnight at +4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0450376:4c [Intellectual Product]

Phrase: "followed by 1h of incubation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   806   C0332283:Followed by [Temporal Concept]
           followed
   760   C1442450:1H [Temporal Concept]
   726 E C1719822:Follow [Intellectual Product]

Phrase: "with TRITC-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076308:TRITC [Organic Chemical,Pharmacologic Substance]

Phrase: "or"

Phrase: "fluorescein isothiocyanate-conjugated secondary antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   771 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Jackson ImmunoResearch Laboratories,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0022877:Laboratories [Manufactured Object,Organization]
   827   C1619828:Laboratories [Intellectual Product]
   793 E C3244292:laboratory [Functional Concept]

Phrase: "Inc.)"

Phrase: "corresponding to the species where"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1705920:Species [Conceptual Entity]

Phrase: "the primary antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "made."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]
Processing 00000000.tx.60: The cells were finally counter-stained with nuclear stain DAPI (Molecular Probes, Inc.). 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "finally"

Phrase: "counter-stained with nuclear stain DAPI (Molecular Probes,"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   770   C0026381:Molecular Probes [Indicator, Reagent, or Diagnostic Aid]
   744   C0057142:DAPI [Organic Chemical,Pharmacologic Substance]
   744   C0182400:Probes [Medical Device]
   744   C0521447:Nuclear [Spatial Concept]
   744   C0677601:Counter [Manufactured Object]
   744   C1521991:Molecular [Qualitative Concept]
   744   C1705206:Counter [Medical Device]
   744   C2986582:Stained [Qualitative Concept]
   711 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   711 E C1704681:Probe [Gene or Genome]
   711 E C2347609:Probe [Chemical Viewed Functionally]
   711 E C3536729:Probe [Manufactured Object]

Phrase: "Inc."

Phrase: ")."
Processing 00000000.tx.61: The cells were examined with an Olympus Provis AX-70 fluorescence microscope, and photomicrographs were obtained with Photometrics SenSys chare-coupled device camera. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "examined with an Olympus Provis AX-70 fluorescence microscope,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   742   C0016315:Fluorescence [Natural Phenomenon or Process]
   742   C0181839:Microscope [Medical Device]
   742   C0332128:Examined [Finding]
   742   C0336669:Ax [Manufactured Object]
   742   C1706379:Microscope [Medical Device]

Phrase: "and"

Phrase: "photomicrographs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   893   C0031753:Photomicrographies [Laboratory Procedure]

Phrase: "were"

Phrase: "obtained with Photometrics SenSys chare-coupled device camera."
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   770   C0179533:Camera, device [Medical Device]
           Camera
   770   C1706254:Device Camera [Medical Device]
           CAMERA
   744   C0025080:Device [Medical Device]
   744   C0699733:Device [Manufactured Object]
   744   C1301820:Obtained [Functional Concept]
   744   C1654607:Camera [Eukaryote]
   744   C1948027:Coupled [Functional Concept]
   711 E C0010222:couple [Family Group]
   711 E C1706701:Obtain [Activity]
Processing 00000000.tx.62: The proportions of cells that stained positive for NFL, GFAP, Tuj1, or GluR1 to total number cells (DAPI) were counted on five randomly selected fields (total of 300-400 cells/sample). 

Phrase: "The proportions of cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1709707:Proportion [Quantitative Concept]

Phrase: "that stained positive for NFL,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0439178:% Positive [Quantitative Concept]
   760   C1446409:Positive [Qualitative Concept]
   760   C1514241:Positive [Finding]
   760   C2825490:Positive [Qualitative Concept]

Phrase: "GFAP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017626:Glial fibrillar acidic protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Tuj1,"

Phrase: "or"

Phrase: "GluR1 to total number cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1415287:GLUR1 [Gene or Genome]

Phrase: "(DAPI)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0057142:DAPI [Organic Chemical,Pharmacologic Substance]

Phrase: "were"

Phrase: "counted on five randomly selected fields"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0205451:Five [Quantitative Concept]
   719   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   719   C0750480:Count [Activity]
   719   C1521738:Field [Conceptual Entity]
   719   C1705566:Count [Quantitative Concept]
   719   C1707391:Select [Activity]
   719   C2346620:Field [Conceptual Entity]
   719   C2349184:Field [Conceptual Entity]
   719   C3539073:FIELD [Spatial Concept]

Phrase: "(total of 300-400 cells/sample"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1441375:Cells.total [Cell]
   753   C0439175:% total [Quantitative Concept]
   753   C0439810:Total [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.63: Cell proliferation was assayed by labeling the cells with 100M bromodeoxyuridine (BrdUrd; Sigma) for 18h and then detecting cells actively synthesizing DNA with an immunocytochemical assay kit using a monoclonal anti-BrdUrd antibody (Amersham Biosciences). 

Phrase: "Cell proliferation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0596290:Cell Proliferation [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0334094:Proliferation [Pathologic Function]
   861   C1269647:Cell [Cell]
   861   C1514485:Proliferation [Functional Concept]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "assayed by labeling"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1167624:Labeling [Mental Process]
   790   C1947902:Labeling [Manufactured Object]
   790   C2827499:Labeling [Governmental or Regulatory Activity]
   756   C0005507:Assay [Laboratory Procedure]
   756   C0243073:assay [Qualitative Concept]
   756   C1510438:Assay [Laboratory Procedure]

Phrase: "the cells with 100M bromodeoxyuridine"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0007634:THE CELL [Cell]
           Cells
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "(BrdUrd"

Phrase: "; Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "for 18h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442448:18H [Temporal Concept]

Phrase: "and"

Phrase: "then detecting cells actively synthesizing DNA with an immunocytochemical assay kit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a monoclonal anti-BrdUrd antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   902   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   875   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Amersham Biosciences"

Phrase: ")."
Processing 00000000.tx.64: The proportion of BrdUrd-positive cells to total cells was calculated in five randomly selected fields under a light microscope. 

Phrase: "The proportion of BrdUrd-positive cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1709707:Proportion [Quantitative Concept]

Phrase: "to total cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "calculated in five randomly selected fields"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0205451:Five [Quantitative Concept]
   753   C0444686:Calculated [Functional Concept]
   753   C1441506:Calculated [Activity]
   753   C1443182:Calculated [Laboratory Procedure]
   719   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   719   C1521738:Field [Conceptual Entity]
   719   C1707391:Select [Activity]
   719   C2346620:Field [Conceptual Entity]
   719   C2349184:Field [Conceptual Entity]
   719   C3539073:FIELD [Spatial Concept]

Phrase: "under a light microscope."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0491970:Light Microscope [Medical Device]
   861   C0023693:Light [Natural Phenomenon or Process]
   861   C0181839:Microscope [Medical Device]
   861   C1306462:Light [Functional Concept]
   861   C1706379:Microscope [Medical Device]
   861   C1881376:Light [Qualitative Concept]
Processing 00000000.tx.65: RT-PCR methods-- Differential display RT-PCR (DDRT-PCR) was performed according to the method described previously (25) with some modifications. 

Phrase: "RT-PCR methods"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0025663:Methods [Intellectual Product]
   827   C0025664:methods [Intellectual Product]
   827   C0449851:Methods [Functional Concept]
   793 E C0871511:METHOD [Intellectual Product]
   734   C0599161:RT-PCR [Molecular Biology Research Technique]

Phrase: "--"

Phrase: "Differential display RT-PCR (DDRT-PCR)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0599161:RT-PCR [Molecular Biology Research Technique]
   812   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   812   C0677874:pCR [Finding]

Phrase: "was"

Phrase: "performed according to the method"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0025663:Method [Intellectual Product]
   760   C0449851:Method [Functional Concept]
   760   C0680240:according [Social Behavior]
   760   C0871511:METHOD [Intellectual Product]
   760   C0884358:Performed [Functional Concept]
   726 E C2947996:Perform [Pharmacologic Substance]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(25"

Phrase: ")"

Phrase: "with some modifications."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0392747:Modification [Functional Concept]
   966   C1554963:modification [Qualitative Concept]
Processing 00000000.tx.66: Briefly, total RNA was isolated using the RNAeasy kit with RNase-free DNase set (Qiagen) from stable N18 cell clones expressing either full-length RAGE or cytoplasmic deletion RAGE. 

Phrase: "Briefly,"

Phrase: "total RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "isolated"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205409:Isolated [Functional Concept]
  1000   C1548221:Isolated [Idea or Concept]
   966 E C0370215:Isolate [Substance]
   966 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the RNAeasy kit with RNase-free DNase set (Qiagen"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   742   C0812225:KIT [Medical Device]
   742   C1150635:KIT [Molecular Function]
   742   C1705212:Kit [Medical Device]
   742   C1705213:KIT [Medical Device]
   742   C3273202:Kit [Manufactured Object]

Phrase: ")"

Phrase: "from stable N18 cell clones"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0009013:cell clones [Cell]
           Clones
   779 E C1522642:Clone [Tissue]
   729 E C1704387:Clonal [Qualitative Concept]
   706 E C0796368:clonality [Diagnostic Procedure]

Phrase: "expressing"

Phrase: "either full-length RAGE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   882   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   742   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "or"

Phrase: "cytoplasmic deletion RAGE."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   909   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   767   C0206587:Cytoplasmic Receptor [Amino Acid, Peptide, or Protein,Receptor]
   744   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.67: Cells were plated on amphoterin-coated (20g/ml, o/n at +4C) plates 24h before RNA isolation. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "plated on amphoterin-coated"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   770   C0019796:Amphoterin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1333908:AMPHOTERIN [Gene or Genome]
   770   C1522408:Coated [Qualitative Concept]
   737   C0005971:Plate [Medical Device]
   737 E C0453946:Coat [Manufactured Object]
   737   C1139930:plate [Medical Device]
   737 E C2987482:Coat [Body Part, Organ, or Organ Component]
   737   C3537155:Plate [Manufactured Object]

Phrase: "(20g/ml,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "o/n at +4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0450376:4c [Intellectual Product]

Phrase: ")"

Phrase: "plates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005971:Plate [Medical Device]
  1000   C1139930:plate [Medical Device]
  1000   C3537155:Plate [Manufactured Object]

Phrase: "24h before RNA isolation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0456696:/24h [Temporal Concept]
   770   C1442770:24H [Temporal Concept]
Processing 00000000.tx.68: Total RNA was reverse transcribed on reaction containing 0.5g of RNA, 0.6mM dNTP-mix, 0.2M (dT)11VN (V=G, A, C), 20units of RNasin (Promega), 140units of Moloney murine leukemia virus-reverse transcriptase (Promega) with 1 Moloney murine leukemia virus-RT reaction buffer supplied by the manufacturer. 

Phrase: "Total RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "reverse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: "transcribed on reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0443286:Reaction [Functional Concept]
   790   C1114821:Reaction [Clinical Attribute]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.5g of RNA,"

Phrase: "0.6mM dNTP-mix,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0205430:Mix [Functional Concept]
   812   C1421951:MIX [Gene or Genome]
   812   C1720722:Mix [Qualitative Concept]

Phrase: "0.2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3171718:2M [Quantitative Concept]

Phrase: "(dT)11VN"

Phrase: "(V=G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "A,"

Phrase: "C"

Phrase: ")"

Phrase: ","

Phrase: "20units of RNasin"

Phrase: "(Promega"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0072149:Promega [Lipid]

Phrase: ")"

Phrase: ","

Phrase: "140units of Moloney murine leukemia virus-reverse transcriptase"

Phrase: "(Promega"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0072149:Promega [Lipid]

Phrase: ")"

Phrase: "with 1 Moloney murine leukemia virus-RT reaction buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "supplied by the manufacturer."
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   770   C0947322:Manufacturer [Intellectual Product]
   770   C1705426:Manufacturer [Population Group]
   770   C1999230:Supplied [Activity]
   737 E C0243163:supply [Idea or Concept]
   737 E C0699914:supply [Quantitative Concept]
   737 E C1314650:SUPPLY, NOT OTHERWISE SPECIFIED [Medical Device]
   737 E C1561604:supply [Functional Concept]
   737 E C1875802:SUPPLY [Medical Device]
Processing 00000000.tx.69: A 2-l sample of the reverse transcription mixture was then used for polymerase chain reaction. 

Phrase: "A 2-l sample of the reverse transcription mixture"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0370003:Sample [Substance]
   742   C2347026:Sample [Conceptual Entity]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "used for polymerase chain reaction."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   862   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0337112:Chain [Manufactured Object]
   760   C0443286:Reaction [Functional Concept]
   760   C1114821:Reaction [Clinical Attribute]
   760   C1273517:used [Finding]
   760   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1524075:Chain [Idea or Concept]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.70: Subsequent PCR reaction was performed in 1 PCR mix (2.5M dNTP, 10mM Tris-HCl, pH 8.8,150mM KCl, 1.5mM MgCl2, 0.1% Triton X-100) containing 0.2M one of the 12possible (dT)11VN primer with 0.2M one of the 26different arbitrary primers, 0.1l of [32P]dCTP (6000Ci/mmol), and 1unit of DyNAzyme II DNA Polymerase (Finnzymes). 

Phrase: "Subsequent PCR reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "performed in 1 PCR mix"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0205430:Mix [Functional Concept]
   760   C0677874:pCR [Finding]
   760   C0884358:Performed [Functional Concept]
   760   C1421951:MIX [Gene or Genome]
   760   C1720722:Mix [Qualitative Concept]
   726 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(2.5M dNTP,"

Phrase: "10mM Tris-HCl,"

Phrase: "pH 8.8,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "150mM KCl,"

Phrase: "1.5mM MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "0.1% Triton X-100"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   840   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   804   C0242759:Triton [Geographic Area]

Phrase: ")"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.2M one of the 12possible"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205447:One [Quantitative Concept]

Phrase: "(dT)11VN primer with 0.2M one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "of the 26different arbitrary primers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "0.1l of [32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1553631:32p [Medical Device]

Phrase: "]dCTP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0045191:dCTP [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(6000Ci/mmol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439190:MMOLE [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "1unit of DyNAzyme II DNA Polymerase"

Phrase: "(Finnzymes"

Phrase: ")."
Processing 00000000.tx.71: The amplification products were separated on a 6% denaturing polyacrylamide gel and blotted onto Whatman 3-mm paper, vacuum-dried, and exposed to BioMaxMR film (Kodak) overnight. 

Phrase: "The amplification products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "separated on a 6% denaturing polyacrylamide gel"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   748   C0017243:Gel [Biomedical or Dental Material]
   748   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   748   C0086972:Separated [Finding]
   748   C0443299:separated [Spatial Concept]
   748   C0687118:Separated [Functional Concept]
   748   C1382104:Gel [Substance]

Phrase: "and"

Phrase: "blotted onto Whatman 3-mm paper,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0030351:Paper [Manufactured Object]
   753   C1547566:Paper [Idea or Concept]

Phrase: "vacuum-dried,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1512080:Dried [Qualitative Concept]
   861   C2827485:Dried [Body Substance]

Phrase: "and"

Phrase: "exposed to BioMaxMR film"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0332157:Exposed to [Clinical Attribute]
           Exposed
   770   C0086296:Film [Manufactured Object]
   770   C1561571:film [Biomedical or Dental Material]
   770   C1561572:film [Substance]

Phrase: "(Kodak"

Phrase: ")"

Phrase: "overnight."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439583:Overnight [Temporal Concept]
Processing 00000000.tx.72: Differentially expressed bands were excised from the dried gel and incubated in 50l of 1 PCR buffer for 1h at +56C. 

Phrase: "Differentially expressed bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0175723:Bands [Medical Device]
   793 E C0439645:Band [Spatial Concept]
   793 E C1521913:band [Cell Component]

Phrase: "were"

Phrase: "excised from the dried gel"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0017243:Gel [Biomedical or Dental Material]
   760   C1382104:Gel [Substance]
   760   C1512080:Dried [Qualitative Concept]
   760   C2827485:Dried [Body Substance]

Phrase: "and"

Phrase: "incubated in 50l of 1 PCR buffer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   748   C0677874:pCR [Finding]
   748   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 1h at +56C."
Processing 00000000.tx.73: Reamplification was carried out from 2l of eluate with the same primers using the same PCR conditions as in the first round of amplification except that 20M dNTP and no labeled dCTP were used. 

Phrase: "Reamplification"

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out from 2l of eluate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0301870:Eluate [Body Substance]
   760   C0439787:Out [Spatial Concept]
   760   C0849355:Out [Qualitative Concept]
   760   C1272724:Eluate [Substance]

Phrase: "with the same primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the same PCR conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "as in the first round of amplification"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0205435:First [Quantitative Concept]
   748   C0332490:Round [Spatial Concept]
   748   C1279901:First [Qualitative Concept]
   748   C1517480:Amplification [Molecular Biology Research Technique]
   748   C1521871:Amplification [Phenomenon or Process]
   748   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "except"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332300:except [Functional Concept]

Phrase: "that 20M dNTP"

Phrase: "and"

Phrase: "no labeled dCTP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0045191:dCTP [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.74: Reamplified fragments were cloned into the pGEM-T vector (Promega) and subsequently sequenced by the dideoxy-sequencing technique. 

Phrase: "Reamplified fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332255:fragments [Functional Concept]
   861   C0486805:Fragments [Body Substance]
   827 E C1708096:Fragment [Qualitative Concept]

Phrase: "were"

Phrase: "cloned into the pGEM-T vector"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0009013:cloned [Cell]
   753   C0049896:PGE-M [Eicosanoid]
   753   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0442335:Vector [Spatial Concept]
   753   C1705099:Vector [Idea or Concept]
   719 E C1522642:Clone [Tissue]

Phrase: "(Promega"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0072149:Promega [Lipid]

Phrase: ")"

Phrase: "and"

Phrase: "subsequently"

Phrase: "sequenced by the dideoxy-sequencing technique."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0449851:Technique [Functional Concept]
   753   C1553778:Sequencing [Intellectual Product]
   753   C1561491:Sequencing [Functional Concept]
   719   C0004793:Sequence [Nucleotide Sequence]
   719   C0162326:Sequence [Nucleotide Sequence]
   719   C0162327:Sequence [Nucleotide Sequence]
   719   C1519249:Sequence [Functional Concept]
Processing 00000000.tx.75: Semiquantitative RT-PCR was performed similarly to the DDRT-PCR except that specific primer pairs were used and labeled nucleotides were excluded from the PCR reaction. 

Phrase: "Semiquantitative RT-PCR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0599161:RT-PCR [Molecular Biology Research Technique]
   827   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0677874:pCR [Finding]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "similarly to the DDRT-PCR"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0599161:RT-PCR [Molecular Biology Research Technique]
   778   C0887824:Differential Display [Laboratory Procedure,Molecular Biology Research Technique]
   748   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   748   C0443199:Differential [Qualitative Concept]
   748   C0677874:pCR [Finding]
   748   C1705242:Differential [Qualitative Concept]
   748   C1705417:Display [Manufactured Object]

Phrase: "except"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332300:except [Functional Concept]

Phrase: "that specific primer pairs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1709450:Pair [Qualitative Concept]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "and"

Phrase: "labeled nucleotides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0028630:Nucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "excluded from the PCR reaction."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0443286:Reaction [Functional Concept]
   760   C0677874:pCR [Finding]
   760   C1114821:Reaction [Clinical Attribute]
   760   C1554077:Excluded [Idea or Concept]
   760   C2828389:Excluded [Activity]
   726 E C0332196:Exclude [Functional Concept]
Processing 00000000.tx.76: All oligonucleotides were purchased from Sigma. 

Phrase: "All oligonucleotides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028953:Oligonucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "purchased from Sigma."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0869011:purchased [Activity]
   790   C1719918:Sigma [Intellectual Product]
Processing 00000000.tx.77: Western Blotting-- To analyze protein expression the cells were washed once with ice-cold PBS and lysed in RIPA buffer (PBS containing 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS, 10mg/ml phenylmethylsulfonyl fluoride, 2g/ml aprotinin, 1mM sodium orthovanadate) on ice. 

Phrase: "Western Blotting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   983 E C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]

Phrase: "--"

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "analyze"

Phrase: "protein expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1171362:protein expression [Genetic Function]
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "once with ice-cold PBS"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0456963:Ice cold [Qualitative Concept]
   760   C0009264:Cold [Natural Phenomenon or Process]
   760   C0009443:Cold [Disease or Syndrome]
   760   C0020746:Ice [Inorganic Chemical]
   760   C0234192:Cold [Physiologic Function]
   760   C1720092:Once [Intellectual Product]
   760   C1720830:PBS [Disease or Syndrome]
   760   C1823521:PBS [Gene or Genome]
   760   C1948045:Once [Temporal Concept]

Phrase: "and"

Phrase: "lysed in RIPA buffer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0024348:lysed [Pathologic Function]
   770   C0034584:RIPA [Laboratory Procedure]

Phrase: "(PBS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720830:PBS [Disease or Syndrome]
  1000   C1823521:PBS [Gene or Genome]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "1% Nonidet P-40,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0068941:Nonidet P-40 [Organic Chemical,Pharmacologic Substance]
   812   C0068940:nonidet [Organic Chemical,Pharmacologic Substance]
   812   C0439509:/40 [Temporal Concept]

Phrase: "0.5% sodium deoxycholate,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0037500:SODIUM DESOXYCHOLATE [Pharmacologic Substance,Steroid]
   812   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   812   C0086123:Deoxycholate [Hormone,Pharmacologic Substance,Steroid]
   812   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "0.1% SDS,"

Phrase: "10mg/ml phenylmethylsulfonyl fluoride,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031493:Phenylmethylsulfonyl Fluoride [Organic Chemical,Pharmacologic Substance]
   812   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "2g/ml aprotinin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003641:Aprotinin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "1mM sodium orthovanadate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0029366:Orthovanadate [Inorganic Chemical]
   827   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   827   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: ")"

Phrase: "on ice."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020746:Ice [Inorganic Chemical]
Processing 00000000.tx.78: Equal amounts of proteins were separated in SDS-PAGE gels and electrotransferred on nitrocellulose filters as has been described previously (14). 

Phrase: "Equal amounts of proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:amounts [Quantitative Concept]

Phrase: "were"

Phrase: "separated in SDS-PAGE gels"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   760   C0017243:Gels [Biomedical or Dental Material]
   760   C0086972:Separated [Finding]
   760   C0443299:separated [Spatial Concept]
   760   C0687118:Separated [Functional Concept]
   760   C1704732:Page [Intellectual Product]
   726 E C1382104:Gel [Substance]

Phrase: "and"

Phrase: "electrotransferred on nitrocellulose filters"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   770   C0180860:Filters [Manufactured Object]
   770   C0600190:Nitrocellulose [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   737 E C0581406:Filter [Medical Device]
   737 E C1522664:Filter [Intellectual Product]
   737 E C1704449:Filter [Conceptual Entity]
   737 E C1704684:Filter [Medical Device]
   737 E C1875155:FILTER [Medical Device]

Phrase: "as"

Phrase: "has"

Phrase: "been"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.79: Filters were blocked with either 5% nonfat dry milk powder or 2% BSA and incubated with the primary antibody followed by incubation with a peroxidase-conjugated secondary antibody after which the bands were visualized with enhanced chemiluminescence (Amersham Biosciences). 

Phrase: "Filters"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0180860:Filters [Manufactured Object]
   966 E C0581406:Filter [Medical Device]
   966 E C1522664:Filter [Intellectual Product]
   966 E C1704449:Filter [Conceptual Entity]
   966 E C1704684:Filter [Medical Device]
   966 E C1875155:FILTER [Medical Device]

Phrase: "were"

Phrase: "blocked with either 5% nonfat dry milk powder"
Meta Candidates (Total=16; Excluded=3; Pruned=0; Remaining=13)
   770   C1440965:Milk powder [Immunologic Factor]
   744   C0011682:Dry [Natural Phenomenon or Process]
   744   C0026131:Milk [Body Substance]
   744   C0028778:Blocked [Pathologic Function]
   744   C0032861:Powder [Biomedical or Dental Material]
   744   C0205222:Dry [Qualitative Concept]
   744   C0332206:Blocked [Functional Concept]
   744   C0349374:Milk [Food]
   744   C0444318:Milk [Substance]
   744   C1382110:Powder [Substance]
   744   C1512080:Dry [Qualitative Concept]
   744   C2825079:Milk [Food]
   744   C2983591:BLOCKED [Research Activity]
   711 E C1533157:Block [Substance]
   711 E C1706084:Block [Geographic Area]
   711 E C2828370:Block [Quantitative Concept]

Phrase: "or"

Phrase: "2% BSA"

Phrase: "and"

Phrase: "incubated with the primary antibody"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0205225:Primary [Qualitative Concept]
   760   C0439631:Primary [Therapeutic or Preventive Procedure]
   760   C1439852:Incubated [Laboratory Procedure]

Phrase: "followed by incubation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   882   C0332283:Followed by [Temporal Concept]
           followed
   756 E C1719822:Follow [Intellectual Product]

Phrase: "with a peroxidase-conjugated secondary antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "after which"

Phrase: "the bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0175723:Bands [Medical Device]
   966 E C0439645:Band [Spatial Concept]
   966 E C1521913:band [Cell Component]

Phrase: "were"

Phrase: "visualized with enhanced chemiluminescence"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0162524:Chemiluminescence [Natural Phenomenon or Process]
   770   C0234621:Visualized [Functional Concept]
   770   C1450278:Chemiluminescence [Natural Phenomenon or Process]
   770   C2349975:Enhanced [Activity]

Phrase: "(Amersham Biosciences"

Phrase: ")."
Processing 00000000.tx.80: When necessary, the filters were stripped and reprobed with another antibody to confirm equal loading. 

Phrase: "When"

Phrase: "necessary,"

Phrase: "the filters"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0180860:Filters [Manufactured Object]
   966 E C0581406:Filter [Medical Device]
   966 E C1522664:Filter [Intellectual Product]
   966 E C1704449:Filter [Conceptual Entity]
   966 E C1704684:Filter [Medical Device]
   966 E C1875155:FILTER [Medical Device]

Phrase: "were"

Phrase: "stripped"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1321564:Strip [Medical Device]

Phrase: "and"

Phrase: "reprobed with another antibody to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "equal loading."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708715:Loading [Activity]
Processing 00000000.tx.81: To compare relative band intensities densitometric analysis was performed by scanning the blots and measuring the pixel intensities in the scanned images. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "relative band intensities densitometric analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0002778:Analysis [Laboratory Procedure]
   804   C0936012:Analysis [Research Activity]
   804   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "performed by scanning"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C1550369:Performed By [Qualitative Concept]
   790   C0034606:Scanning [Diagnostic Procedure]
   790   C0441633:Scanning [Diagnostic Procedure]
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "the blots"

Phrase: "and"

Phrase: "measuring"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:measuring [Qualitative Concept]
  1000   C0449770:measuring [Quantitative Concept]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "the pixel intensities in the scanned images."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0522510:intensities [Qualitative Concept]
Processing 00000000.tx.82: After background normalization, the optical densities of RAGE-expressing cell samples were compared with the reference value (1.0) of similarly treated RAGEcyto cell samples. 

Phrase: "After background normalization,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1882115:Normalization [Research Activity]

Phrase: "the optical densities of RAGE-"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   862   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   806   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   741   C0599283:receptor density [Genetic Function]
   739   C0178587:densities [Quantitative Concept]
   739   C0205179:Advanced [Qualitative Concept]
   739   C0444930:End [Spatial Concept]
   739   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   739   C0598528:glycation [Phenomenon or Process]
   739   C1514468:Products [Entity]
   739   C2746065:End [Temporal Concept]
   726   C0439164:Optical density [Quantitative Concept]
   726   C1268822:Optical density [Clinical Attribute]
   706 E C0725066:Advance [Medical Device]
   706 E C1704444:Product [Quantitative Concept]

Phrase: "expressing"

Phrase: "cell samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "compared with the reference value"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0086715:Value, Reference [Quantitative Concept]
   760   C1514811:Reference [Idea or Concept]
   760   C1522609:Value [Quantitative Concept]
   760   C1706462:Reference [Conceptual Entity]
   760   C1707455:Compared [Activity]

Phrase: "(1.0"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "of similarly treated RAGEcyto cell samples."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C0370003:Sample [Substance]
   771   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.83: To analyze the phosphorylation of ERK1/2 and CREB upon RAGE ligation, cells were first serum-starved overnight. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "analyze"

Phrase: "the phosphorylation of ERK1/2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0031715:Phosphorylation [Molecular Function]
   742   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "CREB"
Meta Candidates (Total=21; Excluded=1; Pruned=0; Remaining=20)
  1000   C0056695:Cyclic AMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   947   C3158668:cyclic-AMP response element binding [Genetic Function]
   901   C1511573:Cyclic AMP Response Element [Gene or Genome]
   885   C1148918:cyclic AMP binding [Molecular Function]
   858   C1148922:AMP binding [Molecular Function]
   827   C0001455:Cyclic AMP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   827   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0013879:Element [Element, Ion, or Isotope]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0243122:binding [Functional Concept]
   799   C0439596:Cyclic [Temporal Concept]
   799   C0871261:Response [Organism Attribute]
   799   C1145667:Binding [Activity]
   799   C1167622:Binding [Molecular Function]
   799   C1511572:Cyclic [Temporal Concept]
   799   C1704632:Response [Finding]
   799   C1705248:Element [Conceptual Entity]
   799   C1706817:Response [Intellectual Product]
   799   C2911692:Response [Mental Process]
   727 E C0031084:Cyclicities [Temporal Concept]

Phrase: "upon RAGE ligation,"
Meta Candidates (Total=15; Excluded=5; Pruned=0; Remaining=10)
   923   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   861   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   793   C0023690:Ligation [Therapeutic or Preventive Procedure]
   793   C0205179:Advanced [Qualitative Concept]
   793   C0444930:End [Spatial Concept]
   793   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   793   C0598528:glycation [Phenomenon or Process]
   793   C1514468:Products [Entity]
   793   C1720176:Upon [Functional Concept]
   793   C2746065:End [Temporal Concept]
   760 E C0725066:Advance [Medical Device]
   760 E C1704444:Product [Quantitative Concept]
   737 E C0205088:Terminal [Temporal Concept]
   737 E C1705314:Terminal [Manufactured Object]
   737 E C1705315:Terminal [Spatial Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "first serum-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0229671:Serum [Body Substance]
   861   C1546774:Serum [Intellectual Product]
   861   C1550100:Serum [Body Substance]

Phrase: "starved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2348531:Starve [Activity]

Phrase: "overnight."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439583:Overnight [Temporal Concept]
Processing 00000000.tx.84: All of the following steps were performed without the presence of serum. 

Phrase: "All of the following steps"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0444868:All [Quantitative Concept]
   760   C1261552:steps [Conceptual Entity]
   760   C3539085:All [Idea or Concept]
   726   C0332283:follow [Temporal Concept]
   726 E C1704379:Step [Functional Concept]
   726 E C1705117:Step [Quantitative Concept]
   726   C1719822:Follow [Intellectual Product]
   726 E C2825408:Step [Manufactured Object]

Phrase: "were"

Phrase: "performed without the presence of serum."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0229671:Serum [Body Substance]
   753   C0392148:Presence [Therapeutic or Preventive Procedure]
   753   C0884358:Performed [Functional Concept]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   719 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.85: Cells were detached from culture plates by incubation in PBS+0.5mM EDTA. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "detached from culture plates"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   833   C0180454:culture plates [Medical Device]
   770   C0010453:Culture [Idea or Concept]
   770   C0220814:culture [Functional Concept]
   770   C0430400:Culture [Laboratory Procedure]
   770   C0687118:Detached [Functional Concept]
   770   C1139930:plates [Medical Device]
   770   C1561504:detached [Idea or Concept]
   770   C2242979:Culture [Laboratory Procedure]
   737 E C0005971:Plate [Medical Device]
   737 E C3537155:Plate [Manufactured Object]

Phrase: "by incubation"

Phrase: "in PBS+0.5mM EDTA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.86: Cells were resuspended in DMEM supplemented with 0.1mg/ml streptomycin, 100units/ml penicillin G, and 1% BSA (Sigma; cell culture grade), optionally preincubated with kinase inhibitors for 30min, washed, and plated on gelatin-, laminin- or amphoterin-coated plates. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "resuspended in DMEM"

Phrase: "supplemented with 0.1mg/ml streptomycin,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0038425:Streptomycin [Antibiotic,Carbohydrate]
   753   C0439526:/mL [Quantitative Concept]
   719   C0242295:Supplement [Food]
   719   C1947943:Supplement [Intellectual Product]
   719   C2348609:Supplement [Functional Concept]

Phrase: "100units/ml penicillin G,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   875   C1637390:mL/g [Quantitative Concept]
   861   C0030827:Penicillin G [Antibiotic,Organic Chemical]
   812   C0030842:Penicillin [Antibiotic,Organic Chemical]
   812   C0220892:Penicillin [Antibiotic,Organic Chemical]
   812   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "1% BSA (Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1719918:Sigma [Intellectual Product]

Phrase: "; cell culture grade"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0441800:Grade [Classification]
   827   C0919553:Grade [Classification]
   827   C3244287:grade [Finding]
   734   C0007585:Cell Culture [Laboratory Procedure]

Phrase: ")"

Phrase: ","

Phrase: "optionally"

Phrase: "preincubated with kinase inhibitors"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   833   C1152564:Kinase Inhibitors [Molecular Function]
   819 E C3537035:inhibitors kinase [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   816 E C1171350:Kinase Inhibitor [Pharmacologic Substance]
   816 E C3537023:kinase inhibitor [Molecular Function]
   770   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0243077:inhibitors [Chemical Viewed Functionally]
   737 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "for 30min,"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: ","

Phrase: "and"

Phrase: "plated on gelatin-,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0017237:Gelatin [Amino Acid, Peptide, or Protein,Biomedical or Dental Material,Pharmacologic Substance]
   790   C1145617:Gelatin [Food]
   756   C0005971:Plate [Medical Device]
   756   C1139930:plate [Medical Device]
   756   C3537155:Plate [Manufactured Object]

Phrase: "laminin-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022984:Laminin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "amphoterin-coated plates."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1139930:plates [Medical Device]
   793 E C0005971:Plate [Medical Device]
   793 E C3537155:Plate [Manufactured Object]
Processing 00000000.tx.87: At specific time points (0,30,60,or 90min) the cells were washed once with ice-cold PBS and lysed in RIPA buffer on ice. 

Phrase: "At specific time points"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   867   C2348792:Time Point [Temporal Concept]
   827   C0040223:Time [Temporal Concept]
   827   C3541383:Time [Temporal Concept]
   793   C1552961:Point [Quantitative Concept]
   793   C2347617:point [Quantitative Concept]
   771 E C0442043:Temporal [Spatial Concept]
   771 E C2362314:Temporal [Temporal Concept]
   743 E C1632851:Times [Quantitative Concept]

Phrase: "(0,"

Phrase: "30,"

Phrase: "60,"

Phrase: "or"

Phrase: "90min"

Phrase: ")"

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "once with ice-cold PBS"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0456963:Ice cold [Qualitative Concept]
   760   C0009264:Cold [Natural Phenomenon or Process]
   760   C0009443:Cold [Disease or Syndrome]
   760   C0020746:Ice [Inorganic Chemical]
   760   C0234192:Cold [Physiologic Function]
   760   C1720092:Once [Intellectual Product]
   760   C1720830:PBS [Disease or Syndrome]
   760   C1823521:PBS [Gene or Genome]
   760   C1948045:Once [Temporal Concept]

Phrase: "and"

Phrase: "lysed in RIPA buffer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0024348:lysed [Pathologic Function]
   770   C0034584:RIPA [Laboratory Procedure]

Phrase: "on ice."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020746:Ice [Inorganic Chemical]
Processing 00000000.tx.88: To further characterize the signal pathway leading to CREB phosphorylation and chromogranin expression the cells were treated with a set of various protein kinase C inhibitors, including calphostin C, chelerythrine chloride, bisindolylmaleimide (BIM), Go 6976,and a protein kinase A inhibitor H-89 (Calbiochem). 

Phrase: "To further"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1517331:Further [Spatial Concept]
   861   C1883351:To [Qualitative Concept]
   827 E C0205108:far [Spatial Concept]

Phrase: "characterize"

Phrase: "the signal pathway"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037080:Signal Pathway [Molecular Function]
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "leading to CREB phosphorylation"
Meta Candidates (Total=32; Excluded=5; Pruned=0; Remaining=27)
   882   C0056695:Cyclic AMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   849   C3158668:cyclic-AMP response element binding [Genetic Function]
   818   C1511573:Cyclic AMP Response Element [Gene or Genome]
   810   C1657589:response to cyclic AMP [Cell Function]
   784   C1148918:cyclic AMP binding [Molecular Function]
   764   C0001455:Cyclic AMP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   764   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   764   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   762 E C0033618:Protein Binding [Molecular Function]
   762   C1148922:AMP binding [Molecular Function]
   762   C1157225:AMP phosphorylation [Molecular Function]
   742   C0013879:Element [Element, Ion, or Isotope]
   742   C0031715:Phosphorylation [Molecular Function]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0243122:binding [Functional Concept]
   742   C0332152:Leading [Temporal Concept]
   742   C0439596:Cyclic [Temporal Concept]
   742   C0871261:Response [Organism Attribute]
   742   C1145667:Binding [Activity]
   742   C1167622:Binding [Molecular Function]
   742   C1511572:Cyclic [Temporal Concept]
   742   C1522538:Leading [Functional Concept]
   742   C1704632:Response [Finding]
   742   C1705248:Element [Conceptual Entity]
   742   C1706817:Response [Intellectual Product]
   742   C2911692:Response [Mental Process]
   708 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   708 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   708 E C2348269:Lead [Element, Ion, or Isotope]
   708 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "chromogranin expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with a set of various protein kinase C inhibitors,"
Meta Candidates (Total=30; Excluded=7; Pruned=0; Remaining=23)
   784   C0243459:Protein Kinase A Inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   777   C0007634:Set of cells [Cell]
           Cells set
           Cells
   777   C0010531:Protein Kinase A [Amino Acid, Peptide, or Protein,Enzyme]
   777   C1449702:Protein Kinase Inhibitors [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   777   C2757016:Protein Kinase Inhibitors [Molecular Function]
   760   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   757   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   757   C1137947:Protein SET [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C1152564:Kinase Inhibitors [Molecular Function]
   757   C3537035:inhibitors kinase [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   741 E C1171350:Kinase Inhibitor [Pharmacologic Substance]
   741 E C3537023:kinase inhibitor [Molecular Function]
   739   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0036849:Set [Mental Process]
   739   C0243077:inhibitors [Chemical Viewed Functionally]
   739   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   739   C1442518:Set [Functional Concept]
   739   C1522326:Treated [Functional Concept]
   739   C1705195:Set [Conceptual Entity]
   739   C3282337:Cells [Cell]
   706 E C1269647:Cell [Cell]
   706 E C1292734:TREAT [Functional Concept]
   706 E C1704653:Cell [Medical Device]
   706 E C1948049:Cell [Spatial Concept]
   706 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "calphostin C,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "chelerythrine chloride,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0109289:chelerythrine chloride [Organic Chemical,Pharmacologic Substance]
   861   C0008203:Chloride, NOS [Inorganic Chemical]
   861   C0596019:Chloride [Element, Ion, or Isotope]

Phrase: "bisindolylmaleimide (BIM),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0256431:bis(indolyl)maleimide [Organic Chemical,Pharmacologic Substance]

Phrase: "Go"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1822658:GO [Gene or Genome]

Phrase: "6976,"

Phrase: "and"

Phrase: "a protein kinase A inhibitor H-89"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   901   C0243459:Protein Kinase A Inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   867   C1449702:Protein kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C0010531:Protein Kinase A [Amino Acid, Peptide, or Protein,Enzyme]
   839   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   839   C1171350:Kinase Inhibitor [Pharmacologic Substance]
   839   C3537023:kinase inhibitor [Molecular Function]
   839   C3537035:kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   827   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0082782:H 89 [Organic Chemical,Pharmacologic Substance]
   799   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0033727:H+ [Element, Ion, or Isotope]
   799   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0441932:H+ [Classification]
   799   C0564385:/h [Quantitative Concept]
   799   C1999216:Inhibitor [Qualitative Concept]

Phrase: "(Calbiochem"

Phrase: ")."
Processing 00000000.tx.89: U0126, a specific MEK inhibitor (Calbiochem), was used to inhibit ERK1/2 activation.  

Phrase: "U0126,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0755562:U0126 [Organic Chemical,Pharmacologic Substance]

Phrase: "a specific MEK inhibitor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C2347168:MEK Inhibitor [Pharmacologic Substance]
   827   C1999216:Inhibitor [Qualitative Concept]

Phrase: "(Calbiochem"

Phrase: ")"

Phrase: ","

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "ERK1/2 activation."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   795   C1879547:Activation [Activity]
   747   C0082529:Extracellular Signal-Regulated Kinase 1 [Amino Acid, Peptide, or Protein,Enzyme]
   747   C1366765:EXTRACELLULAR SIGNAL-REGULATED KINASE 1 [Gene or Genome]
   744   C0170168:Extracellular Signal-Regulated Kinase 2 [Amino Acid, Peptide, or Protein,Enzyme]
   744   C1366882:EXTRACELLULAR SIGNAL-REGULATED KINASE 2 [Gene or Genome]
Processing 00000000.tx.90: RESULTS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES RAGE Activation Induces Proliferation Arrest and Morphological Differentiation-- RAGE has been reported to mediate neurite outgrowth of neuron-like cells on amphoterin-coated matrices (6, 14, 15). 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "RAGE Activation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   946   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   774   C1514758:Receptor Activation [Cell Function]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "Induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "Proliferation Arrest"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0237477:Arrest [Temporal Concept]
   861   C0392351:arrest [Governmental or Regulatory Activity]

Phrase: "and"

Phrase: "Morphological Differentiation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0007589:Differentiation [Cell Function]
   861   C1511938:Differentiation [Clinical Attribute]
   861   C2945687:Differentiation [Functional Concept]
   789 E C0205615:Differentiated [Qualitative Concept]

Phrase: "--"

Phrase: "RAGE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   716   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "neurite outgrowth of neuron-like cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C3158384:neurite outgrowth [Cell Function]
   753   C0085103:Neurite [Cell Component]

Phrase: "on amphoterin-coated matrices"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1704639:Matrices [Manufactured Object]
   793 E C1704640:Matrix [Spatial Concept]
   793 E C1706515:Matrix [Body Substance]

Phrase: "(6,"

Phrase: "14,"

Phrase: "15"

Phrase: ")."
Processing 00000000.tx.91: N18 neuroblastoma cells expressing full-length RAGE extend an elaborate network of neurites when grown on amphoterin-coated surface (N18/RAGE; Fig. 1, D and K), whereas cells expressing a signaling-incapable, cytoplasmic domain deletion mutant of RAGE do not display such morphology (N18/RAGEcyto; Fig. 1, I and K). 

Phrase: "N18 neuroblastoma cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   884   C0815000:neuroblastoma cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "full-length RAGE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   909   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   744   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "extend"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0231448:Extend [Functional Concept]
  1000   C0439792:extend [Spatial Concept]

Phrase: "an elaborate network of neurites"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1513822:Network [Professional or Occupational Group]
   760   C1705739:Network [Manufactured Object]
   760   C1882071:Network [Conceptual Entity]

Phrase: "when"

Phrase: "grown on amphoterin-coated surface"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0019796:Amphoterin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0205148:Surface [Spatial Concept]
   760   C1333908:AMPHOTERIN [Gene or Genome]
   760   C1522408:Coated [Qualitative Concept]
   726 E C0453946:Coat [Manufactured Object]
   726 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "(N18/RAGE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   946   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "; Fig. 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "K"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "a signaling-incapable, cytoplasmic domain deletion mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "of RAGE"
Meta Candidates (Total=14; Excluded=5; Pruned=0; Remaining=9)
   954   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   877   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   795   C0205179:Advanced [Qualitative Concept]
   795   C0332285:Of [Spatial Concept]
   795   C0444930:End [Spatial Concept]
   795   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   795   C0598528:glycation [Phenomenon or Process]
   795   C1514468:Products [Entity]
   795   C2746065:End [Temporal Concept]
   762 E C0725066:Advance [Medical Device]
   762 E C1704444:Product [Quantitative Concept]
   740 E C0205088:Terminal [Temporal Concept]
   740 E C1705314:Terminal [Manufactured Object]
   740 E C1705315:Terminal [Spatial Concept]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "such morphology"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0332437:Morphology [Qualitative Concept]
  1000   C0543482:morphology [Spatial Concept]
  1000   C0700329:Morphology, NOS [Finding]
  1000   C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "(N18/RAGEcyto"

Phrase: "; Fig. 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "K"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.92: The amphoterin promoted neurite outgrowth response appears to be specifically dependent on RAGE signaling as N18/RAGEcyto cells are capable of neurite outgrowth upon RAGE-independent stimuli, such as retinoic acid and laminin (Fig. 1, A-K). 

Phrase: "The amphoterin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0019796:Amphoterin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1333908:AMPHOTERIN [Gene or Genome]

Phrase: "promoted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0033414:Promote [Activity]

Phrase: "neurite outgrowth response"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]
   734   C3158384:neurite outgrowth [Cell Function]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "specifically dependent on RAGE"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   882   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   818   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   742   C0205179:Advanced [Qualitative Concept]
   742   C0444930:End [Spatial Concept]
   742   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   742   C0598528:glycation [Phenomenon or Process]
   742   C0851827:Dependent [Qualitative Concept]
   742   C1514468:Products [Entity]
   742   C1701901:Dependent [Qualitative Concept]
   742   C2746065:End [Temporal Concept]
   742   C3244310:dependent [Functional Concept]
   708 E C0725066:Advance [Medical Device]
   708 E C1704444:Product [Quantitative Concept]

Phrase: "signaling as N18/RAGEcyto cells"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   781   C0037083:Cell Signaling [Cell Function]
           Signaling
   760   C0007634:Cells [Cell]
   760   C0442791:N18 [Finding]
   760   C3282337:Cells [Cell]
   760   C3537152:signaling [Biologic Function]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1710082:Signal [Phenomenon or Process]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "capable of neurite outgrowth"

Phrase: "upon RAGE-independent stimuli,"
Meta Candidates (Total=17; Excluded=5; Pruned=0; Remaining=12)
   901   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   849   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   791   C0085862:Independent [Idea or Concept]
   791   C0205179:Advanced [Qualitative Concept]
   791   C0234402:Stimuli [Phenomenon or Process]
   791   C0444930:End [Spatial Concept]
   791   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   791   C0598528:glycation [Phenomenon or Process]
   791   C1299583:Independent [Finding]
   791   C1514468:Products [Entity]
   791   C1720176:Upon [Functional Concept]
   791   C2746065:End [Temporal Concept]
   758 E C0725066:Advance [Medical Device]
   758 E C1704444:Product [Quantitative Concept]
   735 E C0205088:Terminal [Temporal Concept]
   735 E C1705314:Terminal [Manufactured Object]
   735 E C1705315:Terminal [Spatial Concept]

Phrase: "such as retinoic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0040845:Retinoic Acid [Organic Chemical,Pharmacologic Substance,Vitamin]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "laminin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022984:Laminin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A-K"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.93: View larger version (91K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(91K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.94: 1.  

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.95: Morphological differentiation and proliferation arrest of RAGE-expressing N18 neuroblastoma cells. 

Phrase: "Morphological differentiation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0007589:Differentiation [Cell Function]
   861   C1511938:Differentiation [Clinical Attribute]
   861   C2945687:Differentiation [Functional Concept]
   789 E C0205615:Differentiated [Qualitative Concept]

Phrase: "and"

Phrase: "proliferation arrest of RAGE-"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   882   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   818   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   742   C0205179:Advanced [Qualitative Concept]
   742   C0237477:Arrest [Temporal Concept]
   742   C0334094:Proliferation [Pathologic Function]
   742   C0392351:arrest [Governmental or Regulatory Activity]
   742   C0444930:End [Spatial Concept]
   742   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   742   C0598528:glycation [Phenomenon or Process]
   742   C1514468:Products [Entity]
   742   C1514485:Proliferation [Functional Concept]
   742   C2746065:End [Temporal Concept]
   708 E C0725066:Advance [Medical Device]
   708 E C1704444:Product [Quantitative Concept]

Phrase: "expressing"

Phrase: "N18 neuroblastoma cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   884   C0815000:neuroblastoma cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.96: N18 neuroblastoma cells stably transfected either with full-length RAGE (N18/RAGE; A-E) or cytoplasmic domain deletion mutant of RAGE (N18/RAGEcyto; F-J) were grown without serum either on gelatin-coated surface (0.1%; A and F), gelatin-coated surface with 1M retinoic acid (B and G), laminin-coated surface (10g/ml; C and H), amphoterin-coated surface (20g/ml; D and I) or amphoterin-coated surface with 1M retinoic acid (E and J) for 5days. 

Phrase: "N18 neuroblastoma cells stably"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   844   C0815000:neuroblastoma cell [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "transfected"

Phrase: "either with full-length RAGE"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   862   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   806   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   739   C0205179:Advanced [Qualitative Concept]
   739   C0443225:Full [Qualitative Concept]
   739   C0444930:End [Spatial Concept]
   739   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   739   C0598528:glycation [Phenomenon or Process]
   739   C1444754:Length [Quantitative Concept]
   739   C1514468:Products [Entity]
   739   C1706316:LENGTH [Research Activity]
   739   C2746065:End [Temporal Concept]
   706 E C0725066:Advance [Medical Device]
   706 E C1704444:Product [Quantitative Concept]

Phrase: "(N18/RAGE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   946   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "; A-E)"

Phrase: "or"

Phrase: "cytoplasmic domain deletion mutant of RAGE"
Meta Candidates (Total=21; Excluded=2; Pruned=0; Remaining=19)
   846   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   797   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   756   C1511625:Cytoplasmic Domain [Cell Component]
   754   C0206587:Cytoplasmic Receptor [Amino Acid, Peptide, or Protein,Receptor]
   738   C0010834:Cytoplasmic [Cell Component]
   738   C0205179:Advanced [Qualitative Concept]
   738   C0444930:End [Spatial Concept]
   738   C0521449:Cytoplasmic [Body Location or Region]
   738   C0596988:Mutant [Cell or Molecular Dysfunction]
   738   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   738   C0598528:glycation [Phenomenon or Process]
   738   C1442161:Deletion [Cell or Molecular Dysfunction]
   738   C1511760:Deletion [Genetic Function]
   738   C1514468:Products [Entity]
   738   C1880274:Deletion [Activity]
   738   C1880389:Domain [Functional Concept]
   738   C1883221:Domain [Conceptual Entity]
   738   C2746065:End [Temporal Concept]
   738   C3541951:Domain [Intellectual Product]
   704 E C0725066:Advance [Medical Device]
   704 E C1704444:Product [Quantitative Concept]

Phrase: "(N18/RAGEcyto"

Phrase: "; F-J)"

Phrase: "were"

Phrase: "grown without serum either"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0229671:Serum [Body Substance]
   770   C1546774:Serum [Intellectual Product]
   770   C1550100:Serum [Body Substance]

Phrase: "on gelatin-coated surface"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205148:Surface [Spatial Concept]

Phrase: "(0.1%"

Phrase: ";"

Phrase: "A"

Phrase: "and"

Phrase: "F),"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "gelatin-coated surface with 1M retinoic acid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205148:Surface [Spatial Concept]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "laminin-coated surface"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205148:Surface [Spatial Concept]

Phrase: "(10g/ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "; C"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "H"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "amphoterin-coated surface"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205148:Surface [Spatial Concept]

Phrase: "(20g/ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "; D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "I)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "or"

Phrase: "amphoterin-coated surface with 1M retinoic acid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205148:Surface [Spatial Concept]

Phrase: "(E"

Phrase: "and"

Phrase: "J) for 5days."
Processing 00000000.tx.97: K, quantitation of neurite outgrowth of cells treated as described above. 

Phrase: "K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "quantitation of neurite outgrowth of cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1709793:Quantitation [Quantitative Concept]

Phrase: "treated as described above."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0332293:treated [Therapeutic or Preventive Procedure]
   770   C1522326:Treated [Functional Concept]
   770   C1552738:described [Idea or Concept]
   737 E C1292734:TREAT [Functional Concept]
Processing 00000000.tx.98: The proportions of neurite-bearing cells (processes longer than one diameter of the cell soma) of all cells in five random fields plus standard deviation is shown. 

Phrase: "The proportions of neurite-bearing cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1709707:Proportion [Quantitative Concept]

Phrase: "(processes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1184743:Process [Body Part, Organ, or Organ Component]
   966   C1522240:Process [Phenomenon or Process]

Phrase: "longer than one diameter of the cell soma"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   750   C0552406:Diameter.long [Quantitative Concept]
   711   C0205166:Long [Qualitative Concept]
   711   C1706317:Long [Qualitative Concept]

Phrase: ")"

Phrase: "of all cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "in five random fields"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   793   C1521738:Field [Conceptual Entity]
   793   C2346620:Field [Conceptual Entity]
   793   C2349184:Field [Conceptual Entity]
   793   C3539073:FIELD [Spatial Concept]

Phrase: "plus standard deviation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0871420:Standard deviation [Quantitative Concept]
   861   C0012727:Deviation [Spatial Concept]
   861   C0205419:Deviation [Qualitative Concept]
   861   C1442989:Standard [Qualitative Concept]
   861   C1705236:Deviation [Finding]
   861   C2828392:Standard [Intellectual Product]

Phrase: "is"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.99: L, cell proliferation was assayed by labeling cells with BrdUrd and counting the number of cells actively synthesizing DNA. 

Phrase: "L,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "cell proliferation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0596290:Cell Proliferation [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0334094:Proliferation [Pathologic Function]
   861   C1269647:Cell [Cell]
   861   C1514485:Proliferation [Functional Concept]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "assayed by labeling cells"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   770   C0007634:Cells [Cell]
   770   C1167624:Labeling [Mental Process]
   770   C1947902:Labeling [Manufactured Object]
   770   C2827499:Labeling [Governmental or Regulatory Activity]
   770   C3282337:Cells [Cell]
   737   C0005507:Assay [Laboratory Procedure]
   737 E C0181496:Label [Manufactured Object]
   737   C0243073:assay [Qualitative Concept]
   737 E C1269647:Cell [Cell]
   737   C1510438:Assay [Laboratory Procedure]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "with BrdUrd"

Phrase: "and"

Phrase: "counting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0750480:Count [Activity]
   966   C1705566:Count [Quantitative Concept]

Phrase: "the number of cells actively synthesizing DNA."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C0007584:Cell Number [Laboratory Procedure]
   748   C0237753:*Number [Quantitative Concept]
   748   C0449788:Number [Quantitative Concept]
Processing 00000000.tx.100: Cells were plated either on gelatin-coated (0.1%), amphoterin-coated (20g/ml), or laminin-coated (10g/ml) surfaces with or without serum or 1M retinoic acid. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "plated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005971:Plate [Medical Device]
   966   C1139930:plate [Medical Device]
   966   C3537155:Plate [Manufactured Object]

Phrase: "either on gelatin-coated"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0017237:Gelatin [Amino Acid, Peptide, or Protein,Biomedical or Dental Material,Pharmacologic Substance]
   770   C1145617:Gelatin [Food]
   770   C1522408:Coated [Qualitative Concept]
   737 E C0453946:Coat [Manufactured Object]
   737 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "(0.1%"

Phrase: ")"

Phrase: ","

Phrase: "amphoterin-coated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1522408:Coated [Qualitative Concept]
   827 E C0453946:Coat [Manufactured Object]
   827 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "(20g/ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "laminin-coated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1522408:Coated [Qualitative Concept]
   827 E C0453946:Coat [Manufactured Object]
   827 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "(10g/ml)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "surfaces with"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0205148:Surface [Spatial Concept]

Phrase: "or without serum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0229671:Serum [Body Substance]
   790   C1546774:Serum [Intellectual Product]
   790   C1550100:Serum [Body Substance]

Phrase: "or"

Phrase: "1M retinoic acid."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0040845:Retinoic Acid [Organic Chemical,Pharmacologic Substance,Vitamin]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.101: After 6h 100M BrdUrd was added, and the cells were incubated for a further 18h before detection of incorporated BrdUrd by immunocytochemical methods. 

Phrase: "After 6h 100M BrdUrd"

Phrase: "was"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated for a further 18h"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C1439852:Incubated [Laboratory Procedure]
   760   C1442448:18H [Temporal Concept]
   760   C1517331:Further [Spatial Concept]
   726 E C0205108:far [Spatial Concept]

Phrase: "before detection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "of incorporated BrdUrd"

Phrase: "by immunocytochemical methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0025663:Methods [Intellectual Product]
   861   C0025664:methods [Intellectual Product]
   861   C0449851:Methods [Functional Concept]
   827 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.102: The proportion of BrdUrd-positive cells to total cells plus standard deviation is shown. 

Phrase: "The proportion of BrdUrd-positive cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1709707:Proportion [Quantitative Concept]

Phrase: "to total cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "plus standard deviation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0871420:Standard deviation [Quantitative Concept]
   861   C0012727:Deviation [Spatial Concept]
   861   C0205419:Deviation [Qualitative Concept]
   861   C1442989:Standard [Qualitative Concept]
   861   C1705236:Deviation [Finding]
   861   C2828392:Standard [Intellectual Product]

Phrase: "is"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.103: Bar=20m. 

Phrase: "Bar=20m."
Processing 00000000.tx.104: Whether the amphoterin-RAGE interaction-induced neurite outgrowth is a simple motility-related morphological response or a sign of a neuronal differentiation program that these cells are committed to has remained elusive. 

Phrase: "Whether"

Phrase: "the amphoterin-RAGE interaction-induced neurite outgrowth"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   753   C0101725:amphoterin receptor [Amino Acid, Peptide, or Protein,Receptor]
   736   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "is"

Phrase: "a simple motility-related morphological response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0871261:Response [Organism Attribute]
   804   C1704632:Response [Finding]
   804   C1706817:Response [Intellectual Product]
   804   C2911692:Response [Mental Process]

Phrase: "or"

Phrase: "a sign of a neuronal differentiation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0311392:Sign [Finding]
   753   C1547188:Sign [Idea or Concept]

Phrase: "program"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1709697:Program [Conceptual Entity]
  1000   C2728259:Program [Pharmacologic Substance]
  1000   C3484370:Program [Functional Concept]

Phrase: "that"

Phrase: "these cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "committed to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   833   C1171947:committed [Organic Chemical,Pharmacologic Substance]
   799 E C2347840:Commit [Machine Activity]

Phrase: "has"

Phrase: "remained elusive."
Processing 00000000.tx.105: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.106: 1L, the morphological differentiation upon RAGE activation (Fig. 1L; gray bars) is accompanied by a decreased rate of cell proliferation, even in the presence of serum, suggesting that these cells are withdrawn from the cell cycle and submitted to a differentiation program. 

Phrase: "1L,"

Phrase: "the morphological differentiation upon RAGE activation"
Meta Candidates (Total=18; Excluded=2; Pruned=0; Remaining=16)
   846   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   797   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   754   C1514758:Receptor Activation [Cell Function]
   738   C0007589:Differentiation [Cell Function]
   738   C0205179:Advanced [Qualitative Concept]
   738   C0444930:End [Spatial Concept]
   738   C0543482:morphological [Spatial Concept]
   738   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   738   C0598528:glycation [Phenomenon or Process]
   738   C1511938:Differentiation [Clinical Attribute]
   738   C1514468:Products [Entity]
   738   C1879547:Activation [Activity]
   738   C2746065:End [Temporal Concept]
   738   C2945687:Differentiation [Functional Concept]
   737   C0596035:activation product [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   726   C2752630:terminal differentiation [Cell Function]
   704 E C0725066:Advance [Medical Device]
   704 E C1704444:Product [Quantitative Concept]

Phrase: "(Fig. 1L"

Phrase: "; gray bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: ")"

Phrase: "is"

Phrase: "accompanied by a decreased rate of cell proliferation,"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   770   C0596290:Cell Proliferation [Cell Function]
   744   C0007634:Cell [Cell]
   744   C0205216:Decreased [Quantitative Concept]
   744   C0334094:Proliferation [Pathologic Function]
   744   C0392756:Decreased [Qualitative Concept]
   744   C0442797:decreased [Qualitative Concept]
   744   C0871208:Rate [Activity]
   744   C1269647:Cell [Cell]
   744   C1514485:Proliferation [Functional Concept]
   744   C1521828:Rate [Quantitative Concept]
   744   C1704653:Cell [Medical Device]
   744   C1948049:Cell [Spatial Concept]
   711 E C0547047:Decrease [Quantitative Concept]

Phrase: "even in the presence of serum,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0229671:Serum [Body Substance]
   753   C0392148:Presence [Therapeutic or Preventive Procedure]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "these cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "withdrawn from the cell cycle"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C0007586:Cell Cycle [Cell Function]
   806   C1155839:Cell Cycle [Cell Function]
   760   C0007634:Cell [Cell]
   760   C0424092:Withdrawn [Finding]
   760   C1269647:Cell [Cell]
   760   C1511572:Cycle [Temporal Concept]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   760   C2349954:Withdrawn [Activity]
   760   C2825032:Withdrawn [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "submitted to a differentiation program."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0007589:Differentiation [Cell Function]
   760   C1511938:Differentiation [Clinical Attribute]
   760   C1515023:Submitted [Functional Concept]
   760   C1709697:Program [Conceptual Entity]
   760   C2728259:Program [Pharmacologic Substance]
   760   C2945687:Differentiation [Functional Concept]
   760   C3484370:Program [Functional Concept]
Processing 00000000.tx.107: Importantly, neither the morphological differentiation nor the proliferation arrest are induced in N18/RAGEcyto cells (Fig. 1L; white bars) showing that RAGE signaling is required for these cells to exit cell cycle and begin differentiation in response to amphoterin stimulation. 

Phrase: "Importantly,"

Phrase: "neither"

Phrase: "the morphological differentiation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0007589:Differentiation [Cell Function]
   861   C1511938:Differentiation [Clinical Attribute]
   861   C2945687:Differentiation [Functional Concept]
   789 E C0205615:Differentiated [Qualitative Concept]

Phrase: "nor"

Phrase: "the proliferation arrest"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0237477:Arrest [Temporal Concept]
   861   C0392351:arrest [Governmental or Regulatory Activity]

Phrase: "are"

Phrase: "induced in N18/RAGEcyto cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0007634:Cells [Cell]
   760   C0205263:Induced [Functional Concept]
   760   C0442791:N18 [Finding]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 1L"

Phrase: "; white bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: ")"

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that RAGE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   946   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "signaling"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0037083:Signaling [Cell Function]
  1000   C3537152:signaling [Biologic Function]
   966 E C1710082:Signal [Phenomenon or Process]

Phrase: "is"

Phrase: "required for these cells to"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0007634:Cells [Cell]
   760   C1514873:Required [Functional Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "exit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0337094:Exit [Spatial Concept]
  1000   C1550550:exit [Temporal Concept]

Phrase: "cell cycle"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007586:Cell Cycle [Cell Function]
  1000   C1155839:Cell Cycle [Cell Function]
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1511572:Cycle [Temporal Concept]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "begin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439659:Begin [Temporal Concept]

Phrase: "differentiation in response"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0007589:Differentiation [Cell Function]
   790   C1511938:Differentiation [Clinical Attribute]
   790   C2945687:Differentiation [Functional Concept]
   718 E C0205615:Differentiated [Qualitative Concept]

Phrase: "to amphoterin stimulation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   861   C1948023:Stimulation [Natural Phenomenon or Process]
Processing 00000000.tx.108: However, both N18/RAGE and N18RAGEcyto cells respond similarly to retinoic acid or laminin treatment confirming that the proliferation arrest induced by amphoterin specifically depends on RAGE signaling (Fig. 1L). 

Phrase: "However,"

Phrase: "both N18/RAGE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   909   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   744   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "N18RAGEcyto cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "respond"

Phrase: "similarly to retinoic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0040845:Retinoic Acid [Organic Chemical,Pharmacologic Substance,Vitamin]
   770   C0001128:Acid [Chemical]
   770   C0202406:Acid [Laboratory Procedure]

Phrase: "or"

Phrase: "laminin treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "confirming"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirming [Qualitative Concept]
  1000   C0750484:confirming [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "that"

Phrase: "the proliferation arrest"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0237477:Arrest [Temporal Concept]
   861   C0392351:arrest [Governmental or Regulatory Activity]

Phrase: "induced by amphoterin specifically"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0019796:Amphoterin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0205263:Induced [Functional Concept]
   770   C1333908:AMPHOTERIN [Gene or Genome]

Phrase: "depends on RAGE"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   909   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   833   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   744   C0205179:Advanced [Qualitative Concept]
   744   C0444930:End [Spatial Concept]
   744   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   744   C0598528:glycation [Phenomenon or Process]
   744   C0725813:depend [Medical Device]
   744   C1514468:Products [Entity]
   744   C2746065:End [Temporal Concept]
   711 E C0725066:Advance [Medical Device]
   711 E C1704444:Product [Quantitative Concept]

Phrase: "signaling"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0037083:Signaling [Cell Function]
  1000   C3537152:signaling [Biologic Function]
   966 E C1710082:Signal [Phenomenon or Process]

Phrase: "(Fig. 1L"

Phrase: ")."
Processing 00000000.tx.109: Chromogranins Are Up-regulated during RAGE-induced Differentiation-- To study changes in gene expression during RAGE-induced differentiation we have used a DDRT-PCR method. 

Phrase: "Chromogranins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008586:Chromogranins [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "Are"

Phrase: "Up-regulated during RAGE-induced Differentiation"
Meta Candidates (Total=20; Excluded=3; Pruned=0; Remaining=17)
   846   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   797   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   754   C3242459:regulated products [Intellectual Product]
   738   C0007589:Differentiation [Cell Function]
   738   C0205179:Advanced [Qualitative Concept]
   738   C0205263:Induced [Functional Concept]
   738   C0444930:End [Spatial Concept]
   738   C0547043:Up [Spatial Concept]
   738   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   738   C0598528:glycation [Phenomenon or Process]
   738   C0851285:Regulated [Governmental or Regulatory Activity]
   738   C1282911:Up [Spatial Concept]
   738   C1511938:Differentiation [Clinical Attribute]
   738   C1514468:Products [Entity]
   738   C2746065:End [Temporal Concept]
   738   C2945687:Differentiation [Functional Concept]
   737 E C1552022:regulated product [Idea or Concept]
   726   C2752630:terminal differentiation [Cell Function]
   704 E C0725066:Advance [Medical Device]
   704 E C1704444:Product [Quantitative Concept]

Phrase: "--"

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "changes in gene expression"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0392747:changes [Functional Concept]
   770   C0443172:changes [Quantitative Concept]
   737 E C1705241:Change [Quantitative Concept]

Phrase: "during RAGE-induced differentiation"
Meta Candidates (Total=21; Excluded=6; Pruned=0; Remaining=15)
   901   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   849   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   802   C2752630:terminal differentiation [Cell Function]
   791   C0007589:Differentiation [Cell Function]
   791   C0205179:Advanced [Qualitative Concept]
   791   C0205263:Induced [Functional Concept]
   791   C0347984:During [Temporal Concept]
   791   C0444930:End [Spatial Concept]
   791   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   791   C0598528:glycation [Phenomenon or Process]
   791   C1511938:Differentiation [Clinical Attribute]
   791   C1514468:Products [Entity]
   791   C1706551:During [Intellectual Product]
   791   C2746065:End [Temporal Concept]
   791   C2945687:Differentiation [Functional Concept]
   758 E C0725066:Advance [Medical Device]
   758 E C1704444:Product [Quantitative Concept]
   735 E C0205088:Terminal [Temporal Concept]
   735 E C1705314:Terminal [Manufactured Object]
   735 E C1705315:Terminal [Spatial Concept]
   720 E C0205615:Differentiated [Qualitative Concept]

Phrase: "we"

Phrase: "have"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a DDRT-PCR method."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0025663:Method [Intellectual Product]
   804   C0449851:Method [Functional Concept]
   804   C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.110: Cells were grown on amphoterin-coated surface for 24h after which total RNA was isolated and RT-PCR was performed with a set of random primers and [32P]dCTP to detect differentially displayed mRNAs in N18/RAGE cells compared with N18/RAGEcyto cells. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "grown on amphoterin-coated surface"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0019796:Amphoterin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0205148:Surface [Spatial Concept]
   760   C1333908:AMPHOTERIN [Gene or Genome]
   760   C1522408:Coated [Qualitative Concept]
   726 E C0453946:Coat [Manufactured Object]
   726 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "for 24h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]

Phrase: "after which total RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "isolated"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205409:Isolated [Functional Concept]
  1000   C1548221:Isolated [Idea or Concept]
   966 E C0370215:Isolate [Substance]
   966 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "and"

Phrase: "RT-PCR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0599161:RT-PCR [Molecular Biology Research Technique]
   861   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0677874:pCR [Finding]

Phrase: "was"

Phrase: "performed with a set of random primers"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   748   C0034656:RANDOM [Research Activity]
   748   C0036849:Set [Mental Process]
   748   C0439605:Random [Qualitative Concept]
   748   C0884358:Performed [Functional Concept]
   748   C1442518:Set [Functional Concept]
   748   C1705195:Set [Conceptual Entity]
   714   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]
   714 E C2947996:Perform [Pharmacologic Substance]

Phrase: "and ["

Phrase: "32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553631:32p [Medical Device]

Phrase: "]dCTP to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0045191:dCTP [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "differentially displayed mRNAs in N18/RAGE cells"
Meta Candidates (Total=21; Excluded=6; Pruned=0; Remaining=15)
   833   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   790   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   736   C0007634:Cells [Cell]
   736   C0205179:Advanced [Qualitative Concept]
   736   C0442791:N18 [Finding]
   736   C0444930:End [Spatial Concept]
   736   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   736   C0598528:glycation [Phenomenon or Process]
   736   C0870432:displayed [Functional Concept]
   736   C1514468:Products [Entity]
   736   C2746065:End [Temporal Concept]
   736   C3282337:Cells [Cell]
   734   C1514760:Receptor Cell [Cell]
   734   C1656978:cell end [Cell Component]
   703   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   703 E C0725066:Advance [Medical Device]
   703 E C1269647:Cell [Cell]
   703 E C1704444:Product [Quantitative Concept]
   703 E C1704653:Cell [Medical Device]
   703 E C1705417:Display [Manufactured Object]
   703 E C1948049:Cell [Spatial Concept]

Phrase: "compared with N18/RAGEcyto cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0007634:Cells [Cell]
   760   C0442791:N18 [Finding]
   760   C1707455:Compared [Activity]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.111: The products of the DDRT-PCR were separated on a denaturing polyacrylamide gel, and N18/RAGE versus N18/RAGEcyto lanes were compared to identify bands of different intensity (Fig. 2A). 

Phrase: "The products of the DDRT-PCR"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C1514468:Products [Entity]
   711 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "separated on a denaturing polyacrylamide gel,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   753   C0017243:Gel [Biomedical or Dental Material]
   753   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   753   C0086972:Separated [Finding]
   753   C0443299:separated [Spatial Concept]
   753   C0687118:Separated [Functional Concept]
   753   C1382104:Gel [Substance]

Phrase: "and"

Phrase: "N18/RAGE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   946   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "versus"

Phrase: "N18/RAGEcyto lanes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: "were"

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "identify"

Phrase: "bands of different intensity"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0175723:Bands [Medical Device]
   737 E C0439645:Band [Spatial Concept]
   737 E C1521913:band [Cell Component]

Phrase: "(Fig. 2A"

Phrase: ")."
Processing 00000000.tx.112: The most prominently induced bands in N18/RAGE cells were excised from the gel, reamplified, cloned, and sequenced. 

Phrase: "The most prominently induced bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0175723:Bands [Medical Device]
   779 E C0439645:Band [Spatial Concept]
   779 E C1521913:band [Cell Component]

Phrase: "in N18/RAGE cells"
Meta Candidates (Total=22; Excluded=8; Pruned=0; Remaining=14)
   901   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   850   C1514760:Receptor Cell [Cell]
   849   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   791   C0007634:Cells [Cell]
   791   C0150312:In [Quantitative Concept]
   791   C0205179:Advanced [Qualitative Concept]
   791   C0332285:In [Spatial Concept]
   791   C0442791:N18 [Finding]
   791   C0444930:End [Spatial Concept]
   791   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   791   C0598528:glycation [Phenomenon or Process]
   791   C1514468:Products [Entity]
   791   C2746065:End [Temporal Concept]
   791   C3282337:Cells [Cell]
   758 E C0725066:Advance [Medical Device]
   758 E C1269647:Cell [Cell]
   758 E C1704444:Product [Quantitative Concept]
   758 E C1704653:Cell [Medical Device]
   758 E C1948049:Cell [Spatial Concept]
   735 E C0205088:Terminal [Temporal Concept]
   735 E C1705314:Terminal [Manufactured Object]
   735 E C1705315:Terminal [Spatial Concept]

Phrase: "were"

Phrase: "excised from the gel,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0017243:Gel [Biomedical or Dental Material]
   770   C1382104:Gel [Substance]

Phrase: "reamplified"

Phrase: ","

Phrase: "cloned"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0009013:cloned [Cell]
   966 E C1522642:Clone [Tissue]

Phrase: ","

Phrase: "and"

Phrase: "sequenced."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0004793:Sequence [Nucleotide Sequence]
   966   C0162326:Sequence [Nucleotide Sequence]
   966   C0162327:Sequence [Nucleotide Sequence]
   966   C1519249:Sequence [Functional Concept]
Processing 00000000.tx.113: Three of these cloned products gave an exact sequence match for mouse chromogranin B in a BLAST search (data not shown). 

Phrase: "Three of these cloned products"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0009013:cloned [Cell]
   760   C0205449:Three [Quantitative Concept]
   760   C1514468:Products [Entity]
   726 E C1522642:Clone [Tissue]
   726 E C1704444:Product [Quantitative Concept]

Phrase: "gave"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "an exact sequence match for mouse chromogranin B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0150103:match [Research Activity]
   744   C1708943:Match [Qualitative Concept]

Phrase: "in a BLAST search"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1552603:search [Intellectual Product]
   861   C1706202:Search [Activity]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.114: View larger version (67K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(67K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.115: 2.  

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.116: Identification of members of the chromogranin family as genes regulated by RAGE signaling. 

Phrase: "Identification of members of the chromogranin family"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0020792:Identification [Mental Process]
   748   C0205396:Identification [Qualitative Concept]

Phrase: "as genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "regulated by RAGE"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   909   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   833   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   767   C3242459:regulated products [Intellectual Product]
   750 E C1552022:regulated product [Idea or Concept]
   744   C0205179:Advanced [Qualitative Concept]
   744   C0444930:End [Spatial Concept]
   744   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   744   C0598528:glycation [Phenomenon or Process]
   744   C0851285:Regulated [Governmental or Regulatory Activity]
   744   C1514468:Products [Entity]
   744   C2746065:End [Temporal Concept]
   711 E C0725066:Advance [Medical Device]
   711 E C1704444:Product [Quantitative Concept]

Phrase: "signaling."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0037083:Signaling [Cell Function]
  1000   C3537152:signaling [Biologic Function]
   966 E C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.117: A, N18 neuroblastoma cells stably transfected either with full-length RAGE (N18/RAGE) or cytoplasmic domain deletion mutant of RAGE (N18/RAGEcyto) were grown on an amphoterin-coated (20g/ml) surface for 24h. 

Phrase: "A,"

Phrase: "N18 neuroblastoma cells stably"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   844   C0815000:neuroblastoma cell [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "transfected"

Phrase: "either with full-length RAGE"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   862   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   806   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   739   C0205179:Advanced [Qualitative Concept]
   739   C0443225:Full [Qualitative Concept]
   739   C0444930:End [Spatial Concept]
   739   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   739   C0598528:glycation [Phenomenon or Process]
   739   C1444754:Length [Quantitative Concept]
   739   C1514468:Products [Entity]
   739   C1706316:LENGTH [Research Activity]
   739   C2746065:End [Temporal Concept]
   706 E C0725066:Advance [Medical Device]
   706 E C1704444:Product [Quantitative Concept]

Phrase: "(N18/RAGE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   946   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: ")"

Phrase: "or"

Phrase: "cytoplasmic domain deletion mutant of RAGE"
Meta Candidates (Total=21; Excluded=2; Pruned=0; Remaining=19)
   846   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   797   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   756   C1511625:Cytoplasmic Domain [Cell Component]
   754   C0206587:Cytoplasmic Receptor [Amino Acid, Peptide, or Protein,Receptor]
   738   C0010834:Cytoplasmic [Cell Component]
   738   C0205179:Advanced [Qualitative Concept]
   738   C0444930:End [Spatial Concept]
   738   C0521449:Cytoplasmic [Body Location or Region]
   738   C0596988:Mutant [Cell or Molecular Dysfunction]
   738   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   738   C0598528:glycation [Phenomenon or Process]
   738   C1442161:Deletion [Cell or Molecular Dysfunction]
   738   C1511760:Deletion [Genetic Function]
   738   C1514468:Products [Entity]
   738   C1880274:Deletion [Activity]
   738   C1880389:Domain [Functional Concept]
   738   C1883221:Domain [Conceptual Entity]
   738   C2746065:End [Temporal Concept]
   738   C3541951:Domain [Intellectual Product]
   704 E C0725066:Advance [Medical Device]
   704 E C1704444:Product [Quantitative Concept]

Phrase: "(N18/RAGEcyto"

Phrase: ")"

Phrase: "were"

Phrase: "grown on an amphoterin-coated"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0019796:Amphoterin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1333908:AMPHOTERIN [Gene or Genome]
   760   C1522408:Coated [Qualitative Concept]
   726 E C0453946:Coat [Manufactured Object]
   726 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "(20g/ml) surface for 24h."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205148:Surface [Spatial Concept]
Processing 00000000.tx.118: Differential display RT-PCR revealed several differentially expressed bands that were excised from the gel, reamplified, and cloned (e.g. one indicated by a white arrow). 

Phrase: "Differential display RT-PCR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0599161:RT-PCR [Molecular Biology Research Technique]
   812   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   812   C0677874:pCR [Finding]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "several differentially expressed bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0175723:Bands [Medical Device]
   779 E C0439645:Band [Spatial Concept]
   779 E C1521913:band [Cell Component]

Phrase: "that"

Phrase: "were"

Phrase: "excised from the gel,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0017243:Gel [Biomedical or Dental Material]
   770   C1382104:Gel [Substance]

Phrase: "reamplified"

Phrase: ","

Phrase: "and"

Phrase: "cloned"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0009013:cloned [Cell]
   966 E C1522642:Clone [Tissue]

Phrase: "("

Phrase: "e.g. one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "indicated by a white arrow"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0007457:White [Population Group]
   760   C0043157:White [Population Group]
   760   C0220938:White [Qualitative Concept]
   760   C0336721:Arrow [Manufactured Object]
   760   C1444656:Indicated [Finding]

Phrase: ")."
Processing 00000000.tx.119: Sequenced clones were identified as mouse chromogranin B in a BLAST search. 

Phrase: "Sequenced clones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0009013:Clones [Cell]
   827 E C1522642:Clone [Tissue]
   777 E C1704387:Clonal [Qualitative Concept]
   755 E C0796368:clonality [Diagnostic Procedure]

Phrase: "were"

Phrase: "identified as mouse chromogranin B"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   862   C1569748:chromogranin B, mouse [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C0055635:chromogranin B [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C1332755:CHROMOGRANIN B [Gene or Genome]
   760   C0008586:Chromogranin [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   760   C0025914:Mouse [Mammal]
   760   C0025929:mouse [Mammal]
   760   C0026809:Mouse [Mammal]
   760   C0205396:Identified [Qualitative Concept]
   760   C1550043:Identified [Finding]
   760   C1551388:Identified [Functional Concept]

Phrase: "in a BLAST search."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1552603:search [Intellectual Product]
   861   C1706202:Search [Activity]
Processing 00000000.tx.120: B, N18/RAGE and N18/RAGEcyto cells grown without serum either on gelatin-coated surface (0.1%), gelatin-coated surface with 1M retinoic acid, amphoterin-coated surface (20g/ml), laminin-coated surface (10g/ml), or gelatin-coated surface in the presence of 500nM S100B for 24h. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "N18/RAGE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   946   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "N18/RAGEcyto cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "grown without serum either"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0229671:Serum [Body Substance]
   770   C1546774:Serum [Intellectual Product]
   770   C1550100:Serum [Body Substance]

Phrase: "on gelatin-coated surface"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205148:Surface [Spatial Concept]

Phrase: "(0.1%"

Phrase: ")"

Phrase: ","

Phrase: "gelatin-coated surface with 1M retinoic acid,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205148:Surface [Spatial Concept]

Phrase: "amphoterin-coated surface"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205148:Surface [Spatial Concept]

Phrase: "(20g/ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "laminin-coated surface"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205148:Surface [Spatial Concept]

Phrase: "(10g/ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "gelatin-coated surface in the presence of 500nM S100B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0205148:Surface [Spatial Concept]

Phrase: "for 24h."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]
Processing 00000000.tx.121: The cells were lysed, and expression levels of chromogranin B, chromogranin A, and secretogranin II were analyzed by Western blotting. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "lysed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024348:lysed [Pathologic Function]

Phrase: ","

Phrase: "and"

Phrase: "expression levels of chromogranin B,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   827   C1531661:Chromogranin B level [Laboratory Procedure]
   781   C1531662:Chromogranin level [Laboratory Procedure]
   773   C3244092:expression level [Idea or Concept]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "chromogranin A,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0055633:Chromogranin A [Amino Acid, Peptide, or Protein,Hormone,Indicator, Reagent, or Diagnostic Aid]
  1000   C1332754:CHROMOGRANIN A [Gene or Genome]
   861   C0008586:Chromogranin [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "and"

Phrase: "secretogranin II"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0055637:Secretogranin II [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1335805:SECRETOGRANIN II [Gene or Genome]

Phrase: "were"

Phrase: "analyzed by Western blotting."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]
Processing 00000000.tx.122: Densitometric analysis for relative induction in RAGE cells compared with RAGEcyto cells (1.0) is indicated. 

Phrase: "Densitometric analysis for relative induction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "in RAGE cells"
Meta Candidates (Total=21; Excluded=8; Pruned=0; Remaining=13)
   923   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   861   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   861   C1514760:Receptor Cell [Cell]
   793   C0007634:Cells [Cell]
   793   C0150312:In [Quantitative Concept]
   793   C0205179:Advanced [Qualitative Concept]
   793   C0332285:In [Spatial Concept]
   793   C0444930:End [Spatial Concept]
   793   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   793   C0598528:glycation [Phenomenon or Process]
   793   C1514468:Products [Entity]
   793   C2746065:End [Temporal Concept]
   793   C3282337:Cells [Cell]
   760 E C0725066:Advance [Medical Device]
   760 E C1269647:Cell [Cell]
   760 E C1704444:Product [Quantitative Concept]
   760 E C1704653:Cell [Medical Device]
   760 E C1948049:Cell [Spatial Concept]
   737 E C0205088:Terminal [Temporal Concept]
   737 E C1705314:Terminal [Manufactured Object]
   737 E C1705315:Terminal [Spatial Concept]

Phrase: "compared with RAGEcyto cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C1707455:Compared [Activity]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "(1.0"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "is"

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.123: The level of ERK1/2 was monitored as a control. 

Phrase: "The level of ERK1/2"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   762   C0456947:Level 1 [Intellectual Product]
   762   C0456948:Level 2 [Intellectual Product]
   742   C0441889:Level [Qualitative Concept]
   742   C0456079:Level [Classification]
   742   C1547707:Level [Geographic Area]
   742   C2946261:Level [Pharmacologic Substance]

Phrase: "was"

Phrase: "monitored as a control."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737   C0030695:monitor [Health Care Activity]
   737   C0150369:monitor [Health Care Activity]
   737   C0181904:Monitor [Medical Device]
   737   C0596972:Monitor [Medical Device]
   737   C1521743:Monitor [Professional or Occupational Group]
   737   C1704646:Monitor [Manufactured Object]
Processing 00000000.tx.124: To confirm the increase in chromogranin B expression on protein level, the cells were plated on amphoterin, as a control on gelatin or laminin, or stimulated with 1M retinoic acid. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "the increase in chromogranin B expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "on protein level,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0428479:Protein level [Laboratory or Test Result]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0441889:Level [Qualitative Concept]
   861   C0456079:Level [Classification]
   861   C1547707:Level [Geographic Area]
   861   C2946261:Level [Pharmacologic Substance]

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "plated on amphoterin,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0019796:Amphoterin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1333908:AMPHOTERIN [Gene or Genome]
   756   C0005971:Plate [Medical Device]
   756   C1139930:plate [Medical Device]
   756   C3537155:Plate [Manufactured Object]

Phrase: "as"

Phrase: "a control on gelatin"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]

Phrase: "or"

Phrase: "laminin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022984:Laminin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "stimulated with 1M retinoic acid."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0040845:Retinoic Acid [Organic Chemical,Pharmacologic Substance,Vitamin]
   760   C0001128:Acid [Chemical]
   760   C0202406:Acid [Laboratory Procedure]
   760   C0470296:1M [Quantitative Concept]
   760   C1948023:Stimulated [Natural Phenomenon or Process]
Processing 00000000.tx.125: After 24h, the cells were lysed, and the total cell lysate was probed in a Western blot for chromogranin B expression. 

Phrase: "After 24h,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "lysed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024348:lysed [Pathologic Function]

Phrase: ","

Phrase: "and"

Phrase: "the total cell lysate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "was"

Phrase: "probed in a Western blot"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   806   C0949466:Western Blot [Laboratory Procedure]
   760   C1705493:Western [Spatial Concept]
   726   C0182400:Probe [Medical Device]
   726   C1704681:Probe [Gene or Genome]
   726   C2347609:Probe [Chemical Viewed Functionally]
   726   C3536729:Probe [Manufactured Object]

Phrase: "for chromogranin B expression."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C0055635:chromogranin B [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1332755:CHROMOGRANIN B [Gene or Genome]
Processing 00000000.tx.126: As can be seen in Fig. 

Phrase: "As"

Phrase: "can"

Phrase: "be"

Phrase: "seen in Fig."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0205397:Seen [Qualitative Concept]
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]
Processing 00000000.tx.127: 2B, upon amphoterin stimulation chromogranin B protein is highly up-regulated in N18/RAGE cells (3.1-fold induction), whereas in N18/RAGEcyto cells chromogranin B protein is barely detectable. 

Phrase: "2B,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450354:2b [Intellectual Product]
  1000   C1706096:2B [Research Activity]

Phrase: "upon amphoterin stimulation chromogranin B protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "highly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:Highly [Qualitative Concept]

Phrase: "up-regulated in N18/RAGE cells"
Meta Candidates (Total=23; Excluded=6; Pruned=0; Remaining=17)
   846   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   797   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   754   C3242459:regulated products [Intellectual Product]
   738   C0007634:Cells [Cell]
   738   C0205179:Advanced [Qualitative Concept]
   738   C0442791:N18 [Finding]
   738   C0444930:End [Spatial Concept]
   738   C0547043:Up [Spatial Concept]
   738   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   738   C0598528:glycation [Phenomenon or Process]
   738   C0851285:Regulated [Governmental or Regulatory Activity]
   738   C1282911:Up [Spatial Concept]
   738   C1514468:Products [Entity]
   738   C2746065:End [Temporal Concept]
   738   C3282337:Cells [Cell]
   737   C1514760:Receptor Cell [Cell]
   737 E C1552022:regulated product [Idea or Concept]
   737   C1656978:cell end [Cell Component]
   704 E C0725066:Advance [Medical Device]
   704 E C1269647:Cell [Cell]
   704 E C1704444:Product [Quantitative Concept]
   704 E C1704653:Cell [Medical Device]
   704 E C1948049:Cell [Spatial Concept]

Phrase: "(3.1-fold induction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0205263:Induction [Functional Concept]
   812   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: ")"

Phrase: ","

Phrase: "whereas in N18/RAGEcyto cells chromogranin B protein"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   770   C0055635:chromogranin B [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1332755:CHROMOGRANIN B [Gene or Genome]
   767   C0377800:protein B [Amino Acid, Peptide, or Protein,Receptor]
   744   C0007634:Cells [Cell]
   744   C0008586:Chromogranin [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0442791:N18 [Finding]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "barely detectable."
Processing 00000000.tx.128: Importantly, in N18/RAGE cells stimulated with gelatin or retinoic acid there is no change in the expression level of chromogranin B.

Phrase: "Importantly,"

Phrase: "in N18/RAGE cells"
Meta Candidates (Total=22; Excluded=8; Pruned=0; Remaining=14)
   901   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   850   C1514760:Receptor Cell [Cell]
   849   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   791   C0007634:Cells [Cell]
   791   C0150312:In [Quantitative Concept]
   791   C0205179:Advanced [Qualitative Concept]
   791   C0332285:In [Spatial Concept]
   791   C0442791:N18 [Finding]
   791   C0444930:End [Spatial Concept]
   791   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   791   C0598528:glycation [Phenomenon or Process]
   791   C1514468:Products [Entity]
   791   C2746065:End [Temporal Concept]
   791   C3282337:Cells [Cell]
   758 E C0725066:Advance [Medical Device]
   758 E C1269647:Cell [Cell]
   758 E C1704444:Product [Quantitative Concept]
   758 E C1704653:Cell [Medical Device]
   758 E C1948049:Cell [Spatial Concept]
   735 E C0205088:Terminal [Temporal Concept]
   735 E C1705314:Terminal [Manufactured Object]
   735 E C1705315:Terminal [Spatial Concept]

Phrase: "stimulated with gelatin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0017237:Gelatin [Amino Acid, Peptide, or Protein,Biomedical or Dental Material,Pharmacologic Substance]
   790   C1145617:Gelatin [Food]
   790   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "or"

Phrase: "retinoic acid there"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0040845:Retinoic Acid [Organic Chemical,Pharmacologic Substance,Vitamin]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: "is"

Phrase: "no change in the expression level of chromogranin B."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   764   C0442739:No change [Finding]
   764   C1548568:No change [Intellectual Product]
   742   C0392747:Change [Functional Concept]
   742   C0443172:change [Quantitative Concept]
   742   C1705241:Change [Quantitative Concept]
Processing 00000000.tx.129: However, in N18/RAGE cells stimulated with laminin chromogranin B seems to up-regulated (2.0-fold induction). 

Phrase: "However,"

Phrase: "in N18/RAGE cells"
Meta Candidates (Total=22; Excluded=8; Pruned=0; Remaining=14)
   901   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   850   C1514760:Receptor Cell [Cell]
   849   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   791   C0007634:Cells [Cell]
   791   C0150312:In [Quantitative Concept]
   791   C0205179:Advanced [Qualitative Concept]
   791   C0332285:In [Spatial Concept]
   791   C0442791:N18 [Finding]
   791   C0444930:End [Spatial Concept]
   791   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   791   C0598528:glycation [Phenomenon or Process]
   791   C1514468:Products [Entity]
   791   C2746065:End [Temporal Concept]
   791   C3282337:Cells [Cell]
   758 E C0725066:Advance [Medical Device]
   758 E C1269647:Cell [Cell]
   758 E C1704444:Product [Quantitative Concept]
   758 E C1704653:Cell [Medical Device]
   758 E C1948049:Cell [Spatial Concept]
   735 E C0205088:Terminal [Temporal Concept]
   735 E C1705314:Terminal [Manufactured Object]
   735 E C1705315:Terminal [Spatial Concept]

Phrase: "stimulated with laminin chromogranin B"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0055635:chromogranin B [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C1332755:CHROMOGRANIN B [Gene or Genome]
   760   C0008586:Chromogranin [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   760   C0022984:Laminin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "seems"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "up-regulated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0547043:Up [Spatial Concept]
   861   C0851285:Regulated [Governmental or Regulatory Activity]
   861   C1282911:Up [Spatial Concept]

Phrase: "(2.0-fold induction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0205263:Induction [Functional Concept]
   812   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: ")."
Processing 00000000.tx.130: This might be due to secretion of endogenous amphoterin known to occur during laminin-induced process growth (26). 

Phrase: "This"

Phrase: "might"

Phrase: "be due to secretion of endogenous amphoterin"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C0678226:Due to [Functional Concept]
           due
   748   C0019796:Amphoterin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0036536:secretion [Biologic Function]
   748   C0036537:Secretion [Body Substance]
   748   C0205227:Endogenous [Functional Concept]
   748   C1333908:AMPHOTERIN [Gene or Genome]
   748   C2987476:Be [Conceptual Entity]
   748   C3146286:Due [Idea or Concept]

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "occur during laminin-induced process growth"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0018270:'growth' NOS [Organism Function]
   753   C0022984:Laminin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0205263:Induced [Functional Concept]
   753   C0220844:growth [Physiologic Function]
   753   C1184743:Process [Body Part, Organ, or Organ Component]
   753   C1522240:Process [Phenomenon or Process]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C1709305:Occur [Activity]
   753   C2745955:OCCUR [Temporal Concept]
   753   C2911660:Growth [Activity]

Phrase: "(26"

Phrase: ")."
Processing 00000000.tx.131: In N18/RAGE cells stimulated with 500nM S100B, another ligand of RAGE (14, 16), there is a strong up-regulation of chromogranin B (2.3-fold induction) in comparison to N18/RAGEcyto cells (Fig. 2B). 

Phrase: "In N18/RAGE cells"
Meta Candidates (Total=22; Excluded=8; Pruned=0; Remaining=14)
   901   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   850   C1514760:Receptor Cell [Cell]
   849   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   791   C0007634:Cells [Cell]
   791   C0150312:In [Quantitative Concept]
   791   C0205179:Advanced [Qualitative Concept]
   791   C0332285:In [Spatial Concept]
   791   C0442791:N18 [Finding]
   791   C0444930:End [Spatial Concept]
   791   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   791   C0598528:glycation [Phenomenon or Process]
   791   C1514468:Products [Entity]
   791   C2746065:End [Temporal Concept]
   791   C3282337:Cells [Cell]
   758 E C0725066:Advance [Medical Device]
   758 E C1269647:Cell [Cell]
   758 E C1704444:Product [Quantitative Concept]
   758 E C1704653:Cell [Medical Device]
   758 E C1948049:Cell [Spatial Concept]
   735 E C0205088:Terminal [Temporal Concept]
   735 E C1705314:Terminal [Manufactured Object]
   735 E C1705315:Terminal [Spatial Concept]

Phrase: "stimulated with 500nM S100B,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1419790:S100B [Gene or Genome]
   770   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "another ligand of RAGE"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   882   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   818   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   762   C1621296:receptor ligand [Molecular Function]
   742   C0023688:Ligand [Chemical]
   742   C0205179:Advanced [Qualitative Concept]
   742   C0444930:End [Spatial Concept]
   742   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   742   C0598528:glycation [Phenomenon or Process]
   742   C1514468:Products [Entity]
   742   C2746065:End [Temporal Concept]
   708 E C0725066:Advance [Medical Device]
   708 E C1704444:Product [Quantitative Concept]

Phrase: "(14,"

Phrase: "16"

Phrase: ")"

Phrase: ","

Phrase: "there"

Phrase: "is"

Phrase: "a strong up-regulation of chromogranin B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1327622:Regulation [Biologic Function]

Phrase: "(2.3-fold induction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0205263:Induction [Functional Concept]
   812   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: ")"

Phrase: "in comparison to N18/RAGEcyto cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")."
Processing 00000000.tx.132: This confirms chromogranin B as a gene target specifically up-regulated during RAGE-induced differentiation. 

Phrase: "This"

Phrase: "confirms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "chromogranin B as a gene"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   844   C1706599:Chromogranin A Gene [Gene or Genome]
   806   C0055635:chromogranin B [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C1332755:CHROMOGRANIN B [Gene or Genome]
   797   C0055633:Chromogranin A [Amino Acid, Peptide, or Protein,Hormone,Indicator, Reagent, or Diagnostic Aid]
   797   C1332754:CHROMOGRANIN A [Gene or Genome]
   797   C1333031:Chromogranin Gene [Gene or Genome]
   760   C0008586:Chromogranin [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "target"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1521840:Target [Functional Concept]
  1000   C2986546:TARGET [Diagnostic Procedure]

Phrase: "specifically"

Phrase: "up-regulated during RAGE-induced differentiation."
Meta Candidates (Total=20; Excluded=3; Pruned=0; Remaining=17)
   846   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   797   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   754   C3242459:regulated products [Intellectual Product]
   738   C0007589:Differentiation [Cell Function]
   738   C0205179:Advanced [Qualitative Concept]
   738   C0205263:Induced [Functional Concept]
   738   C0444930:End [Spatial Concept]
   738   C0547043:Up [Spatial Concept]
   738   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   738   C0598528:glycation [Phenomenon or Process]
   738   C0851285:Regulated [Governmental or Regulatory Activity]
   738   C1282911:Up [Spatial Concept]
   738   C1511938:Differentiation [Clinical Attribute]
   738   C1514468:Products [Entity]
   738   C2746065:End [Temporal Concept]
   738   C2945687:Differentiation [Functional Concept]
   737 E C1552022:regulated product [Idea or Concept]
   726   C2752630:terminal differentiation [Cell Function]
   704 E C0725066:Advance [Medical Device]
   704 E C1704444:Product [Quantitative Concept]
Processing 00000000.tx.133: Chromogranins are a family of acidic proteins that are found in the secretory granules of a wide variety of endocrine cells and neurons (reviewed in Refs. 21-23). 

Phrase: "Chromogranins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008586:Chromogranins [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "are"

Phrase: "a family of acidic proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C1335532:Protein Family [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0015576:Family [Family Group]
   760   C1704727:Family [Conceptual Entity]

Phrase: "that"

Phrase: "are"

Phrase: "found in the secretory granules of a wide variety of endocrine cells"
Meta Candidates (Total=22; Excluded=5; Pruned=0; Remaining=17)
   753   C0229525:Endocrine Cells [Cell]
   753   C0886515:Secretory Granules [Cell Component]
   751   C0230682:Secretory granule, endocrine [Cell Component]
   736   C0007634:Cells [Cell]
   736   C0010837:Granules [Cell Component]
           Cell granule
   736   C0014136:Endocrine [Body System]
   736   C0150312:Found [Quantitative Concept]
   736   C0332464:Wide [Spatial Concept]
   736   C0521425:Endocrine [Functional Concept]
   736   C0993609:Granules [Biomedical or Dental Material]
   736   C1327616:Secretory [Cell Function]
   736   C1883525:Variety [Conceptual Entity]
   736   C2346866:Variety [Conceptual Entity]
   736   C3282337:Cells [Cell]
   734   C1519221:Secretory cell [Cell]
   719 E C3271154:Secretory Granule [Cell Component]
   718   C0596630:granule cell [Cell]
   703 E C0243095:Find [Finding]
   703 E C1269647:Cell [Cell]
   703 E C1704653:Cell [Medical Device]
   703 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "("

Phrase: "reviewed in Refs. 21-23"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0282443:reviewed [Intellectual Product]
   760   C0450348:23 [Quantitative Concept]
   760   C1425988:REF [Gene or Genome]
   760   C1709940:Reviewed [Qualitative Concept]
   726 E C1552617:Review [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.134: Several members of the family are currently known, of which the most studied are chromogranin A, chromogranin B, and secretogranin II (also known as chromogranin C). 

Phrase: "Several members of the family"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   797   C0086282:Family Members [Family Group]
   781 E C1611821:Family Member [Intellectual Product]
   760   C0680022:members [Population Group]
   726 E C2698041:Member [Professional or Occupational Group]

Phrase: "are"

Phrase: "currently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521116:Currently [Temporal Concept]

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: ","

Phrase: "of which"

Phrase: "the most"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205393:Most [Quantitative Concept]

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "are"

Phrase: "chromogranin A,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0055633:Chromogranin A [Amino Acid, Peptide, or Protein,Hormone,Indicator, Reagent, or Diagnostic Aid]
  1000   C1332754:CHROMOGRANIN A [Gene or Genome]
   861   C0008586:Chromogranin [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "chromogranin B,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0055635:chromogranin B [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332755:CHROMOGRANIN B [Gene or Genome]
   861   C0008586:Chromogranin [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "and"

Phrase: "secretogranin II"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0055637:Secretogranin II [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1335805:SECRETOGRANIN II [Gene or Genome]

Phrase: "(also"

Phrase: "known as chromogranin C"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0007634:Cells [Cell]
   770   C0008586:Chromogranin [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   770   C0205309:Known [Qualitative Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.135: To study whether the two other members of the chromogranin family are also up-regulated by RAGE signaling, their expression was analyzed on a Western blot. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "whether"

Phrase: "the two"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205448:Two [Quantitative Concept]

Phrase: "other members of the chromogranin family"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   783   C0086282:Family Members [Family Group]
   767 E C1611821:Family Member [Intellectual Product]
   753   C0680022:members [Population Group]
   719 E C2698041:Member [Professional or Occupational Group]

Phrase: "are"

Phrase: "also"

Phrase: "up-regulated by RAGE"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   882   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   818   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   762   C3242459:regulated products [Intellectual Product]
   745 E C1552022:regulated product [Idea or Concept]
   742   C0205179:Advanced [Qualitative Concept]
   742   C0444930:End [Spatial Concept]
   742   C0547043:Up [Spatial Concept]
   742   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   742   C0598528:glycation [Phenomenon or Process]
   742   C0851285:Regulated [Governmental or Regulatory Activity]
   742   C1282911:Up [Spatial Concept]
   742   C1514468:Products [Entity]
   742   C2746065:End [Temporal Concept]
   708 E C0725066:Advance [Medical Device]
   708 E C1704444:Product [Quantitative Concept]

Phrase: "signaling"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0037083:Signaling [Cell Function]
  1000   C3537152:signaling [Biologic Function]
   966 E C1710082:Signal [Phenomenon or Process]

Phrase: ","

Phrase: "their expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "analyzed on a Western blot."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   806   C0949466:Western Blot [Laboratory Procedure]
   760   C0936012:Analyzed [Research Activity]
   760   C1705493:Western [Spatial Concept]
Processing 00000000.tx.136: As Fig. 

Phrase: "As Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.137: 2B shows, in addition to chromogranin B (3.1-fold induction), also chromogranin A (3.1-fold induction) and secretogranin II (3.5-fold induction) are up-regulated by RAGE-mediated amphoterin stimulus. 

Phrase: "2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450354:2b [Intellectual Product]
  1000   C1706096:2B [Research Activity]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: ","

Phrase: "in addition to chromogranin B"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0055635:chromogranin B [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332755:CHROMOGRANIN B [Gene or Genome]
   861   C0008586:Chromogranin [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "(3.1-fold induction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0205263:Induction [Functional Concept]
   812   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: ")"

Phrase: ","

Phrase: "also chromogranin A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0055633:Chromogranin A [Amino Acid, Peptide, or Protein,Hormone,Indicator, Reagent, or Diagnostic Aid]
   901   C1332754:CHROMOGRANIN A [Gene or Genome]
   827   C0008586:Chromogranin [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "(3.1-fold induction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0205263:Induction [Functional Concept]
   812   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: ")"

Phrase: "and"

Phrase: "secretogranin II"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0055637:Secretogranin II [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1335805:SECRETOGRANIN II [Gene or Genome]

Phrase: "(3.5-fold induction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0205263:Induction [Functional Concept]
   812   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: ")"

Phrase: "are"

Phrase: "up-regulated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0547043:Up [Spatial Concept]
   861   C0851285:Regulated [Governmental or Regulatory Activity]
   861   C1282911:Up [Spatial Concept]

Phrase: "by RAGE-mediated amphoterin stimulus."
Meta Candidates (Total=19; Excluded=5; Pruned=0; Remaining=14)
   884   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   840   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   790   C0006539:BY [Geographic Area]
   790   C0019796:Amphoterin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0086597:mediated [Social Behavior]
   790   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   790   C0205179:Advanced [Qualitative Concept]
   790   C0234402:Stimulus [Phenomenon or Process]
   790   C0444930:End [Spatial Concept]
   790   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   790   C0598528:glycation [Phenomenon or Process]
   790   C1333908:AMPHOTERIN [Gene or Genome]
   790   C1514468:Products [Entity]
   790   C2746065:End [Temporal Concept]
   756 E C0725066:Advance [Medical Device]
   756 E C1704444:Product [Quantitative Concept]
   734 E C0205088:Terminal [Temporal Concept]
   734 E C1705314:Terminal [Manufactured Object]
   734 E C1705315:Terminal [Spatial Concept]
Processing 00000000.tx.138: S100B, a RAGE ligand acting efficiently both in solution and as a substrate-attached material, seemed to have a very similar effect on chromogranin A and secretogranin II expression levels as on chromogranin B, whereas with laminin the induction of chromogranin A and secretogranin II was less prominent than that of chromogranin B (Fig. 2B). 

Phrase: "S100B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419790:S100B [Gene or Genome]

Phrase: "a RAGE ligand"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   909   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   767   C1621296:receptor ligand [Molecular Function]
   744   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "acting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "efficiently"

Phrase: "both in solution"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0037633:Solution [Substance]
   861   C0150312:In [Quantitative Concept]
   861   C0332285:In [Spatial Concept]
   861   C0525069:Solution [Biomedical or Dental Material]

Phrase: "and as a substrate-attached material,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0075415:substrate-attached material [Amino Acid, Peptide, or Protein]
   753   C0231441:Attached [Finding]
   753   C0520510:Material [Substance]
   753   C1515981:And [Idea or Concept]
   753   C1710236:Substrate [Manufactured Object]
   719 E C1314972:ATTACH [Intellectual Product]

Phrase: "seemed"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "a very similar effect on chromogranin A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "secretogranin II expression levels as on chromogranin B,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   892   C0055635:Secretogranin B [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           chromogranin B
   892   C1332755:secretogranin B [Gene or Genome]
           CHROMOGRANIN B
   793   C0008586:Chromogranin [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "whereas with laminin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0022984:Laminin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "the induction of chromogranin A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205263:Induction [Functional Concept]
   760   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "secretogranin II"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0055637:Secretogranin II [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1335805:SECRETOGRANIN II [Gene or Genome]

Phrase: "was"

Phrase: "less prominent than that of chromogranin B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205402:Prominent [Qualitative Concept]

Phrase: "(Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")."
Processing 00000000.tx.139: To exclude the possibility of clonal differences the differential display and the chromogranin expression data was verified in two independent clones of N18/RAGE and N18/RAGEcyto with similar results (data not shown). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "exclude"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332196:Exclude [Functional Concept]
  1000   C2828389:Exclude [Activity]

Phrase: "the possibility of clonal differences"

Phrase: "the differential display"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0887824:Differential Display [Laboratory Procedure,Molecular Biology Research Technique]
   861   C1705417:Display [Manufactured Object]

Phrase: "and"

Phrase: "the chromogranin expression data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1511726:Data [Idea or Concept]
   827   C3245479:data [Medical Device]

Phrase: "was"

Phrase: "verified in two independent clones of N18/RAGE"
Meta Candidates (Total=18; Excluded=3; Pruned=0; Remaining=15)
   822   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   784   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   749   C0332291:Independent of [Functional Concept]
   735   C0009013:Clones [Cell]
   735   C0085862:Independent [Idea or Concept]
   735   C0205179:Advanced [Qualitative Concept]
   735   C0205448:Two [Quantitative Concept]
   735   C0442791:N18 [Finding]
   735   C0444930:End [Spatial Concept]
   735   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   735   C0598528:glycation [Phenomenon or Process]
   735   C1299583:Independent [Finding]
   735   C1514468:Products [Entity]
   735   C1711411:Verified [Functional Concept]
   735   C2746065:End [Temporal Concept]
   702 E C0725066:Advance [Medical Device]
   702 E C1522642:Clone [Tissue]
   702 E C1704444:Product [Quantitative Concept]

Phrase: "and"

Phrase: "N18/RAGEcyto with similar results"

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.140: Although chromogranins are known to be structural components of mature secretory vesicles, especially large dense core vesicles, they have been found in precursor vesicles in immature axonal growth cones (27). 

Phrase: "Although"

Phrase: "chromogranins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008586:Chromogranins [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "are"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "structural components of mature secretory vesicles,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   767   C0036538:Secretory Component [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   753   C0449432:Components [Manufactured Object]
   719 E C1705248:Component [Conceptual Entity]

Phrase: "especially large dense core vesicles,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   884   C0887944:Dense Core Vesicles [Cell Component]
   804   C0333262:VESICLES [Acquired Abnormality]
   771 E C1622418:vesicle [Cell Component]
   721 E C0205378:Vesicular [Qualitative Concept]

Phrase: "they"

Phrase: "have"

Phrase: "been"

Phrase: "found in precursor vesicles"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0150312:Found [Quantitative Concept]
   770   C0333262:VESICLES [Acquired Abnormality]
   770   C1709634:Precursor [Idea or Concept]
   737 E C0243095:Find [Finding]
   737 E C1622418:vesicle [Cell Component]

Phrase: "in immature axonal growth cones"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   906   C2752547:axonal growth cone [Cell Component]
   861   C0596632:Growth Cones [Cell Component]
   825   C1749784:axon growth [Organ or Tissue Function]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0206428:Cones [Cell]
   812   C0220844:growth [Physiologic Function]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2911660:Growth [Activity]
   779 E C0330095:Cone [Plant]
   779 E C2350017:Cone [Spatial Concept]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.141: To further characterize the role of chromogranins in RAGE-induced differentiation, subcellular localization of chromogranin B was studied by immunocytochemistry. 

Phrase: "To further"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1517331:Further [Spatial Concept]
   861   C1883351:To [Qualitative Concept]
   827 E C0205108:far [Spatial Concept]

Phrase: "characterize"

Phrase: "the role of chromogranins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "in RAGE-induced differentiation,"
Meta Candidates (Total=21; Excluded=6; Pruned=0; Remaining=15)
   901   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   849   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   802   C2752630:terminal differentiation [Cell Function]
   791   C0007589:Differentiation [Cell Function]
   791   C0150312:In [Quantitative Concept]
   791   C0205179:Advanced [Qualitative Concept]
   791   C0205263:Induced [Functional Concept]
   791   C0332285:In [Spatial Concept]
   791   C0444930:End [Spatial Concept]
   791   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   791   C0598528:glycation [Phenomenon or Process]
   791   C1511938:Differentiation [Clinical Attribute]
   791   C1514468:Products [Entity]
   791   C2746065:End [Temporal Concept]
   791   C2945687:Differentiation [Functional Concept]
   758 E C0725066:Advance [Medical Device]
   758 E C1704444:Product [Quantitative Concept]
   735 E C0205088:Terminal [Temporal Concept]
   735 E C1705314:Terminal [Manufactured Object]
   735 E C1705315:Terminal [Spatial Concept]
   720 E C0205615:Differentiated [Qualitative Concept]

Phrase: "subcellular localization of chromogranin B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0475264:Localisation [Functional Concept]
   760   C1744691:localisation [Biologic Function]

Phrase: "was"

Phrase: "studied by immunocytochemistry."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0242349:Immunocytochemistry [Laboratory Procedure]
   756   C0557651:Study [Manufactured Object]
   756   C2603343:Study [Research Activity]
Processing 00000000.tx.142: N18/RAGE and N18/RAGEcyto cells were grown either on gelatin- or amphoterin-coated surface for 3days, after which the cells were double-stained with chromogranin B (Fig. 3, B, D, F; green) and synaptophysin antibodies (Fig. 3, B, D, F; red). 

Phrase: "N18/RAGE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   946   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "N18/RAGEcyto cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "grown"

Phrase: "either on gelatin-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0017237:Gelatin [Amino Acid, Peptide, or Protein,Biomedical or Dental Material,Pharmacologic Substance]
   790   C1145617:Gelatin [Food]

Phrase: "or"

Phrase: "amphoterin-coated surface for 3days,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205148:Surface [Spatial Concept]

Phrase: "after"

Phrase: "which the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "double-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Double [Functional Concept]
  1000   C1705764:Double [Activity]
  1000   C1705765:Double [Qualitative Concept]

Phrase: "stained with chromogranin B"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0055635:chromogranin B [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1332755:CHROMOGRANIN B [Gene or Genome]
   770   C0008586:Chromogranin [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   770   C2986582:Stained [Qualitative Concept]
   737 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(Fig. 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "F"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "; green"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332583:Green [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "synaptophysin antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Fig. 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "F"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "; red"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332575:Red [Finding]
  1000   C1260956:Red [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.143: As is seen in the merged images (Fig. 3, B, D, F; yellow), chromogranin B signal colocalizes together with synaptophysin signal in the growth cones of differentiated N18/RAGE cells (Fig. 3D), suggesting that these cells are capable of producing neuron-like secretory machinery. 

Phrase: "As is"

Phrase: "seen in the merged images"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0205397:Seen [Qualitative Concept]
   760   C1881786:Merged [Activity]
   726 E C0042789:see [Organism Function]
   726   C1704254:Image [Intellectual Product]
   726   C1704922:Image [Entity]
   726 E C1947903:See [Activity]
   726   C3542466:Image [Intellectual Product]

Phrase: "(Fig. 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "F"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "; yellow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221205:Yellow [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "chromogranin B signal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1710082:Signal [Phenomenon or Process]
   734   C0055635:chromogranin B [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1332755:CHROMOGRANIN B [Gene or Genome]

Phrase: "colocalizes together with synaptophysin signal"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0085255:Synaptophysin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1420554:SYNAPTOPHYSIN [Gene or Genome]
   760   C1710082:Signal [Phenomenon or Process]
   760   C1883357:Together [Qualitative Concept]

Phrase: "in the growth cones"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0596632:Growth Cones [Cell Component]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0206428:Cones [Cell]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]
   827 E C0330095:Cone [Plant]
   827 E C2350017:Cone [Spatial Concept]

Phrase: "of differentiated N18/RAGE cells"
Meta Candidates (Total=25; Excluded=10; Pruned=0; Remaining=15)
   884   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   841   C1514760:Receptor Cell [Cell]
   840   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   790   C0007589:Differentiated [Cell Function]
   790   C0007634:Cells [Cell]
   790   C0205179:Advanced [Qualitative Concept]
   790   C0205615:Differentiated [Qualitative Concept]
   790   C0332285:Of [Spatial Concept]
   790   C0442791:N18 [Finding]
   790   C0444930:End [Spatial Concept]
   790   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   790   C0598528:glycation [Phenomenon or Process]
   790   C1514468:Products [Entity]
   790   C2746065:End [Temporal Concept]
   790   C3282337:Cells [Cell]
   756 E C0725066:Advance [Medical Device]
   756 E C1269647:Cell [Cell]
   756 E C1704444:Product [Quantitative Concept]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]
   734 E C0205088:Terminal [Temporal Concept]
   734 E C1705314:Terminal [Manufactured Object]
   734 E C1705315:Terminal [Spatial Concept]
   718 E C1511938:Differentiation [Clinical Attribute]
   718 E C2945687:Differentiation [Functional Concept]

Phrase: "(Fig. 3D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450363:3D [Spatial Concept]
   861   C2986797:3D [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "these cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "capable of producing neuron-like secretory machinery."
Processing 00000000.tx.144: Neither chromogranin nor synaptophysin staining gives a clear signal in less-differentiated N18/RAGEcyto cells grown on amphoterin-coated surface (Fig. 3F) or in N18/RAGE cells grown on gelatin-coated surface (Fig. 3B). 

Phrase: "Neither chromogranin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008586:Chromogranin [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "nor"

Phrase: "synaptophysin staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]

Phrase: "gives"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947971:Give [Functional Concept]

Phrase: "a clear signal in less-differentiated N18/RAGEcyto cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   745   C0037083:signal cell [Cell Function]
   742   C1710082:Signal [Phenomenon or Process]

Phrase: "grown on amphoterin-coated surface"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0019796:Amphoterin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0205148:Surface [Spatial Concept]
   760   C1333908:AMPHOTERIN [Gene or Genome]
   760   C1522408:Coated [Qualitative Concept]
   726 E C0453946:Coat [Manufactured Object]
   726 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "(Fig. 3F"

Phrase: ")"

Phrase: "or in N18/RAGE cells"
Meta Candidates (Total=18; Excluded=5; Pruned=0; Remaining=13)
   862   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   806   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   741   C1514760:Receptor Cell [Cell]
   741   C1656978:cell end [Cell Component]
   739   C0007634:Cells [Cell]
   739   C0205179:Advanced [Qualitative Concept]
   739   C0442791:N18 [Finding]
   739   C0444930:End [Spatial Concept]
   739   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   739   C0598528:glycation [Phenomenon or Process]
   739   C1514468:Products [Entity]
   739   C2746065:End [Temporal Concept]
   739   C3282337:Cells [Cell]
   706 E C0725066:Advance [Medical Device]
   706 E C1269647:Cell [Cell]
   706 E C1704444:Product [Quantitative Concept]
   706 E C1704653:Cell [Medical Device]
   706 E C1948049:Cell [Spatial Concept]

Phrase: "grown on gelatin-coated surface"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0017237:Gelatin [Amino Acid, Peptide, or Protein,Biomedical or Dental Material,Pharmacologic Substance]
   760   C0205148:Surface [Spatial Concept]
   760   C1145617:Gelatin [Food]
   760   C1522408:Coated [Qualitative Concept]
   726 E C0453946:Coat [Manufactured Object]
   726 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "(Fig. 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")."
Processing 00000000.tx.145: View larger version (69K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(69K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.146: 3.  

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.147: Colocalization of chromogranin B with synaptophysin in differentiating N18 neuroblastoma cells. 

Phrase: "Colocalization of chromogranin B"

Phrase: "with synaptophysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0085255:Synaptophysin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420554:SYNAPTOPHYSIN [Gene or Genome]

Phrase: "in differentiating N18 neuroblastoma cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   844   C0815000:neuroblastoma cell [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   708   C1511934:Differentiating Neuroblastoma [Neoplastic Process]
Processing 00000000.tx.148: N18 neuroblastoma cells stably transfected either with RAGE (A-D) or RAGEcyto (E-F) were grown on gelatin-coated surface (A and B) or amphoterin-coated surface (C-F) without serum for 3days, double-stained with chromogranin B (B, D, F; green) and synaptophysin (B, D, F; red) antibodies and visualized with fluorescence microscopy. 

Phrase: "N18 neuroblastoma cells stably"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   844   C0815000:neuroblastoma cell [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "transfected"

Phrase: "either with RAGE"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   909   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   833   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   744   C0205179:Advanced [Qualitative Concept]
   744   C0444930:End [Spatial Concept]
   744   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   744   C0598528:glycation [Phenomenon or Process]
   744   C1514468:Products [Entity]
   744   C2746065:End [Temporal Concept]
   711 E C0725066:Advance [Medical Device]
   711 E C1704444:Product [Quantitative Concept]

Phrase: "(A-D)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0718133:a & d [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "or"

Phrase: "RAGEcyto"

Phrase: "(E-F)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "were"

Phrase: "grown on gelatin-coated surface"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0017237:Gelatin [Amino Acid, Peptide, or Protein,Biomedical or Dental Material,Pharmacologic Substance]
   760   C0205148:Surface [Spatial Concept]
   760   C1145617:Gelatin [Food]
   760   C1522408:Coated [Qualitative Concept]
   726 E C0453946:Coat [Manufactured Object]
   726 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "(A"

Phrase: "and"

Phrase: "B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "or"

Phrase: "amphoterin-coated surface"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205148:Surface [Spatial Concept]

Phrase: "(C-F) without serum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   770   C0439133:(f) [Intellectual Product]
   770   C1553038:[f] [Quantitative Concept]

Phrase: "for 3days,"

Phrase: "double"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Double [Functional Concept]
  1000   C1705764:Double [Activity]
  1000   C1705765:Double [Qualitative Concept]

Phrase: "-"

Phrase: "stained with chromogranin B"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0055635:chromogranin B [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1332755:CHROMOGRANIN B [Gene or Genome]
   770   C0008586:Chromogranin [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   770   C2986582:Stained [Qualitative Concept]
   737 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "F"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "; green"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332583:Green [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "synaptophysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0085255:Synaptophysin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420554:SYNAPTOPHYSIN [Gene or Genome]

Phrase: "(B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "F"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "; red) antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "visualized with fluorescence microscopy."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0026022:Microscopy, Fluorescence [Laboratory Procedure]
   770   C0016315:Fluorescence [Natural Phenomenon or Process]
   770   C0026018:Microscopy [Laboratory Procedure]
   770   C0234621:Visualized [Functional Concept]
Processing 00000000.tx.149: Arrowheads point out colocalized signals (yellow in merged images (B, D, F)) in the tips of growing neurites. 

Phrase: "Arrowheads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1080898:Arrowheads [Plant]
   966 E C0453107:Arrowhead [Food]

Phrase: "point"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552961:Point [Quantitative Concept]
  1000   C2347617:point [Quantitative Concept]

Phrase: "out colocalized signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1710082:Signal [Phenomenon or Process]

Phrase: "(yellow in merged images"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0221205:Yellow [Qualitative Concept]

Phrase: "(B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "F)) in the tips of growing neurites."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   748   C0439133:(f) [Intellectual Product]
   748   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.150: Bar=20m. 

Phrase: "Bar=20m."
Processing 00000000.tx.151: RAGE Activation Induces Phosphorylation and Nuclear Translocation of CREB-- A functional cAMP response element has been shown to be crucial for inducible and cell type-specific expression of chromogranins (28-30). 

Phrase: "RAGE Activation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   946   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   774   C1514758:Receptor Activation [Cell Function]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "Induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "Phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "Nuclear Translocation of CREB"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   764   C1518440:Nuclear Translocation [Molecular Function]
   762   C0599893:Protein translocation [Cell Function]
   742   C0040715:Translocation [Cell or Molecular Dysfunction]
   742   C2987521:Translocation [Activity]
   716   C0056695:Cyclic AMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "-"

Phrase: "-"

Phrase: "A functional cAMP response element"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   937   C1511573:Cyclic AMP Response Element [Gene or Genome]
   840   C0001455:Cyclic AMP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   840   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0013879:Element [Element, Ion, or Isotope]
   804   C0439596:Cyclic [Temporal Concept]
   804   C0871261:Response [Organism Attribute]
   804   C1511572:Cyclic [Temporal Concept]
   804   C1704632:Response [Finding]
   804   C1705248:Element [Conceptual Entity]
   804   C1706817:Response [Intellectual Product]
   804   C2911692:Response [Mental Process]
   733 E C0031084:Cyclicities [Temporal Concept]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "crucial for inducible"

Phrase: "and"

Phrase: "cell type-specific expression of chromogranins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(28-30"

Phrase: ")."
Processing 00000000.tx.152: Furthermore, in PC12 cells ERK1/2-mediated CREB activation has been shown to be both necessary and sufficient for inducible chromogranin A expression (31, 32). 

Phrase: "Furthermore,"

Phrase: "in PC12 cells ERK1/2-mediated CREB activation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   866   C1326120:cell activation [Cell Function]
   793   C0599177:protein activation [Genetic Function]
   785   C1879547:Activation [Activity]
   702   C1333498:Extracellular Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "both necessary"

Phrase: "and"

Phrase: "sufficient for inducible chromogranin A expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205410:Sufficient [Qualitative Concept]

Phrase: "(31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "32"

Phrase: ")."
Processing 00000000.tx.153: On the other hand, RAGE is known to be able to activate multiple MAP kinase pathways upon ligation, including ERK1/2, SAPK/JNK, and p38 MAP kinases (5, 7). 

Phrase: "On the"

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "RAGE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   716   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "multiple MAP kinase pathways upon ligation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1704259:Pathways [Molecular Function]
   753   C1705987:Pathways [Conceptual Entity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "ERK1/2,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   947   C0082529:Extracellular Signal-Regulated Kinase 1 [Amino Acid, Peptide, or Protein,Enzyme]
   947   C1366765:EXTRACELLULAR SIGNAL-REGULATED KINASE 1 [Gene or Genome]
   941   C0170168:Extracellular Signal-Regulated Kinase 2 [Amino Acid, Peptide, or Protein,Enzyme]
   941   C1366882:EXTRACELLULAR SIGNAL-REGULATED KINASE 2 [Gene or Genome]
   880   C0600388:Extracellular Signal Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   880   C0752312:Extracellular Signal-Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0521119:Extracellular [Cell Component]
   799   C0851285:Regulated [Governmental or Regulatory Activity]
   799   C1710082:Signal [Phenomenon or Process]

Phrase: "SAPK/JNK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   877   C1259877:protein kinase C kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "p38 MAP kinases"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   983   C0257535:p38 map kinase [Amino Acid, Peptide, or Protein,Enzyme]
   983   C1120843:p38 MAP Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   867   C0752312:Map Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0024779:Map [Manufactured Object]
   827   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1706473:Map [Conceptual Entity]

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "7"

Phrase: ")."
Processing 00000000.tx.154: To find out if RAGE activation is able to induce CREB phosphorylation, cell lysates were probed with phospho-specific CREB and ERK1/2 antibodies. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "find"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243095:Find [Finding]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "if"

Phrase: "RAGE activation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   946   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   774   C1514758:Receptor Activation [Cell Function]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "is"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "CREB phosphorylation,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   877   C1157225:AMP phosphorylation [Molecular Function]
   818   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   795   C0031715:Phosphorylation [Molecular Function]
   787   C0056695:Cyclic AMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   747   C3158668:cyclic-AMP response element binding [Genetic Function]
   710   C1511573:Cyclic AMP Response Element [Gene or Genome]
   701   C1148918:cyclic AMP binding [Molecular Function]

Phrase: "cell lysates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "were"

Phrase: "probed with phospho-specific CREB"
Meta Candidates (Total=28; Excluded=1; Pruned=0; Remaining=27)
   862   C0056695:Cyclic AMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C3158668:cyclic-AMP response element binding [Genetic Function]
   806   C1511573:Cyclic AMP Response Element [Gene or Genome]
   777   C1148918:cyclic AMP binding [Molecular Function]
   760   C0001455:Cyclic AMP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   760   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   757 E C0033618:Protein Binding [Molecular Function]
   757   C1148922:AMP binding [Molecular Function]
   741   C1441707:Probe.amp [Laboratory Procedure]
   739   C0013879:Element [Element, Ion, or Isotope]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0205369:Specific [Qualitative Concept]
   739   C0243122:binding [Functional Concept]
   739   C0439596:Cyclic [Temporal Concept]
   739   C0871261:Response [Organism Attribute]
   739   C1145667:Binding [Activity]
   739   C1167622:Binding [Molecular Function]
   739   C1511572:Cyclic [Temporal Concept]
   739   C1552740:specific [Intellectual Product]
   739   C1704632:Response [Finding]
   739   C1705248:Element [Conceptual Entity]
   739   C1706817:Response [Intellectual Product]
   739   C2911692:Response [Mental Process]
   706   C0182400:Probe [Medical Device]
   706   C1704681:Probe [Gene or Genome]
   706   C2347609:Probe [Chemical Viewed Functionally]
   706   C3536729:Probe [Manufactured Object]

Phrase: "and"

Phrase: "ERK1/2 antibodies."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   795   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   762 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   747   C0082529:Extracellular Signal-Regulated Kinase 1 [Amino Acid, Peptide, or Protein,Enzyme]
   747   C1366765:EXTRACELLULAR SIGNAL-REGULATED KINASE 1 [Gene or Genome]
   744   C0170168:Extracellular Signal-Regulated Kinase 2 [Amino Acid, Peptide, or Protein,Enzyme]
   744   C1366882:EXTRACELLULAR SIGNAL-REGULATED KINASE 2 [Gene or Genome]
Processing 00000000.tx.155: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.156: 4A, both ERK1/2 and CREB phosphorylation were induced in N18/RAGE cells stimulated with amphoterin for 90min, whereas in N18/RAGEcyto cells no ERK1/2 or CREB phosphorylation could be detected. 

Phrase: "4A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450373:4a [Intellectual Product]
  1000   C1553636:4a [Medical Device]

Phrase: "both ERK1/2"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   947   C0082529:Extracellular Signal-Regulated Kinase 1 [Amino Acid, Peptide, or Protein,Enzyme]
   947   C1366765:EXTRACELLULAR SIGNAL-REGULATED KINASE 1 [Gene or Genome]
   941   C0170168:Extracellular Signal-Regulated Kinase 2 [Amino Acid, Peptide, or Protein,Enzyme]
   941   C1366882:EXTRACELLULAR SIGNAL-REGULATED KINASE 2 [Gene or Genome]
   880   C0600388:Extracellular Signal Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   880   C0752312:Extracellular Signal-Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0521119:Extracellular [Cell Component]
   799   C0851285:Regulated [Governmental or Regulatory Activity]
   799   C1710082:Signal [Phenomenon or Process]

Phrase: "and"

Phrase: "CREB phosphorylation"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   877   C1157225:AMP phosphorylation [Molecular Function]
   818   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   795   C0031715:Phosphorylation [Molecular Function]
   787   C0056695:Cyclic AMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   747   C3158668:cyclic-AMP response element binding [Genetic Function]
   710   C1511573:Cyclic AMP Response Element [Gene or Genome]
   701   C1148918:cyclic AMP binding [Molecular Function]

Phrase: "were"

Phrase: "induced in N18/RAGE cells"
Meta Candidates (Total=19; Excluded=5; Pruned=0; Remaining=14)
   862   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   806   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   741   C1514760:Receptor Cell [Cell]
   741   C1656978:cell end [Cell Component]
   739   C0007634:Cells [Cell]
   739   C0205179:Advanced [Qualitative Concept]
   739   C0205263:Induced [Functional Concept]
   739   C0442791:N18 [Finding]
   739   C0444930:End [Spatial Concept]
   739   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   739   C0598528:glycation [Phenomenon or Process]
   739   C1514468:Products [Entity]
   739   C2746065:End [Temporal Concept]
   739   C3282337:Cells [Cell]
   706 E C0725066:Advance [Medical Device]
   706 E C1269647:Cell [Cell]
   706 E C1704444:Product [Quantitative Concept]
   706 E C1704653:Cell [Medical Device]
   706 E C1948049:Cell [Spatial Concept]

Phrase: "stimulated with amphoterin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0019796:Amphoterin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1333908:AMPHOTERIN [Gene or Genome]
   790   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "for 90min,"

Phrase: "whereas in N18/RAGEcyto cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0007634:Cells [Cell]
   760   C0442791:N18 [Finding]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "no ERK1/2"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   947   C0082529:Extracellular Signal-Regulated Kinase 1 [Amino Acid, Peptide, or Protein,Enzyme]
   947   C1366765:EXTRACELLULAR SIGNAL-REGULATED KINASE 1 [Gene or Genome]
   941   C0170168:Extracellular Signal-Regulated Kinase 2 [Amino Acid, Peptide, or Protein,Enzyme]
   941   C1366882:EXTRACELLULAR SIGNAL-REGULATED KINASE 2 [Gene or Genome]
   880   C0600388:Extracellular Signal Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   880   C0752312:Extracellular Signal-Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0521119:Extracellular [Cell Component]
   799   C0851285:Regulated [Governmental or Regulatory Activity]
   799   C1710082:Signal [Phenomenon or Process]

Phrase: "or"

Phrase: "CREB phosphorylation"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   877   C1157225:AMP phosphorylation [Molecular Function]
   818   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   795   C0031715:Phosphorylation [Molecular Function]
   787   C0056695:Cyclic AMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   747   C3158668:cyclic-AMP response element binding [Genetic Function]
   710   C1511573:Cyclic AMP Response Element [Gene or Genome]
   701   C1148918:cyclic AMP binding [Molecular Function]

Phrase: "could"

Phrase: "be"

Phrase: "detected."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]
Processing 00000000.tx.157: Gelatin or retinoic acid did not induce ERK1/2 or CREB phosphorylation in N18/RAGE or N18/RAGEcyto cells (Fig. 4A). 

Phrase: "Gelatin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017237:Gelatin [Amino Acid, Peptide, or Protein,Biomedical or Dental Material,Pharmacologic Substance]
  1000   C1145617:Gelatin [Food]

Phrase: "or"

Phrase: "retinoic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0040845:Retinoic Acid [Organic Chemical,Pharmacologic Substance,Vitamin]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "ERK1/2"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   947   C0082529:Extracellular Signal-Regulated Kinase 1 [Amino Acid, Peptide, or Protein,Enzyme]
   947   C1366765:EXTRACELLULAR SIGNAL-REGULATED KINASE 1 [Gene or Genome]
   941   C0170168:Extracellular Signal-Regulated Kinase 2 [Amino Acid, Peptide, or Protein,Enzyme]
   941   C1366882:EXTRACELLULAR SIGNAL-REGULATED KINASE 2 [Gene or Genome]
   880   C0600388:Extracellular Signal Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   880   C0752312:Extracellular Signal-Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0521119:Extracellular [Cell Component]
   799   C0851285:Regulated [Governmental or Regulatory Activity]
   799   C1710082:Signal [Phenomenon or Process]

Phrase: "or"

Phrase: "CREB phosphorylation"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   877   C1157225:AMP phosphorylation [Molecular Function]
   818   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   795   C0031715:Phosphorylation [Molecular Function]
   787   C0056695:Cyclic AMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   747   C3158668:cyclic-AMP response element binding [Genetic Function]
   710   C1511573:Cyclic AMP Response Element [Gene or Genome]
   701   C1148918:cyclic AMP binding [Molecular Function]

Phrase: "in N18/RAGE"
Meta Candidates (Total=16; Excluded=5; Pruned=0; Remaining=11)
   923   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   861   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   793   C0150312:In [Quantitative Concept]
   793   C0205179:Advanced [Qualitative Concept]
   793   C0332285:In [Spatial Concept]
   793   C0442791:N18 [Finding]
   793   C0444930:End [Spatial Concept]
   793   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   793   C0598528:glycation [Phenomenon or Process]
   793   C1514468:Products [Entity]
   793   C2746065:End [Temporal Concept]
   760 E C0725066:Advance [Medical Device]
   760 E C1704444:Product [Quantitative Concept]
   737 E C0205088:Terminal [Temporal Concept]
   737 E C1705314:Terminal [Manufactured Object]
   737 E C1705315:Terminal [Spatial Concept]

Phrase: "or"

Phrase: "N18/RAGEcyto cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.158: Interestingly, laminin induced ERK1/2 phosphorylation in both N18/RAGE and N18/RAGEcyto cells (only ~1.2-fold induction of ERK1/2 phosphorylation in N18/RAGE cells in comparison to similarly treated N18/RAGEcyto cells), but CREB phosphorylation only in N18/RAGE cells (~3.9-fold induction of CREB phosphorylation in N18/RAGE cells as compared with similarly treated N18/RAGEcyto cells). 

Phrase: "Interestingly,"

Phrase: "laminin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022984:Laminin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "ERK1/2 phosphorylation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   795   C0031715:Phosphorylation [Molecular Function]
   795   C1158886:Phosphorylation [Molecular Function]
   747   C0082529:Extracellular Signal-Regulated Kinase 1 [Amino Acid, Peptide, or Protein,Enzyme]
   747   C1366765:EXTRACELLULAR SIGNAL-REGULATED KINASE 1 [Gene or Genome]
   744   C0170168:Extracellular Signal-Regulated Kinase 2 [Amino Acid, Peptide, or Protein,Enzyme]
   744   C1366882:EXTRACELLULAR SIGNAL-REGULATED KINASE 2 [Gene or Genome]

Phrase: "in both N18/RAGE"
Meta Candidates (Total=16; Excluded=5; Pruned=0; Remaining=11)
   901   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   849   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   791   C0150312:In [Quantitative Concept]
   791   C0205179:Advanced [Qualitative Concept]
   791   C0332285:In [Spatial Concept]
   791   C0442791:N18 [Finding]
   791   C0444930:End [Spatial Concept]
   791   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   791   C0598528:glycation [Phenomenon or Process]
   791   C1514468:Products [Entity]
   791   C2746065:End [Temporal Concept]
   758 E C0725066:Advance [Medical Device]
   758 E C1704444:Product [Quantitative Concept]
   735 E C0205088:Terminal [Temporal Concept]
   735 E C1705314:Terminal [Manufactured Object]
   735 E C1705315:Terminal [Spatial Concept]

Phrase: "and"

Phrase: "N18/RAGEcyto cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(only ~1.2-fold induction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0205263:Induction [Functional Concept]
   804   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "of ERK1/2 phosphorylation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   795   C0031715:Phosphorylation [Molecular Function]
   795   C1158886:Phosphorylation [Molecular Function]
   747   C0082529:Extracellular Signal-Regulated Kinase 1 [Amino Acid, Peptide, or Protein,Enzyme]
   747   C1366765:EXTRACELLULAR SIGNAL-REGULATED KINASE 1 [Gene or Genome]
   744   C0170168:Extracellular Signal-Regulated Kinase 2 [Amino Acid, Peptide, or Protein,Enzyme]
   744   C1366882:EXTRACELLULAR SIGNAL-REGULATED KINASE 2 [Gene or Genome]

Phrase: "in N18/RAGE cells"
Meta Candidates (Total=22; Excluded=8; Pruned=0; Remaining=14)
   901   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   850   C1514760:Receptor Cell [Cell]
   849   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   791   C0007634:Cells [Cell]
   791   C0150312:In [Quantitative Concept]
   791   C0205179:Advanced [Qualitative Concept]
   791   C0332285:In [Spatial Concept]
   791   C0442791:N18 [Finding]
   791   C0444930:End [Spatial Concept]
   791   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   791   C0598528:glycation [Phenomenon or Process]
   791   C1514468:Products [Entity]
   791   C2746065:End [Temporal Concept]
   791   C3282337:Cells [Cell]
   758 E C0725066:Advance [Medical Device]
   758 E C1269647:Cell [Cell]
   758 E C1704444:Product [Quantitative Concept]
   758 E C1704653:Cell [Medical Device]
   758 E C1948049:Cell [Spatial Concept]
   735 E C0205088:Terminal [Temporal Concept]
   735 E C1705314:Terminal [Manufactured Object]
   735 E C1705315:Terminal [Spatial Concept]

Phrase: "in comparison to similarly treated N18/RAGEcyto cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "CREB phosphorylation only"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   864   C1157225:AMP phosphorylation [Molecular Function]
   812   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   793   C0031715:Phosphorylation [Molecular Function]
   756   C0056695:Cyclic AMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   723   C3158668:cyclic-AMP response element binding [Genetic Function]

Phrase: "in N18/RAGE cells"
Meta Candidates (Total=22; Excluded=8; Pruned=0; Remaining=14)
   901   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   850   C1514760:Receptor Cell [Cell]
   849   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   791   C0007634:Cells [Cell]
   791   C0150312:In [Quantitative Concept]
   791   C0205179:Advanced [Qualitative Concept]
   791   C0332285:In [Spatial Concept]
   791   C0442791:N18 [Finding]
   791   C0444930:End [Spatial Concept]
   791   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   791   C0598528:glycation [Phenomenon or Process]
   791   C1514468:Products [Entity]
   791   C2746065:End [Temporal Concept]
   791   C3282337:Cells [Cell]
   758 E C0725066:Advance [Medical Device]
   758 E C1269647:Cell [Cell]
   758 E C1704444:Product [Quantitative Concept]
   758 E C1704653:Cell [Medical Device]
   758 E C1948049:Cell [Spatial Concept]
   735 E C0205088:Terminal [Temporal Concept]
   735 E C1705314:Terminal [Manufactured Object]
   735 E C1705315:Terminal [Spatial Concept]

Phrase: "(~3.9-fold induction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0205263:Induction [Functional Concept]
   812   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "of CREB phosphorylation"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   877   C1157225:AMP phosphorylation [Molecular Function]
   818   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   795   C0031715:Phosphorylation [Molecular Function]
   787   C0056695:Cyclic AMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   747   C3158668:cyclic-AMP response element binding [Genetic Function]
   710   C1511573:Cyclic AMP Response Element [Gene or Genome]
   701   C1148918:cyclic AMP binding [Molecular Function]

Phrase: "in N18/RAGE cells"
Meta Candidates (Total=22; Excluded=8; Pruned=0; Remaining=14)
   901   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   850   C1514760:Receptor Cell [Cell]
   849   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   791   C0007634:Cells [Cell]
   791   C0150312:In [Quantitative Concept]
   791   C0205179:Advanced [Qualitative Concept]
   791   C0332285:In [Spatial Concept]
   791   C0442791:N18 [Finding]
   791   C0444930:End [Spatial Concept]
   791   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   791   C0598528:glycation [Phenomenon or Process]
   791   C1514468:Products [Entity]
   791   C2746065:End [Temporal Concept]
   791   C3282337:Cells [Cell]
   758 E C0725066:Advance [Medical Device]
   758 E C1269647:Cell [Cell]
   758 E C1704444:Product [Quantitative Concept]
   758 E C1704653:Cell [Medical Device]
   758 E C1948049:Cell [Spatial Concept]
   735 E C0205088:Terminal [Temporal Concept]
   735 E C1705314:Terminal [Manufactured Object]
   735 E C1705315:Terminal [Spatial Concept]

Phrase: "as"

Phrase: "compared with similarly treated N18/RAGEcyto cells"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   774   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   748   C0007634:Cells [Cell]
   748   C0442791:N18 [Finding]
   748   C1522326:Treated [Functional Concept]
   748   C1707455:Compared [Activity]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1292734:TREAT [Functional Concept]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.159: It is possible that in this case laminin-induced secretion of endogenous amphoterin (26) activates RAGE signaling in an autocrine manner and contributes to the laminin-induced, integrin-mediated activation of signaling pathways in N18/RAGE cells. 

Phrase: "It"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that in this case laminin-induced secretion of endogenous amphoterin"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   739   C0019796:Amphoterin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0022984:Laminin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0036536:secretion [Biologic Function]
   739   C0036537:Secretion [Body Substance]
   739   C0205227:Endogenous [Functional Concept]
   739   C0205263:Induced [Functional Concept]
   739   C0868928:Case [Functional Concept]
   739   C1333908:AMPHOTERIN [Gene or Genome]
   739   C1706255:CASE [Medical Device]
   739   C1706256:Case [Conceptual Entity]

Phrase: "(26"

Phrase: ")"

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "RAGE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   716   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]

Phrase: "signaling in an autocrine manner"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   797   C0525010:Autocrine Signaling [Cell Function]
   760   C0037083:Signaling [Cell Function]
   760   C0596138:Autocrine [Organ or Tissue Function]
   760   C3537152:signaling [Biologic Function]
   726 E C1710082:Signal [Phenomenon or Process]

Phrase: "and"

Phrase: "contributes to the laminin-induced, integrin-mediated activation of signaling pathways"
Meta Candidates (Total=18; Excluded=3; Pruned=0; Remaining=15)
   781   C1155451:integrin-mediated signaling pathway [Molecular Function]
   761   C1512812:Integrin Signaling Pathway [Molecular Function]
   754   C0037080:pathways signaling [Molecular Function]
   754   C2247060:integrin activation [Cell Function]
   739 E C0037083:signaling pathway [Cell Function]
           Signaling
   739 E C0086982:Signaling Pathway [Molecular Function]
   738   C0021701:Integrin [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   738   C0022984:Laminin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0086597:mediated [Social Behavior]
   738   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   738   C0205263:Induced [Functional Concept]
   738   C1704259:Pathways [Molecular Function]
   738   C1705987:Pathways [Conceptual Entity]
   738   C1879547:Activation [Activity]
   738   C1880177:Contribute [Activity]
   738   C3537152:signaling [Biologic Function]
   704 E C1710082:Signal [Phenomenon or Process]

Phrase: "in N18/RAGE cells."
Meta Candidates (Total=22; Excluded=8; Pruned=0; Remaining=14)
   901   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   850   C1514760:Receptor Cell [Cell]
   849   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   791   C0007634:Cells [Cell]
   791   C0150312:In [Quantitative Concept]
   791   C0205179:Advanced [Qualitative Concept]
   791   C0332285:In [Spatial Concept]
   791   C0442791:N18 [Finding]
   791   C0444930:End [Spatial Concept]
   791   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   791   C0598528:glycation [Phenomenon or Process]
   791   C1514468:Products [Entity]
   791   C2746065:End [Temporal Concept]
   791   C3282337:Cells [Cell]
   758 E C0725066:Advance [Medical Device]
   758 E C1269647:Cell [Cell]
   758 E C1704444:Product [Quantitative Concept]
   758 E C1704653:Cell [Medical Device]
   758 E C1948049:Cell [Spatial Concept]
   735 E C0205088:Terminal [Temporal Concept]
   735 E C1705314:Terminal [Manufactured Object]
   735 E C1705315:Terminal [Spatial Concept]
Processing 00000000.tx.160: Analysis of the phosphorylation kinetics showed that ERK1/2 and CREB phosphorylation in N18/RAGE cells peaks between 30-60 min after amphoterin stimulation (Fig. 4B). 

Phrase: "Analysis of the phosphorylation kinetics"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that ERK1/2"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   947   C0082529:Extracellular Signal-Regulated Kinase 1 [Amino Acid, Peptide, or Protein,Enzyme]
   947   C1366765:EXTRACELLULAR SIGNAL-REGULATED KINASE 1 [Gene or Genome]
   941   C0170168:Extracellular Signal-Regulated Kinase 2 [Amino Acid, Peptide, or Protein,Enzyme]
   941   C1366882:EXTRACELLULAR SIGNAL-REGULATED KINASE 2 [Gene or Genome]
   880   C0600388:Extracellular Signal Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   880   C0752312:Extracellular Signal-Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0521119:Extracellular [Cell Component]
   799   C0851285:Regulated [Governmental or Regulatory Activity]
   799   C1710082:Signal [Phenomenon or Process]

Phrase: "and"

Phrase: "CREB phosphorylation"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   877   C1157225:AMP phosphorylation [Molecular Function]
   818   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   795   C0031715:Phosphorylation [Molecular Function]
   787   C0056695:Cyclic AMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   747   C3158668:cyclic-AMP response element binding [Genetic Function]
   710   C1511573:Cyclic AMP Response Element [Gene or Genome]
   701   C1148918:cyclic AMP binding [Molecular Function]

Phrase: "in N18/RAGE cells"
Meta Candidates (Total=22; Excluded=8; Pruned=0; Remaining=14)
   901   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   850   C1514760:Receptor Cell [Cell]
   849   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   791   C0007634:Cells [Cell]
   791   C0150312:In [Quantitative Concept]
   791   C0205179:Advanced [Qualitative Concept]
   791   C0332285:In [Spatial Concept]
   791   C0442791:N18 [Finding]
   791   C0444930:End [Spatial Concept]
   791   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   791   C0598528:glycation [Phenomenon or Process]
   791   C1514468:Products [Entity]
   791   C2746065:End [Temporal Concept]
   791   C3282337:Cells [Cell]
   758 E C0725066:Advance [Medical Device]
   758 E C1269647:Cell [Cell]
   758 E C1704444:Product [Quantitative Concept]
   758 E C1704653:Cell [Medical Device]
   758 E C1948049:Cell [Spatial Concept]
   735 E C0205088:Terminal [Temporal Concept]
   735 E C1705314:Terminal [Manufactured Object]
   735 E C1705315:Terminal [Spatial Concept]

Phrase: "peaks between 30-60 min"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0456693:/30 min [Temporal Concept]
   797   C1442458:30 min [Temporal Concept]
   760   C0444505:Peak [Quantitative Concept]
   760   C0702093:/min [Temporal Concept]

Phrase: "after amphoterin stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   861   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "(Fig. 4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.161: In addition, phosphorylated CREB was translocated to the nucleus in N18/RAGE cells stimulated with amphoterin (Fig. 4C), whereas in N18/RAGEcyto cells (Fig. 4D), N18/RAGE cells stimulated with gelatin (Fig. 4E), gelatin and retinoic acid (Fig. 4F), or laminin (Fig. 4G) nuclear translocation of phosphorylated CREB was not observed. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "phosphorylated CREB"
Meta Candidates (Total=21; Excluded=1; Pruned=0; Remaining=20)
   954   C0056695:Cyclic AMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C3158668:cyclic-AMP response element binding [Genetic Function]
   877   C1511573:Cyclic AMP Response Element [Gene or Genome]
   868   C1148918:cyclic AMP binding [Molecular Function]
   845   C1148922:AMP binding [Molecular Function]
   818   C0001455:Cyclic AMP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   818   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   795   C0013879:Element [Element, Ion, or Isotope]
   795   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0243122:binding [Functional Concept]
   795   C0439596:Cyclic [Temporal Concept]
   795   C0871261:Response [Organism Attribute]
   795   C1145667:Binding [Activity]
   795   C1167622:Binding [Molecular Function]
   795   C1511572:Cyclic [Temporal Concept]
   795   C1704632:Response [Finding]
   795   C1705248:Element [Conceptual Entity]
   795   C1706817:Response [Intellectual Product]
   795   C2911692:Response [Mental Process]
   724 E C0031084:Cyclicities [Temporal Concept]

Phrase: "was"

Phrase: "translocated to the nucleus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0007610:Nucleus [Cell Component]

Phrase: "in N18/RAGE cells"
Meta Candidates (Total=22; Excluded=8; Pruned=0; Remaining=14)
   901   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   850   C1514760:Receptor Cell [Cell]
   849   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   791   C0007634:Cells [Cell]
   791   C0150312:In [Quantitative Concept]
   791   C0205179:Advanced [Qualitative Concept]
   791   C0332285:In [Spatial Concept]
   791   C0442791:N18 [Finding]
   791   C0444930:End [Spatial Concept]
   791   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   791   C0598528:glycation [Phenomenon or Process]
   791   C1514468:Products [Entity]
   791   C2746065:End [Temporal Concept]
   791   C3282337:Cells [Cell]
   758 E C0725066:Advance [Medical Device]
   758 E C1269647:Cell [Cell]
   758 E C1704444:Product [Quantitative Concept]
   758 E C1704653:Cell [Medical Device]
   758 E C1948049:Cell [Spatial Concept]
   735 E C0205088:Terminal [Temporal Concept]
   735 E C1705314:Terminal [Manufactured Object]
   735 E C1705315:Terminal [Spatial Concept]

Phrase: "stimulated with amphoterin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0019796:Amphoterin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1333908:AMPHOTERIN [Gene or Genome]
   790   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "(Fig. 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450376:4c [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "whereas in N18/RAGEcyto cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0007634:Cells [Cell]
   760   C0442791:N18 [Finding]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 4D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450377:4d [Intellectual Product]
   861   C2986754:4D [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "N18/RAGE cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   909   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   750   C1514760:Receptor Cell [Cell]
   744   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "stimulated with gelatin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0017237:Gelatin [Amino Acid, Peptide, or Protein,Biomedical or Dental Material,Pharmacologic Substance]
   790   C1145617:Gelatin [Food]
   790   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "(Fig. 4E"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450378:4e [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "gelatin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017237:Gelatin [Amino Acid, Peptide, or Protein,Biomedical or Dental Material,Pharmacologic Substance]
  1000   C1145617:Gelatin [Food]

Phrase: "and"

Phrase: "retinoic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0040845:Retinoic Acid [Organic Chemical,Pharmacologic Substance,Vitamin]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "(Fig. 4F"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450379:4f [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "laminin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022984:Laminin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 4G"

Phrase: ")"

Phrase: "nuclear translocation of phosphorylated CREB"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1518440:Nuclear Translocation [Molecular Function]
   757   C0599893:Protein translocation [Cell Function]
   739   C0040715:Translocation [Cell or Molecular Dysfunction]
   739   C2987521:Translocation [Activity]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "observed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]
Processing 00000000.tx.162: View larger version (37K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(37K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.163: 4.  

Phrase: "4."
Processing 00000000.tx.164: Activation of RAGE induces phosphorylation and nuclear translocation of CREB. 

Phrase: "Activation of RAGE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C1514758:Receptor Activation [Cell Function]
   750   C0596035:activation product [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1879547:Activation [Activity]
   743   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "nuclear translocation of CREB."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   764   C1518440:Nuclear Translocation [Molecular Function]
   762   C0599893:Protein translocation [Cell Function]
   742   C0040715:Translocation [Cell or Molecular Dysfunction]
   742   C2987521:Translocation [Activity]
   716   C0056695:Cyclic AMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.165: A, N18 neuroblastoma cells stably transfected with RAGE or RAGEcyto were serum-starved overnight and plated either on gelatin-coated surface (0.1%) with or without 1M retinoic acid, on laminin-coated surface (10g/ml), or on amphoterin-coated (20g/ml) surface without serum. 

Phrase: "A,"

Phrase: "N18 neuroblastoma cells stably"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   844   C0815000:neuroblastoma cell [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with RAGE"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   909   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   833   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   744   C0205179:Advanced [Qualitative Concept]
   744   C0444930:End [Spatial Concept]
   744   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   744   C0598528:glycation [Phenomenon or Process]
   744   C1514468:Products [Entity]
   744   C2746065:End [Temporal Concept]
   711 E C0725066:Advance [Medical Device]
   711 E C1704444:Product [Quantitative Concept]

Phrase: "or"

Phrase: "RAGEcyto"

Phrase: "were"

Phrase: "serum-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0229671:Serum [Body Substance]
  1000   C1546774:Serum [Intellectual Product]
  1000   C1550100:Serum [Body Substance]

Phrase: "starved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2348531:Starve [Activity]

Phrase: "overnight"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439583:Overnight [Temporal Concept]

Phrase: "and"

Phrase: "plated either on gelatin-coated surface"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   753   C0017237:Gelatin [Amino Acid, Peptide, or Protein,Biomedical or Dental Material,Pharmacologic Substance]
   753   C0205148:Surface [Spatial Concept]
   753   C1145617:Gelatin [Food]
   753   C1522408:Coated [Qualitative Concept]
   719   C0005971:Plate [Medical Device]
   719 E C0453946:Coat [Manufactured Object]
   719   C1139930:plate [Medical Device]
   719 E C2987482:Coat [Body Part, Organ, or Organ Component]
   719   C3537155:Plate [Manufactured Object]

Phrase: "(0.1%"

Phrase: ")"

Phrase: "with"

Phrase: "or without 1M retinoic acid,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0040845:Retinoic Acid [Organic Chemical,Pharmacologic Substance,Vitamin]
   760   C0001128:Acid [Chemical]
   760   C0202406:Acid [Laboratory Procedure]
   760   C0470296:1M [Quantitative Concept]

Phrase: "on laminin-coated surface"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205148:Surface [Spatial Concept]

Phrase: "(10g/ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "or on amphoterin-coated"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0019796:Amphoterin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1333908:AMPHOTERIN [Gene or Genome]
   770   C1522408:Coated [Qualitative Concept]
   737 E C0453946:Coat [Manufactured Object]
   737 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "(20g/ml) surface without serum."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205148:Surface [Spatial Concept]
Processing 00000000.tx.166: Cells were lysed after 90min and probed in a Western blot with antibodies specific for phosphorylated CREB, phosphorylated ERK1/2, and non-phosphorylated ERK1/2. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "lysed after 90min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0024348:lysed [Pathologic Function]

Phrase: "and"

Phrase: "probed in a Western blot"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   806   C0949466:Western Blot [Laboratory Procedure]
   760   C1705493:Western [Spatial Concept]
   726   C0182400:Probe [Medical Device]
   726   C1704681:Probe [Gene or Genome]
   726   C2347609:Probe [Chemical Viewed Functionally]
   726   C3536729:Probe [Manufactured Object]

Phrase: "with antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "specific for phosphorylated CREB,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0205369:Specific [Qualitative Concept]
   742   C1552740:specific [Intellectual Product]
   716   C0056695:Cyclic AMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "phosphorylated ERK1/2,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   913   C0082529:Extracellular Signal-Regulated Kinase 1 [Amino Acid, Peptide, or Protein,Enzyme]
   913   C1366765:EXTRACELLULAR SIGNAL-REGULATED KINASE 1 [Gene or Genome]
   911   C0170168:Extracellular Signal-Regulated Kinase 2 [Amino Acid, Peptide, or Protein,Enzyme]
   911   C1366882:EXTRACELLULAR SIGNAL-REGULATED KINASE 2 [Gene or Genome]
   856   C0600388:Extracellular Signal Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   856   C0752312:Extracellular Signal-Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0521119:Extracellular [Cell Component]
   795   C0851285:Regulated [Governmental or Regulatory Activity]
   795   C1710082:Signal [Phenomenon or Process]

Phrase: "and"

Phrase: "non-phosphorylated ERK1/2."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   890   C0082529:Extracellular Signal-Regulated Kinase 1 [Amino Acid, Peptide, or Protein,Enzyme]
   890   C0170168:Extracellular Signal-Regulated Kinase 2 [Amino Acid, Peptide, or Protein,Enzyme]
   890   C1366765:EXTRACELLULAR SIGNAL-REGULATED KINASE 1 [Gene or Genome]
   890   C1366882:EXTRACELLULAR SIGNAL-REGULATED KINASE 2 [Gene or Genome]
   840   C0600388:Extracellular Signal Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0752312:Extracellular Signal-Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   793   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   793   C0521119:Extracellular [Cell Component]
   793   C0851285:Regulated [Governmental or Regulatory Activity]
   793   C1518422:Non [Functional Concept]
   793   C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.167: Densitometric analysis of relative induction (N18/RAGE cells versus similarly treated N18/RAGEcyto cells (reference value 1.0)) is indicated. 

Phrase: "Densitometric analysis of relative induction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "(N18/RAGE cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   909   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   750   C1514760:Receptor Cell [Cell]
   744   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "versus"

Phrase: "similarly treated N18/RAGEcyto cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "(reference value 1.0"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0086715:Value, Reference [Quantitative Concept]
   812   C1514811:Reference [Idea or Concept]
   812   C1522609:Value [Quantitative Concept]
   812   C1706462:Reference [Conceptual Entity]

Phrase: ")"

Phrase: ")"

Phrase: "is"

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.168: B, cells were plated on amphoterin-coated (20g/ml) surface and lysed after 0,30,or 60min of incubation and probed as described above. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "plated on amphoterin-coated"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   770   C0019796:Amphoterin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1333908:AMPHOTERIN [Gene or Genome]
   770   C1522408:Coated [Qualitative Concept]
   737   C0005971:Plate [Medical Device]
   737 E C0453946:Coat [Manufactured Object]
   737   C1139930:plate [Medical Device]
   737 E C2987482:Coat [Body Part, Organ, or Organ Component]
   737   C3537155:Plate [Manufactured Object]

Phrase: "(20g/ml) surface"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205148:Surface [Spatial Concept]

Phrase: "and"

Phrase: "lysed after 0,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0024348:lysed [Pathologic Function]

Phrase: "30,"

Phrase: "or"

Phrase: "60min of incubation"

Phrase: "and"

Phrase: "probed as described above."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C1552738:described [Idea or Concept]
   737   C0182400:Probe [Medical Device]
   737   C1704681:Probe [Gene or Genome]
   737   C2347609:Probe [Chemical Viewed Functionally]
   737   C3536729:Probe [Manufactured Object]
Processing 00000000.tx.169: C-L, double immunostaining of phosphorylated CREB (red) and phosphorylated ERK1/2 (green) in N18/RAGE cells (C) and N18/RAGEcyto cells (D) on an amphoterin-coated surface, N18/RAGE cells on gelatin-coated surface without (E) or with 1M retinoic acid (F), and N18/RAGE cells on laminin-coated surface (G). 

Phrase: "C-L,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0347983:cells/L [Quantitative Concept]
   983 E C0022827:cell l [Cell]

Phrase: "double immunostaining of phosphorylated CREB"

Phrase: "(red)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332575:Red [Finding]
  1000   C1260956:Red [Qualitative Concept]

Phrase: "and"

Phrase: "phosphorylated ERK1/2"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   913   C0082529:Extracellular Signal-Regulated Kinase 1 [Amino Acid, Peptide, or Protein,Enzyme]
   913   C1366765:EXTRACELLULAR SIGNAL-REGULATED KINASE 1 [Gene or Genome]
   911   C0170168:Extracellular Signal-Regulated Kinase 2 [Amino Acid, Peptide, or Protein,Enzyme]
   911   C1366882:EXTRACELLULAR SIGNAL-REGULATED KINASE 2 [Gene or Genome]
   856   C0600388:Extracellular Signal Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   856   C0752312:Extracellular Signal-Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0521119:Extracellular [Cell Component]
   795   C0851285:Regulated [Governmental or Regulatory Activity]
   795   C1710082:Signal [Phenomenon or Process]

Phrase: "(green"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332583:Green [Qualitative Concept]

Phrase: ")"

Phrase: "in N18/RAGE cells (C)"
Meta Candidates (Total=22; Excluded=8; Pruned=0; Remaining=14)
   901   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   850   C1514760:Receptor Cell [Cell]
   849   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   791   C0007634:Cells [Cell]
   791   C0150312:In [Quantitative Concept]
   791   C0205179:Advanced [Qualitative Concept]
   791   C0332285:In [Spatial Concept]
   791   C0442791:N18 [Finding]
   791   C0444930:End [Spatial Concept]
   791   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   791   C0598528:glycation [Phenomenon or Process]
   791   C1514468:Products [Entity]
   791   C2746065:End [Temporal Concept]
   791   C3282337:Cells [Cell]
   758 E C0725066:Advance [Medical Device]
   758 E C1269647:Cell [Cell]
   758 E C1704444:Product [Quantitative Concept]
   758 E C1704653:Cell [Medical Device]
   758 E C1948049:Cell [Spatial Concept]
   735 E C0205088:Terminal [Temporal Concept]
   735 E C1705314:Terminal [Manufactured Object]
   735 E C1705315:Terminal [Spatial Concept]

Phrase: "and"

Phrase: "N18/RAGEcyto cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "("

Phrase: "D) on an amphoterin-coated surface,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   753   C0019796:Amphoterin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0205148:Surface [Spatial Concept]
   753   C1333908:AMPHOTERIN [Gene or Genome]
   753   C1522408:Coated [Qualitative Concept]
   719 E C0453946:Coat [Manufactured Object]
   719 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "N18/RAGE cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   909   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   750   C1514760:Receptor Cell [Cell]
   744   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "on gelatin-coated surface"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205148:Surface [Spatial Concept]

Phrase: "without"

Phrase: "(E)"

Phrase: "or with 1M retinoic acid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0040845:Retinoic Acid [Organic Chemical,Pharmacologic Substance,Vitamin]
   760   C0001128:Acid [Chemical]
   760   C0202406:Acid [Laboratory Procedure]
   760   C0470296:1M [Quantitative Concept]

Phrase: "(F),"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "N18/RAGE cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   909   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   750   C1514760:Receptor Cell [Cell]
   744   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "on laminin-coated surface"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205148:Surface [Spatial Concept]

Phrase: "(G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.170: DAPI counter-staining (blue) of the same cells is shown in H-L. 

Phrase: "DAPI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0057142:DAPI [Organic Chemical,Pharmacologic Substance]

Phrase: "counter-staining"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0487602:Staining [Laboratory Procedure]
   861   C0677601:Counter [Manufactured Object]
   861   C1704680:Staining [Finding]
   861   C1705206:Counter [Medical Device]
   827 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(blue"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260957:Blue [Qualitative Concept]

Phrase: ")"

Phrase: "of the same cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "shown in H-L."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C2346686:h l [Quantitative Concept]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   737   C1547282:Show [Intellectual Product]
Processing 00000000.tx.171: Bar=10m. 

Phrase: "Bar=10m."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1442446:10M [Temporal Concept]
Processing 00000000.tx.172: RAGE-induced Chromogranin Expression Requires ERK1/2-Rsk2-dependent CREB Phosphorylation-- MEK1/2ERK1/2Rsk2CREB-pathway has been shown to be both necessary and sufficient for inducible chromogranin A expression in PC12 cells (31, 32). 

Phrase: "RAGE-induced Chromogranin Expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   882   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   762   C0597360:receptor expression [Genetic Function]
   742   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "Requires"

Phrase: "ERK1/2-Rsk2-dependent CREB Phosphorylation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   823   C1157225:AMP phosphorylation [Molecular Function]
   794   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   785   C0031715:Phosphorylation [Molecular Function]
   715   C1333498:Extracellular Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "--"

Phrase: "MEK1/2ERK1/2Rsk2CREB-pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1704259:Pathway [Molecular Function]
   812   C1705987:Pathway [Conceptual Entity]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "both necessary"

Phrase: "and"

Phrase: "sufficient for inducible chromogranin A expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205410:Sufficient [Qualitative Concept]

Phrase: "in PC12 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085262:PC12 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "32"

Phrase: ")."
Processing 00000000.tx.173: Protein kinase C (PKC) inhibitors BIM and the structurally related Go6976 have been found to be potent inhibitors of the ribosomal S6 kinases, p90 Rsk2 and p70 S6 kinase, probably due to the homology between these enzymes and PKC within their ATP-binding subdomains (33). 

Phrase: "Protein kinase C (PKC) inhibitors BIM"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0256431:bis(indolyl)maleimide [Organic Chemical,Pharmacologic Substance]
   722   C1449702:Protein Kinase Inhibitors [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   722   C2757016:Protein Kinase Inhibitors [Molecular Function]

Phrase: "and"

Phrase: "the structurally related Go6976"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0215863:Go6976 [Organic Chemical]

Phrase: "have"

Phrase: "been"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "potent inhibitors of the ribosomal S6 kinases,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   757   C1152564:Kinase Inhibitors [Molecular Function]
   757   C3537035:inhibitors kinase [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   748   C0243077:inhibitors [Chemical Viewed Functionally]
   741 E C1171350:Kinase Inhibitor [Pharmacologic Substance]
   741 E C3537023:kinase inhibitor [Molecular Function]
   714 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "p90 Rsk2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419744:RSK2 [Gene or Genome]

Phrase: "and"

Phrase: "p70 S6 kinase,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1136240:p70 S6 Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0073337:S6 Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "probably due to the homology"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0678226:Due to [Functional Concept]
           due
   760   C0750492:Probably [Idea or Concept]
   760   C1334043:Homology [Gene or Genome]
   760   C2697616:Homology [Qualitative Concept]
   760   C3146286:Due [Idea or Concept]

Phrase: "between these enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014442:Enzymes [Enzyme,Organic Chemical]
  1000   C0014445:enzymes [Functional Concept]

Phrase: "and"

Phrase: "PKC within their ATP-binding subdomains"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   822   C1152874:protein kinase C binding [Molecular Function]
   800   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   793   C1149290:protein kinase binding [Molecular Function]
   793 E C1259877:kinase c protein [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   767   C0033618:Protein Binding [Molecular Function]
   767   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   767   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C1149289:kinase binding [Molecular Function]
   767   C1168438:Protein C [Laboratory Procedure]
   767   C1418943:PROTEIN C [Gene or Genome]
   767   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(33"

Phrase: ")."
Processing 00000000.tx.174: We tested U0126 (a specific MEK1/2 inhibitor), BIM, Go6976, calphostin C, and chelerythrine chloride (two commonly used PKC inhibitors not affecting Rsk2), and H-89 (a specific protein kinase A inhibitor) for their ability to inhibit RAGE-induced ERK1/2 and CREB phosphorylation. 

Phrase: "We"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "U0126"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0755562:U0126 [Organic Chemical,Pharmacologic Substance]

Phrase: "("

Phrase: "a specific MEK1/2 inhibitor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1999216:Inhibitor [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "BIM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0256431:bis(indolyl)maleimide [Organic Chemical,Pharmacologic Substance]

Phrase: "Go6976,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0215863:Go6976 [Organic Chemical]

Phrase: "calphostin C,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "chelerythrine chloride"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0109289:chelerythrine chloride [Organic Chemical,Pharmacologic Substance]
   861   C0008203:Chloride, NOS [Inorganic Chemical]
   861   C0596019:Chloride [Element, Ion, or Isotope]

Phrase: "(two commonly used PKC inhibitors"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   860   C1514555:Protein Kinase C Inhibitor [Pharmacologic Substance]
   852   C1449702:Protein Kinase Inhibitors [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   852   C2757016:Protein Kinase Inhibitors [Molecular Function]
   841   C0072348:Protein C Inhibitor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   841   C1418370:PROTEIN C INHIBITOR [Gene or Genome]
   829   C1152564:Kinase Inhibitors [Molecular Function]
   813 E C1171350:Kinase Inhibitor [Pharmacologic Substance]
   813 E C3537023:kinase inhibitor [Molecular Function]
   813 E C3537035:kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   795   C0243077:inhibitors [Chemical Viewed Functionally]
   762 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affecting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affecting [Functional Concept]
  1000   C1314939:Affecting [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "Rsk2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419744:RSK2 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "H-89"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0082782:H 89 [Organic Chemical,Pharmacologic Substance]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "("

Phrase: "a specific protein kinase A inhibitor"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   937   C0243459:Protein Kinase A Inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   888   C1449702:Protein kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   884   C0010531:Protein Kinase A [Amino Acid, Peptide, or Protein,Enzyme]
   853   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   853   C1171350:Kinase Inhibitor [Pharmacologic Substance]
   853   C3537023:kinase inhibitor [Molecular Function]
   853   C3537035:kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   840   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1999216:Inhibitor [Qualitative Concept]

Phrase: ")"

Phrase: "for their ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "RAGE-induced ERK1/2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   852   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   786   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "CREB phosphorylation."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   877   C1157225:AMP phosphorylation [Molecular Function]
   818   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   795   C0031715:Phosphorylation [Molecular Function]
   787   C0056695:Cyclic AMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   747   C3158668:cyclic-AMP response element binding [Genetic Function]
   710   C1511573:Cyclic AMP Response Element [Gene or Genome]
   701   C1148918:cyclic AMP binding [Molecular Function]
Processing 00000000.tx.175: As seen in Fig. 

Phrase: "As"

Phrase: "seen in Fig."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0205397:Seen [Qualitative Concept]
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]
Processing 00000000.tx.176: 5A, U0126 inhibits RAGE-mediated ERK1/2 and CREB phosphorylation on amphoterin-coated surface. 

Phrase: "5A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553637:5a [Medical Device]

Phrase: "U0126"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0755562:U0126 [Organic Chemical,Pharmacologic Substance]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "RAGE-mediated ERK1/2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   852   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   786   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "CREB phosphorylation on amphoterin-coated surface."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   756   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   754   C1157225:AMP phosphorylation [Molecular Function]
   738   C0031715:Phosphorylation [Molecular Function]
Processing 00000000.tx.177: BIM and Go6976 had no effect on ERK1/2 phosphorylation, whereas they potently inhibited RAGE-induced CREB phosphorylation. 

Phrase: "BIM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0256431:bis(indolyl)maleimide [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "Go6976"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0215863:Go6976 [Organic Chemical]

Phrase: "had"

Phrase: "no effect on ERK1/2 phosphorylation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1301751:No effect [Qualitative Concept]
   739   C1280500:Effect [Qualitative Concept]
   739   C2348382:Effect [Qualitative Concept]

Phrase: "whereas"

Phrase: "they potently"

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "RAGE-induced CREB phosphorylation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   882   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   874   C0597358:Receptor Binding [Molecular Function]
   845   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
Processing 00000000.tx.178: Calphostin C, chelerythrine chloride, and H-89 had no effect on either ERK1/2 or CREB phosphorylation. 

Phrase: "Calphostin C,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "chelerythrine chloride,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0109289:chelerythrine chloride [Organic Chemical,Pharmacologic Substance]
   861   C0008203:Chloride, NOS [Inorganic Chemical]
   861   C0596019:Chloride [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "H-89"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0082782:H 89 [Organic Chemical,Pharmacologic Substance]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "had"

Phrase: "no effect on either ERK1/2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1301751:No effect [Qualitative Concept]
   739   C1280500:Effect [Qualitative Concept]
   739   C2348382:Effect [Qualitative Concept]

Phrase: "or"

Phrase: "CREB phosphorylation."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   877   C1157225:AMP phosphorylation [Molecular Function]
   818   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   795   C0031715:Phosphorylation [Molecular Function]
   787   C0056695:Cyclic AMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   747   C3158668:cyclic-AMP response element binding [Genetic Function]
   710   C1511573:Cyclic AMP Response Element [Gene or Genome]
   701   C1148918:cyclic AMP binding [Molecular Function]
Processing 00000000.tx.179: These results suggest that RAGE-mediated CREB phosphorylation requires ERK1/2-dependent Rsk2 activation but is not affected by inhibition of cAMP-protein kinase A signaling, another important CREB activation pathway (34). 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that RAGE-mediated CREB phosphorylation"
Meta Candidates (Total=43; Excluded=6; Pruned=0; Remaining=37)
   875   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   867   C0597358:Receptor Binding [Molecular Function]
   840   C0056695:Cyclic AMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   827   C3158668:cyclic-AMP response element binding [Genetic Function]
   823   C1157225:AMP phosphorylation [Molecular Function]
   817   C1148918:cyclic AMP binding [Molecular Function]
   815   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   815   C1511573:Cyclic AMP Response Element [Gene or Genome]
   808   C0870868:mediated response [Mental Process]
   808   C1148922:AMP binding [Molecular Function]
   794   C0001455:Cyclic AMP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   794   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   794   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   794   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   785   C0013879:Element [Element, Ion, or Isotope]
   785   C0031715:Phosphorylation [Molecular Function]
   785   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   785   C0086597:mediated [Social Behavior]
   785   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   785   C0205179:Advanced [Qualitative Concept]
   785   C0243122:binding [Functional Concept]
   785   C0439596:Cyclic [Temporal Concept]
   785   C0444930:End [Spatial Concept]
   785   C0598528:glycation [Phenomenon or Process]
   785   C0871261:Response [Organism Attribute]
   785   C1145667:Binding [Activity]
   785   C1167622:Binding [Molecular Function]
   785   C1511572:Cyclic [Temporal Concept]
   785   C1514468:Products [Entity]
   785   C1704632:Response [Finding]
   785   C1705248:Element [Conceptual Entity]
   785   C1706817:Response [Intellectual Product]
   785   C2746065:End [Temporal Concept]
   785   C2911692:Response [Mental Process]
   752 E C0725066:Advance [Medical Device]
   752 E C1704444:Product [Quantitative Concept]
   730 E C0205088:Terminal [Temporal Concept]
   730 E C1705314:Terminal [Manufactured Object]
   730 E C1705315:Terminal [Spatial Concept]
   714 E C0031084:Cyclicities [Temporal Concept]

Phrase: "requires"

Phrase: "ERK1/2-dependent Rsk2 activation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   791   C1879547:Activation [Activity]
   708   C0170168:Extracellular Signal-Regulated Kinase 2 [Amino Acid, Peptide, or Protein,Enzyme]
   708   C1366882:EXTRACELLULAR SIGNAL-REGULATED KINASE 2 [Gene or Genome]
   707   C0082529:Extracellular Signal-Regulated Kinase 1 [Amino Acid, Peptide, or Protein,Enzyme]
   707   C1366765:EXTRACELLULAR SIGNAL-REGULATED KINASE 1 [Gene or Genome]

Phrase: "but"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affected by inhibition of cAMP-protein kinase A signaling,"
Meta Candidates (Total=19; Excluded=1; Pruned=0; Remaining=18)
   782   C0010531:Protein Kinase A [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0001455:Cyclic AMP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   760   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   757   C0001497:AMP Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   757   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   757   C1335962:Signaling Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0021467:Inhibition [Mental Process]
   739   C0021469:Inhibition [Molecular Function]
   739   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0037083:Signaling [Cell Function]
   739   C0392760:Affected [Functional Concept]
   739   C0439596:Cyclic [Temporal Concept]
   739   C1314939:Affected [Functional Concept]
   739   C1511572:Cyclic [Temporal Concept]
   739   C1628982:% inhibition [Quantitative Concept]
   739   C3463820:Inhibition [Activity]
   739   C3537152:signaling [Biologic Function]
   706 E C0001721:Affect [Mental Process]

Phrase: "another important CREB activation pathway"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C1514528:Protein Activation Pathway [Functional Concept]
   827   C3156336:protein activation pathway [Molecular Function]
   791   C1704259:Pathway [Molecular Function]
   791   C1705987:Pathway [Conceptual Entity]
   734   C0056695:Cyclic AMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   707   C3158668:cyclic-AMP response element binding [Genetic Function]

Phrase: "(34"

Phrase: ")."
Processing 00000000.tx.180: Importantly, the MEK1/2 inhibitor U0126, and the Rsk2 inhibitors BIM and Go6976 blocked RAGE-mediated up-regulation of chromogranin A and B expression upon amphoterin stimulation (Fig. 5B) showing that the ERK1/2Rsk2CREB pathway is necessary for regulation of chromogranin expression by RAGE. 

Phrase: "Importantly,"

Phrase: "the MEK1/2 inhibitor U0126,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0755562:U0126 [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "the Rsk2 inhibitors BIM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0256431:bis(indolyl)maleimide [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "Go6976"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0215863:Go6976 [Organic Chemical]

Phrase: "blocked"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0028778:Blocked [Pathologic Function]
  1000   C0332206:Blocked [Functional Concept]
  1000   C2983591:BLOCKED [Research Activity]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "RAGE-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   716   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]

Phrase: "mediated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086597:mediated [Social Behavior]
  1000   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]

Phrase: "up-regulation of chromogranin A"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0041904:Up-Regulation [Cell Function,Molecular Function]
   806   C0162493:Up-Regulation [Genetic Function]
   760   C0547043:Up [Spatial Concept]
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1282911:Up [Spatial Concept]
   760   C1327622:Regulation [Biologic Function]

Phrase: "and"

Phrase: "B expression upon amphoterin stimulation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(Fig. 5B"

Phrase: ")"

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the ERK1/2Rsk2CREB pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1704259:Pathway [Molecular Function]
   827   C1705987:Pathway [Conceptual Entity]

Phrase: "is"

Phrase: "necessary for regulation of chromogranin expression"

Phrase: "by RAGE."
Meta Candidates (Total=14; Excluded=5; Pruned=0; Remaining=9)
   954   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   877   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   795   C0006539:BY [Geographic Area]
   795   C0205179:Advanced [Qualitative Concept]
   795   C0444930:End [Spatial Concept]
   795   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   795   C0598528:glycation [Phenomenon or Process]
   795   C1514468:Products [Entity]
   795   C2746065:End [Temporal Concept]
   762 E C0725066:Advance [Medical Device]
   762 E C1704444:Product [Quantitative Concept]
   740 E C0205088:Terminal [Temporal Concept]
   740 E C1705314:Terminal [Manufactured Object]
   740 E C1705315:Terminal [Spatial Concept]
Processing 00000000.tx.181: Interestingly, as inhibition of RAGE-induced ERK1/2 activation has no effect on RAGE-mediated neurite outgrowth on amphoterin-coated surface (6), it seems that RAGE-activated signaling pathways responsible for changes in cell morphology differ from the signaling pathways regulating chromogranin expression. 

Phrase: "Interestingly,"

Phrase: "as"

Phrase: "inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0021467:Inhibition [Mental Process]
  1000   C0021469:Inhibition [Molecular Function]
  1000   C1628982:% inhibition [Quantitative Concept]
  1000   C3463820:Inhibition [Activity]
   928 E C0311403:Inhibited [Qualitative Concept]

Phrase: "of RAGE-induced ERK1/2 activation"
Meta Candidates (Total=27; Excluded=5; Pruned=0; Remaining=22)
   882   C1514758:Receptor Activation [Cell Function]
   840   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   830   C0170168:Extracellular Signal-Regulated Kinase 2 [Amino Acid, Peptide, or Protein,Enzyme]
   830   C1366882:EXTRACELLULAR SIGNAL-REGULATED KINASE 2 [Gene or Genome]
   827   C0082529:Extracellular Signal-Regulated Kinase 1 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1366765:EXTRACELLULAR SIGNAL-REGULATED KINASE 1 [Gene or Genome]
   815   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   794   C0600388:Extracellular Signal Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   794   C0752312:Extracellular Signal-Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   785   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   785   C0205179:Advanced [Qualitative Concept]
   785   C0205263:Induced [Functional Concept]
   785   C0332285:Of [Spatial Concept]
   785   C0444930:End [Spatial Concept]
   785   C0521119:Extracellular [Cell Component]
   785   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   785   C0598528:glycation [Phenomenon or Process]
   785   C0851285:Regulated [Governmental or Regulatory Activity]
   785   C1514468:Products [Entity]
   785   C1710082:Signal [Phenomenon or Process]
   785   C1879547:Activation [Activity]
   785   C2746065:End [Temporal Concept]
   752 E C0725066:Advance [Medical Device]
   752 E C1704444:Product [Quantitative Concept]
   730 E C0205088:Terminal [Temporal Concept]
   730 E C1705314:Terminal [Manufactured Object]
   730 E C1705315:Terminal [Spatial Concept]

Phrase: "has"

Phrase: "no effect on RAGE-mediated neurite outgrowth"
Meta Candidates (Total=19; Excluded=2; Pruned=0; Remaining=17)
   833   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   790   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   753   C1301751:No effect [Qualitative Concept]
   753   C3158384:neurite outgrowth [Cell Function]
   736   C0085103:Neurite [Cell Component]
   736   C0086597:mediated [Social Behavior]
   736   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   736   C0205179:Advanced [Qualitative Concept]
   736   C0444930:End [Spatial Concept]
   736   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   736   C0598528:glycation [Phenomenon or Process]
   736   C1280500:Effect [Qualitative Concept]
   736   C1298908:no [Idea or Concept]
   736   C1514468:Products [Entity]
   736   C1549444:No [Idea or Concept]
   736   C2348382:Effect [Qualitative Concept]
   736   C2746065:End [Temporal Concept]
   703 E C0725066:Advance [Medical Device]
   703 E C1704444:Product [Quantitative Concept]

Phrase: "on amphoterin-coated surface"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205148:Surface [Spatial Concept]

Phrase: "(6"

Phrase: ")"

Phrase: ","

Phrase: "it"

Phrase: "seems"

Phrase: "that RAGE-activated signaling pathways"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   862   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   757   C1514762:Receptor Signaling [Molecular Function]
   739   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "responsible for changes in cell morphology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1273518:Responsible [Finding]

Phrase: "differ from the signaling pathways"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   797   C0037080:pathways signaling [Molecular Function]
   790 E C0037083:signaling pathway [Cell Function]
           Signaling
   790 E C0086982:Signaling Pathway [Molecular Function]
   760   C1704259:Pathways [Molecular Function]
   760   C1705987:Pathways [Conceptual Entity]
   760   C3537152:signaling [Biologic Function]
   726 E C1710082:Signal [Phenomenon or Process]

Phrase: "regulating"

Phrase: "chromogranin expression."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.182: View larger version (30K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(30K"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1413114:30K [Gene or Genome]

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.183: 5.  

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.184: Requirement of ERK1/2-Rsk2-dependent CREB activation for RAGE-induced chromogranin expression. 

Phrase: "Requirement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Requirement [Functional Concept]

Phrase: "of ERK1/2-Rsk2-dependent CREB activation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   794   C0599177:protein activation [Genetic Function]
   785   C1879547:Activation [Activity]
   715   C1333498:Extracellular Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "for RAGE-induced chromogranin expression."
Meta Candidates (Total=17; Excluded=5; Pruned=0; Remaining=12)
   880   C0597360:receptor expression [Genetic Function]
   840   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   790   C0008586:Chromogranin [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   790   C0185117:Expression [Therapeutic or Preventive Procedure]
   790   C0205179:Advanced [Qualitative Concept]
   790   C0205263:Induced [Functional Concept]
   790   C0444930:End [Spatial Concept]
   790   C0521125:For [Qualitative Concept]
   790   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   790   C0598528:glycation [Phenomenon or Process]
   790   C1514468:Products [Entity]
   790   C2746065:End [Temporal Concept]
   756 E C0725066:Advance [Medical Device]
   756 E C1704444:Product [Quantitative Concept]
   734 E C0205088:Terminal [Temporal Concept]
   734 E C1705314:Terminal [Manufactured Object]
   734 E C1705315:Terminal [Spatial Concept]
Processing 00000000.tx.185: N18 neuroblastoma cells stably transfected with full-length RAGE were harvested after an overnight serum starvation. 

Phrase: "N18 neuroblastoma cells stably"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   844   C0815000:neuroblastoma cell [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with full-length RAGE"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   862   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   806   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   739   C0205179:Advanced [Qualitative Concept]
   739   C0443225:Full [Qualitative Concept]
   739   C0444930:End [Spatial Concept]
   739   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   739   C0598528:glycation [Phenomenon or Process]
   739   C1444754:Length [Quantitative Concept]
   739   C1514468:Products [Entity]
   739   C1706316:LENGTH [Research Activity]
   739   C2746065:End [Temporal Concept]
   706 E C0725066:Advance [Medical Device]
   706 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "harvested after an overnight serum starvation."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0038187:Starvation [Finding]
   753   C0229671:Serum [Body Substance]
   753   C0439583:Overnight [Temporal Concept]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   719   C1512335:Harvest [Health Care Activity]
Processing 00000000.tx.186: Before plating on amphoterin-coated (20g/ml) surface the cells were pretreated for 30min with the following protein kinase inhibitors: U0126 (10M), calphostin C (100nM), chelerythrine chloride (1.5M), BIM (40nM), Go6976 (25nM), and H-89 (25M). 

Phrase: "Before plating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0407295:Plating [Therapeutic or Preventive Procedure]

Phrase: "on amphoterin-coated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1522408:Coated [Qualitative Concept]
   827 E C0453946:Coat [Manufactured Object]
   827 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "(20g/ml) surface"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205148:Surface [Spatial Concept]

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "pretreated for 30min"

Phrase: "with the following protein kinase inhibitors"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   923   C1449702:Protein Kinase Inhibitors [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   923   C2757016:Protein Kinase Inhibitors [Molecular Function]
   861   C1152564:Kinase Inhibitors [Molecular Function]
   844 E C1171350:Kinase Inhibitor [Pharmacologic Substance]
   844 E C3537023:kinase inhibitor [Molecular Function]
   844 E C3537035:kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0243077:inhibitors [Chemical Viewed Functionally]
   779 E C1999216:Inhibitor [Qualitative Concept]

Phrase: ":"

Phrase: "U0126"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0755562:U0126 [Organic Chemical,Pharmacologic Substance]

Phrase: "(10M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442446:10M [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "calphostin C"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(100nM"

Phrase: ")"

Phrase: ","

Phrase: "chelerythrine chloride"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0109289:chelerythrine chloride [Organic Chemical,Pharmacologic Substance]
   861   C0008203:Chloride, NOS [Inorganic Chemical]
   861   C0596019:Chloride [Element, Ion, or Isotope]

Phrase: "(1.5M"

Phrase: ")"

Phrase: ","

Phrase: "BIM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0256431:bis(indolyl)maleimide [Organic Chemical,Pharmacologic Substance]

Phrase: "(40nM"

Phrase: ")"

Phrase: ","

Phrase: "Go6976"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0215863:Go6976 [Organic Chemical]

Phrase: "(25nM"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "H-89"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0082782:H 89 [Organic Chemical,Pharmacologic Substance]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "(25M"

Phrase: ")."
Processing 00000000.tx.187: After 60min (A) or 24h (B) amphoterin stimulation in the presence of the indicated kinase inhibitors, the cells were lysed and analyzed in a Western blot. 

Phrase: "After 60min"

Phrase: "(A)"

Phrase: "or"

Phrase: "24h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]

Phrase: "(B) amphoterin stimulation in the presence of the indicated kinase inhibitors,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   738   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "lysed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024348:lysed [Pathologic Function]

Phrase: "and"

Phrase: "analyzed in a Western blot."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   806   C0949466:Western Blot [Laboratory Procedure]
   760   C0936012:Analyzed [Research Activity]
   760   C1705493:Western [Spatial Concept]
Processing 00000000.tx.188: A, phosphorylation of CREB and ERK1/2 after 60min of stimulation. 

Phrase: "A,"

Phrase: "phosphorylation of CREB"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   767   C1157225:AMP phosphorylation [Molecular Function]
   767   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   744   C0031715:Phosphorylation [Molecular Function]
   743   C0056695:Cyclic AMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   703   C3158668:cyclic-AMP response element binding [Genetic Function]

Phrase: "and"

Phrase: "ERK1/2 after 60min of stimulation."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   833   C0082529:Extracellular Signal-Regulated Kinase 1 [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1366765:EXTRACELLULAR SIGNAL-REGULATED KINASE 1 [Gene or Genome]
   824   C0170168:Extracellular Signal-Regulated Kinase 2 [Amino Acid, Peptide, or Protein,Enzyme]
   824   C1366882:EXTRACELLULAR SIGNAL-REGULATED KINASE 2 [Gene or Genome]
   785   C0600388:Extracellular Signal Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   785   C0752312:Extracellular Signal-Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0521119:Extracellular [Cell Component]
   739   C0851285:Regulated [Governmental or Regulatory Activity]
   739   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   739   C1710082:Signal [Phenomenon or Process]
   739   C1948023:Stimulation [Natural Phenomenon or Process]
Processing 00000000.tx.189: B, expression of chromogranin A and chromogranin B after 24h of stimulation. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "expression of chromogranin A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "chromogranin B after 24h of stimulation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0055635:chromogranin B [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1332755:CHROMOGRANIN B [Gene or Genome]
   753   C0008586:Chromogranin [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
Processing 00000000.tx.190: The blots were reprobed with ERK1/2 antibody to verify equal loading. 

Phrase: "The blots"

Phrase: "were"

Phrase: "reprobed with ERK1/2 antibody to"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   833   C0082529:Extracellular Signal-Regulated Kinase 1 [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1366765:EXTRACELLULAR SIGNAL-REGULATED KINASE 1 [Gene or Genome]
   824   C0170168:Extracellular Signal-Regulated Kinase 2 [Amino Acid, Peptide, or Protein,Enzyme]
   824   C1366882:EXTRACELLULAR SIGNAL-REGULATED KINASE 2 [Gene or Genome]
   785   C0600388:Extracellular Signal Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   785   C0752312:Extracellular Signal-Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   739   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   739   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0521119:Extracellular [Cell Component]
   739   C0851285:Regulated [Governmental or Regulatory Activity]
   739   C1710082:Signal [Phenomenon or Process]

Phrase: "verify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1711411:Verify [Functional Concept]

Phrase: "equal loading."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708715:Loading [Activity]
Processing 00000000.tx.191: RAGE Signaling Induces Differentiation toward Neuronal Phenotype in Embryonic Stem Cells-- As the N18 neuroblastoma cell line is already committed to neuronal/neuroendocrine direction, we wanted to see if RAGE could induce neuronal differentiation on a nave, noncommitted background. 

Phrase: "RAGE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   716   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]

Phrase: "Signaling"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0037083:Signaling [Cell Function]
  1000   C3537152:signaling [Biologic Function]
   966 E C1710082:Signal [Phenomenon or Process]

Phrase: "Induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "Differentiation toward Neuronal Phenotype"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   819   C1518294:Neuronal Differentiation [Finding]
   783 E C1159970:neuron differentiation [Cell Function]
   770   C0007589:Differentiation [Cell Function]
   770   C1511938:Differentiation [Clinical Attribute]
   770   C2945687:Differentiation [Functional Concept]

Phrase: "in Embryonic Stem Cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
  1000   C0596508:Embryonic Stem Cells [Cell]
   901   C0038250:Stem cells [Cell]
   896   C1947950:Embryonic Cell [Embryonic Structure]
   827   C0007634:Cells [Cell]
   827   C0013935:Embryonic [Embryonic Structure]
   827   C0242767:Stem [Plant]
   827   C1186763:Stem [Body Part, Organ, or Organ Component]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "-"

Phrase: "-"

Phrase: "As"

Phrase: "the N18 neuroblastoma cell line"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   861   C0007600:Cell Line [Cell]
   861   C0815000:neuroblastoma cell [Cell]
   812   C0007634:Cell [Cell]
   812   C0027819:Neuroblastoma [Neoplastic Process]
   812   C0205132:Line [Spatial Concept]
   812   C0700095:neuroblastoma [Neoplastic Process]
   812   C1269647:Cell [Cell]
   812   C1550648:Line [Substance]
   812   C1552960:Line [Quantitative Concept]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   812   C3540583:Neuroblastoma [Intellectual Product]

Phrase: "is"

Phrase: "already"

Phrase: "committed to neuronal/neuroendocrine direction,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0027912:Neuroendocrine [Body System]
   760   C0449738:Direction [Spatial Concept]
   760   C0521390:Neuronal [Immunologic Factor]
   760   C1171947:committed [Organic Chemical,Pharmacologic Substance]
   726 E C2347840:Commit [Machine Activity]

Phrase: "we"

Phrase: "wanted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444647:Wanted [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "if"

Phrase: "RAGE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   716   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]

Phrase: "could"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "neuronal differentiation on a nave,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C1518294:Neuronal Differentiation [Finding]
   770 E C1159970:neuron differentiation [Cell Function]
   760   C0007589:Differentiation [Cell Function]
   760   C1511938:Differentiation [Clinical Attribute]
   760   C2945687:Differentiation [Functional Concept]

Phrase: "noncommitted background."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1706907:Background [Conceptual Entity]
Processing 00000000.tx.192: We created stably transfected mouse embryonic stem cell lines expressing either full-length RAGE (R1/RAGE) or cytoplasmic domain deletion mutant of RAGE (R1/RAGEcyto). 

Phrase: "We"

Phrase: "created"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1706214:Created [Activity]
   966 E C3244320:create [Functional Concept]

Phrase: "stably transfected mouse embryonic stem cell lines"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   860   C1512140:Embryonic Stem Cell Line [Cell]
   851   C1513528:Mouse Cell Line [Cell]
   818   C0007600:Cell lines [Cell]
   795   C0205132:lines [Spatial Concept]
   762 E C1550648:Line [Substance]
   762 E C1552960:Line [Quantitative Concept]

Phrase: "expressing"

Phrase: "either full-length RAGE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   882   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   742   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(R1/RAGE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   946   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: ")"

Phrase: "or"

Phrase: "cytoplasmic domain deletion mutant of RAGE"
Meta Candidates (Total=21; Excluded=2; Pruned=0; Remaining=19)
   846   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   797   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   756   C1511625:Cytoplasmic Domain [Cell Component]
   754   C0206587:Cytoplasmic Receptor [Amino Acid, Peptide, or Protein,Receptor]
   738   C0010834:Cytoplasmic [Cell Component]
   738   C0205179:Advanced [Qualitative Concept]
   738   C0444930:End [Spatial Concept]
   738   C0521449:Cytoplasmic [Body Location or Region]
   738   C0596988:Mutant [Cell or Molecular Dysfunction]
   738   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   738   C0598528:glycation [Phenomenon or Process]
   738   C1442161:Deletion [Cell or Molecular Dysfunction]
   738   C1511760:Deletion [Genetic Function]
   738   C1514468:Products [Entity]
   738   C1880274:Deletion [Activity]
   738   C1880389:Domain [Functional Concept]
   738   C1883221:Domain [Conceptual Entity]
   738   C2746065:End [Temporal Concept]
   738   C3541951:Domain [Intellectual Product]
   704 E C0725066:Advance [Medical Device]
   704 E C1704444:Product [Quantitative Concept]

Phrase: "(R1/RAGEcyto"

Phrase: ")."
Processing 00000000.tx.193: Differentiation of parental R1 cells, R1/RAGE and R1/RAGEcyto cells, was studied by comparing the effects of amphoterin and retinoic acid to non-stimulated cells. 

Phrase: "Differentiation of parental R1 cells,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0007589:cells differentiation [Cell Function]
           Differentiation
   760   C1511938:Differentiation [Clinical Attribute]
   760   C2945687:Differentiation [Functional Concept]

Phrase: "R1/RAGE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   946   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "R1/RAGEcyto cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "studied by comparing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0557651:Study [Manufactured Object]
   756   C1707455:Compare [Activity]
   756   C2603343:Study [Research Activity]

Phrase: "the effects of amphoterin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "retinoic acid to non-stimulated cells."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0040845:Retinoic Acid [Organic Chemical,Pharmacologic Substance,Vitamin]
   753   C0001128:Acid [Chemical]
   753   C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.194: To begin differentiation, the cells were grown as embryoid bodies for 4days in the presence of amphoterin, retinoic acid, or without any added factors. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "begin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439659:Begin [Temporal Concept]

Phrase: "differentiation,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "grown as embryoid bodies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   833   C2936498:Embryoid Bodies [Cell]
   770   C0242821:bodies [Human]
   770   C1995017:Bodies [Cell Component]
   737 E C0460148:Body [Anatomical Structure]
   737 E C1268086:Body [Anatomical Structure]

Phrase: "for 4days"

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of amphoterin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0019796:Amphoterin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1333908:AMPHOTERIN [Gene or Genome]

Phrase: "retinoic acid,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0040845:Retinoic Acid [Organic Chemical,Pharmacologic Substance,Vitamin]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "or without any added factors."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C1524062:Added [Functional Concept]
   726   C1521761:Factor [Functional Concept]
   726 E C1883712:Add [Functional Concept]
   726   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.195: Dissociated cells from embryonic bodies were cultured on gelatin-coated plates again in the presence of amphoterin, retinoic acid, or no addition. 

Phrase: "Dissociated cells from embryonic bodies"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   797   C0599444:bodies cells [Cell Component]
   781   C1947950:Embryonic Cell [Embryonic Structure]
   764 E C2752549:cell body [Cell Component]
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "cultured on gelatin-coated plates again"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   767   C0180454:culture plates [Medical Device]
   753   C0017237:Gelatin [Amino Acid, Peptide, or Protein,Biomedical or Dental Material,Pharmacologic Substance]
   753   C1139930:plates [Medical Device]
   753   C1145617:Gelatin [Food]
   753   C1522408:Coated [Qualitative Concept]
   719 E C0005971:Plate [Medical Device]
   719   C0010453:Culture [Idea or Concept]
   719   C0220814:culture [Functional Concept]
   719   C0430400:Culture [Laboratory Procedure]
   719 E C0453946:Coat [Manufactured Object]
   719   C2242979:Culture [Laboratory Procedure]
   719 E C2987482:Coat [Body Part, Organ, or Organ Component]
   719 E C3537155:Plate [Manufactured Object]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of amphoterin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0019796:Amphoterin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1333908:AMPHOTERIN [Gene or Genome]

Phrase: "retinoic acid,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0040845:Retinoic Acid [Organic Chemical,Pharmacologic Substance,Vitamin]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "or"

Phrase: "no addition."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]
Processing 00000000.tx.196: After 4+2days the culture medium was changed to neurobasal medium with B27 supplement. 

Phrase: "After 4+2days"

Phrase: "the culture medium"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   861   C0009458:Medium [Intellectual Product]
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C2242979:Culture [Laboratory Procedure]
   861   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "changed to neurobasal medium"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0009458:Medium [Intellectual Product]
   770   C0392747:Changed [Functional Concept]
   770   C0439536:Medium [Quantitative Concept]
   770   C0443172:Changed [Quantitative Concept]
   770   C1705217:Medium [Substance]
   770   C3244283:medium [Intellectual Product]
   737 E C1705241:Change [Quantitative Concept]

Phrase: "with B27 supplement."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0242295:Supplement [Food]
   861   C1947943:Supplement [Intellectual Product]
   861   C2348609:Supplement [Functional Concept]
Processing 00000000.tx.197: Neurobasal medium does not induce neuronal differentiation per se but permits growth of neuronal progenitor cells and suppresses generation of astrocytes. 

Phrase: "Neurobasal medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0009458:Medium [Intellectual Product]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "neuronal differentiation"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C1518294:Neuronal Differentiation [Finding]
   964 E C1159970:neuron differentiation [Cell Function]
   861   C0007589:Differentiation [Cell Function]
   861   C1511938:Differentiation [Clinical Attribute]
   861   C2945687:Differentiation [Functional Concept]
   789 E C0205615:Differentiated [Qualitative Concept]

Phrase: "per se"

Phrase: "but"

Phrase: "permits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0023636:Permit [Regulation or Law]
  1000   C0329040:Permit [Fish]

Phrase: "growth of neuronal progenitor cells"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0007595:growth of cell [Cell Function]
           cells growth
   797   C0814002:Neuronal Growth [Cell Function,Organism Function]
   760   C0018270:'growth' NOS [Organism Function]
   760   C0220844:growth [Physiologic Function]
   760   C1621966:Growth [Organ or Tissue Function]
   760   C2911660:Growth [Activity]

Phrase: "and"

Phrase: "suppresses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:suppress [Functional Concept]

Phrase: "generation of astrocytes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0079411:Generation [Temporal Concept]
   790   C3146294:Generation [Activity]
Processing 00000000.tx.198: As low-density culturing in the absence of growth factors has been shown to favor acquirement of a neural identity in certain ES cell lines (35), differentiation studies were performed at relatively high cell densities (approx. 100,000cells/cm2). 

Phrase: "As low-density culturing"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C0010453:Culture [Idea or Concept]
   793   C0220814:culture [Functional Concept]
   793   C0430400:Culture [Laboratory Procedure]
   793   C2242979:Culture [Laboratory Procedure]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of growth factors"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "favor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309049:FAVOR [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "acquirement of a neural identity"

Phrase: "in certain ES cell lines"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   921   C1512140:Embryonic Stem Cell Line [Cell]
   840   C0007600:Cell lines [Cell]
   804   C0205132:lines [Spatial Concept]
   771 E C1550648:Line [Substance]
   771 E C1552960:Line [Quantitative Concept]
   717   C0596508:Embryonic stem cell [Cell]

Phrase: "(35"

Phrase: ")"

Phrase: ","

Phrase: "differentiation studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "were"

Phrase: "performed at relatively high cell densities"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   790   C0162339:Densities, Cell [Quantitative Concept]
   753   C0007634:Cell [Cell]
   753   C0178587:densities [Quantitative Concept]
   753   C0205250:High [Qualitative Concept]
   753   C0884358:Performed [Functional Concept]
   753   C1269647:Cell [Cell]
   753   C1299351:High [Qualitative Concept]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   753   C2700149:HIGH [Intellectual Product]
   719 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(approx. 100,"

Phrase: "000cells/cm2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439479:cm2 [Quantitative Concept]
   861   C0555206:CM2 [Congenital Abnormality]

Phrase: ")."
Processing 00000000.tx.199: After 4+4days of differentiation, all three ES cell clones grown in the presence of retinoic acid (Fig. 6, A and B) started extending neurite-like processes. 

Phrase: "After 4+4days"

Phrase: "of differentiation,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]

Phrase: "all three ES cell clones"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   840   C0009013:cell clones [Cell]
           Clones
   771 E C1522642:Clone [Tissue]
   721 E C1704387:Clonal [Qualitative Concept]
   717   C0596508:Embryonic stem cell [Cell]

Phrase: "grown in the presence of retinoic acid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0040845:Retinoic Acid [Organic Chemical,Pharmacologic Substance,Vitamin]
   748   C0001128:Acid [Chemical]
   748   C0202406:Acid [Laboratory Procedure]
   748   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "(Fig. 6,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "started"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1272689:Started [Qualitative Concept]
   966 E C0439659:Start [Temporal Concept]

Phrase: "extending neurite-like processes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C1184743:Process [Body Part, Organ, or Organ Component]
   779   C1522240:Process [Phenomenon or Process]
Processing 00000000.tx.200: Of the cells treated with amphoterin, only cells expressing RAGE displayed clear neuritic morphology, whereas RAGEcyto-expressing cells stimulated with amphoterin were unable to grow neurites (Fig. 6, A and B). 

Phrase: "Of the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "treated with amphoterin,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0019796:Amphoterin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1333908:AMPHOTERIN [Gene or Genome]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "only cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "RAGE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   716   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "clear neuritic morphology,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0332437:Morphology [Qualitative Concept]
   827   C0543482:morphology [Spatial Concept]
   827   C0700329:Morphology, NOS [Finding]
   827   C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "whereas"

Phrase: "RAGEcyto-expressing cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "stimulated with amphoterin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0019796:Amphoterin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1333908:AMPHOTERIN [Gene or Genome]
   790   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "were"

Phrase: "unable to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1299582:Unable [Finding]

Phrase: "grow"

Phrase: "neurites"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085103:Neurites [Cell Component]

Phrase: "(Fig. 6,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.201: As with the neuroblastoma cell differentiation studies, the possibility of clonal variances was excluded by analyzing ES cell differentiation in two independent clones of both R1/RAGE and R1/RAGEcyto cells with similar results in repeated experiments. 

Phrase: "As with the neuroblastoma cell differentiation studies,"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   778   C0007589:Cell Differentiation [Cell Function]
           Differentiation
   778   C0815000:neuroblastoma cell [Cell]
   748   C0007634:Cell [Cell]
   748   C0027819:Neuroblastoma [Neoplastic Process]
   748   C0700095:neuroblastoma [Neoplastic Process]
   748   C0947630:studies [Laboratory Procedure]
   748   C1269647:Cell [Cell]
   748   C1511938:Differentiation [Clinical Attribute]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   748   C2945687:Differentiation [Functional Concept]
   748   C3540583:Neuroblastoma [Intellectual Product]
   714 E C0557651:Study [Manufactured Object]
   714 E C2603343:Study [Research Activity]

Phrase: "the possibility of clonal variances"

Phrase: "was"

Phrase: "excluded by analyzing ES cell differentiation"
Meta Candidates (Total=18; Excluded=1; Pruned=0; Remaining=17)
   814   C0596508:Embryonic stem cell [Cell]
   814   C1514964:Stem Cell Differentiation [Cell Function]
   778   C0007589:Cell Differentiation [Cell Function]
           Differentiation
   778   C0038250:Stem cell [Cell]
   774   C1947950:Embryonic Cell [Embryonic Structure]
   748   C0007634:Cell [Cell]
   748   C0013935:Embryonic [Embryonic Structure]
   748   C0242767:Stem [Plant]
   748   C1186763:Stem [Body Part, Organ, or Organ Component]
   748   C1269647:Cell [Cell]
   748   C1511938:Differentiation [Clinical Attribute]
   748   C1554077:Excluded [Idea or Concept]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   748   C2828389:Excluded [Activity]
   748   C2945687:Differentiation [Functional Concept]
   714 E C0332196:Exclude [Functional Concept]

Phrase: "in two independent clones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0009013:Clones [Cell]
   793 E C1522642:Clone [Tissue]
   743 E C1704387:Clonal [Qualitative Concept]
   721 E C0796368:clonality [Diagnostic Procedure]

Phrase: "of both R1/RAGE"
Meta Candidates (Total=17; Excluded=5; Pruned=0; Remaining=12)
   901   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   849   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   791   C0205179:Advanced [Qualitative Concept]
   791   C0332285:Of [Spatial Concept]
   791   C0444930:End [Spatial Concept]
   791   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   791   C0598528:glycation [Phenomenon or Process]
   791   C1335648:R1 [Gene or Genome]
   791   C1514468:Products [Entity]
   791   C1824685:R1 [Gene or Genome]
   791   C2697937:R1 [Quantitative Concept]
   791   C2746065:End [Temporal Concept]
   758 E C0725066:Advance [Medical Device]
   758 E C1704444:Product [Quantitative Concept]
   735 E C0205088:Terminal [Temporal Concept]
   735 E C1705314:Terminal [Manufactured Object]
   735 E C1705315:Terminal [Spatial Concept]

Phrase: "and"

Phrase: "R1/RAGEcyto cells with similar results"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   753   C0007634:Cells [Cell]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "in repeated experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.202: View larger version (60K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(60K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.203: 6.  

Phrase: "6."
Processing 00000000.tx.204: Neuronal differentiation of embryonic stem cell lines stimulated with amphoterin or retinoic acid. 

Phrase: "Neuronal differentiation of embryonic stem cell lines"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   804   C1514964:Stem Cell Differentiation [Cell Function]
   778   C1518294:Neuronal Differentiation [Finding]
   774   C0007589:Cell Differentiation [Cell Function]
           Differentiation
   748   C1511938:Differentiation [Clinical Attribute]
   748   C2945687:Differentiation [Functional Concept]
   743 E C1159970:neuron differentiation [Cell Function]

Phrase: "stimulated with amphoterin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0019796:Amphoterin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1333908:AMPHOTERIN [Gene or Genome]
   790   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "or"

Phrase: "retinoic acid."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0040845:Retinoic Acid [Organic Chemical,Pharmacologic Substance,Vitamin]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.205: Parental R1 cells, R1/RAGE and R1/RAGEcyto cells were first grown as embryoid bodies in the presence of 1M retinoic acid, 20g/ml amphoterin, or no addition in the control. 

Phrase: "Parental R1 cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "R1/RAGE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   946   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "R1/RAGEcyto cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "grown as embryoid bodies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   833   C2936498:Embryoid Bodies [Cell]
   770   C0242821:bodies [Human]
   770   C1995017:Bodies [Cell Component]
   737 E C0460148:Body [Anatomical Structure]
   737 E C1268086:Body [Anatomical Structure]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 1M retinoic acid,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0040845:Retinoic Acid [Organic Chemical,Pharmacologic Substance,Vitamin]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: "20g/ml amphoterin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0019796:Amphoterin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1333908:AMPHOTERIN [Gene or Genome]

Phrase: "or"

Phrase: "no addition in the control."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1883712:Addition [Functional Concept]
Processing 00000000.tx.206: After 4days the cells were plated on gelatin-coated (0.1%) plates with or without 1M retinoic acid or on amphoterin-coated (20g/ml) plates. 

Phrase: "After 4days"

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "plated on gelatin-coated"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   770   C0017237:Gelatin [Amino Acid, Peptide, or Protein,Biomedical or Dental Material,Pharmacologic Substance]
   770   C1145617:Gelatin [Food]
   770   C1522408:Coated [Qualitative Concept]
   737   C0005971:Plate [Medical Device]
   737 E C0453946:Coat [Manufactured Object]
   737   C1139930:plate [Medical Device]
   737 E C2987482:Coat [Body Part, Organ, or Organ Component]
   737   C3537155:Plate [Manufactured Object]

Phrase: "(0.1%"

Phrase: ")"

Phrase: "plates with"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0005971:Plate [Medical Device]
   833   C1139930:plate [Medical Device]
   833   C3537155:Plate [Manufactured Object]

Phrase: "or without 1M retinoic acid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0040845:Retinoic Acid [Organic Chemical,Pharmacologic Substance,Vitamin]
   760   C0001128:Acid [Chemical]
   760   C0202406:Acid [Laboratory Procedure]
   760   C0470296:1M [Quantitative Concept]

Phrase: "or on amphoterin-coated"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0019796:Amphoterin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1333908:AMPHOTERIN [Gene or Genome]
   770   C1522408:Coated [Qualitative Concept]
   737 E C0453946:Coat [Manufactured Object]
   737 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "(20g/ml) plates."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1139930:plates [Medical Device]
   793 E C0005971:Plate [Medical Device]
   793 E C3537155:Plate [Manufactured Object]
Processing 00000000.tx.207: Finally, after 2days the medium was changed to neurobasal medium containing the B27 supplement. 

Phrase: "Finally,"

Phrase: "after"

Phrase: "2days"

Phrase: "the medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009458:Medium [Intellectual Product]
  1000   C0439536:Medium [Quantitative Concept]
  1000   C1705217:Medium [Substance]
  1000   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "changed to neurobasal medium"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0009458:Medium [Intellectual Product]
   770   C0392747:Changed [Functional Concept]
   770   C0439536:Medium [Quantitative Concept]
   770   C0443172:Changed [Quantitative Concept]
   770   C1705217:Medium [Substance]
   770   C3244283:medium [Intellectual Product]
   737 E C1705241:Change [Quantitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the B27 supplement."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0242295:Supplement [Food]
   861   C1947943:Supplement [Intellectual Product]
   861   C2348609:Supplement [Functional Concept]
Processing 00000000.tx.208: The ES cell lines were cultured in these conditions for up to 4+16days and the presence of cells differentiating toward neuronal phenotype was analyzed at specific time points. 

Phrase: "The ES cell lines"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   983   C1512140:Embryonic Stem Cell Line [Cell]
   861   C0007600:Cell lines [Cell]
   812   C0205132:lines [Spatial Concept]
   779 E C1550648:Line [Substance]
   779 E C1552960:Line [Quantitative Concept]
   756   C0596508:Embryonic stem cell [Cell]
   708   C1947950:Embryonic Cell [Embryonic Structure]

Phrase: "were"

Phrase: "cultured in these conditions"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   737   C0010453:Culture [Idea or Concept]
   737   C0012634:condition [Disease or Syndrome]
   737   C0220814:culture [Functional Concept]
   737   C0348080:Condition [Qualitative Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737   C1705253:Condition [Conceptual Entity]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "for"

Phrase: "up to 4+16days"

Phrase: "and"

Phrase: "the presence of cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   909   C0427850:Presence of cells [Laboratory or Test Result]
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "differentiating toward neuronal phenotype"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0031437:Phenotype [Organism Attribute]
   770   C0205615:differentiating [Qualitative Concept]
   770   C0521390:Neuronal [Immunologic Factor]
   770   C1285572:Phenotype [Laboratory Procedure]

Phrase: "was"

Phrase: "analyzed at specific time points."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   773   C2348792:Time Point [Temporal Concept]
   760   C0040223:Time [Temporal Concept]
   760   C0205369:Specific [Qualitative Concept]
   760   C0936012:Analyzed [Research Activity]
   760   C1552740:specific [Intellectual Product]
   760   C3541383:Time [Temporal Concept]
   726   C1552961:Point [Quantitative Concept]
   726   C2347617:point [Quantitative Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]
Processing 00000000.tx.209: A, morphology of ES cell lines after 4+4days of differentiation. 

Phrase: "A,"

Phrase: "morphology of ES cell lines"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   783   C0243091:cell morphology [Qualitative Concept]
   783   C1521816:Cell morphology [Clinical Attribute]
   783   C2700385:Cell Morphology [Biomedical Occupation or Discipline]
   753   C0332437:Morphology [Qualitative Concept]
   753   C0543482:morphology [Spatial Concept]
   753   C0700329:Morphology, NOS [Finding]
   753   C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "after 4+4days"

Phrase: "of differentiation."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]
Processing 00000000.tx.210: B, quantitation of neurite outgrowth after 4+4days of differentiation. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "quantitation of neurite outgrowth"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1709793:Quantitation [Quantitative Concept]

Phrase: "after 4+4days"

Phrase: "of differentiation."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]
Processing 00000000.tx.211: C, expression of light NFL protein and GFAP in ES cell lines after 4+8days of differentiation. 

Phrase: "C,"

Phrase: "expression of light NFL protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1171362:expression protein [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "GFAP in ES cell lines"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   818   C0017626:Glial fibrillar acidic protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   784   C0378781:Stem Cell Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C0920499:embryonic protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "after 4+8days"

Phrase: "of differentiation."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]
Processing 00000000.tx.212: D, quantitation of NFL- and GFAP-positive cells after 4+8days of differentiation. 

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "quantitation of NFL-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1709793:Quantitation [Quantitative Concept]

Phrase: "and"

Phrase: "GFAP-positive cells after 4+8days of differentiation."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   759   C1326073:glial cell differentiation [Cell Function]
   756   C0439178:% positive cells [Quantitative Concept]
   754   C0007589:cells differentiation [Cell Function]
   754   C0027836:Glial Cells [Cell]
   738   C0007634:Cells [Cell]
   738   C3282337:Cells [Cell]
   704 E C1269647:Cell [Cell]
   704 E C1704653:Cell [Medical Device]
   704 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.213: E, expression of -III-tubulin (Tuj1) and glutamate receptor subunit 1(GluR1) in ES cell lines after 4+16days of differentiation. 

Phrase: "E,"

Phrase: "expression of -III-tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C2937342:tubulin [Cell Component]

Phrase: "(Tuj1"

Phrase: ")"

Phrase: "and"

Phrase: "glutamate receptor subunit 1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C1415287:GLUTAMATE RECEPTOR 1 [Gene or Genome]
   861   C0061465:Glutamate Receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   812   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1711351:Subunit [Quantitative Concept]

Phrase: "(GluR1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415287:GLUR1 [Gene or Genome]

Phrase: ")"

Phrase: "in ES cell lines"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   983   C1512140:Embryonic Stem Cell Line [Cell]
   861   C0007600:Cell lines [Cell]
   812   C0205132:lines [Spatial Concept]
   779 E C1550648:Line [Substance]
   779 E C1552960:Line [Quantitative Concept]
   756   C0596508:Embryonic stem cell [Cell]
   708   C1947950:Embryonic Cell [Embryonic Structure]

Phrase: "after 4+16days"

Phrase: "of differentiation."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]
Processing 00000000.tx.214: F, quantitation of cells expressing both Tuj1 and GluR1 after 4+16days of differentiation. 

Phrase: "F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "quantitation of cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1709793:Quantitation [Quantitative Concept]

Phrase: "expressing"

Phrase: "both Tuj1"

Phrase: "and"

Phrase: "GluR1 after 4+16days of differentiation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1415287:GLUR1 [Gene or Genome]
Processing 00000000.tx.215: White arrowheads point out GluR1-positive (red) distal tips of neuronal processes. 

Phrase: "White arrowheads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1080898:Arrowheads [Plant]
   827 E C0453107:Arrowhead [Food]

Phrase: "point"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552961:Point [Quantitative Concept]
  1000   C2347617:point [Quantitative Concept]

Phrase: "out GluR1-positive"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0439178:% Positive [Quantitative Concept]
   827   C1446409:Positive [Qualitative Concept]
   827   C1514241:Positive [Finding]
   827   C2825490:Positive [Qualitative Concept]

Phrase: "(red) distal tips of neuronal processes."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C0339897:TIPS [Therapeutic or Preventive Procedure]
   719 E C1710425:Tip [Medical Device]
   719 E C3282898:Tip [Qualitative Concept]
Processing 00000000.tx.216: Bar=10m. 

Phrase: "Bar=10m."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1442446:10M [Temporal Concept]
Processing 00000000.tx.217: After 4+8days of differentiation, the cells were stained with light NFL and GFAP antibodies to analyze neuronal versus glial differentiation. 

Phrase: "After 4+8days"

Phrase: "of differentiation,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "stained with light NFL"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   770   C0023693:Light [Natural Phenomenon or Process]
   770   C1306462:Light [Functional Concept]
   770   C1417668:NFL [Gene or Genome]
   770   C1455438:NF-L [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1518285:NF-L [Cell Component]
   770   C1881376:Light [Qualitative Concept]
   770   C2981619:NF-L [Gene or Genome]
   770   C2986582:Stained [Qualitative Concept]
   737 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "GFAP antibodies to"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   810   C1445860:Protein antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   766 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   734   C0017626:Glial fibrillar acidic protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "analyze"

Phrase: "neuronal"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0521390:Neuronal [Immunologic Factor]
   928 E C0027882:Neuron [Cell]

Phrase: "versus"

Phrase: "glial differentiation."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C1512195:Glial Differentiation [Finding]
   861   C0007589:Differentiation [Cell Function]
   861   C1511938:Differentiation [Clinical Attribute]
   861   C2945687:Differentiation [Functional Concept]
   789 E C0205615:Differentiated [Qualitative Concept]
Processing 00000000.tx.218: As can be seen in Fig. 

Phrase: "As"

Phrase: "can"

Phrase: "be"

Phrase: "seen in Fig."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0205397:Seen [Qualitative Concept]
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]
Processing 00000000.tx.219: 6, C and D, a vast majority of cells stimulated with retinoic acid stained positive for NFL with only a few GFAP-positive cells, whereas very few mock-treated cells stained positive for either NFL or GFAP. 

Phrase: "6,"

Phrase: "C"

Phrase: "and"

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "a vast majority of cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0680220:majority [Social Behavior]

Phrase: "stimulated with retinoic acid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0040845:Retinoic Acid [Organic Chemical,Pharmacologic Substance,Vitamin]
   770   C0001128:Acid [Chemical]
   770   C0202406:Acid [Laboratory Procedure]
   770   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "stained"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C2986582:Stained [Qualitative Concept]
   966 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "positive for NFL"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0439178:% Positive [Quantitative Concept]
   790   C1446409:Positive [Qualitative Concept]
   790   C1514241:Positive [Finding]
   790   C2825490:Positive [Qualitative Concept]

Phrase: "with only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "a few GFAP-positive cells,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   877   C0027836:Glial Cells [Cell]
   818   C0439178:% positive cells [Quantitative Concept]
   795   C0007634:Cells [Cell]
   795   C3282337:Cells [Cell]
   762 E C1269647:Cell [Cell]
   762 E C1704653:Cell [Medical Device]
   762 E C1948049:Cell [Spatial Concept]
   710   C0017626:Glial fibrillar acidic protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "whereas"

Phrase: "very few mock-treated cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "stained"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C2986582:Stained [Qualitative Concept]
   966 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "positive for either NFL"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0439178:% Positive [Quantitative Concept]
   770   C1446409:Positive [Qualitative Concept]
   770   C1514241:Positive [Finding]
   770   C2825490:Positive [Qualitative Concept]

Phrase: "or"

Phrase: "GFAP."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017626:Glial fibrillar acidic protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.220: Many RAGE-expressing cells treated with amphoterin were also found positive for NFL, whereas in R1/RAGEcyto cells NFL expression was not detected. 

Phrase: "Many RAGE-expressing cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   882   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   745   C1514760:Receptor Cell [Cell]
   742   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "treated with amphoterin"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0019796:Amphoterin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1333908:AMPHOTERIN [Gene or Genome]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "were"

Phrase: "also found positive for NFL,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0439178:% Positive [Quantitative Concept]
   760   C1446409:Positive [Qualitative Concept]
   760   C1514241:Positive [Finding]
   760   C2825490:Positive [Qualitative Concept]

Phrase: "whereas in R1/RAGEcyto cells NFL expression"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   748   C0007634:Cells [Cell]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C1335648:R1 [Gene or Genome]
   748   C1417668:NFL [Gene or Genome]
   748   C1455438:NF-L [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1518285:NF-L [Cell Component]
   748   C1824685:R1 [Gene or Genome]
   748   C2697937:R1 [Quantitative Concept]
   748   C2981619:NF-L [Gene or Genome]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "detected."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]
Processing 00000000.tx.221: Interestingly, some of the parental R1 cells treated with amphoterin stained also positive for NFL (Fig. 6, C and D). 

Phrase: "Interestingly,"

Phrase: "some of the parental R1 cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   753   C0007634:Cells [Cell]
   753   C0030551:Parental [Family Group]
   753   C0205392:Some [Quantitative Concept]
   753   C1335648:R1 [Gene or Genome]
   753   C1824685:R1 [Gene or Genome]
   753   C2697937:R1 [Quantitative Concept]
   753   C3282337:Cells [Cell]
   753   C3540770:Some [Intellectual Product]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "treated with amphoterin"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0019796:Amphoterin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1333908:AMPHOTERIN [Gene or Genome]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "stained"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C2986582:Stained [Qualitative Concept]
   966 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "also positive for NFL"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0439178:% Positive [Quantitative Concept]
   770   C1446409:Positive [Qualitative Concept]
   770   C1514241:Positive [Finding]
   770   C2825490:Positive [Qualitative Concept]

Phrase: "(Fig. 6,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "C"

Phrase: "and"

Phrase: "D)."
Processing 00000000.tx.222: After 4+16days of differentiation, the cells were stained with a neuronal marker Tuj1 (-III-tubulin) and glutamate receptor subunit 1(GluR1) antibodies (Fig. 6 E and F). 

Phrase: "After 4+16days"

Phrase: "of differentiation,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "stained with a neuronal marker Tuj1"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0005516:Marker [Clinical Attribute]
   753   C0521390:Neuronal [Immunologic Factor]
   753   C2986582:Stained [Qualitative Concept]
   719 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(-III-tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2937342:tubulin [Cell Component]

Phrase: ")"

Phrase: "and"

Phrase: "glutamate receptor subunit 1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C1415287:GLUTAMATE RECEPTOR 1 [Gene or Genome]
   861   C0061465:Glutamate Receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   812   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1711351:Subunit [Quantitative Concept]

Phrase: "(GluR1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415287:GLUR1 [Gene or Genome]

Phrase: ")"

Phrase: "antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Fig. 6 E"

Phrase: "and"

Phrase: "F)."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.223: All cells treated with retinoic acid displayed numerous Tuj1-positive cells having neuron-like appearance: relatively small cell soma and nucleus and long neuronal processes with GluR1-positive distal tips. 

Phrase: "All cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "treated with retinoic acid"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0040845:Retinoic Acid [Organic Chemical,Pharmacologic Substance,Vitamin]
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0001128:Acid [Chemical]
   770   C0202406:Acid [Laboratory Procedure]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "numerous Tuj1-positive cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0439178:% positive cells [Quantitative Concept]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "having"

Phrase: "neuron-like appearance"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0233426:Appearance [Organism Attribute]
   827   C0700364:Appearance [Qualitative Concept]

Phrase: ":"

Phrase: "relatively small cell soma"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0599444:Cell soma [Cell Component]
           soma
   861   C2752549:cell soma [Cell Component]
   812   C0702216:Soma [Organic Chemical,Pharmacologic Substance]
   756 E C0007248:Carisoprodol [Organic Chemical,Pharmacologic Substance]
   719 E C2986476:Somatic [Qualitative Concept]

Phrase: "and"

Phrase: "nucleus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007610:Nucleus [Cell Component]

Phrase: "and"

Phrase: "long neuronal processes with GluR1-positive distal tips."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   718   C0085103:neuron process [Cell Component]
   711   C1184743:Process [Body Part, Organ, or Organ Component]
   711   C1522240:Process [Phenomenon or Process]
Processing 00000000.tx.224: R1/RAGEcyto cells treated with amphoterin displayed no Tuj1 or GluR1 immunoreactivity, whereas a small proportion of parental cells and R1/RAGE cells treated with amphoterin stained positive for Tuj1 and GluR1 (Fig. 6, E and F). 

Phrase: "R1/RAGEcyto cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "treated with amphoterin"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0019796:Amphoterin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1333908:AMPHOTERIN [Gene or Genome]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "no Tuj1"

Phrase: "or"

Phrase: "GluR1 immunoreactivity,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597879:immunoreactivity [Molecular Function]

Phrase: "whereas"

Phrase: "a small proportion of parental cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1709707:Proportion [Quantitative Concept]

Phrase: "and"

Phrase: "R1/RAGE cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   909   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   750   C1514760:Receptor Cell [Cell]
   744   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "treated with amphoterin"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0019796:Amphoterin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1333908:AMPHOTERIN [Gene or Genome]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "stained"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C2986582:Stained [Qualitative Concept]
   966 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "positive for Tuj1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0439178:% Positive [Quantitative Concept]
   790   C1446409:Positive [Qualitative Concept]
   790   C1514241:Positive [Finding]
   790   C2825490:Positive [Qualitative Concept]

Phrase: "and"

Phrase: "GluR1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415287:GLUR1 [Gene or Genome]

Phrase: "(Fig. 6,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "E"

Phrase: "and"

Phrase: "F)."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.225: The levels of -III-tubulin (Tuj1) expression and incorporation into microtubules increase dramatically in developing neurons after they have differentiated their neurites to axons and dendrites (36). 

Phrase: "The levels of -III-tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C2937342:tubulin [Cell Component]

Phrase: "(Tuj1"

Phrase: ")"

Phrase: "expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "incorporation into microtubules"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0243126:incorporation [Functional Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "dramatically in developing neurons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0027882:Neurons [Cell]

Phrase: "after"

Phrase: "they"

Phrase: "have"

Phrase: "differentiated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007589:Differentiated [Cell Function]
  1000   C0205615:Differentiated [Qualitative Concept]

Phrase: "their neurites to axons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0085103:Neurites [Cell Component]

Phrase: "and"

Phrase: "dendrites"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011305:Dendrites [Cell Component]

Phrase: "(36"

Phrase: ")."
Processing 00000000.tx.226: Thus, these results suggest that although RAGE signaling is capable of promoting differentiation of ES cells toward a neuronal phenotype (as manifested by neurite outgrowth and neurofilament expression), it may not be sufficient for generation of terminally differentiated, mature neurons (as manifested by low levels of Tuj1/GluR1-positive cells). 

Phrase: "Thus,"

Phrase: "these results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "although"

Phrase: "RAGE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   716   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]

Phrase: "signaling"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0037083:Signaling [Cell Function]
  1000   C3537152:signaling [Biologic Function]
   966 E C1710082:Signal [Phenomenon or Process]

Phrase: "is"

Phrase: "capable of promoting differentiation of ES cells"

Phrase: "toward a neuronal phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031437:Phenotype [Organism Attribute]
   861   C1285572:Phenotype [Laboratory Procedure]

Phrase: "("

Phrase: "as"

Phrase: "manifested by neurite outgrowth"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C1280444:Manifested by [Qualitative Concept]
           manifested
   833   C3158384:neurite outgrowth [Cell Function]
   770   C0085103:Neurite [Cell Component]
   770   C0205319:manifested [Functional Concept]

Phrase: "and"

Phrase: "neurofilament expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: ")"

Phrase: ","

Phrase: "it"

Phrase: "may"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "sufficient for generation of terminally"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205410:Sufficient [Qualitative Concept]

Phrase: "differentiated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007589:Differentiated [Cell Function]
  1000   C0205615:Differentiated [Qualitative Concept]

Phrase: ","

Phrase: "mature neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "("

Phrase: "as"

Phrase: "manifested by low levels of Tuj1/GluR1-positive cells"
Meta Candidates (Total=21; Excluded=6; Pruned=0; Remaining=15)
   764   C0439178:% positive cells [Quantitative Concept]
           % Positive
   764   C1280444:Manifested by [Qualitative Concept]
           manifested
   742   C0007634:Cells [Cell]
   742   C0205251:low [Qualitative Concept]
   742   C0205319:manifested [Functional Concept]
   742   C0441889:Levels [Qualitative Concept]
   742   C1299352:Low [Qualitative Concept]
   742   C1415287:GLUR1 [Gene or Genome]
   742   C1446409:Positive [Qualitative Concept]
   742   C1514241:Positive [Finding]
   742   C1550472:low [Idea or Concept]
   742   C2825490:Positive [Qualitative Concept]
   742   C3282337:Cells [Cell]
   708 E C0456079:Level [Classification]
   708 E C1269647:Cell [Cell]
   708 E C1547707:Level [Geographic Area]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]
   708 E C2946261:Level [Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.227: Interestingly, although no RAGE expression was detected in undifferentiated parental R1 cells, expression of RAGE was up-regulated in parental R1 cells when grown in the presence of amphoterin (Fig. 7A), explaining why also some of the parental R1 cells differentiated in response to amphoterin stimulation. 

Phrase: "Interestingly,"

Phrase: "although"

Phrase: "no RAGE expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   909   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   767   C0597360:receptor expression [Genetic Function]
   744   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "was"

Phrase: "detected in undifferentiated parental R1 cells,"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   753   C0007634:Cells [Cell]
   753   C0030551:Parental [Family Group]
   753   C0205618:Undifferentiated [Qualitative Concept]
   753   C0442726:Detected [Finding]
   753   C1335648:R1 [Gene or Genome]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]
   753   C1524083:Undifferentiated [Organism Attribute]
   753   C1704620:Undifferentiated [Organism Attribute]
   753   C1824685:R1 [Gene or Genome]
   753   C2697937:R1 [Quantitative Concept]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "expression of RAGE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0597360:receptor expression [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   743   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]

Phrase: "was"

Phrase: "up-regulated in parental R1 cells"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   753   C0007634:Cells [Cell]
   753   C0030551:Parental [Family Group]
   753   C0547043:Up [Spatial Concept]
   753   C0851285:Regulated [Governmental or Regulatory Activity]
   753   C1282911:Up [Spatial Concept]
   753   C1335648:R1 [Gene or Genome]
   753   C1824685:R1 [Gene or Genome]
   753   C2697937:R1 [Quantitative Concept]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "when"

Phrase: "grown in the presence of amphoterin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0019796:Amphoterin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0392148:Presence [Therapeutic or Preventive Procedure]
   753   C1333908:AMPHOTERIN [Gene or Genome]

Phrase: "(Fig. 7A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1571602:7a [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: ","

Phrase: "explaining"

Phrase: "why also"

Phrase: "some of the parental R1 cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   753   C0007634:Cells [Cell]
   753   C0030551:Parental [Family Group]
   753   C0205392:Some [Quantitative Concept]
   753   C1335648:R1 [Gene or Genome]
   753   C1824685:R1 [Gene or Genome]
   753   C2697937:R1 [Quantitative Concept]
   753   C3282337:Cells [Cell]
   753   C3540770:Some [Intellectual Product]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "differentiated in response"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0007589:Differentiated [Cell Function]
   790   C0205615:Differentiated [Qualitative Concept]
   790   C0871261:Response [Organism Attribute]
   790   C1704632:Response [Finding]
   790   C1706817:Response [Intellectual Product]
   790   C2911692:Response [Mental Process]

Phrase: "to amphoterin stimulation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   861   C1948023:Stimulation [Natural Phenomenon or Process]
Processing 00000000.tx.228: View larger version (60K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(60K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.229: 7.  

Phrase: "7."
Processing 00000000.tx.230: Expression of RAGE and chromogranins in differentiating embryonic stem cells. 

Phrase: "Expression of RAGE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0597360:receptor expression [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   743   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]

Phrase: "and"

Phrase: "chromogranins in differentiating embryonic stem cells."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0008586:Chromogranins [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
Processing 00000000.tx.231: A, expression of RAGE in parental R1 cells, R1/RAGE, and R1/RAGEcyto cells at 4+0,4+8,and 4+16days after differentiation with 20g/ml amphoterin. 

Phrase: "A,"

Phrase: "expression of RAGE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0597360:receptor expression [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   743   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]

Phrase: "in parental R1 cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "R1/RAGE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   946   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "R1/RAGEcyto cells at 4+0,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   753   C0007634:Cells [Cell]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "4+8,"

Phrase: "and"

Phrase: "4+16days after differentiation"

Phrase: "with 20g/ml amphoterin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0019796:Amphoterin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1333908:AMPHOTERIN [Gene or Genome]
Processing 00000000.tx.232: B, expression of chromogranin A, chromogranin B, and secretogranin II in ES cell lines differentiated for 4+16days with 1M retinoic acid, 20g/ml amphoterin, or mock-treated control. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "expression of chromogranin A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "chromogranin B,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0055635:chromogranin B [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332755:CHROMOGRANIN B [Gene or Genome]
   861   C0008586:Chromogranin [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "and"

Phrase: "secretogranin II in ES cell lines"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0055637:Secretogranin II [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C1335805:SECRETOGRANIN II [Gene or Genome]

Phrase: "differentiated for 4+16days"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0007589:Differentiated [Cell Function]
   770   C0205615:Differentiated [Qualitative Concept]

Phrase: "with 1M retinoic acid,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0040845:Retinoic Acid [Organic Chemical,Pharmacologic Substance,Vitamin]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: "20g/ml amphoterin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0019796:Amphoterin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1333908:AMPHOTERIN [Gene or Genome]

Phrase: "or"

Phrase: "mock-treated control."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.233: Densitometric analysis of relative induction in RAGE-expressing cells compared with similarly treated RAGEcyto-expressing control cells (reference value 1.0) is indicated. 

Phrase: "Densitometric analysis of relative induction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "in RAGE-expressing cells"
Meta Candidates (Total=21; Excluded=8; Pruned=0; Remaining=13)
   901   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   862   C1514760:Receptor Cell [Cell]
   849   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   791   C0007634:Cells [Cell]
   791   C0150312:In [Quantitative Concept]
   791   C0205179:Advanced [Qualitative Concept]
   791   C0332285:In [Spatial Concept]
   791   C0444930:End [Spatial Concept]
   791   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   791   C0598528:glycation [Phenomenon or Process]
   791   C1514468:Products [Entity]
   791   C2746065:End [Temporal Concept]
   791   C3282337:Cells [Cell]
   758 E C0725066:Advance [Medical Device]
   758 E C1269647:Cell [Cell]
   758 E C1704444:Product [Quantitative Concept]
   758 E C1704653:Cell [Medical Device]
   758 E C1948049:Cell [Spatial Concept]
   735 E C0205088:Terminal [Temporal Concept]
   735 E C1705314:Terminal [Manufactured Object]
   735 E C1705315:Terminal [Spatial Concept]

Phrase: "compared with similarly treated RAGEcyto-expressing control cells"
Meta Candidates (Total=15; Excluded=4; Pruned=0; Remaining=11)
   767   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   744   C0007634:Cells [Cell]
   744   C0243148:control [Qualitative Concept]
   744   C1522326:Treated [Functional Concept]
   744   C1550141:Control [Substance]
   744   C1707455:Compared [Activity]
   744   C1882979:Control [Conceptual Entity]
   744   C2587213:Control [Functional Concept]
   744   C3274648:Control [Qualitative Concept]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1292734:TREAT [Functional Concept]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "(reference value 1.0"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0086715:Value, Reference [Quantitative Concept]
   812   C1514811:Reference [Idea or Concept]
   812   C1522609:Value [Quantitative Concept]
   812   C1706462:Reference [Conceptual Entity]

Phrase: ")"

Phrase: "is"

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.234: The level of ERK1/2 was monitored as a control. 

Phrase: "The level of ERK1/2"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   762   C0456947:Level 1 [Intellectual Product]
   762   C0456948:Level 2 [Intellectual Product]
   742   C0441889:Level [Qualitative Concept]
   742   C0456079:Level [Classification]
   742   C1547707:Level [Geographic Area]
   742   C2946261:Level [Pharmacologic Substance]

Phrase: "was"

Phrase: "monitored as a control."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737   C0030695:monitor [Health Care Activity]
   737   C0150369:monitor [Health Care Activity]
   737   C0181904:Monitor [Medical Device]
   737   C0596972:Monitor [Medical Device]
   737   C1521743:Monitor [Professional or Occupational Group]
   737   C1704646:Monitor [Manufactured Object]
Processing 00000000.tx.235: As chromogranins were strongly up-regulated during RAGE-induced neuronal differentiation in N18 cells, the expression pattern of chromogranins was analyzed by Western blotting in ES cells after 4+16days of differentiation. 

Phrase: "As chromogranins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008586:Chromogranins [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "were"

Phrase: "strongly"

Phrase: "up-regulated during RAGE-induced neuronal differentiation"
Meta Candidates (Total=24; Excluded=4; Pruned=0; Remaining=20)
   833   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   790   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   753   C1518294:Neuronal Differentiation [Finding]
   751   C2325760:Neuronal receptor [Cell Component]
   751   C3242459:regulated products [Intellectual Product]
   736   C0007589:Differentiation [Cell Function]
   736   C0205179:Advanced [Qualitative Concept]
   736   C0205263:Induced [Functional Concept]
   736   C0444930:End [Spatial Concept]
   736   C0521390:Neuronal [Immunologic Factor]
   736   C0547043:Up [Spatial Concept]
   736   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   736   C0598528:glycation [Phenomenon or Process]
   736   C0851285:Regulated [Governmental or Regulatory Activity]
   736   C1282911:Up [Spatial Concept]
   736   C1511938:Differentiation [Clinical Attribute]
   736   C1514468:Products [Entity]
   736   C2746065:End [Temporal Concept]
   736   C2945687:Differentiation [Functional Concept]
   734 E C1552022:regulated product [Idea or Concept]
   723   C2752630:terminal differentiation [Cell Function]
   717 E C1159970:neuron differentiation [Cell Function]
   703 E C0725066:Advance [Medical Device]
   703 E C1704444:Product [Quantitative Concept]

Phrase: "in N18 cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0007634:Cells [Cell]
   861   C0442791:N18 [Finding]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "the expression pattern of chromogranins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0449774:Pattern [Spatial Concept]

Phrase: "was"

Phrase: "analyzed by Western blotting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "in ES cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
  1000   C0596508:Embryonic Stem Cells [Cell]
   901   C0038250:Stem cells [Cell]
   896   C1947950:Embryonic Cell [Embryonic Structure]
   827   C0007634:Cells [Cell]
   827   C0013935:Embryonic [Embryonic Structure]
   827   C0242767:Stem [Plant]
   827   C1186763:Stem [Body Part, Organ, or Organ Component]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "after 4+16days"

Phrase: "of differentiation."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]
Processing 00000000.tx.236: As can be seen in Fig. 

Phrase: "As"

Phrase: "can"

Phrase: "be"

Phrase: "seen in Fig."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0205397:Seen [Qualitative Concept]
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]
Processing 00000000.tx.237: 7B, the mock-treated ES cell lines did not display detectable chromogranin expression. 

Phrase: "7B,"

Phrase: "the mock-treated ES cell lines"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   884   C1512140:Embryonic Stem Cell Line [Cell]
   827   C0007600:Cell lines [Cell]
   799   C0205132:lines [Spatial Concept]
   766 E C1550648:Line [Substance]
   766 E C1552960:Line [Quantitative Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "detectable chromogranin expression."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.238: However, in parental R1 cells and R1/RAGE there was a prominent up-regulation of chromogranin A and chromogranin B but not secretogranin II in response to retinoic acid and amphoterin after 4+16days of differentiation (Fig. 7B). 

Phrase: "However,"

Phrase: "in parental R1 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "R1/RAGE there"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   909   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   744   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "was"

Phrase: "a prominent up-regulation of chromogranin A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1327622:Regulation [Biologic Function]

Phrase: "and"

Phrase: "chromogranin B"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0055635:chromogranin B [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332755:CHROMOGRANIN B [Gene or Genome]
   861   C0008586:Chromogranin [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "but"

Phrase: "not secretogranin II in response"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0055637:Secretogranin II [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C1335805:SECRETOGRANIN II [Gene or Genome]

Phrase: "to retinoic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0040845:Retinoic Acid [Organic Chemical,Pharmacologic Substance,Vitamin]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "amphoterin after 4+16days of differentiation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0019796:Amphoterin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1333908:AMPHOTERIN [Gene or Genome]

Phrase: "(Fig. 7B"

Phrase: ")."
Processing 00000000.tx.239: Importantly, whereas the expression of chromogranins A and B was up-regulated in R1/RAGEcyto cells in response to retinoic acid, no increase was detected in R1/RAGEcyto cells in response to amphoterin stimulation (Fig. 7B) suggesting that the amphoterin-induced up-regulation of chromogranin expression in differentiating ES cells requires intact RAGE signaling. 

Phrase: "Importantly,"

Phrase: "whereas"

Phrase: "the expression of chromogranins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "was"

Phrase: "up-regulated in R1/RAGEcyto cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   753   C0007634:Cells [Cell]
   753   C0547043:Up [Spatial Concept]
   753   C0851285:Regulated [Governmental or Regulatory Activity]
   753   C1282911:Up [Spatial Concept]
   753   C1335648:R1 [Gene or Genome]
   753   C1824685:R1 [Gene or Genome]
   753   C2697937:R1 [Quantitative Concept]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to retinoic acid,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0040845:Retinoic Acid [Organic Chemical,Pharmacologic Substance,Vitamin]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "no increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]

Phrase: "was"

Phrase: "detected in R1/RAGEcyto cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   760   C0007634:Cells [Cell]
   760   C0442726:Detected [Finding]
   760   C1335648:R1 [Gene or Genome]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   760   C1824685:R1 [Gene or Genome]
   760   C2697937:R1 [Quantitative Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to amphoterin stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   861   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "(Fig. 7B"

Phrase: ")"

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the amphoterin-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0019796:Amphoterin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1333908:AMPHOTERIN [Gene or Genome]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "up-regulation of chromogranin expression"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0041904:Up-Regulation [Cell Function,Molecular Function]
   806   C0162493:Up-Regulation [Genetic Function]
   760   C0547043:Up [Spatial Concept]
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1282911:Up [Spatial Concept]
   760   C1327622:Regulation [Biologic Function]

Phrase: "in differentiating ES cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   923   C0596508:Embryonic Stem Cells [Cell]
   861   C0038250:Stem cells [Cell]
   858   C1947950:Embryonic Cell [Embryonic Structure]
   812   C0007634:Cells [Cell]
   812   C0013935:Embryonic [Embryonic Structure]
   812   C0242767:Stem [Plant]
   812   C1186763:Stem [Body Part, Organ, or Organ Component]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "requires"

Phrase: "intact RAGE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   946   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "signaling."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0037083:Signaling [Cell Function]
  1000   C3537152:signaling [Biologic Function]
   966 E C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.240: To further study the role of RAGE signaling in the differentiation process of transfected ES cells, we analyzed the phosphorylation pattern of CREB and ERK1/2. 

Phrase: "To further"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1517331:Further [Spatial Concept]
   861   C1883351:To [Qualitative Concept]
   827 E C0205108:far [Spatial Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "the role of RAGE"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   882   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   818   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   742   C0035820:Role [Social Behavior]
   742   C0205179:Advanced [Qualitative Concept]
   742   C0444930:End [Spatial Concept]
   742   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   742   C0598528:glycation [Phenomenon or Process]
   742   C1514468:Products [Entity]
   742   C1705810:Role [Conceptual Entity]
   742   C2746065:End [Temporal Concept]
   708 E C0725066:Advance [Medical Device]
   708 E C1704444:Product [Quantitative Concept]

Phrase: "signaling in the differentiation process of transfected ES cells,"
Meta Candidates (Total=27; Excluded=4; Pruned=0; Remaining=23)
   782   C0596508:Embryonic Stem Cells [Cell]
   766   C0007589:Cell Differentiation process [Cell Function]
           cells differentiation
           Differentiation
   764   C1516359:Cell Signaling Process [Molecular Function]
   761   C1514964:Stem Cell Differentiation [Cell Function]
   760   C0038250:Stem cells [Cell]
   757   C3537152:signaling process [Biologic Function]
           signaling
   741   C0007613:Cell Process [Cell Function]
   741   C0037083:Cell Signaling [Cell Function]
           Signaling
   741   C0230625:Cell process [Cell Component]
   741   C1947950:Embryonic Cell [Embryonic Structure]
   739   C0007634:Cells [Cell]
   739   C0013935:Embryonic [Embryonic Structure]
   739   C0242767:Stem [Plant]
   739   C1184743:Process [Body Part, Organ, or Organ Component]
   739   C1186763:Stem [Body Part, Organ, or Organ Component]
   739   C1511938:Differentiation [Clinical Attribute]
   739   C1522240:Process [Phenomenon or Process]
   739   C2945687:Differentiation [Functional Concept]
   739   C3282337:Cells [Cell]
   706 E C1269647:Cell [Cell]
   706 E C1704653:Cell [Medical Device]
   706 E C1710082:Signal [Phenomenon or Process]
   706 E C1948049:Cell [Spatial Concept]

Phrase: "we"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "the phosphorylation pattern of CREB"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C1317658:Protein pattern [Clinical Attribute]
   757   C1523331:pattern binding [Molecular Function]
   739   C0449774:Pattern [Spatial Concept]

Phrase: "and"

Phrase: "ERK1/2."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   947   C0082529:Extracellular Signal-Regulated Kinase 1 [Amino Acid, Peptide, or Protein,Enzyme]
   947   C1366765:EXTRACELLULAR SIGNAL-REGULATED KINASE 1 [Gene or Genome]
   941   C0170168:Extracellular Signal-Regulated Kinase 2 [Amino Acid, Peptide, or Protein,Enzyme]
   941   C1366882:EXTRACELLULAR SIGNAL-REGULATED KINASE 2 [Gene or Genome]
   880   C0600388:Extracellular Signal Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   880   C0752312:Extracellular Signal-Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0521119:Extracellular [Cell Component]
   799   C0851285:Regulated [Governmental or Regulatory Activity]
   799   C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.241: Cells differentiated for 4+12days were replated on gelatin- or amphoterin-coated plates with or without retinoic acid for 90min, and the cell lysates were probed with phospho-specific antibodies to CREB and ERK1/2. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "differentiated for 4+12days"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0007589:Differentiated [Cell Function]
   770   C0205615:Differentiated [Qualitative Concept]

Phrase: "were"

Phrase: "replated on gelatin-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0017237:Gelatin [Amino Acid, Peptide, or Protein,Biomedical or Dental Material,Pharmacologic Substance]
   790   C1145617:Gelatin [Food]

Phrase: "or"

Phrase: "amphoterin-coated plates with"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C1139930:plates [Medical Device]
   737 E C0005971:Plate [Medical Device]
   737 E C3537155:Plate [Manufactured Object]

Phrase: "or without retinoic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0040845:Retinoic Acid [Organic Chemical,Pharmacologic Substance,Vitamin]
   770   C0001128:Acid [Chemical]
   770   C0202406:Acid [Laboratory Procedure]

Phrase: "for 90min,"

Phrase: "and"

Phrase: "the cell lysates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "were"

Phrase: "probed with phospho-specific antibodies"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   862   C1257988:Antibodies, Phospho-Specific [Amino Acid, Peptide, or Protein,Immunologic Factor]
   790   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0205369:Specific [Qualitative Concept]
   760   C1552740:specific [Intellectual Product]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   726   C0182400:Probe [Medical Device]
   726   C1704681:Probe [Gene or Genome]
   726   C2347609:Probe [Chemical Viewed Functionally]
   726   C3536729:Probe [Manufactured Object]

Phrase: "to CREB"
Meta Candidates (Total=21; Excluded=1; Pruned=0; Remaining=20)
  1000   C0056695:Cyclic AMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   947   C3158668:cyclic-AMP response element binding [Genetic Function]
   901   C1511573:Cyclic AMP Response Element [Gene or Genome]
   885   C1148918:cyclic AMP binding [Molecular Function]
   858   C1148922:AMP binding [Molecular Function]
   827   C0001455:Cyclic AMP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   827   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0013879:Element [Element, Ion, or Isotope]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0243122:binding [Functional Concept]
   799   C0439596:Cyclic [Temporal Concept]
   799   C0871261:Response [Organism Attribute]
   799   C1145667:Binding [Activity]
   799   C1167622:Binding [Molecular Function]
   799   C1511572:Cyclic [Temporal Concept]
   799   C1704632:Response [Finding]
   799   C1705248:Element [Conceptual Entity]
   799   C1706817:Response [Intellectual Product]
   799   C2911692:Response [Mental Process]
   727 E C0031084:Cyclicities [Temporal Concept]

Phrase: "and"

Phrase: "ERK1/2."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   947   C0082529:Extracellular Signal-Regulated Kinase 1 [Amino Acid, Peptide, or Protein,Enzyme]
   947   C1366765:EXTRACELLULAR SIGNAL-REGULATED KINASE 1 [Gene or Genome]
   941   C0170168:Extracellular Signal-Regulated Kinase 2 [Amino Acid, Peptide, or Protein,Enzyme]
   941   C1366882:EXTRACELLULAR SIGNAL-REGULATED KINASE 2 [Gene or Genome]
   880   C0600388:Extracellular Signal Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   880   C0752312:Extracellular Signal-Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0521119:Extracellular [Cell Component]
   799   C0851285:Regulated [Governmental or Regulatory Activity]
   799   C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.242: As Fig. 

Phrase: "As Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.243: 8A shows, a significant increase of phosphorylated CREB and ERK1/2 was detected in cells stimulated with retinoic acid or amphoterin but not in cells plated on gelatin. 

Phrase: "8A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553640:8a [Medical Device]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: ","

Phrase: "a significant increase of phosphorylated CREB"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0442805:Increase [Functional Concept]

Phrase: "and"

Phrase: "ERK1/2"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   947   C0082529:Extracellular Signal-Regulated Kinase 1 [Amino Acid, Peptide, or Protein,Enzyme]
   947   C1366765:EXTRACELLULAR SIGNAL-REGULATED KINASE 1 [Gene or Genome]
   941   C0170168:Extracellular Signal-Regulated Kinase 2 [Amino Acid, Peptide, or Protein,Enzyme]
   941   C1366882:EXTRACELLULAR SIGNAL-REGULATED KINASE 2 [Gene or Genome]
   880   C0600388:Extracellular Signal Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   880   C0752312:Extracellular Signal-Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0521119:Extracellular [Cell Component]
   799   C0851285:Regulated [Governmental or Regulatory Activity]
   799   C1710082:Signal [Phenomenon or Process]

Phrase: "was"

Phrase: "detected in cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C0007634:Cells [Cell]
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "stimulated with retinoic acid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0040845:Retinoic Acid [Organic Chemical,Pharmacologic Substance,Vitamin]
   770   C0001128:Acid [Chemical]
   770   C0202406:Acid [Laboratory Procedure]
   770   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "or"

Phrase: "amphoterin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0019796:Amphoterin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1333908:AMPHOTERIN [Gene or Genome]

Phrase: "but"

Phrase: "not in cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0007634:Cells [Cell]
   790   C1518422:Not [Functional Concept]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "plated on gelatin."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0017237:Gelatin [Amino Acid, Peptide, or Protein,Biomedical or Dental Material,Pharmacologic Substance]
   790   C1145617:Gelatin [Food]
   756   C0005971:Plate [Medical Device]
   756   C1139930:plate [Medical Device]
   756   C3537155:Plate [Manufactured Object]
Processing 00000000.tx.244: As expected, RAGE signaling seemed to be required for amphoterin-induced effects but not for retinoic acid-induced phosphorylation of CREB and ERK1/2. 

Phrase: "As"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: ","

Phrase: "RAGE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   716   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]

Phrase: "signaling"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0037083:Signaling [Cell Function]
  1000   C3537152:signaling [Biologic Function]
   966 E C1710082:Signal [Phenomenon or Process]

Phrase: "seemed"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "required for amphoterin-induced effects"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0019796:Amphoterin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0205263:Induced [Functional Concept]
   760   C1280500:effects [Qualitative Concept]
   760   C1333908:AMPHOTERIN [Gene or Genome]
   760   C1514873:Required [Functional Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "but"

Phrase: "not for retinoic acid-induced phosphorylation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0040845:Retinoic Acid [Organic Chemical,Pharmacologic Substance,Vitamin]
   753   C0001128:Acid [Chemical]
   753   C0031715:Phosphorylation [Molecular Function]
   753   C0202406:Acid [Laboratory Procedure]
   753   C0205263:Induced [Functional Concept]
   753   C1158886:Phosphorylation [Molecular Function]
   753   C1518422:Not [Functional Concept]

Phrase: "of CREB"
Meta Candidates (Total=21; Excluded=1; Pruned=0; Remaining=20)
  1000   C0056695:Cyclic AMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   947   C3158668:cyclic-AMP response element binding [Genetic Function]
   901   C1511573:Cyclic AMP Response Element [Gene or Genome]
   885   C1148918:cyclic AMP binding [Molecular Function]
   858   C1148922:AMP binding [Molecular Function]
   827   C0001455:Cyclic AMP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   827   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0013879:Element [Element, Ion, or Isotope]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0243122:binding [Functional Concept]
   799   C0439596:Cyclic [Temporal Concept]
   799   C0871261:Response [Organism Attribute]
   799   C1145667:Binding [Activity]
   799   C1167622:Binding [Molecular Function]
   799   C1511572:Cyclic [Temporal Concept]
   799   C1704632:Response [Finding]
   799   C1705248:Element [Conceptual Entity]
   799   C1706817:Response [Intellectual Product]
   799   C2911692:Response [Mental Process]
   727 E C0031084:Cyclicities [Temporal Concept]

Phrase: "and"

Phrase: "ERK1/2."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   947   C0082529:Extracellular Signal-Regulated Kinase 1 [Amino Acid, Peptide, or Protein,Enzyme]
   947   C1366765:EXTRACELLULAR SIGNAL-REGULATED KINASE 1 [Gene or Genome]
   941   C0170168:Extracellular Signal-Regulated Kinase 2 [Amino Acid, Peptide, or Protein,Enzyme]
   941   C1366882:EXTRACELLULAR SIGNAL-REGULATED KINASE 2 [Gene or Genome]
   880   C0600388:Extracellular Signal Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   880   C0752312:Extracellular Signal-Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0521119:Extracellular [Cell Component]
   799   C0851285:Regulated [Governmental or Regulatory Activity]
   799   C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.245: Interestingly, when cells differentiated for 4+16days (4days after last replating) were analyzed for CREB and ERK1/2 phosphorylation sustained CREB phosphorylation but not ERK1/2 phosphorylation was detected in all cells treated with retinoic acid and in R1 parental cells and R1/RAGE cells but not in R1/RAGEcyto cells treated with amphoterin (Fig. 8B). 

Phrase: "Interestingly,"

Phrase: "when"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "differentiated for 4+16days"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0007589:Differentiated [Cell Function]
   770   C0205615:Differentiated [Qualitative Concept]

Phrase: "(4days after last replating"

Phrase: ")"

Phrase: "were"

Phrase: "analyzed for CREB"
Meta Candidates (Total=22; Excluded=1; Pruned=0; Remaining=21)
   909   C0056695:Cyclic AMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   869   C3158668:cyclic-AMP response element binding [Genetic Function]
   833   C1511573:Cyclic AMP Response Element [Gene or Genome]
   793   C1148918:cyclic AMP binding [Molecular Function]
   770   C0001455:Cyclic AMP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   770   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   767 E C0033618:Protein Binding [Molecular Function]
   767   C1148922:AMP binding [Molecular Function]
   744   C0013879:Element [Element, Ion, or Isotope]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0243122:binding [Functional Concept]
   744   C0439596:Cyclic [Temporal Concept]
   744   C0871261:Response [Organism Attribute]
   744   C0936012:Analyzed [Research Activity]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]
   744   C1511572:Cyclic [Temporal Concept]
   744   C1704632:Response [Finding]
   744   C1705248:Element [Conceptual Entity]
   744   C1706817:Response [Intellectual Product]
   744   C2911692:Response [Mental Process]

Phrase: "and"

Phrase: "ERK1/2 phosphorylation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   795   C0031715:Phosphorylation [Molecular Function]
   795   C1158886:Phosphorylation [Molecular Function]
   747   C0082529:Extracellular Signal-Regulated Kinase 1 [Amino Acid, Peptide, or Protein,Enzyme]
   747   C1366765:EXTRACELLULAR SIGNAL-REGULATED KINASE 1 [Gene or Genome]
   744   C0170168:Extracellular Signal-Regulated Kinase 2 [Amino Acid, Peptide, or Protein,Enzyme]
   744   C1366882:EXTRACELLULAR SIGNAL-REGULATED KINASE 2 [Gene or Genome]

Phrase: "sustained"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0443318:Sustained [Functional Concept]
   966 E C2732140:Sustain [Organic Chemical,Pharmacologic Substance]

Phrase: "CREB phosphorylation"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   877   C1157225:AMP phosphorylation [Molecular Function]
   818   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   795   C0031715:Phosphorylation [Molecular Function]
   787   C0056695:Cyclic AMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   747   C3158668:cyclic-AMP response element binding [Genetic Function]
   710   C1511573:Cyclic AMP Response Element [Gene or Genome]
   701   C1148918:cyclic AMP binding [Molecular Function]

Phrase: "but"

Phrase: "not ERK1/2 phosphorylation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   793   C0031715:Phosphorylation [Molecular Function]
   793   C1158886:Phosphorylation [Molecular Function]
   723   C0082529:Extracellular Signal-Regulated Kinase 1 [Amino Acid, Peptide, or Protein,Enzyme]
   723   C0170168:Extracellular Signal-Regulated Kinase 2 [Amino Acid, Peptide, or Protein,Enzyme]
   723   C1366765:EXTRACELLULAR SIGNAL-REGULATED KINASE 1 [Gene or Genome]
   723   C1366882:EXTRACELLULAR SIGNAL-REGULATED KINASE 2 [Gene or Genome]

Phrase: "was"

Phrase: "detected in all cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0007634:Cells [Cell]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "treated with retinoic acid"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0040845:Retinoic Acid [Organic Chemical,Pharmacologic Substance,Vitamin]
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0001128:Acid [Chemical]
   770   C0202406:Acid [Laboratory Procedure]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "and in R1 parental cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   760   C0007634:Cells [Cell]
   760   C0030551:Parental [Family Group]
   760   C1335648:R1 [Gene or Genome]
   760   C1515981:And [Idea or Concept]
   760   C1824685:R1 [Gene or Genome]
   760   C2697937:R1 [Quantitative Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "R1/RAGE cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   909   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   750   C1514760:Receptor Cell [Cell]
   744   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "but"

Phrase: "not in R1/RAGEcyto cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   760   C0007634:Cells [Cell]
   760   C1335648:R1 [Gene or Genome]
   760   C1518422:Not [Functional Concept]
   760   C1824685:R1 [Gene or Genome]
   760   C2697937:R1 [Quantitative Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "treated with amphoterin"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0019796:Amphoterin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1333908:AMPHOTERIN [Gene or Genome]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "(Fig. 8B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1424736:8B [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.246: Thus, sustained CREB phosphorylation seems to correlate with neuronal differentiation of ES cells in response to retinoic acid and amphoterin. 

Phrase: "Thus,"

Phrase: "sustained"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0443318:Sustained [Functional Concept]
   966 E C2732140:Sustain [Organic Chemical,Pharmacologic Substance]

Phrase: "CREB phosphorylation"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   877   C1157225:AMP phosphorylation [Molecular Function]
   818   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   795   C0031715:Phosphorylation [Molecular Function]
   787   C0056695:Cyclic AMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   747   C3158668:cyclic-AMP response element binding [Genetic Function]
   710   C1511573:Cyclic AMP Response Element [Gene or Genome]
   701   C1148918:cyclic AMP binding [Molecular Function]

Phrase: "seems"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "correlate with neuronal differentiation of ES cells"
Meta Candidates (Total=19; Excluded=4; Pruned=0; Remaining=15)
   800   C0596508:Embryonic Stem Cells [Cell]
   776   C1514964:Stem Cell Differentiation [Cell Function]
   770   C0038250:Stem cells [Cell]
   770   C1518294:Neuronal Differentiation [Finding]
   767   C0007589:cells differentiation [Cell Function]
           Differentiation
   750   C1947950:Embryonic Cell [Embryonic Structure]
   744   C0007634:Cells [Cell]
   744   C0013935:Embryonic [Embryonic Structure]
   744   C0242767:Stem [Plant]
   744   C0521390:Neuronal [Immunologic Factor]
   744   C1186763:Stem [Body Part, Organ, or Organ Component]
   744   C1511938:Differentiation [Clinical Attribute]
   744   C2945687:Differentiation [Functional Concept]
   744   C3282337:Cells [Cell]
   735 E C1159970:neuron differentiation [Cell Function]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to retinoic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0040845:Retinoic Acid [Organic Chemical,Pharmacologic Substance,Vitamin]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "amphoterin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0019796:Amphoterin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1333908:AMPHOTERIN [Gene or Genome]
Processing 00000000.tx.247: View larger version (46K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(46K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.248: 8.  

Phrase: "8."
Processing 00000000.tx.249: Phosphorylation of CREB and ERK1/2 in differentiating embryonic stem cells. 

Phrase: "Phosphorylation of CREB"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   767   C1157225:AMP phosphorylation [Molecular Function]
   767   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   744   C0031715:Phosphorylation [Molecular Function]
   743   C0056695:Cyclic AMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   703   C3158668:cyclic-AMP response element binding [Genetic Function]

Phrase: "and"

Phrase: "ERK1/2 in differentiating embryonic stem cells."
Meta Candidates (Total=24; Excluded=3; Pruned=0; Remaining=21)
   820   C0082529:Extracellular Signal-Regulated Kinase 1 [Amino Acid, Peptide, or Protein,Enzyme]
   820   C1366765:EXTRACELLULAR SIGNAL-REGULATED KINASE 1 [Gene or Genome]
   813   C0170168:Extracellular Signal-Regulated Kinase 2 [Amino Acid, Peptide, or Protein,Enzyme]
   813   C1366882:EXTRACELLULAR SIGNAL-REGULATED KINASE 2 [Gene or Genome]
   776   C0600388:Extracellular Signal Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   776   C0752312:Extracellular Signal-Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   775   C0596508:Embryonic Stem Cells [Cell]
   770   C1333409:Embryonic Kinase 2 [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   756   C0038250:Stem cells [Cell]
   738   C0007634:Cells [Cell]
   738   C0013935:Embryonic [Embryonic Structure]
   738   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   738   C0205615:differentiating [Qualitative Concept]
   738   C0242767:Stem [Plant]
   738   C0521119:Extracellular [Cell Component]
   738   C0851285:Regulated [Governmental or Regulatory Activity]
   738   C1186763:Stem [Body Part, Organ, or Organ Component]
   738   C1710082:Signal [Phenomenon or Process]
   738   C3282337:Cells [Cell]
   737   C0037083:signal cell [Cell Function]
   737   C1947950:Embryonic Cell [Embryonic Structure]
   704 E C1269647:Cell [Cell]
   704 E C1704653:Cell [Medical Device]
   704 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.250: A, ES cell lines differentiated for 4+12days were replated on gelatin-coated (0.1%) plates with or without 1M retinoic acid or on amphoterin-coated (20g/ml) plates for 90min after which phosphorylation of CREB and ERK1/2 was analyzed with phospho-specific antibodies. 

Phrase: "A,"

Phrase: "ES cell lines"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   983   C1512140:Embryonic Stem Cell Line [Cell]
   861   C0007600:Cell lines [Cell]
   812   C0205132:lines [Spatial Concept]
   779 E C1550648:Line [Substance]
   779 E C1552960:Line [Quantitative Concept]
   756   C0596508:Embryonic stem cell [Cell]
   708   C1947950:Embryonic Cell [Embryonic Structure]

Phrase: "differentiated for 4+12days"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0007589:Differentiated [Cell Function]
   770   C0205615:Differentiated [Qualitative Concept]

Phrase: "were"

Phrase: "replated on gelatin-coated"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0017237:Gelatin [Amino Acid, Peptide, or Protein,Biomedical or Dental Material,Pharmacologic Substance]
   770   C1145617:Gelatin [Food]
   770   C1522408:Coated [Qualitative Concept]
   737 E C0453946:Coat [Manufactured Object]
   737 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "(0.1%"

Phrase: ")"

Phrase: "plates with"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0005971:Plate [Medical Device]
   833   C1139930:plate [Medical Device]
   833   C3537155:Plate [Manufactured Object]

Phrase: "or without 1M retinoic acid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0040845:Retinoic Acid [Organic Chemical,Pharmacologic Substance,Vitamin]
   760   C0001128:Acid [Chemical]
   760   C0202406:Acid [Laboratory Procedure]
   760   C0470296:1M [Quantitative Concept]

Phrase: "or on amphoterin-coated"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0019796:Amphoterin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1333908:AMPHOTERIN [Gene or Genome]
   770   C1522408:Coated [Qualitative Concept]
   737 E C0453946:Coat [Manufactured Object]
   737 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "(20g/ml)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "plates for 90min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0005971:Plate [Medical Device]
   790   C1139930:plate [Medical Device]
   790   C3537155:Plate [Manufactured Object]

Phrase: "after which phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "of CREB"
Meta Candidates (Total=21; Excluded=1; Pruned=0; Remaining=20)
  1000   C0056695:Cyclic AMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   947   C3158668:cyclic-AMP response element binding [Genetic Function]
   901   C1511573:Cyclic AMP Response Element [Gene or Genome]
   885   C1148918:cyclic AMP binding [Molecular Function]
   858   C1148922:AMP binding [Molecular Function]
   827   C0001455:Cyclic AMP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   827   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0013879:Element [Element, Ion, or Isotope]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0243122:binding [Functional Concept]
   799   C0439596:Cyclic [Temporal Concept]
   799   C0871261:Response [Organism Attribute]
   799   C1145667:Binding [Activity]
   799   C1167622:Binding [Molecular Function]
   799   C1511572:Cyclic [Temporal Concept]
   799   C1704632:Response [Finding]
   799   C1705248:Element [Conceptual Entity]
   799   C1706817:Response [Intellectual Product]
   799   C2911692:Response [Mental Process]
   727 E C0031084:Cyclicities [Temporal Concept]

Phrase: "and"

Phrase: "ERK1/2"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   947   C0082529:Extracellular Signal-Regulated Kinase 1 [Amino Acid, Peptide, or Protein,Enzyme]
   947   C1366765:EXTRACELLULAR SIGNAL-REGULATED KINASE 1 [Gene or Genome]
   941   C0170168:Extracellular Signal-Regulated Kinase 2 [Amino Acid, Peptide, or Protein,Enzyme]
   941   C1366882:EXTRACELLULAR SIGNAL-REGULATED KINASE 2 [Gene or Genome]
   880   C0600388:Extracellular Signal Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   880   C0752312:Extracellular Signal-Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0521119:Extracellular [Cell Component]
   799   C0851285:Regulated [Governmental or Regulatory Activity]
   799   C1710082:Signal [Phenomenon or Process]

Phrase: "was"

Phrase: "analyzed with phospho-specific antibodies."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   862   C1257988:Antibodies, Phospho-Specific [Amino Acid, Peptide, or Protein,Immunologic Factor]
   790   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0205369:Specific [Qualitative Concept]
   760   C0936012:Analyzed [Research Activity]
   760   C1552740:specific [Intellectual Product]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.251: B, phosphorylation of CREB and ERK1/2 was analyzed in lysates of ES cell lines differentiated for 4+16days (4days after last replating). 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "phosphorylation of CREB"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   767   C1157225:AMP phosphorylation [Molecular Function]
   767   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   744   C0031715:Phosphorylation [Molecular Function]
   743   C0056695:Cyclic AMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   703   C3158668:cyclic-AMP response element binding [Genetic Function]

Phrase: "and"

Phrase: "ERK1/2"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   947   C0082529:Extracellular Signal-Regulated Kinase 1 [Amino Acid, Peptide, or Protein,Enzyme]
   947   C1366765:EXTRACELLULAR SIGNAL-REGULATED KINASE 1 [Gene or Genome]
   941   C0170168:Extracellular Signal-Regulated Kinase 2 [Amino Acid, Peptide, or Protein,Enzyme]
   941   C1366882:EXTRACELLULAR SIGNAL-REGULATED KINASE 2 [Gene or Genome]
   880   C0600388:Extracellular Signal Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   880   C0752312:Extracellular Signal-Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0521119:Extracellular [Cell Component]
   799   C0851285:Regulated [Governmental or Regulatory Activity]
   799   C1710082:Signal [Phenomenon or Process]

Phrase: "was"

Phrase: "analyzed in lysates of ES cell lines"
Meta Candidates (Total=18; Excluded=2; Pruned=0; Remaining=16)
   816   C1512140:Embryonic Stem Cell Line [Cell]
   800   C0596508:Embryonic stem cell [Cell]
   770   C0007600:Cell lines [Cell]
   770   C0038250:Stem cell [Cell]
   767   C1947950:Embryonic Cell [Embryonic Structure]
   750   C1881488:Cell Lysate [Physical Object]
           Lysate
   744   C0007634:Cell [Cell]
   744   C0013935:Embryonic [Embryonic Structure]
   744   C0205132:lines [Spatial Concept]
   744   C0242767:Stem [Plant]
   744   C0936012:Analyzed [Research Activity]
   744   C1186763:Stem [Body Part, Organ, or Organ Component]
   744   C1269647:Cell [Cell]
   744   C1704653:Cell [Medical Device]
   744   C1948049:Cell [Spatial Concept]
   711 E C1550648:Line [Substance]
   711 E C1552960:Line [Quantitative Concept]

Phrase: "differentiated for 4+16days"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0007589:Differentiated [Cell Function]
   770   C0205615:Differentiated [Qualitative Concept]

Phrase: "(4days after last replating"

Phrase: ")."
Processing 00000000.tx.252: Densitometric analysis of relative induction in RAGE-expressing cells compared with similarly treated RAGEcyto-expressing control cells (reference value 1.0) is indicated. 

Phrase: "Densitometric analysis of relative induction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "in RAGE-expressing cells"
Meta Candidates (Total=21; Excluded=8; Pruned=0; Remaining=13)
   901   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   862   C1514760:Receptor Cell [Cell]
   849   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   791   C0007634:Cells [Cell]
   791   C0150312:In [Quantitative Concept]
   791   C0205179:Advanced [Qualitative Concept]
   791   C0332285:In [Spatial Concept]
   791   C0444930:End [Spatial Concept]
   791   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   791   C0598528:glycation [Phenomenon or Process]
   791   C1514468:Products [Entity]
   791   C2746065:End [Temporal Concept]
   791   C3282337:Cells [Cell]
   758 E C0725066:Advance [Medical Device]
   758 E C1269647:Cell [Cell]
   758 E C1704444:Product [Quantitative Concept]
   758 E C1704653:Cell [Medical Device]
   758 E C1948049:Cell [Spatial Concept]
   735 E C0205088:Terminal [Temporal Concept]
   735 E C1705314:Terminal [Manufactured Object]
   735 E C1705315:Terminal [Spatial Concept]

Phrase: "compared with similarly treated RAGEcyto-expressing control cells"
Meta Candidates (Total=15; Excluded=4; Pruned=0; Remaining=11)
   767   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   744   C0007634:Cells [Cell]
   744   C0243148:control [Qualitative Concept]
   744   C1522326:Treated [Functional Concept]
   744   C1550141:Control [Substance]
   744   C1707455:Compared [Activity]
   744   C1882979:Control [Conceptual Entity]
   744   C2587213:Control [Functional Concept]
   744   C3274648:Control [Qualitative Concept]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1292734:TREAT [Functional Concept]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "(reference value 1.0"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0086715:Value, Reference [Quantitative Concept]
   812   C1514811:Reference [Idea or Concept]
   812   C1522609:Value [Quantitative Concept]
   812   C1706462:Reference [Conceptual Entity]

Phrase: ")"

Phrase: "is"

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.253: The level of ERK1/2 was monitored as a control.  

Phrase: "The level of ERK1/2"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   762   C0456947:Level 1 [Intellectual Product]
   762   C0456948:Level 2 [Intellectual Product]
   742   C0441889:Level [Qualitative Concept]
   742   C0456079:Level [Classification]
   742   C1547707:Level [Geographic Area]
   742   C2946261:Level [Pharmacologic Substance]

Phrase: "was"

Phrase: "monitored as a control."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737   C0030695:monitor [Health Care Activity]
   737   C0150369:monitor [Health Care Activity]
   737   C0181904:Monitor [Medical Device]
   737   C0596972:Monitor [Medical Device]
   737   C1521743:Monitor [Professional or Occupational Group]
   737   C1704646:Monitor [Manufactured Object]
Processing 00000000.tx.254: DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES During the past few years it has become evident that RAGE is involved in a plethora of pathophysiologically relevant conditions ranging from complications of diabetes and amyloidosis to inflammatory responses and cancer (reviewed in Ref. 4). 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES During the past few years"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0439234:years [Temporal Concept]
   753   C1444637:Past [Temporal Concept]
   753   C1514811:Reference [Idea or Concept]
   753   C1706462:Reference [Conceptual Entity]
   719 E C0439508:/year [Temporal Concept]

Phrase: "it"

Phrase: "has"

Phrase: "become"

Phrase: "evident"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0332120:Evidence [Functional Concept]

Phrase: "that RAGE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   946   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "is"

Phrase: "involved in a plethora of pathophysiologically relevant conditions"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0232370:Plethora [Finding]
   744   C1314939:Involved [Functional Concept]
   744   C2347946:Relevant [Qualitative Concept]
   711   C0012634:condition [Disease or Syndrome]
   711   C0348080:Condition [Qualitative Concept]
   711   C1705253:Condition [Conceptual Entity]

Phrase: "ranging from complications of diabetes"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   797   C0342257:Diabetes Complications [Pathologic Function]
   760   C0009566:Complications [Pathologic Function]
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C1171258:complications [Pathologic Function]
   726   C1514721:Range [Quantitative Concept]
   726   C2348147:Range [Quantitative Concept]
   726 E C2362589:Complication [Idea or Concept]
   726   C3542016:Range [Intellectual Product]

Phrase: "and"

Phrase: "amyloidosis to inflammatory responses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0002726:Amyloidosis [Disease or Syndrome]

Phrase: "and"

Phrase: "cancer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0006826:Cancer [Neoplastic Process]
  1000   C0998265:Cancer [Eukaryote]
  1000   C1306459:Cancer [Finding]

Phrase: "("

Phrase: "reviewed in Ref. 4"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0282443:reviewed [Intellectual Product]
   770   C1425988:REF [Gene or Genome]
   770   C1709940:Reviewed [Qualitative Concept]
   737 E C1552617:Review [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.255: However, the roles of RAGE in the developing nervous system have been studied to a lesser extent. 

Phrase: "However,"

Phrase: "the roles of RAGE"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   882   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   818   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   742   C0035820:Roles [Social Behavior]
   742   C0205179:Advanced [Qualitative Concept]
   742   C0444930:End [Spatial Concept]
   742   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   742   C0598528:glycation [Phenomenon or Process]
   742   C1514468:Products [Entity]
   742   C2746065:End [Temporal Concept]
   708 E C0725066:Advance [Medical Device]
   708 E C1704444:Product [Quantitative Concept]
   708 E C1705810:Role [Conceptual Entity]

Phrase: "in the developing nervous system"
Meta Candidates (Total=15; Excluded=7; Pruned=0; Remaining=8)
   901   C0027763:Nervous System [Body System]
   901   C0422837:NERVOUS SYSTEM [Finding]
   901   C1269560:Nervous system [Body System]
   845 E C0205494:Neurologic [Qualitative Concept]
   827   C0027769:Nervous [Sign or Symptom]
   827   C0449913:System [Functional Concept]
   827   C0599851:Nervous [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   808 E C0027855:Neurology [Biomedical Occupation or Discipline]
   790 E C2707261:Neurological [Clinical Attribute]
   755 E C0205373:Systemic [Functional Concept]
   711 E C0027740:Nerve [Tissue]
   711 E C0027757:NERVE [Tissue]
   711 E C1280541:Nerve [Body Part, Organ, or Organ Component]

Phrase: "have"

Phrase: "been"

Phrase: "studied to a lesser extent."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0439792:Extent [Spatial Concept]
   760   C0547044:Lesser [Qualitative Concept]
   726   C0557651:Study [Manufactured Object]
   726   C2603343:Study [Research Activity]
Processing 00000000.tx.256: It is known that RAGE mediates neurite outgrowth and promotes cell survival upon binding to its ligands amphoterin and members of the S100 protein family (6, 14, 15, 37). 

Phrase: "It"

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "that RAGE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   946   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "neurite outgrowth"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3158384:neurite outgrowth [Cell Function]
   861   C0085103:Neurite [Cell Component]

Phrase: "and"

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "cell survival upon binding"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0007620:Cell Survival [Cell Function]
   770   C0007634:Cell [Cell]
   770   C0038952:Survival [Activity]
   770   C0220921:survival [Functional Concept]
   770   C1269647:Cell [Cell]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]

Phrase: "to its ligands amphoterin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0019796:Amphoterin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1333908:AMPHOTERIN [Gene or Genome]

Phrase: "and"

Phrase: "members of the S100 protein family"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   783   C0086282:Family Members [Family Group]
   767 E C1611821:Family Member [Intellectual Product]
   753   C0680022:members [Population Group]
   719 E C2698041:Member [Professional or Occupational Group]

Phrase: "(6,"

Phrase: "14,"

Phrase: "15,"

Phrase: "37"

Phrase: ")."
Processing 00000000.tx.257: In addition, RAGE has been shown to colocalize with amphoterin in developing rat nervous system (15). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "RAGE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   716   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "colocalize with amphoterin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0019796:Amphoterin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1333908:AMPHOTERIN [Gene or Genome]

Phrase: "in developing rat nervous system"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   923   C1882791:Rat Nervous System [Body Part, Organ, or Organ Component]
   861   C0027763:Nervous System [Body System]
   861   C0422837:NERVOUS SYSTEM [Finding]
   861   C1269560:Nervous system [Body System]
   812   C0027769:Nervous [Sign or Symptom]
   812   C0449913:System [Functional Concept]
   812   C0599851:Nervous [Functional Concept]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   805 E C0205494:Neurologic [Qualitative Concept]
   768 E C0027855:Neurology [Biomedical Occupation or Discipline]
   750 E C2707261:Neurological [Clinical Attribute]
   741 E C0205373:Systemic [Functional Concept]

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.258: In endothelial and microglial cells activation of RAGE has been reported to induce expression of various inflammation-related genes, such as interleukin-6, vascular cell adhesion molecule-1, macrophage-colony stimulating factor, and tissue factor (10-13). 

Phrase: "In endothelial"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014257:Endothelial [Tissue]

Phrase: "and"

Phrase: "microglial cells activation of RAGE"
Meta Candidates (Total=24; Excluded=5; Pruned=0; Remaining=19)
   862   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   806   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   771   C1326169:microglial cell activation [Cell Function]
   757   C1326120:activation cells [Cell Function]
   757   C1514758:Receptor Activation [Cell Function]
   743   C0206116:Microglial cell [Cell]
   741   C0596035:activation product [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   741   C1514760:Receptor Cell [Cell]
   741   C1656978:cell end [Cell Component]
   739   C0007634:Cells [Cell]
   739   C0205179:Advanced [Qualitative Concept]
   739   C0444930:End [Spatial Concept]
   739   C0521398:Microglial [Body Location or Region]
   739   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   739   C0598528:glycation [Phenomenon or Process]
   739   C1514468:Products [Entity]
   739   C1879547:Activation [Activity]
   739   C2746065:End [Temporal Concept]
   739   C3282337:Cells [Cell]
   706 E C0725066:Advance [Medical Device]
   706 E C1269647:Cell [Cell]
   706 E C1704444:Product [Quantitative Concept]
   706 E C1704653:Cell [Medical Device]
   706 E C1948049:Cell [Spatial Concept]

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "expression of various inflammation-related genes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0017262:Gene Expression [Genetic Function]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "such as interleukin-6,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021760:Interleukin-6 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1527132:interleukin 6 [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "vascular cell adhesion molecule-1,"
Meta Candidates (Total=26; Excluded=8; Pruned=0; Remaining=18)
  1000   C0078056:Vascular Cell Adhesion Molecule-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Vascular Cell Adhesion Molecule
  1000   C1421435:VASCULAR CELL ADHESION MOLECULE 1 [Gene or Genome]
   937   C1416373:cell adhesion molecule 1 [Gene or Genome]
   884   C0007578:Cell adhesion molecule [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Adhesion Molecule
   840   C0007577:Cell Adhesion [Cell Function]
   804   C0001511:Adhesion [Pathologic Function]
   804   C0005847:vascular [Body Part, Organ, or Organ Component]
   804   C0007634:Cell [Cell]
   804   C0175633:Adhesion [Natural Phenomenon or Process]
   804   C0567416:Molecule [Substance]
   804   C1269647:Cell [Cell]
   804   C1558950:VASCULAR [Finding]
   804   C1704653:Cell [Medical Device]
   804   C1801960:Vascular [Qualitative Concept]
   804   C1948049:Cell [Spatial Concept]
   798   C2328697:Hemal cell [Cell]
   790 E C0005773:Blood cell [Cell]
   748 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   748 E C1511228:VESSEL, BLOOD [Tissue]
   733 E C1521991:Molecular [Qualitative Concept]
   704 E C0005767:Blood [Tissue]
   704 E C0005768:blood [Body Substance]
   704 E C0229664:Blood [Body Substance]
   704 E C0392895:Bloods [Population Group]

Phrase: "macrophage-colony stimulating factor,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0079784:Macrophage Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1524095:macrophage colony-stimulating factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   923   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0024432:macrophage [Cell]
   812   C0439158:colony [Quantitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C1947989:Colony [Cell]
   812   C1948023:Stimulating [Natural Phenomenon or Process]
   812   C2827422:Factor [Conceptual Entity]

Phrase: "and"

Phrase: "tissue factor"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0040048:Tissue Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1333522:TISSUE FACTOR [Gene or Genome]
   861   C0040300:Tissue [Tissue]
   861   C1521761:Factor [Functional Concept]
   861   C1547928:Tissue [Intellectual Product]
   861   C2827422:Factor [Conceptual Entity]

Phrase: "(10-13"

Phrase: ")."
Processing 00000000.tx.259: It is unlikely that up-regulation of these particular genes would be beneficial in developing or regenerating neurons. 

Phrase: "It"

Phrase: "is"

Phrase: "unlikely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0750558:Unlikely [Conceptual Entity]
  1000   C1710571:Unlikely [Qualitative Concept]

Phrase: "that up-regulation of these particular genes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0017263:genes regulation [Genetic Function]
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1327622:Regulation [Biologic Function]

Phrase: "would"

Phrase: "be"

Phrase: "beneficial in developing"

Phrase: "or"

Phrase: "regenerating neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.260: Thus we started characterizing RAGE-induced gene expression on a neuronal background. 

Phrase: "Thus"

Phrase: "we"

Phrase: "started"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1272689:Started [Qualitative Concept]
   966 E C0439659:Start [Temporal Concept]

Phrase: "characterizing RAGE-induced gene expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   862   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   757   C0597360:receptor expression [Genetic Function]
   757   C1335671:Receptor Gene [Gene or Genome]
   739   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "on a neuronal background."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1706907:Background [Conceptual Entity]
Processing 00000000.tx.261: The results of this study demonstrate that: (a) in addition to previously characterized neurite outgrowth response, RAGE activation is capable of inducing proliferation arrest and neuronal differentiation; 

Phrase: "The results of this study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0683954:results study [Finding]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "demonstrate"

Phrase: "that"

Phrase: ":"

Phrase: "(a) in addition to previously characterized neurite outgrowth response,"

Phrase: "RAGE activation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   946   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   774   C1514758:Receptor Activation [Cell Function]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "is"

Phrase: "capable of inducing proliferation arrest"

Phrase: "and"

Phrase: "neuronal differentiation"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C1518294:Neuronal Differentiation [Finding]
   964 E C1159970:neuron differentiation [Cell Function]
   861   C0007589:Differentiation [Cell Function]
   861   C1511938:Differentiation [Clinical Attribute]
   861   C2945687:Differentiation [Functional Concept]
   789 E C0205615:Differentiated [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.262: (b) members of the chromogranin family are gene targets up-regulated by RAGE signaling in neuronal cells; 

Phrase: "(b) members of the chromogranin family"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   783   C0086282:Family Members [Family Group]
   767 E C1611821:Family Member [Intellectual Product]
   753   C0680022:members [Population Group]
   719 E C2698041:Member [Professional or Occupational Group]

Phrase: "are"

Phrase: "gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "targets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1521840:Target [Functional Concept]
  1000   C2986546:TARGET [Diagnostic Procedure]

Phrase: "up-regulated by RAGE"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   882   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   818   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   762   C3242459:regulated products [Intellectual Product]
   745 E C1552022:regulated product [Idea or Concept]
   742   C0205179:Advanced [Qualitative Concept]
   742   C0444930:End [Spatial Concept]
   742   C0547043:Up [Spatial Concept]
   742   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   742   C0598528:glycation [Phenomenon or Process]
   742   C0851285:Regulated [Governmental or Regulatory Activity]
   742   C1282911:Up [Spatial Concept]
   742   C1514468:Products [Entity]
   742   C2746065:End [Temporal Concept]
   708 E C0725066:Advance [Medical Device]
   708 E C1704444:Product [Quantitative Concept]

Phrase: "signaling in neuronal cells"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   802   C0037083:Cell Signaling [Cell Function]
           Signaling
   770   C0007634:Cells [Cell]
   770   C0521390:Neuronal [Immunologic Factor]
   770   C3282337:Cells [Cell]
   770   C3537152:signaling [Biologic Function]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1710082:Signal [Phenomenon or Process]
   737 E C1948049:Cell [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.263: (c) RAGE activation induces MEK1/2-ERK1/2-Rsk2-dependent phosphorylation and nuclear translocation of CREB; 

Phrase: "(c) RAGE activation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   909   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   767   C1514758:Receptor Activation [Cell Function]
   744   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "MEK1/2-ERK1/2-Rsk2-dependent phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   788   C0031715:Phosphorylation [Molecular Function]
   788   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "nuclear translocation of CREB"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   764   C1518440:Nuclear Translocation [Molecular Function]
   762   C0599893:Protein translocation [Cell Function]
   742   C0040715:Translocation [Cell or Molecular Dysfunction]
   742   C2987521:Translocation [Activity]
   716   C0056695:Cyclic AMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.264: and (d) RAGE activation is capable of driving uncommitted embryonic stem cells to differentiate toward a neuronal phenotype. 

Phrase: "and ("

Phrase: "d)"

Phrase: "RAGE activation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   946   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   774   C1514758:Receptor Activation [Cell Function]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "is"

Phrase: "capable of driving uncommitted embryonic stem cells to"

Phrase: "differentiate toward a neuronal phenotype."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0031437:Phenotype [Organism Attribute]
   760   C0205615:differentiate [Qualitative Concept]
   760   C0521390:Neuronal [Immunologic Factor]
   760   C1285572:Phenotype [Laboratory Procedure]
Processing 00000000.tx.265: Chromogranins, a family of soluble acidic proteins, are constituents of secretory vesicles of neuroendocrine cells and some populations of neurons, and they also serve as pro-hormone-type precursors for small bioactive peptides (reviewed in Refs. 21, 22, 38). 

Phrase: "Chromogranins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008586:Chromogranins [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "a family of soluble acidic proteins,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C1335532:Protein Family [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0015576:Family [Family Group]
   753   C1704727:Family [Conceptual Entity]

Phrase: "are"

Phrase: "constituents of secretory vesicles of neuroendocrine cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0729650:Constituents [Substance]

Phrase: "and"

Phrase: "some populations of neurons,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0032659:Population [Quantitative Concept]
   770   C1257890:Population [Population Group]

Phrase: "and"

Phrase: "they also"

Phrase: "serve as pro-hormone-type precursors"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   767   C0301817:Hormone precursor [Hormone]
   753   C0019932:Hormone [Hormone]
   753   C0033382:Pro [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0332307:Type [Qualitative Concept]
   753   C1547052:*Type [Quantitative Concept]
   753   C2987124:PRO [Intellectual Product]
   719   C1709634:Precursor [Idea or Concept]

Phrase: "for small bioactive peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "("

Phrase: "reviewed in Refs. 21,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0282443:reviewed [Intellectual Product]
   770   C1425988:REF [Gene or Genome]
   770   C1709940:Reviewed [Qualitative Concept]
   737 E C1552617:Review [Idea or Concept]

Phrase: "22,"

Phrase: "38"

Phrase: ")."
Processing 00000000.tx.266: Chromogranin expression has previously been shown to be regulated by neuronal activity in certain brain areas (39) and by neurotrophic factors in neuronal cell lines (40-42). 

Phrase: "Chromogranin expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "has"

Phrase: "previously"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "regulated by neuronal activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C0521390:Neuronal [Immunologic Factor]
   770   C0851285:Regulated [Governmental or Regulatory Activity]
   770   C1561536:*Activity [Idea or Concept]

Phrase: "in certain brain areas"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C0205146:areas [Spatial Concept]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   793 E C0017446:Area [Geographic Area]

Phrase: "(39"

Phrase: ")"

Phrase: "and by neurotrophic factors"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0027754:Neurotrophic Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799 E C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799 E C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   799 E C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   770   C1515981:And [Idea or Concept]
   737   C1521761:Factor [Functional Concept]
   737   C2827422:Factor [Conceptual Entity]

Phrase: "in neuronal cell lines"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   901   C0007600:Cell lines [Cell]
   827   C0007634:Cell [Cell]
   827   C0205132:lines [Spatial Concept]
   827   C0521390:Neuronal [Immunologic Factor]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]
   755 E C0027882:Neuron [Cell]

Phrase: "(40-42"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.267: Interestingly, recent studies have shown that chromogranin A can serve as a switch that alone is sufficient to drive dense-core secretory granule biogenesis and hormone sequestration in endocrine cells (43). 

Phrase: "Interestingly,"

Phrase: "recent studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that chromogranin A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0055633:Chromogranin A [Amino Acid, Peptide, or Protein,Hormone,Indicator, Reagent, or Diagnostic Aid]
  1000   C1332754:CHROMOGRANIN A [Gene or Genome]
   861   C0008586:Chromogranin [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "can"

Phrase: "serve as a switch"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707719:Switch [Manufactured Object]

Phrase: "that alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "is"

Phrase: "sufficient to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205410:Sufficient [Qualitative Concept]

Phrase: "drive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013126:Drive [Mental Process]

Phrase: "dense-core secretory granule biogenesis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   924   C3155640:dense core granule biogenesis [Cell Function]
   804   C0005495:Biogenesis [Natural Phenomenon or Process]
   804   C0220781:Biogenesis [Biologic Function]
   722   C0887944:dense core granule [Cell Component]
   708   C1166757:dense granule [Cell Component]

Phrase: "and"

Phrase: "hormone sequestration in endocrine cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0443301:Sequestration [Functional Concept]

Phrase: "(43"

Phrase: ")."
Processing 00000000.tx.268: This suggests that chromogranins might serve as an important step regulating cellular commitment to the secretory phenotype. 

Phrase: "This"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that chromogranins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008586:Chromogranins [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "might"

Phrase: "serve as an important step"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1261552:Step [Conceptual Entity]
   760   C1704379:Step [Functional Concept]
   760   C1705117:Step [Quantitative Concept]
   760   C2825408:Step [Manufactured Object]

Phrase: "regulating"

Phrase: "cellular commitment to the secretory phenotype."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0870312:commitment [Mental Process]
Processing 00000000.tx.269: Our findings that RAGE activation can serve as a potent inducer of all three members of the chromogranin family suggests that RAGE might function as a regulator of neuronal/neuroendocrine secretory phenotype in general. 

Phrase: "Our findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "that RAGE activation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   909   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   767   C1514758:Receptor Activation [Cell Function]
   744   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "can"

Phrase: "serve as a potent inducer of all three members of the chromogranin family"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   749   C0055633:Chromogranin A [Amino Acid, Peptide, or Protein,Hormone,Indicator, Reagent, or Diagnostic Aid]
   749   C0086282:Family Members [Family Group]
   749   C1332754:CHROMOGRANIN A [Gene or Genome]
   735   C0008586:Chromogranin [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   735   C0015576:Family [Family Group]
   735   C0205449:Three [Quantitative Concept]
   735   C0680022:members [Population Group]
   735   C1704727:Family [Conceptual Entity]
   732 E C1611821:Family Member [Intellectual Product]
   702 E C2698041:Member [Professional or Occupational Group]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that RAGE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   946   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "might"

Phrase: "function as a regulator of neuronal/neuroendocrine secretory phenotype"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   762   C0544458:Secretory function [Functional Concept]
   742   C0027912:Neuroendocrine [Body System]
   742   C0031437:Phenotype [Organism Attribute]
   742   C0031843:function [Physiologic Function]
   742   C0182953:REGULATOR [Medical Device]
   742   C0521390:Neuronal [Immunologic Factor]
   742   C0542341:Function [Functional Concept]
   742   C0700205:FUNCTION [Classification]
   742   C1285572:Phenotype [Laboratory Procedure]
   742   C1327616:Secretory [Cell Function]
   742   C1704734:Regulator [Medical Device]
   742   C1704735:Regulator [Conceptual Entity]
   742   C1705273:Function [Intellectual Product]

Phrase: "in general."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205246:General [Spatial Concept]
  1000   C1553889:General [Idea or Concept]
Processing 00000000.tx.270: Both RAGE and amphoterin have been implicated as regulators of differentiation in various cell types. 

Phrase: "Both RAGE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   946   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "amphoterin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0019796:Amphoterin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1333908:AMPHOTERIN [Gene or Genome]

Phrase: "have"

Phrase: "been"

Phrase: "implicated as regulators of differentiation"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0007589:Differentiation [Cell Function]
   760   C0182953:regulators [Medical Device]
   760   C1511938:Differentiation [Clinical Attribute]
   760   C2945687:Differentiation [Functional Concept]
   726 E C1704734:Regulator [Medical Device]
   726 E C1704735:Regulator [Conceptual Entity]

Phrase: "in various cell types."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C0449475:Cell types [Intellectual Product]
   867 E C0007634:Cell Type [Cell]
           Cell
   827   C0332307:Types [Qualitative Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   793 E C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.271: Studies of Sparatore et al. have shown that secreted amphoterin induces differentiation of erythroleukemia cells (44, 45). 

Phrase: "Studies of Sparatore et al."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0947630:studies [Laboratory Procedure]
   726 E C0557651:Study [Manufactured Object]
   726 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that secreted amphoterin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0019796:Amphoterin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1333908:AMPHOTERIN [Gene or Genome]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "differentiation of erythroleukemia cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C0007589:cells differentiation [Cell Function]
           Differentiation
   770   C1511938:Differentiation [Clinical Attribute]
   770   C2945687:Differentiation [Functional Concept]

Phrase: "(44,"

Phrase: "45"

Phrase: ")."
Processing 00000000.tx.272: On the other hand, RAGE activation by advanced glycation end products was recently reported to promote epithelial-myofibroblast transdifferentiation through increased expression of TGF- (46). 

Phrase: "On the"

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "RAGE activation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   946   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   774   C1514758:Receptor Activation [Cell Function]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "by advanced glycation end products"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   812   C0205179:Advanced [Qualitative Concept]
   812   C0444930:End [Spatial Concept]
   812   C0598528:glycation [Phenomenon or Process]
   812   C1514468:Products [Entity]
   812   C2746065:End [Temporal Concept]
   779 E C0725066:Advance [Medical Device]
   779 E C1704444:Product [Quantitative Concept]
   756 E C0205088:Terminal [Temporal Concept]
   756 E C1705314:Terminal [Manufactured Object]
   756 E C1705315:Terminal [Spatial Concept]

Phrase: "was"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "epithelial-myofibroblast transdifferentiation through increased expression of TGF-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C2610414:transdifferentiation [Cell Function]

Phrase: "(46"

Phrase: ")."
Processing 00000000.tx.273: The fact that TGF- has been reported to promote axonal regeneration following brain injury (47) raises an interesting possibility of TGF- being a downstream target of RAGE also in neuronal development and/or regeneration. 

Phrase: "The fact"

Phrase: "that TGF-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040691:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "axonal regeneration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   964   C1621980:axon regeneration [Organ or Tissue Function]
   861   C0034963:Regeneration [Organ or Tissue Function]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "brain injury"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0270611:Brain Injury [Injury or Poisoning]
   861   C3263722:Injury [Injury or Poisoning]
   861   C3263723:Injury [Injury or Poisoning]

Phrase: "(47"

Phrase: ")"

Phrase: "raises"

Phrase: "an interesting possibility of TGF-"

Phrase: "being"

Phrase: "a downstream target of RAGE also"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   846   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   797   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   738   C0205179:Advanced [Qualitative Concept]
   738   C0444930:End [Spatial Concept]
   738   C0522506:Downstream [Spatial Concept]
   738   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   738   C0598528:glycation [Phenomenon or Process]
   738   C1514468:Products [Entity]
   738   C1521840:Target [Functional Concept]
   738   C2746065:End [Temporal Concept]
   738   C2986546:TARGET [Diagnostic Procedure]
   704 E C0725066:Advance [Medical Device]
   704 E C1704444:Product [Quantitative Concept]

Phrase: "in neuronal development"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   964   C1657987:neuron development [Cell Function]
   861   C0243107:development [Physiologic Function]
   861   C0678723:Development [Organism Function]
   861   C1527148:Development [Functional Concept]
   789 E C0458003:Developmental [Qualitative Concept]

Phrase: "and/or"

Phrase: "regeneration."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034963:Regeneration [Organ or Tissue Function]
Processing 00000000.tx.274: The mechanisms leading to differentiation of neuroblastoma have been of particular therapeutic interest for a long time. 

Phrase: "The mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441712:Mechanisms [Functional Concept]
   966 E C1706376:Mechanism [Manufactured Object]

Phrase: "leading to differentiation of neuroblastoma"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   760   C0007589:Differentiation [Cell Function]
   760   C0027819:Neuroblastoma [Neoplastic Process]
   760   C0332152:Leading [Temporal Concept]
   760   C0700095:neuroblastoma [Neoplastic Process]
   760   C1511938:Differentiation [Clinical Attribute]
   760   C1522538:Leading [Functional Concept]
   760   C2945687:Differentiation [Functional Concept]
   760   C3540583:Neuroblastoma [Intellectual Product]
   726 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   726 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   726 E C2348269:Lead [Element, Ion, or Isotope]
   726 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "have"

Phrase: "been of particular therapeutic interest"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0039796:Therapeutic [Therapeutic or Preventive Procedure]
   760   C0302350:Therapeutic [Functional Concept]
   760   C0543488:Interest [Mental Process]

Phrase: "for a long time."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0040223:Time [Temporal Concept]
   827   C3541383:Time [Temporal Concept]
   771 E C0442043:Temporal [Spatial Concept]
   771 E C2362314:Temporal [Temporal Concept]
   743 E C1632851:Times [Quantitative Concept]
Processing 00000000.tx.275: Although inhibition of RAGE-amphoterin interaction has been shown to suppress tumor growth and metastasis (7), it has been suggested that RAGE could also be used as a target in differentiation therapy of neuroblastoma (37). 

Phrase: "Although"

Phrase: "inhibition of RAGE-amphoterin interaction"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   757   C1514761:Receptor Inhibition [Cell Function]
   739   C0021467:Inhibition [Mental Process]
   739   C0021469:Inhibition [Molecular Function]
   739   C1628982:% inhibition [Quantitative Concept]
   739   C3463820:Inhibition [Activity]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "suppress"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:suppress [Functional Concept]

Phrase: "tumor growth"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0598934:tumor growth [Neoplastic Process]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0027651:Tumor [Neoplastic Process]
   861   C0220844:growth [Physiologic Function]
   861   C1578706:Tumor [Intellectual Product]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]
   861   C3273930:Tumor [Finding]

Phrase: "and"

Phrase: "metastasis"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0027627:Metastasis [Neoplastic Process]
  1000   C2939420:metastasis [Neoplastic Process]
   928 E C0036525:Metastatic [Functional Concept]
   928 E C1522484:metastatic [Quantitative Concept]

Phrase: "(7"

Phrase: ")"

Phrase: ","

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that RAGE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   946   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "could"

Phrase: "also"

Phrase: "be"

Phrase: "used as a target"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C1273517:used [Finding]
   770   C1521840:Target [Functional Concept]
   770   C2986546:TARGET [Diagnostic Procedure]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "in differentiation therapy"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0281375:differentiation therapy [Therapeutic or Preventive Procedure]
   861   C0007589:Differentiation [Cell Function]
   861   C0039798:therapy [Functional Concept]
   861   C0087111:Therapy [Therapeutic or Preventive Procedure]
   861   C1363945:Therapy [Finding]
   861   C1511938:Differentiation [Clinical Attribute]
   861   C2945687:Differentiation [Functional Concept]
   789 E C0205615:Differentiated [Qualitative Concept]

Phrase: "of neuroblastoma"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027819:Neuroblastoma [Neoplastic Process]
  1000   C0700095:neuroblastoma [Neoplastic Process]
  1000   C3540583:Neuroblastoma [Intellectual Product]

Phrase: "(37"

Phrase: ")."
Processing 00000000.tx.276: On the other hand, as chromogranin A is a well known marker of various neuroendocrine tumors (48) and our results identify RAGE as a potent regulator of chromogranin A expression, this could reflect the activity of RAGE in certain tumors. 

Phrase: "On the"

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "as"

Phrase: "chromogranin A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0055633:Chromogranin A [Amino Acid, Peptide, or Protein,Hormone,Indicator, Reagent, or Diagnostic Aid]
  1000   C1332754:CHROMOGRANIN A [Gene or Genome]
   861   C0008586:Chromogranin [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "is"

Phrase: "a well known marker of various neuroendocrine tumors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   750   C0041365:Tumor Marker [Biologically Active Substance]
   744   C0005516:Marker [Clinical Attribute]

Phrase: "(48"

Phrase: ")"

Phrase: "and"

Phrase: "our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "identify"

Phrase: "RAGE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   716   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]

Phrase: "as a potent regulator"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0182953:REGULATOR [Medical Device]
   861   C1704734:Regulator [Medical Device]
   861   C1704735:Regulator [Conceptual Entity]

Phrase: "of chromogranin A expression,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C0055633:Chromogranin A [Amino Acid, Peptide, or Protein,Hormone,Indicator, Reagent, or Diagnostic Aid]
   734   C1332754:CHROMOGRANIN A [Gene or Genome]

Phrase: "this"

Phrase: "could"

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "the activity of RAGE"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   882   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   846   C1325419:advanced glycation end-product receptor activity [Molecular Function]
   818   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   762   C1152633:receptor activity [Molecular Function]
   742   C0205177:Activity [Functional Concept]
   742   C0205179:Advanced [Qualitative Concept]
   742   C0439167:% activity [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C0444930:End [Spatial Concept]
   742   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   742   C0598528:glycation [Phenomenon or Process]
   742   C1514468:Products [Entity]
   742   C1561536:*Activity [Idea or Concept]
   742   C2746065:End [Temporal Concept]
   708 E C0725066:Advance [Medical Device]
   708 E C1704444:Product [Quantitative Concept]

Phrase: "in certain tumors."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0027651:Tumors [Neoplastic Process]
   827 E C1578706:Tumor [Intellectual Product]
   827 E C3273930:Tumor [Finding]
Processing 00000000.tx.277: It would be interesting to see how RAGE and chromogranin A expression correlate in various tumor types. 

Phrase: "It"

Phrase: "would"

Phrase: "be"

Phrase: "interesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0543488:interesting [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "how RAGE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   946   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "chromogranin A expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C0055633:Chromogranin A [Amino Acid, Peptide, or Protein,Hormone,Indicator, Reagent, or Diagnostic Aid]
   734   C1332754:CHROMOGRANIN A [Gene or Genome]

Phrase: "correlate in various tumor types."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0027651:Tumor [Neoplastic Process]
   760   C0332307:Types [Qualitative Concept]
   760   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   760   C1578706:Tumor [Intellectual Product]
   760   C3273930:Tumor [Finding]
   726 E C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.278: In addition to being a marker for various tumors, increased chromogranin A expression has been found e.g. in large dystrophic neurites in Alzheimer's disease brain, Pick bodies and ballooned neurons in Pick's disease brain, Lewy bodies, and axonal swellings in the substantia nigra of Parkinson's disease brain (38, 49, 50). 

Phrase: "In addition to"

Phrase: "being"

Phrase: "a marker for various tumors,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C0041365:Tumor Marker [Biologically Active Substance]
   760   C0005516:Marker [Clinical Attribute]

Phrase: "increased chromogranin A expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "has"

Phrase: "been"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "e.g."

Phrase: "in large dystrophic neurites"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C2674684:Dystrophic neurites [Finding]
   827   C0085103:Neurites [Cell Component]

Phrase: "in Alzheimer's disease brain,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   734   C0002395:Alzheimer's Disease [Disease or Syndrome]
   734   C1521724:Alzheimer's Disease [Pathologic Function]

Phrase: "Pick bodies"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   966   C3546648:Pick body [Cell Component]
   861   C0242821:bodies [Human]
   861   C1707391:Pick [Activity]
   861   C1826583:PICK [Gene or Genome]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]

Phrase: "and"

Phrase: "ballooned neurons in Pick's disease brain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1848921:Ballooned neurons [Finding]
   753   C0027882:Neurons [Cell]

Phrase: "Lewy bodies,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0085200:Lewy Bodies [Cell Component]
   861   C0242821:bodies [Human]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]

Phrase: "and"

Phrase: "axonal swellings in the substantia nigra of Parkinson's disease brain"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   757   C0006114:brain swellings [Pathologic Function]
   757   C1527311:Brain Swellings [Disease or Syndrome]
   743   C0544925:Axonal swelling [Cell or Molecular Dysfunction]
   739   C0013604:swellings [Pathologic Function]
   739   C0038999:swellings [Finding]

Phrase: "(38,"

Phrase: "49,"

Phrase: "50"

Phrase: ")."
Processing 00000000.tx.279: Involvement of RAGE as a receptor for amyloid- peptide in Alzheimer's disease is supported by an accumulating amount of evidence (12, 51, 52). 

Phrase: "Involvement of RAGE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1314939:Involvement [Functional Concept]
   743   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]

Phrase: "as a receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "for amyloid- peptide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "is"

Phrase: "supported by an accumulating amount of evidence"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   774   C0332120:Evidence of [Functional Concept]
           Evidence
   748   C1265611:Amount [Quantitative Concept]
   748   C1521721:Supported [Conceptual Entity]
   714 E C0183683:Support [Medical Device]

Phrase: "(12,"

Phrase: "51,"

Phrase: "52"

Phrase: ")."
Processing 00000000.tx.280: Interestingly, chromogranin A has been suggested to be an early activator of microglial cells in Alzheimer's disease (53). 

Phrase: "Interestingly,"

Phrase: "chromogranin A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0055633:Chromogranin A [Amino Acid, Peptide, or Protein,Hormone,Indicator, Reagent, or Diagnostic Aid]
  1000   C1332754:CHROMOGRANIN A [Gene or Genome]
   861   C0008586:Chromogranin [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "has"

Phrase: "been"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "an early activator of microglial cells"

Phrase: "in Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(53"

Phrase: ")."
Processing 00000000.tx.281: Thus, ligation of RAGE by accumulating amyloid- fibrils might up-regulate chromogranin A expression, the secretion of which could in turn activate microglial cells to produce neurotoxins and sustained inflammation in the Alzheimer's disease brain. 

Phrase: "Thus,"

Phrase: "ligation of RAGE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0023690:Ligation [Therapeutic or Preventive Procedure]
   743   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]

Phrase: "by accumulating amyloid- fibrils"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C1449651:Amyloid Fibrils [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0225328:fibrils [Cell Component]
   793 E C1948066:Fibril [Physical Object]

Phrase: "might"

Phrase: "up-regulate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0547043:Up [Spatial Concept]
   861   C1282911:Up [Spatial Concept]

Phrase: "chromogranin A expression,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C0055633:Chromogranin A [Amino Acid, Peptide, or Protein,Hormone,Indicator, Reagent, or Diagnostic Aid]
   734   C1332754:CHROMOGRANIN A [Gene or Genome]

Phrase: "the secretion of which"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0036536:secretion [Biologic Function]
   770   C0036537:Secretion [Body Substance]

Phrase: "could"

Phrase: "in turn"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0541749:turn [Finding]
   861   C1709743:Turn [Spatial Concept]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "microglial cells to"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   884   C0206116:Microglial cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "produce"

Phrase: "neurotoxins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027934:Neurotoxins [Hazardous or Poisonous Substance]

Phrase: "and"

Phrase: "sustained inflammation in the Alzheimer's disease brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0014038:Inflammation, Brain [Disease or Syndrome]
   748   C0021368:Inflammation [Pathologic Function]
Processing 00000000.tx.282: The results presented in this paper identify a new player in the complex RAGE signaling scheme. 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "presented in this paper"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0030351:Paper [Manufactured Object]
   770   C0449450:Presented [Idea or Concept]
   770   C1547566:Paper [Idea or Concept]
   737 E C0150312:Present [Quantitative Concept]

Phrase: "identify"

Phrase: "a new player in the complex RAGE"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   833   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   790   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   751   C0681520:new products [Intellectual Product,Manufactured Object]
   751   C1523873:receptor complex [Cell Component]
   736   C0205179:Advanced [Qualitative Concept]
   736   C0205314:New [Temporal Concept]
   736   C0439855:Complex [Qualitative Concept]
   736   C0444930:End [Spatial Concept]
   736   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   736   C0598528:glycation [Phenomenon or Process]
   736   C1514468:Products [Entity]
   736   C1704241:Complex [Chemical Viewed Structurally]
   736   C2746065:End [Temporal Concept]
   703 E C0725066:Advance [Medical Device]
   703 E C1704444:Product [Quantitative Concept]

Phrase: "signaling"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0037083:Signaling [Cell Function]
  1000   C3537152:signaling [Biologic Function]
   966 E C1710082:Signal [Phenomenon or Process]

Phrase: "scheme."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1519193:Scheme [Intellectual Product]
Processing 00000000.tx.283: RAGE is known to signal through multiple parallel MAP kinase pathways, including ERK1/2, SAPK/JNK, and p38 MAP kinases (5, 7), as well as Cdc42/Rac small GTPases (6), ultimately leading to activation of the transcription factor NF-B (8). 

Phrase: "RAGE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   716   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]

Phrase: "is"

Phrase: "known to signal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205309:Known [Qualitative Concept]
   790   C1710082:Signal [Phenomenon or Process]

Phrase: "through multiple parallel MAP kinase pathways,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1704259:Pathways [Molecular Function]
   804   C1705987:Pathways [Conceptual Entity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "ERK1/2,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   947   C0082529:Extracellular Signal-Regulated Kinase 1 [Amino Acid, Peptide, or Protein,Enzyme]
   947   C1366765:EXTRACELLULAR SIGNAL-REGULATED KINASE 1 [Gene or Genome]
   941   C0170168:Extracellular Signal-Regulated Kinase 2 [Amino Acid, Peptide, or Protein,Enzyme]
   941   C1366882:EXTRACELLULAR SIGNAL-REGULATED KINASE 2 [Gene or Genome]
   880   C0600388:Extracellular Signal Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   880   C0752312:Extracellular Signal-Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0521119:Extracellular [Cell Component]
   799   C0851285:Regulated [Governmental or Regulatory Activity]
   799   C1710082:Signal [Phenomenon or Process]

Phrase: "SAPK/JNK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   877   C1259877:protein kinase C kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "p38 MAP kinases"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   983   C0257535:p38 map kinase [Amino Acid, Peptide, or Protein,Enzyme]
   983   C1120843:p38 MAP Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   867   C0752312:Map Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0024779:Map [Manufactured Object]
   827   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1706473:Map [Conceptual Entity]

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "7"

Phrase: ")"

Phrase: ","

Phrase: "as well as"

Phrase: "Cdc42/Rac small GTPases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0751984:Small GTPases [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0018296:GTPases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(6"

Phrase: ")"

Phrase: ","

Phrase: "ultimately"

Phrase: "leading to activation of the transcription factor NF-B (8"
Meta Candidates (Total=16; Excluded=4; Pruned=0; Remaining=12)
   777   C1420645:TRANSCRIPTION FACTOR 8 [Gene or Genome]
   777   C3537279:Transcription Factor 8 [Amino Acid, Peptide, or Protein]
   760   C0040648:TRANSCRIPTION FACTOR [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C0033453:Factor B [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   757   C0162493:Transcription Activation [Genetic Function]
   757   C1824728:FACTOR B [Gene or Genome]
   739   C0040649:Transcription [Genetic Function]
   739   C0332152:Leading [Temporal Concept]
   739   C1521761:Factor [Functional Concept]
   739   C1522538:Leading [Functional Concept]
   739   C1879547:Activation [Activity]
   739   C2827422:Factor [Conceptual Entity]
   706 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   706 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   706 E C2348269:Lead [Element, Ion, or Isotope]
   706 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: ")."
Processing 00000000.tx.284: Activation of NF-B is the key step in RAGE-mediated up-regulation of inflammation-related genes. 

Phrase: "Activation of NF-B is"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1879547:Activation [Activity]

Phrase: "the key step in RAGE-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   862   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   739   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "mediated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086597:mediated [Social Behavior]
  1000   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]

Phrase: "up-regulation of inflammation-related genes."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0041904:Up-Regulation [Cell Function,Molecular Function]
   790   C0162493:Up-Regulation [Genetic Function]
   783   C0017263:genes regulation [Genetic Function]
   753   C0547043:Up [Spatial Concept]
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1282911:Up [Spatial Concept]
   753   C1327622:Regulation [Biologic Function]
Processing 00000000.tx.285: Our results show that RAGE ligation induces rapid phosphorylation and nuclear localization of CREB, an immediate early gene and a major mediator of e.g. neuronal neurotrophin responses (54). 

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that RAGE ligation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   909   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   744   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "rapid phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "nuclear localization of CREB,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   762   C0597704:protein localisation [Cell Function]
   762   C1159772:Protein Localization [Cell Function]
   742   C0475264:Localisation [Functional Concept]
   742   C1744691:localisation [Biologic Function]
   716   C0056695:Cyclic AMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "an immediate early gene"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0206256:Immediate-Early Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   827   C0205253:Immediate [Temporal Concept]
   827   C0205548:Immediate [Temporal Concept]
   827   C1279919:Early [Temporal Concept]

Phrase: "and"

Phrase: "a major mediator of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1363844:Mediator [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "e.g. neuronal neurotrophin responses"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0871261:responses [Organism Attribute]
   793 E C1704632:Response [Finding]
   793 E C1706817:Response [Intellectual Product]
   793 E C2911692:Response [Mental Process]

Phrase: "(54"

Phrase: ")."
Processing 00000000.tx.286: CREB is known to be regulated by a dual mechanism, either through a Ca2+/cAMP-mediated mechanism or through ERK1/2-activated ribosomal S6 kinase 2(Rsk2; 

Phrase: "CREB"
Meta Candidates (Total=21; Excluded=1; Pruned=0; Remaining=20)
  1000   C0056695:Cyclic AMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   947   C3158668:cyclic-AMP response element binding [Genetic Function]
   901   C1511573:Cyclic AMP Response Element [Gene or Genome]
   885   C1148918:cyclic AMP binding [Molecular Function]
   858   C1148922:AMP binding [Molecular Function]
   827   C0001455:Cyclic AMP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   827   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0013879:Element [Element, Ion, or Isotope]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0243122:binding [Functional Concept]
   799   C0439596:Cyclic [Temporal Concept]
   799   C0871261:Response [Organism Attribute]
   799   C1145667:Binding [Activity]
   799   C1167622:Binding [Molecular Function]
   799   C1511572:Cyclic [Temporal Concept]
   799   C1704632:Response [Finding]
   799   C1705248:Element [Conceptual Entity]
   799   C1706817:Response [Intellectual Product]
   799   C2911692:Response [Mental Process]
   727 E C0031084:Cyclicities [Temporal Concept]

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "regulated by a dual mechanism,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0441712:Mechanism [Functional Concept]
   760   C0851285:Regulated [Governmental or Regulatory Activity]
   760   C1554184:Dual [Intellectual Product]
   760   C1706376:Mechanism [Manufactured Object]

Phrase: "either through a Ca2+/cAMP-mediated mechanism"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0001455:Cyclic AMP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   744   C0086597:mediated [Social Behavior]
   744   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   744   C0439596:Cyclic [Temporal Concept]
   744   C0441712:Mechanism [Functional Concept]
   744   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   744   C1511572:Cyclic [Temporal Concept]
   744   C1706376:Mechanism [Manufactured Object]

Phrase: "or"

Phrase: "through ERK1/2-activated ribosomal S6 kinase 2"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   832   C0140968:ribosomal S6 kinase 2 [Amino Acid, Peptide, or Protein,Enzyme]
   832   C1419744:RIBOSOMAL S6 KINASE 2 [Gene or Genome]
   788   C0035553:Ribosomal [Cell Component]
   788   C1419024:S6 [Gene or Genome]
   788   C1419741:S6 [Gene or Genome]
   788   C1861424:S6 [Gene or Genome]
   788   C2348600:S6+ [Element, Ion, or Isotope]
   717 E C2984240:Ribosome [Functional Concept]

Phrase: "(Rsk2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419744:RSK2 [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.287: also known as CREB kinase) (55). 

Phrase: "also"

Phrase: "known as CREB kinase"
Meta Candidates (Total=27; Excluded=1; Pruned=0; Remaining=26)
   882   C0056695:Cyclic AMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   849   C3158668:cyclic-AMP response element binding [Genetic Function]
   818   C1511573:Cyclic AMP Response Element [Gene or Genome]
   784   C1148918:cyclic AMP binding [Molecular Function]
   784   C1149290:protein kinase binding [Molecular Function]
   764   C0001455:Cyclic AMP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   764   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   764   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   762   C0001497:AMP Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   762 E C0033618:Protein Binding [Molecular Function]
   762   C1148922:AMP binding [Molecular Function]
   762   C1149289:kinase binding [Molecular Function]
   742   C0013879:Element [Element, Ion, or Isotope]
   742   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0205309:Known [Qualitative Concept]
   742   C0243122:binding [Functional Concept]
   742   C0439596:Cyclic [Temporal Concept]
   742   C0871261:Response [Organism Attribute]
   742   C1145667:Binding [Activity]
   742   C1167622:Binding [Molecular Function]
   742   C1511572:Cyclic [Temporal Concept]
   742   C1704632:Response [Finding]
   742   C1705248:Element [Conceptual Entity]
   742   C1706817:Response [Intellectual Product]
   742   C2911692:Response [Mental Process]

Phrase: ")"

Phrase: "(55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.288: Our results show that inhibition of protein kinase A had no effect on RAGE-induced CREB phosphorylation, whereas inhibition of MEK1/2, an upstream activator of ERK1/2, and Rsk2, a downstream target of ERK1/2 and a CREB phosphorylating kinase, blocked RAGE-induced CREB phosphorylation. 

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that inhibition of protein kinase A"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C3463820:Inhibition [Activity]

Phrase: "had"

Phrase: "no effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "on RAGE-induced CREB phosphorylation,"
Meta Candidates (Total=43; Excluded=6; Pruned=0; Remaining=37)
   875   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   867   C0597358:Receptor Binding [Molecular Function]
   840   C0056695:Cyclic AMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   827   C3158668:cyclic-AMP response element binding [Genetic Function]
   823   C1157225:AMP phosphorylation [Molecular Function]
   817   C1148918:cyclic AMP binding [Molecular Function]
   815   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   815   C1511573:Cyclic AMP Response Element [Gene or Genome]
   808   C1148922:AMP binding [Molecular Function]
   794   C0001455:Cyclic AMP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   794   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   794   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   794   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   785   C0013879:Element [Element, Ion, or Isotope]
   785   C0031715:Phosphorylation [Molecular Function]
   785   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   785   C0205179:Advanced [Qualitative Concept]
   785   C0205263:Induced [Functional Concept]
   785   C0243122:binding [Functional Concept]
   785   C0439596:Cyclic [Temporal Concept]
   785   C0444930:End [Spatial Concept]
   785   C0598528:glycation [Phenomenon or Process]
   785   C0871261:Response [Organism Attribute]
   785   C1145667:Binding [Activity]
   785   C1167622:Binding [Molecular Function]
   785   C1511572:Cyclic [Temporal Concept]
   785   C1514468:Products [Entity]
   785   C1704632:Response [Finding]
   785   C1705248:Element [Conceptual Entity]
   785   C1706817:Response [Intellectual Product]
   785   C1720176:On [Functional Concept]
   785   C1720294:On [Intellectual Product]
   785   C2746065:End [Temporal Concept]
   785   C2911692:Response [Mental Process]
   752 E C0725066:Advance [Medical Device]
   752 E C1704444:Product [Quantitative Concept]
   730 E C0205088:Terminal [Temporal Concept]
   730 E C1705314:Terminal [Manufactured Object]
   730 E C1705315:Terminal [Spatial Concept]
   714 E C0031084:Cyclicities [Temporal Concept]

Phrase: "whereas"

Phrase: "inhibition of MEK1/2,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]

Phrase: "an upstream activator of ERK1/2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C1419349:activator 1 [Gene or Genome]
   757   C2247123:kinase activator [Molecular Function]

Phrase: "and"

Phrase: "Rsk2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419744:RSK2 [Gene or Genome]

Phrase: "a downstream target of ERK1/2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1521840:Target [Functional Concept]
   739   C2986546:TARGET [Diagnostic Procedure]

Phrase: "and"

Phrase: "a CREB phosphorylating kinase,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   878   C0001497:AMP Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   822   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   793   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   756   C0056695:Cyclic AMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   723   C3158668:cyclic-AMP response element binding [Genetic Function]

Phrase: "blocked RAGE-induced CREB phosphorylation."
Meta Candidates (Total=47; Excluded=9; Pruned=0; Remaining=38)
   875   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   867   C0597358:Receptor Binding [Molecular Function]
   840   C0056695:Cyclic AMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   827   C3158668:cyclic-AMP response element binding [Genetic Function]
   823   C1157225:AMP phosphorylation [Molecular Function]
   817   C1148918:cyclic AMP binding [Molecular Function]
   815   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   815   C1511573:Cyclic AMP Response Element [Gene or Genome]
   808   C1148922:AMP binding [Molecular Function]
   794   C0001455:Cyclic AMP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   794   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   794   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   794   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   785   C0013879:Element [Element, Ion, or Isotope]
   785   C0028778:Blocked [Pathologic Function]
   785   C0031715:Phosphorylation [Molecular Function]
   785   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   785   C0205179:Advanced [Qualitative Concept]
   785   C0205263:Induced [Functional Concept]
   785   C0243122:binding [Functional Concept]
   785   C0332206:Blocked [Functional Concept]
   785   C0439596:Cyclic [Temporal Concept]
   785   C0444930:End [Spatial Concept]
   785   C0598528:glycation [Phenomenon or Process]
   785   C0871261:Response [Organism Attribute]
   785   C1145667:Binding [Activity]
   785   C1167622:Binding [Molecular Function]
   785   C1511572:Cyclic [Temporal Concept]
   785   C1514468:Products [Entity]
   785   C1704632:Response [Finding]
   785   C1705248:Element [Conceptual Entity]
   785   C1706817:Response [Intellectual Product]
   785   C2746065:End [Temporal Concept]
   785   C2911692:Response [Mental Process]
   785   C2983591:BLOCKED [Research Activity]
   752 E C0725066:Advance [Medical Device]
   752 E C1704444:Product [Quantitative Concept]
   730 E C0205088:Terminal [Temporal Concept]
   730 E C1705314:Terminal [Manufactured Object]
   730 E C1705315:Terminal [Spatial Concept]
   714 E C0031084:Cyclicities [Temporal Concept]
   714 E C1533157:Block [Substance]
   714 E C1706084:Block [Geographic Area]
   714 E C2828370:Block [Quantitative Concept]
Processing 00000000.tx.289: Thus, it seems clear that MEK1/2ERK1/2Rsk2CREB-pathway is prevalent in the case of RAGE signaling. 

Phrase: "Thus,"

Phrase: "it"

Phrase: "seems"

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "that MEK1/2ERK1/2Rsk2CREB-pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1704259:Pathway [Molecular Function]
   812   C1705987:Pathway [Conceptual Entity]

Phrase: "is"

Phrase: "prevalent in the case of RAGE"

Phrase: "signaling."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0037083:Signaling [Cell Function]
  1000   C3537152:signaling [Biologic Function]
   966 E C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.290: Interestingly, CREB has been shown to be a crucial mediator of neuroprotective actions of neurotrophins (56, 57), partially due to CREB-mediated increase in the expression of the antiapoptotic protein Bcl-2 (58). 

Phrase: "Interestingly,"

Phrase: "CREB"
Meta Candidates (Total=21; Excluded=1; Pruned=0; Remaining=20)
  1000   C0056695:Cyclic AMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   947   C3158668:cyclic-AMP response element binding [Genetic Function]
   901   C1511573:Cyclic AMP Response Element [Gene or Genome]
   885   C1148918:cyclic AMP binding [Molecular Function]
   858   C1148922:AMP binding [Molecular Function]
   827   C0001455:Cyclic AMP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   827   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0013879:Element [Element, Ion, or Isotope]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0243122:binding [Functional Concept]
   799   C0439596:Cyclic [Temporal Concept]
   799   C0871261:Response [Organism Attribute]
   799   C1145667:Binding [Activity]
   799   C1167622:Binding [Molecular Function]
   799   C1511572:Cyclic [Temporal Concept]
   799   C1704632:Response [Finding]
   799   C1705248:Element [Conceptual Entity]
   799   C1706817:Response [Intellectual Product]
   799   C2911692:Response [Mental Process]
   727 E C0031084:Cyclicities [Temporal Concept]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "a crucial mediator of neuroprotective actions of neurotrophins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1363844:Mediator [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(56,"

Phrase: "57"

Phrase: ")"

Phrase: ","

Phrase: "partially due to CREB-mediated increase"
Meta Candidates (Total=29; Excluded=1; Pruned=0; Remaining=28)
   846   C0056695:Cyclic AMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   820   C3158668:cyclic-AMP response element binding [Genetic Function]
   797   C1511573:Cyclic AMP Response Element [Gene or Genome]
   792   C1657589:response to cyclic AMP [Cell Function]
   772   C1148918:cyclic AMP binding [Molecular Function]
   756   C0001455:Cyclic AMP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   756   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   756   C0678226:Due to [Functional Concept]
           due
   754 E C0033618:Protein Binding [Molecular Function]
   754   C0870868:mediated response [Mental Process]
   754   C1148922:AMP binding [Molecular Function]
   738   C0013879:Element [Element, Ion, or Isotope]
   738   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0086597:mediated [Social Behavior]
   738   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   738   C0243122:binding [Functional Concept]
   738   C0439596:Cyclic [Temporal Concept]
   738   C0442805:Increase [Functional Concept]
   738   C0871261:Response [Organism Attribute]
   738   C1145667:Binding [Activity]
   738   C1167622:Binding [Molecular Function]
   738   C1511572:Cyclic [Temporal Concept]
   738   C1704632:Response [Finding]
   738   C1705248:Element [Conceptual Entity]
   738   C1706817:Response [Intellectual Product]
   738   C2911692:Response [Mental Process]
   738   C3146286:Due [Idea or Concept]

Phrase: "in the expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "of the antiapoptotic protein Bcl-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0376515:Bcl-2 [Gene or Genome]

Phrase: "(58"

Phrase: ")."
Processing 00000000.tx.291: Our previous studies have shown that RAGE activation promotes cell survival through increased expression of Bcl-2 (14). 

Phrase: "Our previous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that RAGE activation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   909   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   767   C1514758:Receptor Activation [Cell Function]
   744   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "cell survival through increased expression of Bcl-2"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0007620:Cell Survival [Cell Function]
   744   C0007634:Cell [Cell]
   744   C0038952:Survival [Activity]
   744   C0220921:survival [Functional Concept]
   744   C1269647:Cell [Cell]
   744   C1704653:Cell [Medical Device]
   744   C1948049:Cell [Spatial Concept]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.292: Thus, identification of CREB as a downstream target in RAGE signaling provides a link between RAGE activation and increased Bcl-2 expression. 

Phrase: "Thus,"

Phrase: "identification of CREB"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0020792:Identification [Mental Process]
   744   C0205396:Identification [Qualitative Concept]
   743   C0056695:Cyclic AMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   703   C3158668:cyclic-AMP response element binding [Genetic Function]

Phrase: "as a downstream target"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1521840:Target [Functional Concept]
   861   C2986546:TARGET [Diagnostic Procedure]

Phrase: "in RAGE"
Meta Candidates (Total=15; Excluded=5; Pruned=0; Remaining=10)
   954   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   877   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   795   C0150312:In [Quantitative Concept]
   795   C0205179:Advanced [Qualitative Concept]
   795   C0332285:In [Spatial Concept]
   795   C0444930:End [Spatial Concept]
   795   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   795   C0598528:glycation [Phenomenon or Process]
   795   C1514468:Products [Entity]
   795   C2746065:End [Temporal Concept]
   762 E C0725066:Advance [Medical Device]
   762 E C1704444:Product [Quantitative Concept]
   740 E C0205088:Terminal [Temporal Concept]
   740 E C1705314:Terminal [Manufactured Object]
   740 E C1705315:Terminal [Spatial Concept]

Phrase: "signaling"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0037083:Signaling [Cell Function]
  1000   C3537152:signaling [Biologic Function]
   966 E C1710082:Signal [Phenomenon or Process]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "a link between RAGE activation"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   862   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   806   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   757   C1514758:Receptor Activation [Cell Function]
   741   C0596035:activation product [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0205179:Advanced [Qualitative Concept]
   739   C0444930:End [Spatial Concept]
   739   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   739   C0598528:glycation [Phenomenon or Process]
   739   C1514468:Products [Entity]
   739   C1517892:Link [Intellectual Product]
   739   C1704666:Link [Intellectual Product]
   739   C1879547:Activation [Activity]
   739   C2746065:End [Temporal Concept]
   706 E C0725066:Advance [Medical Device]
   706 E C1704444:Product [Quantitative Concept]

Phrase: "and"

Phrase: "increased Bcl-2 expression."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.293: In addition, overexpression of CREB alone has been shown to be sufficient to induce cerebellar granule cell differentiation (59). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "overexpression of CREB"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C1514559:Protein Overexpression [Genetic Function]
           Overexpression
   743   C0056695:Cyclic AMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   703   C3158668:cyclic-AMP response element binding [Genetic Function]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "sufficient to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205410:Sufficient [Qualitative Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "cerebellar granule cell differentiation"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C1818262:cerebellar granule cell differentiation [Cell Function]
   861   C0007589:Cell Differentiation [Cell Function]
           Differentiation
   812   C1511938:Differentiation [Clinical Attribute]
   812   C2945687:Differentiation [Functional Concept]
   741 E C0205615:Differentiated [Qualitative Concept]

Phrase: "(59"

Phrase: ")."
Processing 00000000.tx.294: Therefore it is likely that in addition to chromogranins CREB activation regulates a wide array of genes contributing to RAGE-induced neuronal differentiation. 

Phrase: "Therefore"

Phrase: "it"

Phrase: "is"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "that in addition to chromogranins CREB activation"
Meta Candidates (Total=26; Excluded=1; Pruned=0; Remaining=25)
   833   C0056695:Cyclic AMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   810   C3158668:cyclic-AMP response element binding [Genetic Function]
   790   C1511573:Cyclic AMP Response Element [Gene or Genome]
   782   C1657589:response to cyclic AMP [Cell Function]
   767   C1148918:cyclic AMP binding [Molecular Function]
   753   C0001455:Cyclic AMP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   753   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0599177:protein activation [Genetic Function]
   753   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   751 E C0033618:Protein Binding [Molecular Function]
   751   C1148922:AMP binding [Molecular Function]
   736   C0008586:Chromogranins [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   736   C0013879:Element [Element, Ion, or Isotope]
   736   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0243122:binding [Functional Concept]
   736   C0439596:Cyclic [Temporal Concept]
   736   C0871261:Response [Organism Attribute]
   736   C1145667:Binding [Activity]
   736   C1167622:Binding [Molecular Function]
   736   C1511572:Cyclic [Temporal Concept]
   736   C1704632:Response [Finding]
   736   C1705248:Element [Conceptual Entity]
   736   C1706817:Response [Intellectual Product]
   736   C1879547:Activation [Activity]
   736   C1883712:Addition [Functional Concept]
   736   C2911692:Response [Mental Process]

Phrase: "regulates"

Phrase: "a wide array of genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1510941:Array [Spatial Concept]

Phrase: "contributing to RAGE-induced neuronal differentiation."
Meta Candidates (Total=20; Excluded=3; Pruned=0; Remaining=17)
   846   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   797   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   756   C1518294:Neuronal Differentiation [Finding]
   754   C2325760:Neuronal receptor [Cell Component]
   738   C0007589:Differentiation [Cell Function]
   738   C0205179:Advanced [Qualitative Concept]
   738   C0205263:Induced [Functional Concept]
   738   C0444930:End [Spatial Concept]
   738   C0521390:Neuronal [Immunologic Factor]
   738   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   738   C0598528:glycation [Phenomenon or Process]
   738   C1511938:Differentiation [Clinical Attribute]
   738   C1514468:Products [Entity]
   738   C1880177:Contributing [Activity]
   738   C2746065:End [Temporal Concept]
   738   C2945687:Differentiation [Functional Concept]
   726   C2752630:terminal differentiation [Cell Function]
   720 E C1159970:neuron differentiation [Cell Function]
   704 E C0725066:Advance [Medical Device]
   704 E C1704444:Product [Quantitative Concept]
Processing 00000000.tx.295: An RT-PCR analysis of neurotransmitter and transcription factor profile showed that tyrosine hydroxylase, dopamine- hydroxylase, and transcription factor Phox2 are up-regulated in differentiating N18/RAGE cells (data not shown), suggesting that these cells are differentiating toward sympathetic noradrenergic phenotype (60). 

Phrase: "An RT-PCR analysis of neurotransmitter"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0200931:PCR analysis [Laboratory Procedure]
   790   C0599161:RT-PCR [Molecular Biology Research Technique]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   753   C0677874:pCR [Finding]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "transcription factor profile"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0040648:TRANSCRIPTION FACTOR [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0040649:Transcription [Genetic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1979963:Profile [Laboratory Procedure]
   827   C2003903:Profile [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that tyrosine hydroxylase,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0041491:Tyrosine Hydroxylase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1420718:TYROSINE HYDROXYLASE [Gene or Genome]
   861   C0020364:Hydroxylase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "dopamine- hydroxylase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020364:Hydroxylase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "transcription factor Phox2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0040648:TRANSCRIPTION FACTOR [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "up-regulated in differentiating N18/RAGE cells"
Meta Candidates (Total=24; Excluded=6; Pruned=0; Remaining=18)
   833   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   790   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   751   C3242459:regulated products [Intellectual Product]
   736   C0007634:Cells [Cell]
   736   C0205179:Advanced [Qualitative Concept]
   736   C0205615:differentiating [Qualitative Concept]
   736   C0442791:N18 [Finding]
   736   C0444930:End [Spatial Concept]
   736   C0547043:Up [Spatial Concept]
   736   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   736   C0598528:glycation [Phenomenon or Process]
   736   C0851285:Regulated [Governmental or Regulatory Activity]
   736   C1282911:Up [Spatial Concept]
   736   C1514468:Products [Entity]
   736   C2746065:End [Temporal Concept]
   736   C3282337:Cells [Cell]
   734   C1514760:Receptor Cell [Cell]
   734 E C1552022:regulated product [Idea or Concept]
   734   C1656978:cell end [Cell Component]
   703 E C0725066:Advance [Medical Device]
   703 E C1269647:Cell [Cell]
   703 E C1704444:Product [Quantitative Concept]
   703 E C1704653:Cell [Medical Device]
   703 E C1948049:Cell [Spatial Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "these cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "differentiating toward sympathetic noradrenergic phenotype"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0031437:Phenotype [Organism Attribute]
   760   C0205615:differentiating [Qualitative Concept]
   760   C0599861:noradrenergic [Molecular Function]
   760   C1285572:Phenotype [Laboratory Procedure]

Phrase: "(60"

Phrase: ")."
Processing 00000000.tx.296: However, it is possible that this neuroblastoma cell line might already be committed to sympathetic differentiation and RAGE activation just serves as a suitable stimulus to launch the differentiation program. 

Phrase: "However,"

Phrase: "it"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that"

Phrase: "this neuroblastoma cell line"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   901   C0007600:Cell Line [Cell]
   901   C0815000:neuroblastoma cell [Cell]
   827   C0007634:Cell [Cell]
   827   C0027819:Neuroblastoma [Neoplastic Process]
   827   C0205132:Line [Spatial Concept]
   827   C0700095:neuroblastoma [Neoplastic Process]
   827   C1269647:Cell [Cell]
   827   C1550648:Line [Substance]
   827   C1552960:Line [Quantitative Concept]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   827   C3540583:Neuroblastoma [Intellectual Product]

Phrase: "might"

Phrase: "already"

Phrase: "be"

Phrase: "committed to sympathetic differentiation"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0007589:Differentiation [Cell Function]
   770   C1171947:committed [Organic Chemical,Pharmacologic Substance]
   770   C1511938:Differentiation [Clinical Attribute]
   770   C2945687:Differentiation [Functional Concept]
   737 E C2347840:Commit [Machine Activity]

Phrase: "and"

Phrase: "RAGE activation just"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   909   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   767   C1514758:Receptor Activation [Cell Function]
   744   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "serves as a suitable stimulus to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0234402:Stimulus [Phenomenon or Process]

Phrase: "launch"

Phrase: "the differentiation program."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1709697:Program [Conceptual Entity]
   861   C2728259:Program [Pharmacologic Substance]
   861   C3484370:Program [Functional Concept]
Processing 00000000.tx.297: Thus, we wanted to test whether RAGE signaling would be sufficient to drive differentiation on a noncommitted cellular background. 

Phrase: "Thus,"

Phrase: "we"

Phrase: "wanted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444647:Wanted [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "whether"

Phrase: "RAGE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   716   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]

Phrase: "signaling"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0037083:Signaling [Cell Function]
  1000   C3537152:signaling [Biologic Function]
   966 E C1710082:Signal [Phenomenon or Process]

Phrase: "would"

Phrase: "be"

Phrase: "sufficient to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205410:Sufficient [Qualitative Concept]

Phrase: "drive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013126:Drive [Mental Process]

Phrase: "differentiation on a noncommitted cellular background."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C1511938:Cellular Differentiation [Clinical Attribute]
           Differentiation
   753   C0007589:Differentiation [Cell Function]
   753   C2945687:Differentiation [Functional Concept]
Processing 00000000.tx.298: As our present results show stimulation of RAGE-expressing embryonic stem cells with amphoterin induces differentiation toward a neuronal phenotype as manifested by expression of neuronal markers NFL and Tuj1. 

Phrase: "As our present results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "stimulation of RAGE-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   744   C1948023:Stimulation [Natural Phenomenon or Process]
   743   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]

Phrase: "expressing"

Phrase: "embryonic stem cells with amphoterin"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   862   C0596508:Embryonic Stem Cells [Cell]
   806   C0038250:Stem cells [Cell]
   781   C1947950:Embryonic Cell [Embryonic Structure]
   760   C0007634:Cells [Cell]
   760   C0013935:Embryonic [Embryonic Structure]
   760   C0242767:Stem [Plant]
   760   C1186763:Stem [Body Part, Organ, or Organ Component]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "differentiation toward a neuronal phenotype"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   797   C1518294:Neuronal Differentiation [Finding]
   762 E C1159970:neuron differentiation [Cell Function]
   760   C0007589:Differentiation [Cell Function]
   760   C1511938:Differentiation [Clinical Attribute]
   760   C2945687:Differentiation [Functional Concept]

Phrase: "as"

Phrase: "manifested by expression of neuronal markers NFL"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   778   C1280444:Manifested by [Qualitative Concept]
           manifested
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C0205319:manifested [Functional Concept]
   748   C0521390:Neuronal [Immunologic Factor]
   748   C1417668:NFL [Gene or Genome]
   748   C1455438:NF-L [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1518285:NF-L [Cell Component]
   748   C2981619:NF-L [Gene or Genome]
   714   C0005516:Marker [Clinical Attribute]

Phrase: "and"

Phrase: "Tuj1."
Processing 00000000.tx.299: Increased expression of chromogranins A and B together with increased CREB phosphorylation was also detected in ES cells expressing RAGE, suggesting that regulation of CREB phosphorylation and chromogranin expression by RAGE is not limited to neuroblastoma cells. 

Phrase: "Increased expression of chromogranins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "A"

Phrase: "and"

Phrase: "B together with increased CREB phosphorylation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   754   C0006030:B element [Element, Ion, or Isotope]
   754   C0377800:b protein [Amino Acid, Peptide, or Protein,Receptor]
   754   C1336694:b-PROTEIN [Gene or Genome]
   754   C1455498:B-Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C2347469:/B [Quantitative Concept]

Phrase: "was"

Phrase: "also"

Phrase: "detected in ES cells"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   862   C0596508:Embryonic Stem Cells [Cell]
   806   C0038250:Stem cells [Cell]
   781   C1947950:Embryonic Cell [Embryonic Structure]
   760   C0007634:Cells [Cell]
   760   C0013935:Embryonic [Embryonic Structure]
   760   C0242767:Stem [Plant]
   760   C0442726:Detected [Finding]
   760   C1186763:Stem [Body Part, Organ, or Organ Component]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "RAGE,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   716   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that regulation of CREB phosphorylation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C1522756:regulation of protein phosphorylation [Molecular Function]
   795   C1655411:regulation of protein binding [Molecular Function]
   777   C1158897:regulation of phosphorylation [Cell Function]
   777   C1523122:regulation of binding [Molecular Function]
   739   C0851285:Regulation [Governmental or Regulatory Activity]
   739   C1327622:Regulation [Biologic Function]

Phrase: "and"

Phrase: "chromogranin expression by RAGE"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   882   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   818   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   762   C0597360:receptor expression [Genetic Function]
   742   C0008586:Chromogranin [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   742   C0185117:Expression [Therapeutic or Preventive Procedure]
   742   C0205179:Advanced [Qualitative Concept]
   742   C0444930:End [Spatial Concept]
   742   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   742   C0598528:glycation [Phenomenon or Process]
   742   C1514468:Products [Entity]
   742   C2746065:End [Temporal Concept]
   708 E C0725066:Advance [Medical Device]
   708 E C1704444:Product [Quantitative Concept]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "limited to neuroblastoma cells."
Meta Candidates (Total=13; Excluded=5; Pruned=0; Remaining=8)
   816   C0815000:neuroblastoma cell [Cell]
   770   C0007634:Cells [Cell]
   770   C0027819:Neuroblastoma [Neoplastic Process]
   770   C0439801:Limited [Functional Concept]
   770   C0700095:neuroblastoma [Neoplastic Process]
   770   C3282337:Cells [Cell]
   770   C3540583:Neuroblastoma [Intellectual Product]
   770   C3542948:Limited [Intellectual Product]
   737 E C1269647:Cell [Cell]
   737 E C1549649:Limit [Idea or Concept]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
   737 E C2349209:Limit [Conceptual Entity]
Processing 00000000.tx.300: These results strongly suggest that under appropriate conditions RAGE signaling is capable of promoting neuronal differentiation. 

Phrase: "These results strongly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that under appropriate conditions RAGE"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   862   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   806   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   739   C0205179:Advanced [Qualitative Concept]
   739   C0444930:End [Spatial Concept]
   739   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   739   C0598528:glycation [Phenomenon or Process]
   739   C1514468:Products [Entity]
   739   C1548787:Appropriate [Qualitative Concept]
   739   C2746065:End [Temporal Concept]
   706   C0012634:condition [Disease or Syndrome]
   706   C0348080:Condition [Qualitative Concept]
   706 E C0725066:Advance [Medical Device]
   706 E C1704444:Product [Quantitative Concept]
   706   C1705253:Condition [Conceptual Entity]

Phrase: "signaling"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0037083:Signaling [Cell Function]
  1000   C3537152:signaling [Biologic Function]
   966 E C1710082:Signal [Phenomenon or Process]

Phrase: "is"

Phrase: "capable of promoting neuronal differentiation."
Processing 00000000.tx.301: Interestingly, RAGE expression was found to be up-regulated in parental R1 ES cells stimulated with amphoterin. 

Phrase: "Interestingly,"

Phrase: "RAGE expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   946   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   774   C0597360:receptor expression [Genetic Function]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "up-regulated in parental R1 ES cells"
Meta Candidates (Total=18; Excluded=3; Pruned=0; Remaining=15)
   800   C0596508:Embryonic Stem Cells [Cell]
   770   C0038250:Stem cells [Cell]
   750   C1947950:Embryonic Cell [Embryonic Structure]
   744   C0007634:Cells [Cell]
   744   C0013935:Embryonic [Embryonic Structure]
   744   C0030551:Parental [Family Group]
   744   C0242767:Stem [Plant]
   744   C0547043:Up [Spatial Concept]
   744   C0851285:Regulated [Governmental or Regulatory Activity]
   744   C1186763:Stem [Body Part, Organ, or Organ Component]
   744   C1282911:Up [Spatial Concept]
   744   C1335648:R1 [Gene or Genome]
   744   C1824685:R1 [Gene or Genome]
   744   C2697937:R1 [Quantitative Concept]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "stimulated with amphoterin."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0019796:Amphoterin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1333908:AMPHOTERIN [Gene or Genome]
   790   C1948023:Stimulated [Natural Phenomenon or Process]
Processing 00000000.tx.302: RAGE is known as capable of inducing its own expression through activation of e.g. 

Phrase: "RAGE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   716   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]

Phrase: "is"

Phrase: "known as capable of inducing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205263:Inducing [Functional Concept]
   760   C0205309:Known [Qualitative Concept]

Phrase: "its own expression through activation of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "e.g."
Processing 00000000.tx.303: NF-B and Sp1 (4, 9); 

Phrase: "NF-B"

Phrase: "and"

Phrase: "Sp1"

Phrase: "(4,"

Phrase: "9"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.304: thus, in the presence of a ligand only trace amounts of RAGE in cells might be sufficient to potently induce RAGE expression. 

Phrase: "thus,"

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of a ligand only trace amounts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   844   C0442822:trace amount [Quantitative Concept]
   812   C1265611:amounts [Quantitative Concept]

Phrase: "of RAGE"
Meta Candidates (Total=14; Excluded=5; Pruned=0; Remaining=9)
   954   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   877   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   795   C0205179:Advanced [Qualitative Concept]
   795   C0332285:Of [Spatial Concept]
   795   C0444930:End [Spatial Concept]
   795   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   795   C0598528:glycation [Phenomenon or Process]
   795   C1514468:Products [Entity]
   795   C2746065:End [Temporal Concept]
   762 E C0725066:Advance [Medical Device]
   762 E C1704444:Product [Quantitative Concept]
   740 E C0205088:Terminal [Temporal Concept]
   740 E C1705314:Terminal [Manufactured Object]
   740 E C1705315:Terminal [Spatial Concept]

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "might"

Phrase: "be"

Phrase: "sufficient to potently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205410:Sufficient [Qualitative Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "RAGE expression."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   946   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   774   C0597360:receptor expression [Genetic Function]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.305: It is worth noting that ES are cells increasingly considered in stem cell technologies aimed at neuronal repair. 

Phrase: "It"

Phrase: "is worth noting"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C1316572:Note [Clinical Attribute]
   756   C1317574:Note [Intellectual Product]
   756   C1369612:Note [Clinical Attribute]

Phrase: "that ES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0242767:Stem [Plant]
   861   C1186763:Stem [Body Part, Organ, or Organ Component]

Phrase: "are"

Phrase: "cells increasingly"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "considered in stem cell technologies"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0038250:Stem cell [Cell]
   760   C0007634:Cell [Cell]
   760   C0039421:technologies [Occupation or Discipline]
   760   C0242767:Stem [Plant]
   760   C0750591:considered [Idea or Concept]
   760   C1186763:Stem [Body Part, Organ, or Organ Component]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]

Phrase: "aimed at neuronal repair."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0043240:Repair, NOS [Organism Function]
   770   C0374711:Repair [Therapeutic or Preventive Procedure]
   770   C0521390:Neuronal [Immunologic Factor]
   737   C1947946:Aim [Idea or Concept]
   737   C2948600:Aim [Pharmacologic Substance]
   737   C3540471:AIM [Gene or Genome]
   737   C3540472:AIM [Functional Concept]
Processing 00000000.tx.306: Exploitation of the ES cells for such purposes requires comprehension of factors and signaling pathways that control proliferation and differentiation of the stem cells. 

Phrase: "Exploitation of the ES cells"

Phrase: "for such purposes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1285529:purposes [Functional Concept]

Phrase: "requires"

Phrase: "comprehension of factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0162340:Comprehension [Mental Process]
   790   C3542413:Comprehension [Intellectual Product]

Phrase: "and"

Phrase: "signaling pathways"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   983   C0037080:Signal Pathways [Molecular Function]
   983   C0037083:signaling pathway [Cell Function]
   983   C0086982:Signaling Pathway [Molecular Function]
   861   C1704259:Pathways [Molecular Function]
   861   C1705987:Pathways [Conceptual Entity]

Phrase: "that"

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "proliferation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0334094:Proliferation [Pathologic Function]
  1000   C1514485:Proliferation [Functional Concept]

Phrase: "and"

Phrase: "differentiation of the stem cells."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C1514964:Stem Cell Differentiation [Cell Function]
   797   C0007589:cells differentiation [Cell Function]
           Differentiation
   760   C1511938:Differentiation [Clinical Attribute]
   760   C2945687:Differentiation [Functional Concept]
Processing 00000000.tx.307: From this viewpoint, the secretory neural phenotype is of particular interest since many therapies aim at using neural cells secreting bioactive substances. 

Phrase: "From this viewpoint,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282411:Viewpoint [Intellectual Product]

Phrase: "the secretory neural phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0031437:Phenotype [Organism Attribute]
   827   C1285572:Phenotype [Laboratory Procedure]

Phrase: "is of particular interest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0543488:Interest [Mental Process]

Phrase: "since"

Phrase: "many therapies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0087111:therapies [Therapeutic or Preventive Procedure]
   966 E C0039798:therapy [Functional Concept]
   966 E C1363945:Therapy [Finding]

Phrase: "aim at"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1947946:Aim [Idea or Concept]
   833   C2948600:Aim [Pharmacologic Substance]
   833   C3540471:AIM [Gene or Genome]
   833   C3540472:AIM [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "neural cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C0027882:Neural cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "secreting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1327616:Secreting [Cell Function]

Phrase: "bioactive substances."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439861:Substances [Substance]
Processing 00000000.tx.308: The roles of RAGE in developing and regenerating the nervous system are not well understood. 

Phrase: "The roles of RAGE"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   882   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   818   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   742   C0035820:Roles [Social Behavior]
   742   C0205179:Advanced [Qualitative Concept]
   742   C0444930:End [Spatial Concept]
   742   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   742   C0598528:glycation [Phenomenon or Process]
   742   C1514468:Products [Entity]
   742   C2746065:End [Temporal Concept]
   708 E C0725066:Advance [Medical Device]
   708 E C1704444:Product [Quantitative Concept]
   708 E C1705810:Role [Conceptual Entity]

Phrase: "in developing"

Phrase: "and"

Phrase: "regenerating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0334213:regenerating [Functional Concept]

Phrase: "the nervous system"
Meta Candidates (Total=15; Excluded=7; Pruned=0; Remaining=8)
  1000   C0027763:Nervous System [Body System]
  1000   C0422837:NERVOUS SYSTEM [Finding]
  1000   C1269560:Nervous system [Body System]
   944 E C0205494:Neurologic [Qualitative Concept]
   907 E C0027855:Neurology [Biomedical Occupation or Discipline]
   888 E C2707261:Neurological [Clinical Attribute]
   861   C0027769:Nervous [Sign or Symptom]
   861   C0449913:System [Functional Concept]
   861   C0599851:Nervous [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]
   745 E C0027740:Nerve [Tissue]
   745 E C0027757:NERVE [Tissue]
   745 E C1280541:Nerve [Body Part, Organ, or Organ Component]

Phrase: "are"

Phrase: "not well understood."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205170:Well [Qualitative Concept]
   827   C3146287:Well [Manufactured Object]
   793   C0162340:Understand [Mental Process]
Processing 00000000.tx.309: Detailed in vivo studies are now required for better understanding of the developmental and regenerative functions of RAGE. 

Phrase: "Detailed in vivo studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   906   C0681829:in vivo study [Research Activity]
   812   C0947630:studies [Laboratory Procedure]
   779 E C0557651:Study [Manufactured Object]
   779 E C2603343:Study [Research Activity]

Phrase: "are"

Phrase: "now"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948052:Now [Temporal Concept]

Phrase: "required for better understanding of the developmental"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0162340:Understanding [Mental Process]
   748   C0332272:Better [Qualitative Concept]
   748   C0458003:Developmental [Qualitative Concept]
   748   C0678723:Developmental [Organism Function]
   748   C1514873:Required [Functional Concept]

Phrase: "and"

Phrase: "regenerative functions of RAGE."
Meta Candidates (Total=15; Excluded=5; Pruned=0; Remaining=10)
   882   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   818   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   745   C0920644:function receptor [Molecular Function]
   742   C0205179:Advanced [Qualitative Concept]
   742   C0444930:End [Spatial Concept]
   742   C0542341:Functions [Functional Concept]
   742   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   742   C0598528:glycation [Phenomenon or Process]
   742   C1514468:Products [Entity]
   742   C2746065:End [Temporal Concept]
   708 E C0031843:function [Physiologic Function]
   708 E C0700205:FUNCTION [Classification]
   708 E C0725066:Advance [Medical Device]
   708 E C1704444:Product [Quantitative Concept]
   708 E C1705273:Function [Intellectual Product]
Processing 00000000.tx.310: Interestingly, quite recently it was reported that transgenic mice expressing the cytoplasmic domain deletion mutant of RAGE in peripheral neurons display significantly impaired nerve regeneration after sciatic nerve injury (61). 

Phrase: "Interestingly,"

Phrase: "quite recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332185:Recently [Temporal Concept]

Phrase: "it"

Phrase: "was"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "expressing"

Phrase: "the cytoplasmic domain deletion mutant of RAGE"
Meta Candidates (Total=21; Excluded=2; Pruned=0; Remaining=19)
   833   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   790   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   753   C1511625:Cytoplasmic Domain [Cell Component]
   751   C0206587:Cytoplasmic Receptor [Amino Acid, Peptide, or Protein,Receptor]
   736   C0010834:Cytoplasmic [Cell Component]
   736   C0205179:Advanced [Qualitative Concept]
   736   C0444930:End [Spatial Concept]
   736   C0521449:Cytoplasmic [Body Location or Region]
   736   C0596988:Mutant [Cell or Molecular Dysfunction]
   736   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   736   C0598528:glycation [Phenomenon or Process]
   736   C1442161:Deletion [Cell or Molecular Dysfunction]
   736   C1511760:Deletion [Genetic Function]
   736   C1514468:Products [Entity]
   736   C1880274:Deletion [Activity]
   736   C1880389:Domain [Functional Concept]
   736   C1883221:Domain [Conceptual Entity]
   736   C2746065:End [Temporal Concept]
   736   C3541951:Domain [Intellectual Product]
   703 E C0725066:Advance [Medical Device]
   703 E C1704444:Product [Quantitative Concept]

Phrase: "in peripheral neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C0682700:Peripheral neuron [Cell]
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "significantly impaired nerve regeneration after sciatic nerve injury"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0027756:Nerve Regeneration [Cell Function]
   767   C0161479:Nerve injury [Injury or Poisoning]
   744   C0027740:Nerve [Tissue]
   744   C0027757:NERVE [Tissue]
   744   C0034963:Regeneration [Organ or Tissue Function]
   744   C1280541:Nerve [Body Part, Organ, or Organ Component]
   725   C0036394:Sciatic Nerves [Body Part, Organ, or Organ Component]

Phrase: "(61"

Phrase: ")."
Processing 00000000.tx.311: On the other hand, we have found that RAGE expression is highly up-regulated in hippocampal organotypic cultures in a glutamate-induced excitotoxicity model.2 The fact that RAGE expression is up-regulated upon different kinds of neuronal damage and that RAGE signaling can regulate CREB, chromogranins, and Bcl-2 suggests that RAGE signaling can elicit neurotrophic effects on regenerating neurons. 

Phrase: "On the"

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "we"

Phrase: "have"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that RAGE expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   909   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   767   C0597360:receptor expression [Genetic Function]
   744   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "is"

Phrase: "highly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:Highly [Qualitative Concept]

Phrase: "up-regulated in hippocampal organotypic cultures"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   753   C0010453:Cultures [Idea or Concept]
   753   C0019564:Hippocampal [Body Part, Organ, or Organ Component]
   753   C0547043:Up [Spatial Concept]
   753   C0851285:Regulated [Governmental or Regulatory Activity]
   753   C1282911:Up [Spatial Concept]
   719 E C0220814:culture [Functional Concept]
   719 E C0430400:Culture [Laboratory Procedure]
   719 E C2242979:Culture [Laboratory Procedure]

Phrase: "in a glutamate-induced excitotoxicity model.2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   804   C0205263:Induced [Functional Concept]
   804   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C3161035:Model [Intellectual Product]

Phrase: "The fact"

Phrase: "that RAGE expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   909   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   767   C0597360:receptor expression [Genetic Function]
   744   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "is"

Phrase: "up-regulated upon different kinds of neuronal damage"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   744   C0010957:Damage [Injury or Poisoning]
   744   C0521390:Neuronal [Immunologic Factor]
   744   C0547043:Up [Spatial Concept]
   744   C0851285:Regulated [Governmental or Regulatory Activity]
   744   C1282911:Up [Spatial Concept]
   744   C1705242:Different [Qualitative Concept]
   744   C1883709:Damage [Functional Concept]
   711   C0332307:Kind [Qualitative Concept]

Phrase: "and"

Phrase: "that RAGE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   946   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "signaling"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0037083:Signaling [Cell Function]
  1000   C3537152:signaling [Biologic Function]
   966 E C1710082:Signal [Phenomenon or Process]

Phrase: "can"

Phrase: "regulate"

Phrase: "CREB,"
Meta Candidates (Total=21; Excluded=1; Pruned=0; Remaining=20)
  1000   C0056695:Cyclic AMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   947   C3158668:cyclic-AMP response element binding [Genetic Function]
   901   C1511573:Cyclic AMP Response Element [Gene or Genome]
   885   C1148918:cyclic AMP binding [Molecular Function]
   858   C1148922:AMP binding [Molecular Function]
   827   C0001455:Cyclic AMP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   827   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0013879:Element [Element, Ion, or Isotope]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0243122:binding [Functional Concept]
   799   C0439596:Cyclic [Temporal Concept]
   799   C0871261:Response [Organism Attribute]
   799   C1145667:Binding [Activity]
   799   C1167622:Binding [Molecular Function]
   799   C1511572:Cyclic [Temporal Concept]
   799   C1704632:Response [Finding]
   799   C1705248:Element [Conceptual Entity]
   799   C1706817:Response [Intellectual Product]
   799   C2911692:Response [Mental Process]
   727 E C0031084:Cyclicities [Temporal Concept]

Phrase: "chromogranins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008586:Chromogranins [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "and"

Phrase: "Bcl-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0376515:Bcl-2 [Gene or Genome]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that RAGE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   946   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "signaling"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0037083:Signaling [Cell Function]
  1000   C3537152:signaling [Biologic Function]
   966 E C1710082:Signal [Phenomenon or Process]

Phrase: "can"

Phrase: "elicit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449265:elicit [Qualitative Concept]

Phrase: "neurotrophic effects on regenerating neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.312: It will be interesting to see how the development and regenerative capacity of the nervous system is affected in the RAGE knockout mice. 

Phrase: "It"

Phrase: "will"

Phrase: "be"

Phrase: "interesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0543488:interesting [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "how"

Phrase: "the development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "and"

Phrase: "regenerative capacity of the nervous system"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1516240:Capacity [Quantitative Concept]

Phrase: "is"

Phrase: "affected in the RAGE knockout mice."
Meta Candidates (Total=19; Excluded=3; Pruned=0; Remaining=16)
   846   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   797   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   756   C0206745:Knock-out Mice [Mammal]
   738   C0025914:Mice [Mammal]
   738   C0025929:mice [Mammal]
   738   C0026809:Mice [Mammal]
   738   C0205179:Advanced [Qualitative Concept]
   738   C0392760:Affected [Functional Concept]
   738   C0444930:End [Spatial Concept]
   738   C0560617:knock out [Injury or Poisoning]
   738   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   738   C0598528:glycation [Phenomenon or Process]
   738   C1314939:Affected [Functional Concept]
   738   C1514468:Products [Entity]
   738   C1522225:Knock-out [Experimental Model of Disease]
   738   C2746065:End [Temporal Concept]
   704 E C0001721:Affect [Mental Process]
   704 E C0725066:Advance [Medical Device]
   704 E C1704444:Product [Quantitative Concept]
Processing 00000000.tx.313: Interestingly, amphoterin knockout mice have been reported to die neonatally and to display generalized atrophy of internal organs (62). 

Phrase: "Interestingly,"

Phrase: "amphoterin knockout mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0206745:Knock-out Mice [Mammal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "have"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "die"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   944   C0011065:Expired [Organism Function]
   944   C0231800:Expired [Organ or Tissue Function]
   944   C1704631:Expire [Idea or Concept]
   916 E C0184532:dying [Organism Function]
   916 E C1546956:Died [Finding]
   916 E C1553404:terminated [Idea or Concept]
   916 E C2348570:Terminated [Functional Concept]

Phrase: "neonatally"

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "generalized atrophy of internal organs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0333641:Atrophy [Pathologic Function]

Phrase: "(62"

Phrase: ")."
Processing 00000000.tx.314: As in this report no attention was paid to the functionality or intactness of the nervous system, it remains to be seen what kind of developmental effects targeted mutation of amphoterin has. 

Phrase: "As in this"

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "no attention"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004268:Attention [Mental Process]

Phrase: "was"

Phrase: "paid to the functionality"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0871051:pay [Quantitative Concept]

Phrase: "or"

Phrase: "intactness of the nervous system,"

Phrase: "it"

Phrase: "remains"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "seen"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205397:Seen [Qualitative Concept]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]

Phrase: "what kind of developmental effects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332307:Kind [Qualitative Concept]

Phrase: "targeted"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521840:Targeted [Functional Concept]
   966 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "mutation of amphoterin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0026882:Mutation [Genetic Function]
   790   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "has."
Processing 00000000.tx.315: Nevertheless, there is no doubt that different in vivo approaches will be needed to unravel the roles of amphoterin and RAGE in the nervous system.  

Phrase: "Nevertheless,"

Phrase: "there"

Phrase: "is"

Phrase: "no doubt"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870444:doubt [Mental Process]
   928 E C0750558:Doubtful [Conceptual Entity]

Phrase: "that different in vivo approaches"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0449445:Approaches [Spatial Concept]
   812   C1292724:Approaches [Functional Concept]

Phrase: "will"

Phrase: "be"

Phrase: "needed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Needed [Qualitative Concept]
  1000   C0686904:needed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "unravel"

Phrase: "the roles of amphoterin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0035820:Roles [Social Behavior]
   737 E C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "RAGE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   716   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]

Phrase: "in the nervous system."
Meta Candidates (Total=15; Excluded=7; Pruned=0; Remaining=8)
  1000   C0027763:Nervous System [Body System]
  1000   C0422837:NERVOUS SYSTEM [Finding]
  1000   C1269560:Nervous system [Body System]
   944 E C0205494:Neurologic [Qualitative Concept]
   907 E C0027855:Neurology [Biomedical Occupation or Discipline]
   888 E C2707261:Neurological [Clinical Attribute]
   861   C0027769:Nervous [Sign or Symptom]
   861   C0449913:System [Functional Concept]
   861   C0599851:Nervous [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]
   745 E C0027740:Nerve [Tissue]
   745 E C0027757:NERVE [Tissue]
   745 E C1280541:Nerve [Body Part, Organ, or Organ Component]
Processing 00000000.tx.316: ACKNOWLEDGEMENTS We thank Dr. 

Phrase: "ACKNOWLEDGEMENTS"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.317: Rosario Donato for generously providing us with the purified recombinant S100B protein. 

Phrase: "Rosario Donato for generously"

Phrase: "providing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1999230:Provide [Activity]

Phrase: "us with the purified recombinant S100B protein."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C0034861:Recombinant protein [Amino Acid, Peptide, or Protein]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1419790:S100B [Gene or Genome]
   748   C1514798:recombinant [Organism]
   748   C1998793:Purified [Functional Concept]
Processing 00000000.tx.318: The excellent technical assistance of Eeva-Liisa Saarikalle and Nina Nevalainen is gratefully acknowledged.  

Phrase: "The excellent technical assistance of Eeva-Liisa Saarikalle"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0018896:Assistance [Social Behavior]
   744   C0449851:Technical [Functional Concept]

Phrase: "and"

Phrase: "Nina Nevalainen"

Phrase: "is"

Phrase: "gratefully"

Phrase: "acknowledged."
Processing 00000000.tx.319: FOOTNOTES * This study was supported by grants from the Academy of Finland (Finnish Center of Excellence Program 2000-2005), the Finnish Cancer Society, and the Sigrid Juslius Foundation.

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "This study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "was"

Phrase: "supported by grants"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0018173:Grants [Quantitative Concept]
   790   C1521721:Supported [Conceptual Entity]
   756 E C0183683:Support [Medical Device]
   756 E C1548284:Grant [Idea or Concept]

Phrase: "from the Academy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000876:Academy [Organization]

Phrase: "of Finland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016132:Finland [Geographic Area]

Phrase: "(Finnish Center of Excellence Program 2000-2005"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205099:Center [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "the Finnish Cancer Society,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0037455:society [Organization]

Phrase: "and"

Phrase: "the Sigrid Juslius Foundation."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0016617:Foundation [Organization]
   743 E C0002055:base [Inorganic Chemical]
   743 E C0178499:Base [Chemical Viewed Functionally]
   743 E C1626935:Bases [Quantitative Concept]
   743 E C1880279:Base [Biomedical or Dental Material]
   721 E C0205112:Basal [Spatial Concept]
Processing 00000000.tx.320: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.321: The article must therefore be hereby marked "advertisement" in accordance with 18U.S.C. 

Phrase: "The article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18U.S.C."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.322: Section 1734solely to indicate this fact. 

Phrase: "Section 1734solely to"

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.323: To whom correspondence should be addressed: P.O. 

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "P.O."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.324: Box 56(Viikinkaari 5), University of Helsinki FIN-00014, Finland. 

Phrase: "Box 56"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0179400:Box [Manufactured Object]
   861   C1533124:Box [Medical Device]

Phrase: "(Viikinkaari 5"

Phrase: ")"

Phrase: ","

Phrase: "University of Helsinki FIN-00014,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0041740:University [Manufactured Object,Organization]
   804   C0230113:Fin [Body Part, Organ, or Organ Component]

Phrase: "Finland."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016132:Finland [Geographic Area]
Processing 00000000.tx.325: Tel.: 

Phrase: "Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.326: 358-9-19159060; 

Phrase: "358-9-19159060"

Phrase: ";"
Processing 00000000.tx.327: Fax: 358-9-19159068; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "358-9-19159068"

Phrase: ";"
Processing 00000000.tx.328: E-mail: Henri.

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "Henri."
Processing 00000000.tx.329: Huttunen@helsinki.fi. 

Phrase: "Huttunen@helsinki.fi."
Processing 00000000.tx.330: Published, JBC Papers in Press, August 7,2002,DOI 10.1074/jbc.M202515200 2 H. 

Phrase: "Published"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034037:Published [Occupational Activity]
  1000   C1704324:Published [Intellectual Product]

Phrase: ","

Phrase: "JBC Papers in Press,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0030351:Papers [Manufactured Object]
   737 E C1547566:Paper [Idea or Concept]

Phrase: "August 7,"

Phrase: "2002,"

Phrase: "DOI 10.1074/jbc.M202515200 2 H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   795   C0033727:H+ [Element, Ion, or Isotope]
   795   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   795   C0441932:H+ [Classification]
   795   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.331: J.

Phrase: "J."
Processing 00000000.tx.332: Huttunen, J.Kuja-Panula, and H.

Phrase: "Huttunen,"

Phrase: "J.Kuja-Panula,"

Phrase: "and"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.333: Rauvala, unpublished results.  

Phrase: "Rauvala,"

Phrase: "unpublished results."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]
Processing 00000000.tx.334: ABBREVIATIONS The abbreviations used are: RAGE, receptor for advanced glycation end products; 

Phrase: "ABBREVIATIONS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "RAGE,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   716   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]

Phrase: "receptor for advanced glycation end products"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   716   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]

Phrase: ";"
Processing 00000000.tx.335: CREB, cyclic AMP response element-binding protein; 

Phrase: "CREB,"
Meta Candidates (Total=21; Excluded=1; Pruned=0; Remaining=20)
  1000   C0056695:Cyclic AMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   947   C3158668:cyclic-AMP response element binding [Genetic Function]
   901   C1511573:Cyclic AMP Response Element [Gene or Genome]
   885   C1148918:cyclic AMP binding [Molecular Function]
   858   C1148922:AMP binding [Molecular Function]
   827   C0001455:Cyclic AMP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   827   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0013879:Element [Element, Ion, or Isotope]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0243122:binding [Functional Concept]
   799   C0439596:Cyclic [Temporal Concept]
   799   C0871261:Response [Organism Attribute]
   799   C1145667:Binding [Activity]
   799   C1167622:Binding [Molecular Function]
   799   C1511572:Cyclic [Temporal Concept]
   799   C1704632:Response [Finding]
   799   C1705248:Element [Conceptual Entity]
   799   C1706817:Response [Intellectual Product]
   799   C2911692:Response [Mental Process]
   727 E C0031084:Cyclicities [Temporal Concept]

Phrase: "cyclic AMP response element-binding protein"
Meta Candidates (Total=21; Excluded=1; Pruned=0; Remaining=20)
  1000   C0056695:Cyclic AMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   947   C3158668:cyclic-AMP response element binding [Genetic Function]
   901   C1511573:Cyclic AMP Response Element [Gene or Genome]
   885   C1148918:cyclic AMP binding [Molecular Function]
   858   C1148922:AMP binding [Molecular Function]
   827   C0001455:Cyclic AMP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   827   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0013879:Element [Element, Ion, or Isotope]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0243122:binding [Functional Concept]
   799   C0439596:Cyclic [Temporal Concept]
   799   C0871261:Response [Organism Attribute]
   799   C1145667:Binding [Activity]
   799   C1167622:Binding [Molecular Function]
   799   C1511572:Cyclic [Temporal Concept]
   799   C1704632:Response [Finding]
   799   C1705248:Element [Conceptual Entity]
   799   C1706817:Response [Intellectual Product]
   799   C2911692:Response [Mental Process]
   727 E C0031084:Cyclicities [Temporal Concept]

Phrase: ";"
Processing 00000000.tx.336: SAPK/JNK, stress-activated protein kinase/c-Jun-NH2-terminal kinase; 

Phrase: "SAPK/JNK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   877   C1259877:protein kinase C kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "stress-activated protein kinase/c-Jun-NH2-terminal kinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   877   C1259877:protein kinase C kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ";"
Processing 00000000.tx.337: ES, embryonic stem; 

Phrase: "ES,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0242767:Stem [Plant]
   861   C1186763:Stem [Body Part, Organ, or Organ Component]

Phrase: "embryonic stem"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0242767:Stem [Plant]
   861   C1186763:Stem [Body Part, Organ, or Organ Component]

Phrase: ";"
Processing 00000000.tx.338: NFL, neurofilament light; 

Phrase: "NFL,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1417668:NFL [Gene or Genome]
  1000   C1455438:NF-L [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1518285:NF-L [Cell Component]
  1000   C2981619:NF-L [Gene or Genome]

Phrase: "neurofilament light"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0023693:Light [Natural Phenomenon or Process]
   861   C1306462:Light [Functional Concept]
   861   C1881376:Light [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.339: GFAP, glial fibrillary acidic protein; 

Phrase: "GFAP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017626:Glial fibrillar acidic protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "glial fibrillary acidic protein"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0017626:Glial Fibrillary Acidic Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1325793:glial fibrillary acidic protein [Cell Component]
  1000   C1415042:GLIAL FIBRILLARY ACIDIC PROTEIN [Gene or Genome]
   812   C0001128:Acidic [Chemical]
   812   C0027836:Glial [Cell]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   741 E C0202406:Acid [Laboratory Procedure]
   741 E C1087003:Glia [Plant]

Phrase: ";"
Processing 00000000.tx.340: TRITC, tetramethylrhodamine isothiocyanate; 

Phrase: "TRITC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076308:TRITC [Organic Chemical,Pharmacologic Substance]

Phrase: "tetramethylrhodamine isothiocyanate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0076308:tetramethylrhodamine isothiocyanate [Organic Chemical,Pharmacologic Substance]
   861   C0076306:tetramethylrhodamine [Organic Chemical,Pharmacologic Substance]
   861   C0124209:Isothiocyanate [Organic Chemical]
   861   C0206359:isothiocyanate [Organic Chemical]

Phrase: ";"
Processing 00000000.tx.341: DMEM, Dulbecco's modified Eagle's medium; 

Phrase: "DMEM,"

Phrase: "Dulbecco's modified Eagle's medium"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0009458:Medium [Intellectual Product]
   812   C0325564:Eagle [Bird]
   812   C0392747:Modified [Functional Concept]
   812   C0439536:Medium [Quantitative Concept]
   812   C1551720:Eagle [Population Group]
   812   C1705217:Medium [Substance]
   812   C3244283:medium [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.342: PBS, phosphate-buffered saline; 

Phrase: "PBS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720830:PBS [Disease or Syndrome]
  1000   C1823521:PBS [Gene or Genome]

Phrase: "phosphate-buffered saline"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.343: BSA, bovine serum albumin; 

Phrase: "BSA,"

Phrase: "bovine serum albumin"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   901   C0728877:serum albumin [Laboratory or Test Result]
   827   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0007452:Bovine [Mammal]
   827   C0229671:Serum [Body Substance]
   827   C1140701:bovine [Mammal]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]

Phrase: ";"
Processing 00000000.tx.344: DAPI, 4',6-diamidino-2-phenylindole; 

Phrase: "DAPI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0057142:DAPI [Organic Chemical,Pharmacologic Substance]

Phrase: "4',"

Phrase: "6-diamidino-2-phenylindole"

Phrase: ";"
Processing 00000000.tx.345: RT-PCR, reverse transcription-PCR; 

Phrase: "RT-PCR,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0599161:RT-PCR [Molecular Biology Research Technique]
   861   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0677874:pCR [Finding]

Phrase: "reverse transcription-PCR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0677874:pCR [Finding]
   734   C0035380:Reverse Transcription [Genetic Function]

Phrase: ";"
Processing 00000000.tx.346: DDRT-PCR, differential display RT-PCR; 

Phrase: "DDRT-PCR,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0599161:RT-PCR [Molecular Biology Research Technique]
   812   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   812   C0677874:pCR [Finding]

Phrase: "differential display RT-PCR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0599161:RT-PCR [Molecular Biology Research Technique]
   812   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   812   C0677874:pCR [Finding]

Phrase: ";"
Processing 00000000.tx.347: BIM, bisindolylmaleimide; 

Phrase: "BIM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0256431:bis(indolyl)maleimide [Organic Chemical,Pharmacologic Substance]

Phrase: "bisindolylmaleimide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0256431:bis(indolyl)maleimide [Organic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.348: MAP, mitogen-activated protein; 

Phrase: "MAP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0024779:Map [Manufactured Object]
  1000   C1706473:Map [Conceptual Entity]

Phrase: "mitogen-activated protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.349: ERK, extracellular signal-regulated kinase; 

Phrase: "ERK,"

Phrase: "extracellular signal-regulated kinase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   979   C0600388:Extracellular Signal Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   979   C0752312:Extracellular Signal-Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0521119:Extracellular [Cell Component]
   812   C0851285:Regulated [Governmental or Regulatory Activity]
   812   C1710082:Signal [Phenomenon or Process]

Phrase: ";"
Processing 00000000.tx.350: MEK, MAPK/ERK kinase; 

Phrase: "MEK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0752313:mek [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "MAPK/ERK kinase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   972   C0752313:MAPK-ERK Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   871   C0169101:MAPK Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ";"
Processing 00000000.tx.351: PKC, protein kinase C.  

Phrase: "PKC,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   913   C1168438:Protein C [Laboratory Procedure]
   913   C1418943:PROTEIN C [Gene or Genome]
   913   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "protein kinase C."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   734   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.352: REFERENCES TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES 1. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.353: Schmidt, A. 

Phrase: "Schmidt,"

Phrase: "A."
Processing 00000000.tx.354: M., Vianna, M., Gerlach, M., Brett, Ryan, J., Kao, J., Esposito, C., Hegarty, H., Hurley, W., and Clauss, M. 

Phrase: "M."

Phrase: ","

Phrase: "Vianna,"

Phrase: "M."

Phrase: ","

Phrase: "Gerlach,"

Phrase: "M."

Phrase: ","

Phrase: "Brett,"

Phrase: "Ryan,"

Phrase: "J.,"

Phrase: "Kao,"

Phrase: "J.,"

Phrase: "Esposito,"

Phrase: "C.,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "Hegarty,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Hurley,"

Phrase: "W.,"

Phrase: "and"

Phrase: "Clauss,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.355: (1992) J. 

Phrase: "(1992"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.356: Biol. 

Phrase: "Biol."
Processing 00000000.tx.357: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.358: 267, 14987-14997[Abstract/Free FullText] 2. 

Phrase: "267,"

Phrase: "14987-14997"

Phrase: "[Abstract/Free FullText"

Phrase: "] 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.359: Rauvala, H., Huttunen, H. 

Phrase: "Rauvala,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Huttunen,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.360: J., Fages, C., Kaksonen, M., Kinnunen, T., Imai, S., Raulo, E., and Kilpelainen, I. 

Phrase: "J.,"

Phrase: "Fages,"

Phrase: "C.,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "Kaksonen,"

Phrase: "M."

Phrase: ","

Phrase: "Kinnunen,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Imai,"

Phrase: "S."

Phrase: ","

Phrase: "Raulo,"

Phrase: "E.,"

Phrase: "and"

Phrase: "Kilpelainen,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.361: (2000) Matrix Biol. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Matrix Biol."
Processing 00000000.tx.362: 19, 377-387[CrossRef][Medline] [OrderarticleviaInfotrieve] 3. 

Phrase: "19,"

Phrase: "377-387"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.363: Schmidt, A. 

Phrase: "Schmidt,"

Phrase: "A."
Processing 00000000.tx.364: M., Yan, S. 

Phrase: "M."

Phrase: ","

Phrase: "Yan,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.365: D., Yan, S. 

Phrase: "D."

Phrase: ","

Phrase: "Yan,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.366: F., and Stern, D. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Stern,"

Phrase: "D."
Processing 00000000.tx.367: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.368: (2000) Biochim. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Biochim."
Processing 00000000.tx.369: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.370: Acta 1498, 99-111[Medline] [OrderarticleviaInfotrieve] 4. 

Phrase: "Acta 1498,"

Phrase: "99-111"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 4."
Processing 00000000.tx.371: Schmidt, A. 

Phrase: "Schmidt,"

Phrase: "A."
Processing 00000000.tx.372: M., Yan, S. 

Phrase: "M."

Phrase: ","

Phrase: "Yan,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.373: D., Yan, S. 

Phrase: "D."

Phrase: ","

Phrase: "Yan,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.374: F., and Stern, D. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Stern,"

Phrase: "D."
Processing 00000000.tx.375: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.376: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.377: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.378: Invest. 

Phrase: "Invest."
Processing 00000000.tx.379: 108, 949-955[Free FullText] 5. 

Phrase: "108,"

Phrase: "949-955"

Phrase: "[Free FullText"

Phrase: "] 5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.380: Lander, H. 

Phrase: "Lander,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.381: M., Tauras, J. 

Phrase: "M."

Phrase: ","

Phrase: "Tauras,"

Phrase: "J."
Processing 00000000.tx.382: M., Ogiste, J. 

Phrase: "M."

Phrase: ","

Phrase: "Ogiste,"

Phrase: "J."
Processing 00000000.tx.383: S., Hori, O., Moss, R. 

Phrase: "S."

Phrase: ","

Phrase: "Hori,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Moss,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282635:Moss [Plant]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.384: A., and Schmidt, A. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Schmidt,"

Phrase: "A."
Processing 00000000.tx.385: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.386: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.387: Biol. 

Phrase: "Biol."
Processing 00000000.tx.388: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.389: 272, 17810-17814[Abstract/Free FullText] 6. 

Phrase: "272,"

Phrase: "17810-17814"

Phrase: "[Abstract/Free FullText"

Phrase: "] 6."
Processing 00000000.tx.390: Huttunen, H. 

Phrase: "Huttunen,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.391: J., Fages, C., and Rauvala, H. 

Phrase: "J.,"

Phrase: "Fages,"

Phrase: "C.,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "Rauvala,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.392: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.393: Biol. 

Phrase: "Biol."
Processing 00000000.tx.394: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.395: 274, 19919-19924[Abstract/Free FullText] 7. 

Phrase: "274,"

Phrase: "19919-19924"

Phrase: "[Abstract/Free FullText"

Phrase: "] 7."
Processing 00000000.tx.396: Taguchi, A., Blood, D. 

Phrase: "Taguchi,"

Phrase: "A.,"

Phrase: "Blood,"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]

Phrase: "D."
Processing 00000000.tx.397: C., Del Toro, G., Canet, A., Lee, D. 

Phrase: "C.,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "Del Toro,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Canet,"

Phrase: "A.,"

Phrase: "Lee,"

Phrase: "D."
Processing 00000000.tx.398: C., Qu, W., Tanji, N., Lu, Y., Lalla, E., Fu, C., Hofmann, M. 

Phrase: "C.,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "Qu,"

Phrase: "W.,"

Phrase: "Tanji,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Lu,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024171:LU [Body System]
  1000   C0024176:LU [Geographic Area]
  1000   C2697939:LU [Quantitative Concept]

Phrase: "Y.,"

Phrase: "Lalla,"

Phrase: "E.,"

Phrase: "Fu,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0016360:FU [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
  1000   C1424823:FU [Gene or Genome]

Phrase: "C.,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "Hofmann,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.399: A., Kislinger, T., Ingram, M., Lu, A., Tanaka, H., Hori, O., Ogawa, S., Stern, D. 

Phrase: "A.,"

Phrase: "Kislinger,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Ingram,"

Phrase: "M."

Phrase: ","

Phrase: "Lu,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024171:LU [Body System]
  1000   C0024176:LU [Geographic Area]
  1000   C2697939:LU [Quantitative Concept]

Phrase: "A.,"

Phrase: "Tanaka,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Hori,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Ogawa,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443037:Ogawa [Intellectual Product]

Phrase: "S."

Phrase: ","

Phrase: "Stern,"

Phrase: "D."
Processing 00000000.tx.400: M., and Schmidt, A. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Schmidt,"

Phrase: "A."
Processing 00000000.tx.401: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.402: (2000) Nature 405, 354-360[CrossRef][Medline] [OrderarticleviaInfotrieve] 8. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Nature 405,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "354-360"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 8."
Processing 00000000.tx.403: Yan, S. 

Phrase: "Yan,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.404: D., Schmidt, A. 

Phrase: "D."

Phrase: ","

Phrase: "Schmidt,"

Phrase: "A."
Processing 00000000.tx.405: M., Anderson, G. 

Phrase: "M."

Phrase: ","

Phrase: "Anderson,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.406: M., Zhang, J., Brett, J., Zou, Y. 

Phrase: "M."

Phrase: ","

Phrase: "Zhang,"

Phrase: "J.,"

Phrase: "Brett,"

Phrase: "J.,"

Phrase: "Zou,"

Phrase: "Y."
Processing 00000000.tx.407: S., Pinsky, D., and Stern, D. 

Phrase: "S."

Phrase: ","

Phrase: "Pinsky,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Stern,"

Phrase: "D."
Processing 00000000.tx.408: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.409: Biol. 

Phrase: "Biol."
Processing 00000000.tx.410: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.411: 269, 9889-9897[Abstract/Free FullText] 9. 

Phrase: "269,"

Phrase: "9889-9897"

Phrase: "[Abstract/Free FullText"

Phrase: "] 9."
Processing 00000000.tx.412: Li, J. 

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "J."
Processing 00000000.tx.413: F., Qu, X.Q., and Schmidt, A. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Qu,"

Phrase: "X."

Phrase: "Q.,"

Phrase: "and"

Phrase: "Schmidt,"

Phrase: "A."
Processing 00000000.tx.414: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.415: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.416: Biol. 

Phrase: "Biol."
Processing 00000000.tx.417: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.418: 273, 30870-30878[Abstract/Free FullText] 10. 

Phrase: "273,"

Phrase: "30870-30878"

Phrase: "[Abstract/Free FullText"

Phrase: "] 10."
Processing 00000000.tx.419: Schmidt, A. 

Phrase: "Schmidt,"

Phrase: "A."
Processing 00000000.tx.420: M., Hasu, M., Popov, D., Zhang, J. 

Phrase: "M."

Phrase: ","

Phrase: "Hasu,"

Phrase: "M."

Phrase: ","

Phrase: "Popov,"

Phrase: "D."

Phrase: ","

Phrase: "Zhang,"

Phrase: "J."
Processing 00000000.tx.421: H., Chen, J., Yan, S. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "J.,"

Phrase: "Yan,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.422: D., Brett, J., Cao, R., Kuwabara, K., and Costache, G. 

Phrase: "D."

Phrase: ","

Phrase: "Brett,"

Phrase: "J.,"

Phrase: "Cao,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Kuwabara,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Costache,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.423: (1994) Proc. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.424: Natl. 

Phrase: "Natl."
Processing 00000000.tx.425: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.426: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.427: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.428: 91, 8807-8811[Abstract] 11. 

Phrase: "91,"

Phrase: "8807-8811"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 11."
Processing 00000000.tx.429: Schmidt, A. 

Phrase: "Schmidt,"

Phrase: "A."
Processing 00000000.tx.430: M., Hori, O., Chen, J. 

Phrase: "M."

Phrase: ","

Phrase: "Hori,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "J."
Processing 00000000.tx.431: X., Li, J.F., Crandall, J., Zhang, J., Cao, R., Yan, SD, Brett, J., and Stern, D. 

Phrase: "X.,"

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "J.F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Crandall,"

Phrase: "J.,"

Phrase: "Zhang,"

Phrase: "J.,"

Phrase: "Cao,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Yan,"

Phrase: "SD,"

Phrase: "Brett,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Stern,"

Phrase: "D."
Processing 00000000.tx.432: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.433: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.434: Invest. 

Phrase: "Invest."
Processing 00000000.tx.435: 96, 1395-1403[Medline] [OrderarticleviaInfotrieve] 12. 

Phrase: "96,"

Phrase: "1395-1403"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 12."
Processing 00000000.tx.436: Yan, S. 

Phrase: "Yan,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.437: D., Zhu, H., Fu, J., Yan, S. 

Phrase: "D."

Phrase: ","

Phrase: "Zhu,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Fu,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0016360:FU [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
  1000   C1424823:FU [Gene or Genome]

Phrase: "J.,"

Phrase: "Yan,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.438: F., Roher, A., Tourtellotte, W. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Roher,"

Phrase: "A.,"

Phrase: "Tourtellotte,"

Phrase: "W."
Processing 00000000.tx.439: W., Rajavashisth, Chen, X., Godman, G. 

Phrase: "W., Rajavashisth,"

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "X.,"

Phrase: "Godman,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.440: C., Stern, D., and Schmidt, A. 

Phrase: "C.,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "Stern,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Schmidt,"

Phrase: "A."
Processing 00000000.tx.441: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.442: (1997) Proc. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.443: Natl. 

Phrase: "Natl."
Processing 00000000.tx.444: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.445: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.446: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.447: 94, 5296-5301[Abstract/Free FullText] 13. 

Phrase: "94,"

Phrase: "5296-5301"

Phrase: "[Abstract/Free FullText"

Phrase: "] 13."
Processing 00000000.tx.448: Bierhaus, A., Illmer, T., Kasper, M., Luther, T., Quehenberger, P., Tritschler, H., Wahl, P., Ziegler, R., Muller, M., and Nawroth, P. 

Phrase: "Bierhaus,"

Phrase: "A.,"

Phrase: "Illmer,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Kasper,"

Phrase: "M."

Phrase: ","

Phrase: "Luther,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Quehenberger,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Tritschler,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Wahl,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Ziegler,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Muller,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Nawroth,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.449: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.450: (1997) Circulation 96, 2262-2271[Abstract/Free FullText] 14. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Circulation 96,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0005775:Circulation [Physiologic Function]
   861   C1516559:Circulation [Organism Function]

Phrase: "2262-2271"

Phrase: "[Abstract/Free FullText"

Phrase: "] 14."
Processing 00000000.tx.451: Huttunen, H. 

Phrase: "Huttunen,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.452: J., Kuja-Panula, J., Sorci, G., Agneletti, A. 

Phrase: "J.,"

Phrase: "Kuja-Panula,"

Phrase: "J.,"

Phrase: "Sorci,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Agneletti,"

Phrase: "A."
Processing 00000000.tx.453: L., Donato, R., and Rauvala, H. 

Phrase: "L., Donato,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Rauvala,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.454: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.455: Biol. 

Phrase: "Biol."
Processing 00000000.tx.456: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.457: 275, 40096-40105[Abstract/Free FullText] 15. 

Phrase: "275,"

Phrase: "40096-40105"

Phrase: "[Abstract/Free FullText"

Phrase: "] 15."
Processing 00000000.tx.458: Hori, O., Brett, J., Slattery, T., Cao, R., Zhang, J., Chen, J. 

Phrase: "Hori,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Brett,"

Phrase: "J.,"

Phrase: "Slattery,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Cao,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Zhang,"

Phrase: "J.,"

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "J."
Processing 00000000.tx.459: X., Nagashima, M., Lundh, E. 

Phrase: "X.,"

Phrase: "Nagashima,"

Phrase: "M."

Phrase: ","

Phrase: "Lundh,"

Phrase: "E."
Processing 00000000.tx.460: R., Vijay, S., Nitecki, D., Morser, J., Stern, D., and Schmidt, A. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Vijay,"

Phrase: "S."

Phrase: ","

Phrase: "Nitecki,"

Phrase: "D."

Phrase: ","

Phrase: "Morser,"

Phrase: "J.,"

Phrase: "Stern,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Schmidt,"

Phrase: "A."
Processing 00000000.tx.461: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.462: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.463: Biol. 

Phrase: "Biol."
Processing 00000000.tx.464: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.465: 270, 25752-25761[Abstract/Free FullText] 16. 

Phrase: "270,"

Phrase: "25752-25761"

Phrase: "[Abstract/Free FullText"

Phrase: "] 16."
Processing 00000000.tx.466: Hofmann, M. 

Phrase: "Hofmann,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.467: A., Drury, S., Fu, C., Qu, W., Taguchi, A., Lu, Y., Avila, C., Kambham, N., Bierhaus, A., Nawroth, P., Neurath, M. 

Phrase: "A.,"

Phrase: "Drury,"

Phrase: "S."

Phrase: ","

Phrase: "Fu,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0016360:FU [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
  1000   C1424823:FU [Gene or Genome]

Phrase: "C.,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "Qu,"

Phrase: "W.,"

Phrase: "Taguchi,"

Phrase: "A.,"

Phrase: "Lu,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024171:LU [Body System]
  1000   C0024176:LU [Geographic Area]
  1000   C2697939:LU [Quantitative Concept]

Phrase: "Y.,"

Phrase: "Avila,"

Phrase: "C.,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "Kambham,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Bierhaus,"

Phrase: "A.,"

Phrase: "Nawroth,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Neurath,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.468: F., Slattery, T., Beach, D., McClary, J., Nagashima, M., Morser, J., Stern, D., and Schmidt, A. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Slattery,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Beach,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331781:Beach [Geographic Area]

Phrase: "D."

Phrase: ","

Phrase: "McClary,"

Phrase: "J.,"

Phrase: "Nagashima,"

Phrase: "M."

Phrase: ","

Phrase: "Morser,"

Phrase: "J.,"

Phrase: "Stern,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Schmidt,"

Phrase: "A."
Processing 00000000.tx.469: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.470: (1999) Cell 97, 889-901[Medline] [OrderarticleviaInfotrieve] 17. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Cell 97,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0007634:Cell [Cell]
   861   C0439073:97 [Intellectual Product]
   861   C0439082:>97 [Quantitative Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "889-901"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 17."
Processing 00000000.tx.471: Rauvala, H., and Pihlaskari, R. 

Phrase: "Rauvala,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Pihlaskari,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.472: (1987) J. 

Phrase: "(1987"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.473: Biol. 

Phrase: "Biol."
Processing 00000000.tx.474: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.475: 262, 16625-16635[Abstract/Free FullText] 18. 

Phrase: "262,"

Phrase: "16625-16635"

Phrase: "[Abstract/Free FullText"

Phrase: "] 18."
Processing 00000000.tx.476: Rauvala, H., Merenmies, J., Pihlaskari, R., Korkolainen, M., Huhtala, M. 

Phrase: "Rauvala,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Merenmies,"

Phrase: "J.,"

Phrase: "Pihlaskari,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Korkolainen,"

Phrase: "M."

Phrase: ","

Phrase: "Huhtala,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.477: L., and Panula, P. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Panula,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.478: (1988) J. 

Phrase: "(1988"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.479: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.480: 107, 2293-2305[Abstract] 19. 

Phrase: "107,"

Phrase: "2293-2305"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 19."
Processing 00000000.tx.481: Merenmies, J., Pihlaskari, R., Laitinen, J., Wartiovaara, J., and Rauvala, H. 

Phrase: "Merenmies,"

Phrase: "J.,"

Phrase: "Pihlaskari,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Laitinen,"

Phrase: "J.,"

Phrase: "Wartiovaara,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Rauvala,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.482: (1991) J. 

Phrase: "(1991"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.483: Biol. 

Phrase: "Biol."
Processing 00000000.tx.484: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.485: 266, 16722-16729[Abstract/Free FullText] 20. 

Phrase: "266,"

Phrase: "16722-16729"

Phrase: "[Abstract/Free FullText"

Phrase: "] 20."
Processing 00000000.tx.486: Donato, R. 

Phrase: "Donato,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.487: (1999) Biochim. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Biochim."
Processing 00000000.tx.488: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.489: Acta 1450, 191-231[Medline] [OrderarticleviaInfotrieve] 21. 

Phrase: "Acta 1450,"

Phrase: "191-231"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 21."
Processing 00000000.tx.490: Huttner, W. 

Phrase: "Huttner,"

Phrase: "W."
Processing 00000000.tx.491: B., Gerdes, H. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Gerdes,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.492: H., and Rosa, P. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Rosa,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035853:Rosa [Plant]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.493: (1991) Trends Biochem. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Biochem."
Processing 00000000.tx.494: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.495: 16, 27-30[CrossRef][Medline] [OrderarticleviaInfotrieve] 22. 

Phrase: "16,"

Phrase: "27-30"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 22."
Processing 00000000.tx.496: Winkler, H., and Fischer-Colbrie, R. 

Phrase: "Winkler,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Fischer-Colbrie,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.497: (1992) Neuroscience 49, 497-528[CrossRef][Medline] [OrderarticleviaInfotrieve] 23. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Neuroscience 49,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0027910:Neuroscience [Biomedical Occupation or Discipline]
   861   C1552241:Neuroscience [Professional or Occupational Group]
   861   C1555991:Neuroscience [Professional or Occupational Group]

Phrase: "497-528"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 23."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]
Processing 00000000.tx.498: Ozawa, H., and Takata, K. 

Phrase: "Ozawa,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Takata,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.499: (1995) Cell Struct. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Cell Struct."
Processing 00000000.tx.500: Funct. 

Phrase: "Funct."
Processing 00000000.tx.501: 20, 415-420[Medline] [OrderarticleviaInfotrieve] 24. 

Phrase: "20,"

Phrase: "415-420"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 24."
Processing 00000000.tx.502: Parkkinen, J., Raulo, E., Merenmies, J., Nolo, R., Kajander, E. 

Phrase: "Parkkinen,"

Phrase: "J.,"

Phrase: "Raulo,"

Phrase: "E.,"

Phrase: "Merenmies,"

Phrase: "J.,"

Phrase: "Nolo,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Kajander,"

Phrase: "E."
Processing 00000000.tx.503: O., Baumann, M., and Rauvala, H. 

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Baumann,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Rauvala,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.504: (1993) J. 

Phrase: "(1993"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.505: Biol. 

Phrase: "Biol."
Processing 00000000.tx.506: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.507: 268, 19726-19738[Abstract/Free FullText] 25. 

Phrase: "268,"

Phrase: "19726-19738"

Phrase: "[Abstract/Free FullText"

Phrase: "] 25."
Processing 00000000.tx.508: Bauer, D., Muller, H., Reich, J., Riedel, H., Ahrenkiel, V., Warthoe, P., and Strauss, M. 

Phrase: "Bauer,"

Phrase: "D."

Phrase: ","

Phrase: "Muller,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Reich,"

Phrase: "J.,"

Phrase: "Riedel,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Ahrenkiel,"

Phrase: "V.,"

Phrase: "Warthoe,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Strauss,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.509: (1993) Nucleic Acids Res. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Nucleic Acids Res."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2347379:RES [Finding]
   734   C0028606:Nucleic Acids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.510: 21, 4272-4280[Abstract] 26. 

Phrase: "21,"

Phrase: "4272-4280"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 26."
Processing 00000000.tx.511: Fages, C., Nolo, R., Huttunen, H. 

Phrase: "Fages,"

Phrase: "C.,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "Nolo,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Huttunen,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.512: J., Eskelinen, E., and Rauvala, H. 

Phrase: "J.,"

Phrase: "Eskelinen,"

Phrase: "E.,"

Phrase: "and"

Phrase: "Rauvala,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.513: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.514: Cell Sci. 

Phrase: "Cell Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.515: 113, 611-620[Abstract/Free FullText] 27. 

Phrase: "113,"

Phrase: "611-620"

Phrase: "[Abstract/Free FullText"

Phrase: "] 27."
Processing 00000000.tx.516: Zhai, R. 

Phrase: "Zhai,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.517: G., Vardinon-Friedman, H., Cases-Langhoff, C., Becker, B., Gundelfinger, E. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Vardinon-Friedman,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Cases-Langhoff,"

Phrase: "C.,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "Becker,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Gundelfinger,"

Phrase: "E."
Processing 00000000.tx.518: D., Ziv, N. 

Phrase: "D."

Phrase: ","

Phrase: "Ziv,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.519: E., and Garner, C. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Garner,"

Phrase: "C."
Processing 00000000.tx.520: C. 

Phrase: "C."
Processing 00000000.tx.521: (2001) Neuron 29, 131-143[Medline] [OrderarticleviaInfotrieve] 28. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Neuron 29,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "131-143"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 28."
Processing 00000000.tx.522: Jungling, S., Cibelli, G., Czardybon, M., Gerdes, H. 

Phrase: "Jungling,"

Phrase: "S."

Phrase: ","

Phrase: "Cibelli,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Czardybon,"

Phrase: "M."

Phrase: ","

Phrase: "Gerdes,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.523: H., and Thiel, G. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Thiel,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.524: (1994) Eur. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Eur."
Processing 00000000.tx.525: J.

Phrase: "J."
Processing 00000000.tx.526: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.527: 226, 925-935[Abstract] 29. 

Phrase: "226,"

Phrase: "925-935"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 29."
Processing 00000000.tx.528: Wu, H., Mahata, S. 

Phrase: "Wu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1431628:wu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Mahata,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.529: K., Mahata, M., Webster, N. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Mahata,"

Phrase: "M."

Phrase: ","

Phrase: "Webster,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.530: J., Parmer, R. 

Phrase: "J.,"

Phrase: "Parmer,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.531: J., and O'Connor, D. 

Phrase: "J.,"

Phrase: "and"

Phrase: "O'Connor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439114:O NOS [Intellectual Product]

Phrase: "D."
Processing 00000000.tx.532: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.533: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.534: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.535: Invest. 

Phrase: "Invest."
Processing 00000000.tx.536: 96, 568-578[Medline] [OrderarticleviaInfotrieve] 30. 

Phrase: "96,"

Phrase: "568-578"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 30."
Processing 00000000.tx.537: Scammell, J. 

Phrase: "Scammell,"

Phrase: "J."
Processing 00000000.tx.538: G., Reddy, S., Valentine, D. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Reddy,"

Phrase: "S."

Phrase: ","

Phrase: "Valentine,"

Phrase: "D."
Processing 00000000.tx.539: L., Coker, T. 

Phrase: "L., Coker,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.540: N., Nikolopoulos, S. 

Phrase: "N., Nikolopoulos,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.541: N., and Ross, R. 

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Ross,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0331968:Ross [Health Care Related Organization]
  1000   C2699100:Ross [Bird]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.542: A. 

Phrase: "A."
Processing 00000000.tx.543: (2000) Brain Res. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.544: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.545: Brain Res. 

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.546: 75, 8-15[Medline] [OrderarticleviaInfotrieve] 31. 

Phrase: "75,"

Phrase: "8-15"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 31."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]
Processing 00000000.tx.547: Tang, K., Wu, H., Mahata, S. 

Phrase: "Tang,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Wu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1431628:wu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Mahata,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.548: K., and O'Connor, D. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "O'Connor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439114:O NOS [Intellectual Product]

Phrase: "D."
Processing 00000000.tx.549: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.550: (1998) Mol. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.551: Pharmacol. 

Phrase: "Pharmacol."
Processing 00000000.tx.552: 54, 59-69[Abstract/Free FullText] 32. 

Phrase: "54,"

Phrase: "59-69"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450388:69 [Intellectual Product]

Phrase: "[Abstract/Free FullText"

Phrase: "] 32."
Processing 00000000.tx.553: Mahata, S. 

Phrase: "Mahata,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.554: K., Mahata, M., Wu, H., Parmer, R. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Mahata,"

Phrase: "M."

Phrase: ","

Phrase: "Wu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1431628:wu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Parmer,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.555: J., and O'Connor, D. 

Phrase: "J.,"

Phrase: "and"

Phrase: "O'Connor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439114:O NOS [Intellectual Product]

Phrase: "D."
Processing 00000000.tx.556: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.557: (1999) Neuroscience 88, 405-424[CrossRef][Medline] [OrderarticleviaInfotrieve] 33. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Neuroscience 88,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0027910:Neuroscience [Biomedical Occupation or Discipline]
   861   C1552241:Neuroscience [Professional or Occupational Group]
   861   C1555991:Neuroscience [Professional or Occupational Group]

Phrase: "405-424"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 33."
Processing 00000000.tx.558: Swanson, K. 

Phrase: "Swanson,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.559: D., Taylor, L. 

Phrase: "D."

Phrase: ","

Phrase: "Taylor,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.560: K., Haung, L., Burlingame, A. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Haung,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Burlingame,"

Phrase: "A."
Processing 00000000.tx.561: L., and Landreth, G. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Landreth,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.562: E. 

Phrase: "E."
Processing 00000000.tx.563: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.564: Biol. 

Phrase: "Biol."
Processing 00000000.tx.565: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.566: 274, 3385-3395[Abstract/Free FullText] 34. 

Phrase: "274,"

Phrase: "3385-3395"

Phrase: "[Abstract/Free FullText"

Phrase: "] 34."
Processing 00000000.tx.567: Shaywitz, A. 

Phrase: "Shaywitz,"

Phrase: "A."
Processing 00000000.tx.568: J., and Greenberg, M. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Greenberg,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.569: E. 

Phrase: "E."
Processing 00000000.tx.570: (1999) Annu. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Annu."
Processing 00000000.tx.571: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.572: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.573: 68, 821-861[CrossRef][Medline] [OrderarticleviaInfotrieve] 35. 

Phrase: "68,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450387:68 [Intellectual Product]

Phrase: "821-861"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 35."
Processing 00000000.tx.574: Tropepe, V., Hitoshi, S., Sirard, C., Mak, T. 

Phrase: "Tropepe,"

Phrase: "V.,"

Phrase: "Hitoshi,"

Phrase: "S."

Phrase: ","

Phrase: "Sirard,"

Phrase: "C.,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "Mak,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416988:MAK [Gene or Genome]
  1000   C1538267:MAK [Gene or Genome]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.575: W., Rossant, J., and van der Kooy, D. 

Phrase: "W., Rossant,"

Phrase: "J.,"

Phrase: "and"

Phrase: "van der Kooy,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557775:Van [Manufactured Object]
   827   C1511780:der [Cell or Molecular Dysfunction]

Phrase: "D."
Processing 00000000.tx.576: (2001) Neuron 30, 65-78[CrossRef][Medline] [OrderarticleviaInfotrieve] 36. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Neuron 30,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "65-78"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450385:65 [Intellectual Product]

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 36."
Processing 00000000.tx.577: Ferreira, A., and Caceres, A. 

Phrase: "Ferreira,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Caceres,"

Phrase: "A."
Processing 00000000.tx.578: (1992) J. 

Phrase: "(1992"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.579: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.580: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.581: 32, 516-529[Medline] [OrderarticleviaInfotrieve] 37. 

Phrase: "32,"

Phrase: "516-529"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 37."
Processing 00000000.tx.582: Sajithlal, G., Huttunen, H., Rauvala, H., and Munch, G. 

Phrase: "Sajithlal,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Huttunen,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Rauvala,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Munch"

Phrase: ","

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.583: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.584: Biol. 

Phrase: "Biol."
Processing 00000000.tx.585: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.586: 277, 6888-6897[Abstract/Free FullText] 38. 

Phrase: "277,"

Phrase: "6888-6897"

Phrase: "[Abstract/Free FullText"

Phrase: "] 38."
Processing 00000000.tx.587: Fischer-Colbrie, R., Laslop, A., and Kirchmair, R. 

Phrase: "Fischer-Colbrie,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Laslop,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Kirchmair,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.588: (1995) Prog. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Prog."
Processing 00000000.tx.589: Neurobiol. 

Phrase: "Neurobiol."
Processing 00000000.tx.590: 46, 49-70[CrossRef][Medline] [OrderarticleviaInfotrieve] 39. 

Phrase: "46,"

Phrase: "49-70"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 39."
Processing 00000000.tx.591: Shen, P. 

Phrase: "Shen,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.592: J., and Gundlach, A. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Gundlach,"

Phrase: "A."
Processing 00000000.tx.593: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.594: (1996) Eur. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Eur."
Processing 00000000.tx.595: J.

Phrase: "J."
Processing 00000000.tx.596: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.597: 8, 988-1000[Medline] [OrderarticleviaInfotrieve] 40. 

Phrase: "8,"

Phrase: "988-1000"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 40."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]
Processing 00000000.tx.598: Giudici, A. 

Phrase: "Giudici,"

Phrase: "A."
Processing 00000000.tx.599: M., Sher, E., Pelagi, M., Clementi, F., and Zanini, A. 

Phrase: "M."

Phrase: ","

Phrase: "Sher,"

Phrase: "E.,"

Phrase: "Pelagi,"

Phrase: "M."

Phrase: ","

Phrase: "Clementi,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Zanini,"

Phrase: "A."
Processing 00000000.tx.600: (1992) Eur. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Eur."
Processing 00000000.tx.601: J.

Phrase: "J."
Processing 00000000.tx.602: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.603: 58, 383-389[Medline] [OrderarticleviaInfotrieve] 41. 

Phrase: "58,"

Phrase: "383-389"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 41."
Processing 00000000.tx.604: Weiss, C., Winkler, H., and Laslop, A. 

Phrase: "Weiss,"

Phrase: "C.,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "Winkler,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Laslop,"

Phrase: "A."
Processing 00000000.tx.605: (2001) Neurochem. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Neurochem."
Processing 00000000.tx.606: Int. 

Phrase: "Int."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063789:INT [Organic Chemical]
  1000   C3272375:INT [Intellectual Product]
Processing 00000000.tx.607: 38, 43-52[CrossRef][Medline] [OrderarticleviaInfotrieve] 42. 

Phrase: "38,"

Phrase: "43-52"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 42."
Processing 00000000.tx.608: Huang, C. 

Phrase: "Huang,"

Phrase: "C."
Processing 00000000.tx.609: M., Shui, H. 

Phrase: "M."

Phrase: ","

Phrase: "Shui,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.610: A., Wu, Y.T., Chu, P. 

Phrase: "A.,"

Phrase: "Wu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1431628:wu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Y.T.,"

Phrase: "Chu,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.611: W., Lin, K. 

Phrase: "W., Lin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0861352:LIN [Neoplastic Process]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.612: G., Kao, L. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Kao,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.613: S., and Chen, S. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.614: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.615: (2001) Brain Res. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.616: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.617: Brain Res. 

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.618: 92, 181-192[Medline] [OrderarticleviaInfotrieve] 43. 

Phrase: "92,"

Phrase: "181-192"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 43."
Processing 00000000.tx.619: Kim, T., Tao-Cheng, J. 

Phrase: "Kim,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Tao-Cheng,"

Phrase: "J."
Processing 00000000.tx.620: H., Eiden, L. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Eiden,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.621: E., and Loh, Y. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Loh,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0524869:LOH [Genetic Function]

Phrase: "Y."
Processing 00000000.tx.622: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.623: (2001) Cell 106, 499-509[CrossRef][Medline] [OrderarticleviaInfotrieve] 44. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Cell 106,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "499-509"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 44."
Processing 00000000.tx.624: Sparatore, B., Passalacqua, M., Patrone, M., Melloni, E., and Pontremoli, S. 

Phrase: "Sparatore,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Passalacqua,"

Phrase: "M."

Phrase: ","

Phrase: "Patrone,"

Phrase: "M."

Phrase: ","

Phrase: "Melloni,"

Phrase: "E.,"

Phrase: "and"

Phrase: "Pontremoli,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.625: (1996) Biochem. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.626: J. 

Phrase: "J."
Processing 00000000.tx.627: 320, 253-256[Medline] [OrderarticleviaInfotrieve] 45. 

Phrase: "320,"

Phrase: "253-256"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 45."
Processing 00000000.tx.628: Sparatore, B., Patrone, M., Passalacqua, M., Pedrazzi, M., Gaggero, D., Pontremoli, S., and Melloni, E. 

Phrase: "Sparatore,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Patrone,"

Phrase: "M."

Phrase: ","

Phrase: "Passalacqua,"

Phrase: "M."

Phrase: ","

Phrase: "Pedrazzi,"

Phrase: "M."

Phrase: ","

Phrase: "Gaggero,"

Phrase: "D."

Phrase: ","

Phrase: "Pontremoli,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Melloni,"

Phrase: "E."
Processing 00000000.tx.629: (2001) Biochem. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.630: J. 

Phrase: "J."
Processing 00000000.tx.631: 357, 569-574[CrossRef][Medline] [OrderarticleviaInfotrieve] 46. 

Phrase: "357,"

Phrase: "569-574"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 46."
Processing 00000000.tx.632: Oldfield, M. 

Phrase: "Oldfield,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.633: D., Bach, L. 

Phrase: "D."

Phrase: ","

Phrase: "Bach,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1825831:BACH [Gene or Genome]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.634: A., Forbes, J. 

Phrase: "A.,"

Phrase: "Forbes,"

Phrase: "J."
Processing 00000000.tx.635: M., Nikolic-Paterson, D., McRobert, A., Thallas, V., Atkins, R. 

Phrase: "M."

Phrase: ","

Phrase: "Nikolic-Paterson,"

Phrase: "D."

Phrase: ","

Phrase: "McRobert,"

Phrase: "A.,"

Phrase: "Thallas,"

Phrase: "V.,"

Phrase: "Atkins,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.636: C., Osicka, T., Jerums, G., and Cooper, M. 

Phrase: "C.,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "Osicka,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Jerums,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Cooper,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0335912:Cooper [Professional or Occupational Group]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.637: E. 

Phrase: "E."
Processing 00000000.tx.638: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.639: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.640: Invest. 

Phrase: "Invest."
Processing 00000000.tx.641: 108, 1853-1863[Abstract/Free FullText] 47. 

Phrase: "108,"

Phrase: "1853-1863"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450336:1853 [Intellectual Product]

Phrase: "[Abstract/Free FullText"

Phrase: "] 47."
Processing 00000000.tx.642: Abe, K., Chu, P. 

Phrase: "Abe,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0155685:abe [Disease or Syndrome]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Chu,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.643: J., Ishihara, A., and Saito, H. 

Phrase: "J.,"

Phrase: "Ishihara,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Saito,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.644: (1996) Brain Res. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.645: 723, 206-209[CrossRef][Medline] [OrderarticleviaInfotrieve] 48. 

Phrase: "723,"

Phrase: "206-209"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 48."
Processing 00000000.tx.646: Lamberts, S. 

Phrase: "Lamberts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1551092:Lambert [Quantitative Concept]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.647: W., Hofland, L. 

Phrase: "W., Hofland,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.648: J., and Nobels, F. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Nobels,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.649: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.650: (2001) Front. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Front."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205094:front [Spatial Concept]
   928 E C0205123:Frontal [Spatial Concept]
   907 E C0016540:Forehead [Body Location or Region]
Processing 00000000.tx.651: Neuroendocrinol. 

Phrase: "Neuroendocrinol."
Processing 00000000.tx.652: 22, 309-339[CrossRef][Medline] [OrderarticleviaInfotrieve] 49. 

Phrase: "22,"

Phrase: "309-339"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 49."
Processing 00000000.tx.653: Yasuhara, O., Kawamata, T., Aimi, Y., McGeer, E. 

Phrase: "Yasuhara,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Kawamata,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Aimi,"

Phrase: "Y.,"

Phrase: "McGeer,"

Phrase: "E."
Processing 00000000.tx.654: G., and McGeer, P. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "McGeer,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.655: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.656: (1994) Neurosci. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Neurosci."
Processing 00000000.tx.657: Lett. 

Phrase: "Lett."
Processing 00000000.tx.658: 170, 13-16[CrossRef][Medline] [OrderarticleviaInfotrieve] 50. 

Phrase: "170,"

Phrase: "13-16"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 50."
Processing 00000000.tx.659: Crain, B. 

Phrase: "Crain,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.660: J., Hu, W., Sze, C. 

Phrase: "J.,"

Phrase: "Hu,"

Phrase: "W.,"

Phrase: "Sze,"

Phrase: "C."
Processing 00000000.tx.661: I., Slunt, H. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Slunt,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.662: H., Koo, E. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Koo,"

Phrase: "E."
Processing 00000000.tx.663: H., Price, D. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "D."
Processing 00000000.tx.664: L., Thinakaran, G., and Sisodia, S. 

Phrase: "L., Thinakaran,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Sisodia,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.665: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.666: (1996) Am. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Am."
Processing 00000000.tx.667: J.Pathol. 

Phrase: "J.Pathol."
Processing 00000000.tx.668: 149, 1087-1095[Abstract] 51. 

Phrase: "149,"

Phrase: "1087-1095"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 51."
Processing 00000000.tx.669: Yan, S. 

Phrase: "Yan,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.670: D., Chen, X., Fu, J., Chen, M., Zhu, H., Roher, A., Slattery, T., Zhao, L., Nagashima, M., Morser, J., Migheli, A., Nawroth, P., Stern, D., and Schmidt, A. 

Phrase: "D."

Phrase: ","

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "X.,"

Phrase: "Fu,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0016360:FU [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
  1000   C1424823:FU [Gene or Genome]

Phrase: "J.,"

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "M."

Phrase: ","

Phrase: "Zhu,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Roher,"

Phrase: "A.,"

Phrase: "Slattery,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Zhao,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Nagashima,"

Phrase: "M."

Phrase: ","

Phrase: "Morser,"

Phrase: "J.,"

Phrase: "Migheli,"

Phrase: "A.,"

Phrase: "Nawroth,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Stern,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Schmidt,"

Phrase: "A."
Processing 00000000.tx.671: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.672: (1996) Nature 382, 685-691[CrossRef][Medline] [OrderarticleviaInfotrieve] 52. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Nature 382,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "685-691"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 52."
Processing 00000000.tx.673: Lue, L. 

Phrase: "Lue,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.674: F., Walker, D. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Walker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043016:Walker [Medical Device]

Phrase: "D."
Processing 00000000.tx.675: G., Brachova, L., Beach, T. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Brachova,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Beach,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331781:Beach [Geographic Area]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.676: G., Rogers, J., Schmidt, A. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Rogers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C3463939:Roger [Eukaryote]

Phrase: "J.,"

Phrase: "Schmidt,"

Phrase: "A."
Processing 00000000.tx.677: M., Stern, D. 

Phrase: "M."

Phrase: ","

Phrase: "Stern,"

Phrase: "D."
Processing 00000000.tx.678: M., and Yan, S. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Yan,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.679: D. 

Phrase: "D."
Processing 00000000.tx.680: (2001) Exp. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.681: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.682: 171, 29-45[CrossRef][Medline] [OrderarticleviaInfotrieve] 53. 

Phrase: "171,"

Phrase: "29-45"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 53."
Processing 00000000.tx.683: Ciesielski-Treska, J., Ulrich, G., Chasserot-Golaz, S., Zwiller, J., Revel, M. 

Phrase: "Ciesielski-Treska,"

Phrase: "J.,"

Phrase: "Ulrich,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Chasserot-Golaz,"

Phrase: "S."

Phrase: ","

Phrase: "Zwiller,"

Phrase: "J.,"

Phrase: "Revel,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.684: O., Aunis, D., and Bader, M. 

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Aunis,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Bader,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.685: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.686: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.687: Biol. 

Phrase: "Biol."
Processing 00000000.tx.688: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.689: 276, 13113-13120[Abstract/Free FullText] 54. 

Phrase: "276,"

Phrase: "13113-13120"

Phrase: "[Abstract/Free FullText"

Phrase: "] 54."
Processing 00000000.tx.690: Finkbeiner, S., Tavazoie, S. 

Phrase: "Finkbeiner,"

Phrase: "S."

Phrase: ","

Phrase: "Tavazoie,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.691: F., Maloratsky, A., Jacobs, K. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Maloratsky,"

Phrase: "A.,"

Phrase: "Jacobs,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.692: M., Harris, K. 

Phrase: "M."

Phrase: ","

Phrase: "Harris,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.693: M., and Greenberg, M. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Greenberg,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.694: E. 

Phrase: "E."
Processing 00000000.tx.695: (1997) Neuron 19, 1031-1047[Medline] [OrderarticleviaInfotrieve] 55. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Neuron 19,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "1031-1047"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 55."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]
Processing 00000000.tx.696: Xing, J., Ginty, D. 

Phrase: "Xing,"

Phrase: "J.,"

Phrase: "Ginty,"

Phrase: "D."
Processing 00000000.tx.697: D., and Greenberg, M. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Greenberg,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.698: E. 

Phrase: "E."
Processing 00000000.tx.699: (1996) Science 273, 959-963[Abstract] 56. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Science 273,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "959-963"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 56."
Processing 00000000.tx.700: Bonni, A., Brunet, A., West, A. 

Phrase: "Bonni,"

Phrase: "A.,"

Phrase: "Brunet,"

Phrase: "A.,"

Phrase: "West,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705493:West [Spatial Concept]

Phrase: "A."
Processing 00000000.tx.701: E., Datta, S. 

Phrase: "E.,"

Phrase: "Datta,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.702: R., Takasu, M. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Takasu,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.703: A., and Greenberg, M. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Greenberg,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.704: E. 

Phrase: "E."
Processing 00000000.tx.705: (1999) Science 286, 1358-1362[Abstract/Free FullText] 57. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Science 286,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "1358-1362"

Phrase: "[Abstract/Free FullText"

Phrase: "] 57."
Processing 00000000.tx.706: Walton, M. 

Phrase: "Walton,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.707: R., and Dragunow, I. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Dragunow,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.708: (2000) Trends Neurosci. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Neurosci."
Processing 00000000.tx.709: 23, 48-53[CrossRef][Medline] [OrderarticleviaInfotrieve] 58. 

Phrase: "23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "48-53"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 58."
Processing 00000000.tx.710: Riccio, A., Ahn, S., Davenport, C. 

Phrase: "Riccio,"

Phrase: "A.,"

Phrase: "Ahn,"

Phrase: "S."

Phrase: ","

Phrase: "Davenport,"

Phrase: "C."
Processing 00000000.tx.711: M., Blendy, J. 

Phrase: "M."

Phrase: ","

Phrase: "Blendy,"

Phrase: "J."
Processing 00000000.tx.712: A., and Ginty, D. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Ginty,"

Phrase: "D."
Processing 00000000.tx.713: D. 

Phrase: "D."
Processing 00000000.tx.714: (1999) Science 286, 2358-2361[Abstract/Free FullText] 59. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Science 286,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "2358-2361"

Phrase: "[Abstract/Free FullText"

Phrase: "] 59."
Processing 00000000.tx.715: Pons, S., Trejo, J. 

Phrase: "Pons,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0032639:Pons [Body Part, Organ, or Organ Component]
  1000   C1280999:Pons [Body Part, Organ, or Organ Component]
   966 E C1418754:PON [Gene or Genome]
   966 E C1709588:PON [Mammal]

Phrase: "S."

Phrase: ","

Phrase: "Trejo,"

Phrase: "J."
Processing 00000000.tx.716: L., Martinez-Morales, J. 

Phrase: "L., Martinez-Morales,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0026530:Morales [Individual Behavior]

Phrase: "J."
Processing 00000000.tx.717: R., and Marti, E. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Marti,"

Phrase: "E."
Processing 00000000.tx.718: (2001) Development 128, 1481-1492[Abstract/Free FullText] 60. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Development 128,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0243107:development [Physiologic Function]
   861   C0678723:Development [Organism Function]
   861   C1527148:Development [Functional Concept]
   789 E C0458003:Developmental [Qualitative Concept]

Phrase: "1481-1492"

Phrase: "[Abstract/Free FullText"

Phrase: "] 60."
Processing 00000000.tx.719: Lo, L., Morin, X., Brunet, J. 

Phrase: "Lo,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Morin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0066801:morin [Organic Chemical,Pharmacologic Substance]

Phrase: "X.,"

Phrase: "Brunet,"

Phrase: "J."
Processing 00000000.tx.720: F., and Anderson, D. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Anderson,"

Phrase: "D."
Processing 00000000.tx.721: J. 

Phrase: "J."
Processing 00000000.tx.722: (1999) Neuron 22, 693-705[Medline] [OrderarticleviaInfotrieve] 61. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Neuron 22,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "693-705"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 61."
Processing 00000000.tx.723: Rong, L.L., Yan, S.F., Hans-Wagner, H., Goova, M.T., Song, F., Hays, A.P., Stern, D.M., and Schmidt, A.M.(2001) Soc. 

Phrase: "Rong,"

Phrase: "L.L., Yan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C3539687:L/L [Quantitative Concept]

Phrase: "S.F.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
   861   C2603362:S' [Clinical Attribute]

Phrase: "Hans-Wagner,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Goova,"

Phrase: "M.T.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Song,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872005:Song [Intellectual Product]

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Hays,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1440666:Hay [Immunologic Factor]

Phrase: "A.P.,"

Phrase: "Stern,"

Phrase: "D."

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Schmidt,"

Phrase: "A.M.(2001"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C2346751:A/m [Quantitative Concept]
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: ")"

Phrase: "Soc."
Processing 00000000.tx.724: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.725: Abstr. 

Phrase: "Abstr."
Processing 00000000.tx.726: (Abstr. 351.4) 62. 

Phrase: "(Abstr. 351.4"

Phrase: ")"

Phrase: "62."
Processing 00000000.tx.727: Calogero, S., Grassi, F., Aguzzi, A., Voigtlander, T., Ferrier, Ferrari, S., and Bianchi, M. 

Phrase: "Calogero,"

Phrase: "S."

Phrase: ","

Phrase: "Grassi,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Aguzzi,"

Phrase: "A.,"

Phrase: "Voigtlander,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Ferrier,"

Phrase: "Ferrari,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Bianchi,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.728: E. 

Phrase: "E."
Processing 00000000.tx.729: (1999) Nat. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.730: Gen. 

Phrase: "Gen."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704351:GEN [Quantitative Concept]
  1000   C2239486:Gen [Gene or Genome]
Processing 00000000.tx.731: 22, 276-280[CrossRef][Medline] [OrderarticleviaInfotrieve] Copyright  2002 by The American Society for Biochemistry and Molecular Biology, Inc.

Phrase: "22,"

Phrase: "276-280"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Copyright  2002 by The American Society"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0009993:Copyright [Intellectual Product]
   753   C0037455:society [Organization]
   753   C0596070:American [Population Group]
   753   C1552856:copyright [Idea or Concept]

Phrase: "for Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "and"

Phrase: "Molecular Biology,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "Inc."

